New Developments and New Applications in Animal Cell Technology
This page intentionally left blank.
New Developments and New Applications in Animal Cell Technology Proceedings of the 15th ESACT Meeting
Edited by
Otto-Wilhelm Merten Pierre Perrin and
Bryan Griffiths
KLUWER ACADEMIC PUBLISHERS NEW YORK, BOSTON, DORDRECHT, LONDON, MOSCOW
eBook ISBN: Print ISBN:
0-306-46860-3 0-792-35016-2
©2002 Kluwer Academic Publishers New York, Boston, Dordrecht, London, Moscow
All rights reserved
No part of this eBook may be reproduced or transmitted in any form or by any means, electronic, mechanical, recording, or otherwise, without written consent from the Publisher
Created in the United States of America
Visit Kluwer Online at: and Kluwer's eBookstore at:
http://www.kluweronline.com http://www.ebooks.kluweronline.com
ORGANIZING COMMITTEE: Otto-Wilhelm Merten (Meeting Secretary) Wolfgang Noé (Sponsoring, Trading)
Georgia Barlovatz-Meimon
Andres Crespo, Génopoïétic Jean-Marc Engasser Fabrice Geoffroy Jean-Marc Guillaume Jan Lupker
Annie Marc Pierre Perrin
v
SPONSORS: The Organizing Committee acknowledges the financial support to :
Companies: Bayer B. Braun Biotech International Biolnvent Production AB Boehringer Ingelheim Bioproducts Boehringer Mannheim Covance Laboratories Ltd. Dr. Karl Thomae GmbH Genzyme Transgenics Corp. Hoffmann-La Roche Inc. Hyclone Europe Intervent International bv JRH Biosciences Laboratoires Serono SA Life Technologies MA BioServices Merck KG Merck Sharp & Dohme MicroSafe B.V. Nature-MacMillan Magazines Novo Nordisk Nunc A/S Pharmacia Biotech AB Promega Q-One Biotech Ltd. Sanofi Recherche Schering AG SmithKline Beecham Biologicals Institutions: City of Tours European Commission - DGXII - Biology
vi
ESACT Executive Committee, 1996-1997 C. MacDonald
Chairperson
University of Paisley, Paisley, U.K.
L. Fabry
Secretary
Smith Kline Beecham, Rixensart, B
B. Griffiths
Treasurer
CAMR, Porton, U.K.
O.-W. Merten
Meeting Secretary
Généthon II, Evry, F
M. Carrondo
IBET/CTQB, Oeiras, P
H. Hauser
GBF, Braunschweig, D
J. Lehmann
University of Bielefeld, Bielefeld, D
W. Noé
Dr. Karl Thomae GmbH, Biberach, D
vii
15th ESACT Meeting, Tours, France Session chairpersons :
Session
1st Chairperson
2nd Chairperson
1.
J. Lehmann
E.T. Papoutsakis
2.
G. Barlowatz-Meimon
W. Scheirer
3.
A. Crespo
J.-M. Guillaume
4.
B. Griffiths
J. Lupker
5.
L. Fabry
F. Geoffroy
6.
H. Hauser
C. MacDonald
7.
M. Carrondo
J.-M. Engasser
8.
M. Al-Rubeai
J. Bailey
Workshop
S. Barteling
viii
CONTENTS Introduction
xxiii
HYCLONE Lecture Genetic manipulation of the mammalian genome (Abstract) R. Jaenisch
1
ESACT Lecture Engineering glycosylation in animal cells J.E. Bailey, E. Prati, J. Jean-Mairet, A. Sburlati, P. Umaña
5
Sessions on : Biosynthesis and post-translational modifications of recombinant proteins, and Cell physiology and metabolic engineering of animal cells
25
Gene expression :
27
Enhanced recombinant protein expression in insect cells in the presence of dimethylsulfoxide (DMSO) L. Ramos, J.F. Kane, A.A. Murnane
29
Studies of the hepatitis C virus recombinant protein production and its effects on Sf-9 insect cells metabolism C.M. Charon
35
Characterization of phosphorylation mutants of the human multidrug transporter (MDR1) expressed in the baculovirus-Sf9 insect cell system K. Szabo, E. Bakos, E. Welker, A. Varadi, H.R. Goodfellow, C.F. Higgins, B. Sarkadi Glutamine synthetase transfected cells may avoid selection by releasing glutamine P. Bird, E. Bolam, L. Castell, O. Obeid, N. Darton, G. Hale Study of different cell culture conditions for the production of a reshaped Mab in NS0 cells A.J. Castillo, A. Fernandez, T. Boggiano, P. Pugeaud, I.W. Marison Increasing monoclonal antibody productivity by semicontinuous substitution of production medium for growth medium
39
43
51
55
x Expression of recombinant human insulin in Chinese hamster ovary cells is
complicated by intracellular insulin-degrading enzymes S.C.O. Pak, S.M.N. Hunt, M.J. Sleigh, P.P. Gray High yield expression of recombinant plasma factors : use of recombinant endoprotease derivatives in vivo and in vitro U. Schlokat, A. Preininger, M. Himmelspach, G. Mohr, B. Fischer, F. Dorner
The role of cell cycle in determining levels of gene expression in CHO cells D.R. Lloyd, V. Leelavatcharamas, D.C. Edwards, A.N. Emery, M. Al-Rubeai Heterogeneity within DHFR-mediated gene amplified population of CHO cells producing chimeric antibodies N.S. Kim, S.J. Kim, G.M. Lee
Immunofluorescence detection of recombinant monoclonal antibody as a tool in the characterization of chinese hamster ovary cell lines
59
69
77
81
85
C.A.S. Kinney, R.E. Trala, L.C. Hendricks, T.D. Hill Electrolyzed reduced water which can scavenge active oxygen species supresses cell growth and regulates gene expression of animal cells S. Shirahata, S. Kabayama, K. Kusumoto, M. Gotoh, K. Teruya, K. Otsubo, T. S. Morisawa, H. Hayashi, K. Katakura Differential gene expression of cytochrome P450 in immortalised hepatocyte cell lines
93
97
H.T. Kelly, K. Anderson, E. Hill, H. Grant, C. MacDonald Post-transcriptional control of recombinant gene expression : mRNA retargeting and regulation of expression
101
K.A. Partridge, A. Johannessen, A. Tauler, I.F. Pryme, J.E. Hesketh Transient transfection in mammalian cells. A basic study for an efficient and costeffective scale-up process E.-J. Schlaeger, L.Y. Legendre, A. Trzeciak, E.A. Kitas, K. Christensen, U. Deuschle, A. Supersaxo Large scale transient gene expression in mammalian cells
E.-J. Schlaeger, K.Christensen, G. Schmid, N. Schaub, B. Wipf, A. Weiss
105
113
xi
Synergistic enhancement of transient expression by dioleoyl-melittin (DOM) and polyethylenimine (PEI) in mammalian cells in suspension culture E.-J. Schlaeger, J.Y. Legendre, A. Trzeciak, E.A. Kitas, K. Christensen, U. Deuschle, A. Supersaxo
117
Transient expression of a soluble and secreted form of heterodimeric T-cell receptor in HEK-293 M. Jordan, C.L. Blanchard, I. Bernasconi, I. Luescher, F.M. Wurm
121
Measurable parameters of cells and precipitate predict transfectability with calcium phosphate M. Jordan, F. Wurm
125
Glycosylation:
129
Influence of Na-butyrate on the production and sialylation of human interferon-g by a2,6-sialyltransferase engineered CHO-cells
131
D. Lamotte, L. Monaco, N. Jenkins, A. Marc Elevated inhibits the polysialylation of the neural cell adhesion molecule in CHO MT2-1-8 cell cultures J.A. Zanghi, T.P. Mendoza, R.H. Knop, W.M. Miller
135
Influence of cultivation conditions on glycosylation pattern - a fed-batch and continuous culture study N.A. Schill, M.Z. Rosenberg, R.L. Dabora
141
Effects of different production systems on glycosylation pattern of murine monoclonal IgA F. Schweikart, E. Lüllau, R. Jones, G.J. Hughes
149
Identification of altered glycosylation as the major difference between intracellulary accumulated and secreted b-trace protein produced in baculovirusinfected insect cells G. Rodriguez, H.S. Conradt, V. Jäger
153
xii
How ammonium dominates the metabolism of in vitro cultivated mammalian cells A. Çayli, M. Wirth, R. Wagner
157
Study of human recombinant GM-CSF produced in different host systems using monoclonal antibodies M. Etcheverrigaray, M. Oggero, M. Bollati, R. Kratje
163
Metabolic engineering :
166
Modification of hybridoma cells metabolism J.J. Cairó, C. Paredes, F. Gòdia, E. Prats, F. Azorín, Ll. Cornudella
167
Cloning and expression of a cytosolic sialidase from CHO cells in a glutathione S-transferase (GST)-encoding expression vector M. Burg, J. Müthing Construction of a novel CHO cell line coexpressing human glycosyltransferases and fusion PSGL-1 - immunoglobulin G
175
181
B. Vonach, B. Hess, C. Leist
Production of defined glycosylation variants of secreted human of secreted human glycoprotein therapeutics by coexpression with human recombinant glycosyltransferases in BHK-21 cells P. Schlenke, E. Grabenhorst, J. Costa, M. Nimtz, H.S. Conradt
185
Antisense RNA for the elimination of NeuGc residues from recombinant glycoproteins A. Gregoire, A. Visvikis, A. Marc, J.-L. Goergen
191
Cell proliferation, proliferation control, apoptosis:
195
Intracellular fatty acid composition affects cell yield, energy metabolism and cell damage in agitated cultures M. Butler, N. Huzel, N. Barnabé, L. Bajno, T. Gray
197
Lipid requirements of a recombinant Chinese hamster ovary cell line (CHO) J.T. McGrew, C.L. Richards, P. Smidt, B. Dell, V. Price
205
xiii
Sustained expression in proliferation controled BHK-21 cells P.P. Müller, S. Kirchhoff, H. Hauser
209
Cell growth inhibition by the IRF-1 system A.V. Carvalhal, J.L. Moreira, P. Müller, H. Hauser, M.J.T. Carrondo
215
Correlation between BHK cell specific productivity and metabolism H.J. Cruz, J.L. Moreira, E.M. Dias, C.M. Peixoto, A.S. Ferreira, M.J.T. Carrondo
219
Effect of growth arrest in BHK metabolism: on line monitoring by 13C and 31P NMR spectroscopy P.M. Alves, A.V. Carvalhal, J.L. Moreira, H. Santos, M.J.T. Carrondo
223
Cell survival in CHO cell cultures grown in a defined protein free medium N. Chatzisavido, C. Fenge, L. Häggström
227
Enhanced apoptosis in insect cells cultivated in simulated microgravity N. Cowger, K. O’Connor
231
Modulation of apoptosis by bcl-2 expression following amino acid deprivation and in high cell density perfusion cultures R.P. Singh, D. Fassnacht, A. Perani, N.H. Simpson, C. Goldenzon, R. Pörtner,
235
M. Al-Rubeai
Effect of bcl-2 expression on hybridoma cell growth during stressful conditions D. Fassnacht, S. Rössing, , M. Al-Rubeai, R. Pörtner
Inhibition of c-jun expression in F-MEL cells causes cell cycle arrest and prevention of apoptosis Y.H. Kim, T. Iida, E.V. Prochownik, E. Suzuki Hippocampal cells in culture as a model to study neuronal apoptosis I. Figiel, J. Jaworski, L. Kaczmarek
243
247
255
Development of carboxy SNARF-1-AM and annexin V assays for the
determination of apoptosis in heterogeneous cultures A. Ishaque, M. Al-Rubeai
259
xiv
Session on : Integrated bioprocessing in animal cell technology
263
Physical environment, cells and products :
265
Diauxic cell behavior enables detoxification of CHO cell culture medium during fed batch cultivation H. Lübben, G. Kretzmer
267
Effects of polysaccharide derived from tea on growth of human cell lines in serum free culture H. Kawahara, M. Maeda-Yamamoto, K. Osada, K. Tsuji
273
Metabolic demands of BTI-TN-5B1-4 (High Five™) insect cells during growth and after infection with baculovirus E. Chico, V. Jäger
277
Effects of ammonium and lactate during continuous hybridoma fermentations in a fluidized-bed bioreactor H. Heine, M. Spies, M. Biselli, C. Wandrey
281
Serum concentration and pH affect the CD13 receptor content of HL60 cells cultured in stirred bioreactors C.L. McDowell, E.T. Papoutsakis
285
Four regulation-friendly serum-free media for mammalian and insect cells T.W. Irish, S.E. Lenk, L.A. Bugner, K.J. Etchberger
293
Proteolytic activities in the baculovirus-insect cell expression system G. Schmid, A. Bischoff
303
Monitoring and control:
307
Development of proteinase assays for improved CHO cell cultures C. Tans, C. vander Maelen, S. Wattiaux-de Coninck, M.-M. Gonze, L. Fabry
309
Digital image analysis: quantitative evaluation of colored microscopic images of animal cells K. Falkner, E.D. Gilles
317
xv
The viable cell monitor: a dielectric spectroscope for growth and metabolic studies of animal cells on macroporous beads Y. Guan, R.B. Kemp
321
Measurements of changes in cell size distribution to monitor baculovirus infection of insect cells E. Chico, V. Jäger
329
Dead cell estimation - a comparison of different methods A. Falkenhain, Th. Lorenz, U. Behrendt, J. Lehmann
333
Fed-batch culture development based on biomass monitoring E. de Buyl, A. Maxwell, L. Fabry
337
On-line monitoring of protein and substrate/product concentration in mammalian cell cultivation H. Lübben, J. Hagedorn, T. Scheper
343
Process control and on-line feeding strategies for fed-batch and dialysis cultures of hybridoma cells J.O. Schwabe, R. Pörtner
347
Metabolic network analysis of a hybridoma cell line using mass balances and labelled glucose and glutamine P.-A. Ruffieux, I.W. Marison, U. von Stockar
351
Dynamic medium optimization by on-line heat flux measurement and a stoichiometric model in mammalian cell culture Y. Guan, R.B. Kemp
355
Modeling of glycoprotein production by chinese hamster ovary cells for process monitoring and control J. Stelling, R.K. Biener, J. Haas, G. Oswald, D. Schuller, W. Noé, E.D. Gilles
359
The temperature effect in mammalian cell culture. An Arrhenius interpretation G. Kretzmer, T. Buch, K. Konstantinov, D. Naveh
363
Integrated processes and scale-up:
367
Dielectrophoretic forces can be exploited to increase the efficiency of animal cell perfusion cultures N. Kalogerakis, A. Docoslis, L.A. Behie
369
xvi Use of a new microcarrier with two-dimensional geometry for the culture of
anchorage-dependent cells in sonoperfused, continuously stirred tank reactors C. Gatot, F. Trampler, M.-P. Wanderpepen, J. Harfield, A. Oudshoorn, A. Johansson, V. Nielsen, A.O.A. Miller
377
Evaluation of porous microcarriers in fluidized bed reactor for protein production by HEK 293 cells M.A. Valle, J. Kaufman, W.E. Bentley, J. Shiloach
381
Fluidized bed technology: influence of fluidization velocity on nutrient consumption and product expression G. Blüml, M. Reiter, Th. Gaida, N. Zach, A. Assadian, C. Schmatz, H. Katinger
385
High density and scale-up cultivation of recombinant CHO cell line and hybridomas with porous microcarrier cytopore C. Xiao, Z. Huang, W. Li, X. Hu, W. Qu, L. Gao, G. Liu
389
Cell-settler perfusion system for the production and glycosylation of human interferon-γ by clumped cells D. Lamotte, J. Straczek, A. Marc
395
Disposable bioreactor for cell culture using wave-induced agitation V. Singh
399
Use of miniPERM system for an efficient production of mouse monoclonal antibodies
409
M.L. Nolli, R. Rossi, A. Soffientini, D. Zanette, C. Quarta
Production of anti-EGF receptor hMAb in hollow fiber bioreactors for in vivo diagnosis M.A. Arias, A. Valdés, D. Curbelo, O.M. Morejón, I. Caballero, J. Villán, J.A. Gómez, A. Fernandéz, J. Rodriguez, A. Morales, T. Boggiano, A. Castillo, L. Bouzó, C. Hermida, G. García, P. Vitón, N. Pérez, T. Rodríguez Optimisation of the production of VLP’s in 2 Lt stirred bioreactors P.E. Cruz, A. Cunha, C.C. Peixoto, J. Clemente, J.L. Moreira, M.J.T. Carrondo
Direct capture of monoclonal antibodies with a new high capacity streamline SP XL ion exchanger C. Priesner, N. Ameskamp, D. Lütkemeyer, J. Lehmann
417
421
429
xvii
The effect of different purification schemes on the activity of a monoclonal antibody D.J. Black, J.P. Barford, C. Harbour, A. Fletcher
Interfacing of protein product recovery with an insect cell baculovirus production system I.A. Carmichael, M. Al-Rubeai, A. Lyddiatt Preparation of plasmid DNA using displacement chromatography R. Freitag, S. Vogt Novel methods for large-scale preparation of nutrient media and buffered salt solutions D.W. Jayme Large scale application of the Semliki Forest Virus system: 5-HT3 receptor production H.D. Blasey, B. Brethon, R. Hovius, K. Lundström, L. Rey, H. Vogel, A.-P. Tairi, A.R. Bernard
From applied research to industrial application: The success story of monitoring intracellular ribonucleotide pools S.I. Grammatikos, K. Tobien, W. Noé, R.G. Werner New technology of production recombinant human erythropoietin for peroral administration T.D. Kolokoltsova, N.E. Kostina, E.A. Nechaeva, N.D. Yurchenko, O.V. Shumakova, A.B. Rizikov, N.A. Varaksin, T.G. Ryabicheva
433
437
441
445
449
457
463
General safety aspects:
467
Significance of multiple testing on murine leukemia virus of mouse hybridomas E.J.M. Al, T. Jorritsma, A. Blok, H.M.G. Sillekens, P.C. van Mourik
469
Murine retrovirus detection using Mus dunni cells and S+L- cells P. Seechurn, B. Mortimer, P. Newton, C. Martin
473
The removal of model viruses during the purification of human albumin using chromatographic procedures R. Cameron, C. Harbour, Y. Cossart, J.P. Barford
481
xviii Inactivation of hepatitis A virus during the production of Nordimmun D.W. Birch, P. Kaersgaard, C. Martin
Session on: Viral vector production for gene therapy Adeno-associated viral vectors: Principles and in vivo use O. Danos Novel retroviral packaging cell lines: Improved vector production for efficient hematopoietic progenitor cell transduction
485
491 493
503
S. Forestall, R. Rigg, J. Dando, J. Chen, B. Joyce, R. Tushinski, C. Reading, E. Böhnlein
Scale-up and otpimisation issues in gene therapy. Viral vector production J.E. Boyd, L. Borland, C.E.Fisher
509
Comparison of manufacturing techniques for adenovirus production J.M. Ostrove, P. Iyer, J. Marshall, D. Vacante
515
Safety considerations in the development of new retroviral and adenoviral vectors for gene therapy D. Morgan, I. Forgie, J. Ostrove, M.H. Wisher Gene therapy for neuromuscular disorders : Macrophages as shuttles for widespread targeting
523
531
E. Parrish, E. Peltékian, L. Garcia Gene transfer into dog myoblasts
541
S. Braun, C. Thioudellet, C. Escriou, M.-C. Claudepierre, F. Längle-Rouault, E. Jacobs, R. Bischoff, D. Elmlinger, H . Homann, Y. Poitevin, M. Lusky, M. Mehtali, F. Perraud, A. Pavirani
Biodistribution analysis of a gene therapy vector using the polymerase chain reaction (PCR) technique
545
J. Proffitt, M. Leibbrandt, K. Jarvis, C. Martin Session on: Developments for immunologicals and vaccines
The production of influenza virus by immobilised MDCK cells D. Looby, J. Tree, A. Talukder, K. Hayes, H. House, G. Stacey
549
551
xix
Serum-free grown MDCK cells: An alternative for influenza vaccine virus production N. Kessler, G. Thomas, L. Gerentes, M. Aymard
555
Evaluation of the new medium (MDSS2N), free of serum and animal proteins,
for the production of biologicals H. Kallel, P. Perrin, O.-W. Merten Production of high titre disabled infectious single cycle (DISC) HSV-2 from a microcarrier culture T.A. Zecchini, R.J. Smith New form of the live measles vaccine for oral administration E.A. Nechaeva, E.A. Kashentseva, A.P. Agafonov, N.A. Varaksin, T.G. Ryabicheva, A.P. Konstantinov, V.N. Bondarenko, T.D. Kolokoltsova, I.V. Kits, T.Yu. Sen’Kina, N.V. Zhilina
561
569
573
Study of Leningrad-16 vaccine strain of measles virus reproduction in cell cultures perspective for biotechnology E.A. Nechaeva, T.N. Getmanova, T.Y. Sen’Kina, N.D. Yurchenko
577
Recent advances with new vaccine adjuvants from preclinical to clinical development (Abstract) T. Voss
581
Vaccination with recombinant suicidal DNA/RNA P. Berglund, M. Fleeton, C. Smerdou, I. Tubulekas, B.J. Sheahan, G.J. Atkins, P. Liljeström
583
Growth of goat endothelial cells for the production of a veterinary vaccine P.M. Miranda, J.L. Moreira, M.J.T. Carrondo
593
Expression in insect cells of the major parasite antigen associated with human resistance to Schistosomiasis L.Argiro, C. Doerig, S. Liabeuf, A. Bourgois, J.L. Romette
597
Modulation of CD4 expression on helper T lymphocytes and U937 cells by ganglioside GM3 and its derivatives D. Heitmann, P. Budde, J. Frey, J. Lehmann, J. Müthing
601
Human serum in leukocyte cultures producing human interferon alpha P. Mattana, L. Scapol, S. Silvestri, G.C. Viscomi
607
xx The new type of immunomodulator
613
M.V. Mezentseva, V.A. Mozgovoi, L. Yu. Mozgovaya, R. Ya. Podchernyaeva
In vitro immunization of human peripheral blood lymphocytes with cholera toxin B subunit A. Ichikawa, Y. Katakura, T. Kawahara, S. Hashizume, S. Shirahata Session on: New technologies for health care products
617
625
Analysis of cell growth in a fixed bed bioreactor using magnetic resonance
spectroscopy and imaging P.E. Thelwall, M.L. Anthony, D. Fassnacht, R. Pörtner, K.M. Brindle Expansion of human hematopoietic progenitor cells in a fixed bed bioreactor (Abstract)
627
635
P. Meissner, P. Werner, B. Schröder, C. Herfurth, C. Wandrey, M. Biselli
A novel assay to determine and quantify the regulation of cell motility and migration demonstrated on hematopoietic cells D. Möbest, S. Ries, R. Mertelsmann, R. Henschler
637
Immortalization of differentiated hepatocytes G.S. Jennings, M. Strauss
645
Fixed-bed reactors for animal cell cultivation: An approach to artificial organs R. Pörtner, S. Rössing, J. Stange, D. Fassnacht
657
High density perfusion culture of primary rat hepatocytes for potential use as a bioartificial liver device K. Bratch, A.J. Strain, M. Al-Rubeai Metabolic competence and hormonal regulation of primary porcine hepatocytes in a 3-D sandwich configuration (Abstract) A. Bader, D. Rocker, A. Acigköz, S. Schwintek, J. von Schweder, M. Maringka, V. Armstrong, R. Wagner, G. Steinhoff, A. Haverich Novel mini-bioreactors for islet cell culture A. Handa-Corrigan, I.C. Green, J. Mabley, S. Hayavi, G.N. Kass, R.H. Hinton,
L.M. Morgan, J. Wright
661
665
669
xxi
Cultivation of skin cells suitable for recovery of burn wounds T.D. Kolokoltsova, N.D. Yurchenko, N.G. Kolosov, O.V. Shumakova, E.A. Nechaeva
673
Tissue therapy for treatment of primary myodystrophies T.B. Krokhina, G.B. Raevskaja, S.S. Shishkin
677
Possibility of application of thyroid organ culture for the treatment of persistent
hypothyroidism I.P. Pasteur, N.D. Tronko, E.N. Gorban, V.I. Kravchenko ESACT Lecture Human cells as therapeutic agents (Abstract) H . Green
Session on: Use of animal cells for in vitro testing
681
685
687
Embryonic stem cell differentiation models: Cardio-vascular, myogenic and neurogenic development in vitro A.M. Wobus, K. Guan, J. Rohwedel, C. Strübing, M. Drab
689
Responses of human lung epithelial cells (A549) to pathogenic infection by Mycoplasma pneumoniae J. Goodman, K. Morley, P. Packer, T. Battle
705
Polar lipid profiling of Mycoplasma pneumoniae-infected human lung epithelial cells J. Goodman, R. Wait, T. Battle
713
Comparison of three dimensional (3-D) rat hepatocyte cultures in simulated microgravity conditions T. Maguire, H.J. Moulsdale, G. Stacey, T. Battle
717
High density culture of the human hepatoma cell line HepG2: Long-term culture for in vitro toxicology A. Handa-Corrigan, R.M. Traynor, I. Adamopoulos, J. Salway
721
Application of primary cultures of rat fetal neurons to the study of neurotrophic
action of peptides O.V. Dolotov, I.A. Grivennikov
725
xxii Development and validation of an image analysis system for single cell
characterization in cell monolayers D. Kaiser, M.A. Freyberg, G. von Wichert, P. Marenbach, H. Tolle, P. Friedl
729
Development of an optically accessible perfusion chamber for in situ assays and for long-term cultivation of mammalian cells M.A. Freyberg, P. Friedl
733
Analysis of mitogenic activity of proteins after separation by gel electrophoresis
737
O. Hohenwarter, G. Marzban, E. Jisa, H. Katinger Workshop on:
The use of animal cells versus the use of transgenic animals for the production of recombinant proteins
741
Secretion of fusion proteins into milk by transgenic mouse mammary epithelium (Abstract)
743
D. Pollok, L. Chen, H. Liem, B. Wilburn, J. Williams, M. Harrington, Y. Echelard, H. Meade The production of proteins in the milk of transgenic livestock: A comparison of
microinjection and nuclear transfer
745
I. Garner
Creation of mice expressing human antibody by introduction of a human chromosome H. Yoshida, K. Tomizuka, H. Uejima, H. Kugoh, K. Satoh, A. Ohguma, M. Hayasaka, K. Hanaoka, M. Oshimura, I. Ishida
751
Transgenic technology - A challenge for mammalian cell culture production systems R.G. Werner
757
General Workshop-Discussion
765
List of trade-fair-sponsors
773
Index
775
INTRODUCTION
New Developments and New Applications in Animal Cell Technology The 15th Meeting of the European Society for Animal Cell Technology (ESACT), entitled « Animal Cell Technology. New Developments - New Applications », was organized in Tours/France at the beginning of September 1997. The objective was to give an overview of the actual and future developments and on new applications in the classical fields covered by ESACT as well as in adjacent areas. Products, like vaccines and recombinant proteins are standard products of aanimal cell technology, and have been covered by ESACT-Meetings for many years. The actual trend in the use of animal cell technology is going towards new domains which have not been covered previously or sufficiently by ESACT, and of which ESACT should be more aware. This is because it can provide a lot of technological expertise: for instance, the development, production, and use of viral vectors for use in gene therapy is comparatively new and has a bright future, or the use of cell culture technology for the development of artificial organs which is steadily becoming more important, as specially as established technologies for entrapment and immobilisation of animal cells are of utmost importance in this field. ESACT is a Society of applied scientists and engineers. It is therefore very important for members to get a deeper insight into the actual developments in fundamental research, because in the near or further future they have to deal with the results of this research by, for instance, developing production, cultivation, or purification methods. In order to fulfil these requirements (getting a view on these subjects and also getting overviews on matters of general interest for applied biotechnologists), several keynote lectures were organized during the 15th ESACT-Meeting. It was possible to get five keynote speakers and the speaker of the opening session (F. Horaud, Inst. Pasteur, Paris/F) all of whom participating actively at this meeting. These speakers gave excellent talks on diverse subjects which included DNA methylation and its role in the genetic manipulation of the mammalian genome (R. Jaenisch, Whitehead Inst., Cambridge, MA); the use of human cells as therapeutic agents (H. Green, Harvard Medical School, Boston, MA), the engineering of glycosylation patterns in mammalian cells (J. Bailey, ETH Zürich, CH), and how genomics, target identification and structure based design could provide a complementary rather than competitive approach to animal cells for human therapy (T. Blundell, University of Cambridge, U.K.). Finally a more global overview on the reshaping of medicine through molecular biology was given by T. Bartfai (Hoffmann La Roche, Basel/CH). During the 15th ESACT-Meeting eight scientific sessions and one workshop were organized : 1. New technologies for health care products, 2. Use of animal cells for in vitro testing. xxiii
xxiv
3. Viral vector production for gene therapy,
4. Biosynthesis and post-translational modifications of recombinant proteins, 5. Developments for immunologicals and vaccines, 6. New cell lines: from transformed to differentiated cells/cell functions, 7. Integrated bioprocessing in animal cell technology, 8. Cell physiology and metabolic engineering of animal cells, and a workshop on: The use of animal cells versus the use of transgenic animals for the production of recombinant proteins. The scientific presentation of these Proceedings is in a slightly different fromate to that of the 15th ESACT-Meeting, nevertheless they reflect very closely the scientific contents
of the meeting. There are two main reasons for the modified presentation: 1. Scientifically, it was preferable to merge sessions 4 and 8 in order to get a more global presentation of the biosynthesis of recombinant proteins, cell physiology and metabolism (including metabolic engineering). 2. There is no chapter with respect to session 6, because only two manuscripts have been collected which were finally attributed to sessions 1 (paper by Jennings & Strauss) or 2 (paper by Wobus et al.). In order to get a better structure of this volume, the chapters corresponding to each session are introduced by a short overview on the contents.
It is obvious that these Proceedings will be most valuable to those who are actively involved in the field of animal cell technology. The chapters on Biosynthesis and posttranslational modifications of recombinant proteins and Cell physiology and metabolic engineering of animal cells and on Integrated bioprocessing in animal cell technology », representing the key-domaines of ESACT, count for about 60% of all presentations. Classical fields, like reactor engineering, development and application of new devices for high cell density rector systems, monitoring, and optimisation are still of large interest. However, the emphasis in optimisation of the product has changed from reactor engineering to cell engineering, for instance, for modifying glycosylation patterns or for reducing apoptosis in reactor cultures (= prolongation of the life time of the active biomass) becomes of growing interest. There are many highlights of general interest scattered through the other sessions; among others to be mentioned, several papers in the session on Viral vector production for gene therapy on the biology and the potential use of adeno associated virus (AAV) in gene therapy, the development of new packaging cell lines for the production of viral
vectors, and the application of gene therapy for the treatment of muscular diseases; papers presenting new approaches in vaccine development (e.g. new adjuvants and new viral vectors) in the session on (« Developments for immunologicals and vaccines ».) A topic in an adjacent field of ESACT but of general interest, is the use of high cell
density (tissue-like) for the development of artificial organs. Originally, techniques developed for hollow-fiber and general immobilisation systems were the base for developments in the field of artificial organs. Today, general animal cell technology profits by developments in this field, like techniques for determining the distribution of biomass in the extracapillary space of high density hollow fiber systems.
xxv
As already mentioned, due to the keen interest a workshop on The use of animal cells versus the use of transgenic animals for the production of recombinant proteins was organized. The production of recombinant proteins in transgenic animals might become a very important concurrence for animal cell technology. The aim of this workshop was to give a comparison between both technologies, to present the advantages and disadvantages of both technologies, followed by a general discussion. As a conclusion, it
seems that production in animals is more economical, however, the system is less defined and this may hamper the registration of the product. Furthermore, the production of pharmaceuticals such as insulin could leak into the blood and consequently impair the health of the animal, which is, of course, never a problem in animal cell culture. In conclusion, as for previous ESACT-Meetings, the whole animal cell production process was considered - from the initial genetic studies of the cells through the stages of production to the regulatory issues surrounding product release. The holistic approach to animal cell technology which is the base of each ESACT-Meeting is the main reason for the continual increasing interest in these meetings.
O.-W. Merten, P. Perrin, B. Griffiths Editors
This page intentionally left blank.
Hyclone Lecture GENETIC MANIPULATION OF THE MAMMALIAN GENOME R. JAENISCH Whitehead Institute for Biomedical Research and Department of Biology M.I.T. Cambridge, MA 02142, USA Abstract: Over the last decade methods have been developed that allow us to precisely alter genetically the germ line of mice, permitting the generation of mouse models for human diseases. In this talk I will first review the technology of gene targeting. I will then illustrate the application of this technology for studying the role of DNA methylation in embryonic development and genomic imprinting. DNA methylation is the most important epigenetic change because DNA methylation is an epigenetic modification : that is, it is altered during normal development as well as during various diseases such as cancer. The implications of DNA methylation for biomedical research will be discussed. Discussion Danos:
The other drugs that have been used for re-activation of gamma globulins, like hydroxyurea (HU), reduce methylation. Can they be used in a cancer setting as well?
Jaenisch:
I believe HU gets cells into cycling and that is how you may get different types of cells; maybe foetal cells which express gamma globulin genes. I am not sure what the mechanism is, but there is no real evidence that HU leads to direct de-methylation of those genes. I should add that HU only works for sickle cell anaemias and not for telosaemias.
Faff:
Is there an enzymatic assay for methyl transferase?
Jaenisch:
Yes, there are very good in vitro assays. You take the purified enzyme, or an extract, label the methyl group and then measure the transfer of methyl to a substrate.
Singhvi:
Are you working with any pharmaceutical company on the development of drugs for de-methylation?
Jaenisch:
Yes, I am very keen on that.
Sasaki:
Would it be possible to summarise what you know about the enzyme responsible for de novo synthesis? 1
O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 1-3. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
2 Jaenisch:
When I say this is a maintenance methylase, it not that strong a statement. The enzyme in vitro prefers a methylated substrate but it also accepts an un-methylated substrate although this is less efficient. So in vitro it has de novo methylase activity. In vivo we know that by using retroviruses to introduce virus into ES cells, they can become de novo methylated very efficiently. One reason that gene therapy trials of stem cells offers nothing is that the virus gets turned off and methylation plays a role here. This is one of the major complications of trying to infect stem cells with retroviruses. When you try to differentiate ES cells there is no de novo methylation activity, so I believe that the enzyme is turned off. It does not exclude the possibility that the maintenance methylase has a low efficiency of de novo methylase activity in vivo. However, we know that there is a separate enzyme which is very efficient in
de novo methylase activity;
we have the following genetic
information. When we take methyl transferase negative cells and infect them with retrovirus, the retrovirus gets de novo methylated with the same kinetics as a wild type cell. However, it never reaches the same level. This argues that the maintenance methylase
activity has been eliminated - there must be a totally independent encoded activity which does that. Biochemically we do not see that
activity, so it is either unstable or we do not have the right assay. Sasaki:
Has any attempt been successful to isolate the genes using homology?
Jaenisch:
Homology studies have been totally unsuccessful. This is surprising
because this enzyme has a highly conserved domain and is very similar in both prokaryotic and mammalian enzymes so antibodies recognise one or the other. There has been no success in finding another enzyme by sequence searches which is convincingly the de novo methyl transferase.
Al-Rubeai:
Is it possible that the drug 5 aza DC influences methylations by affecting the methyl transferase during the cell cycle by preventing cell division? The cells would be blocked in the Gl, thus allowing
another gene to commit the cell to death. So methyl transferase would not be an oncogene itself but a cell cycle gene and, therefore, demethylation will allow the cell to be blocked and committed to
death. Jaenisch:
So this would be a toxic effect. These mice are totally normal so the heterozygous mice age normally. They are protected against tumours by a factor of 3. So there is no difference in the cell cycle of heterozygous mice. We are not at the stage of de-methylation where apoptosis occurs. Apoptosis does occur when you differentiate mutant ES cells, or in the embryos which do not have this enzyme and die. The reason why they die is not known. We
3
believe that they lose the X chromosome gene expression and this would be sufficient to explain the death but is probably not the whole answer. We do not really know what the role of methylation is in development. We know it is important for gene expression and we have evidence for its importance in gene stability. It might be important for repair processes. In prokaryotes, methylation is crucial to mark the parental from daughter strain so you know whether replication errors occur. There is no evidence for this role in mammals but it is probable. Methyl transferase is not an oncogene in the conventional usage but I think it is an oncogenic determinate. Bernard:
Can you make a partially inactive mutant of methyl transferase in vitro?
Jaenisch:
We have partially inactivated mutants in mice, so we can adjust the enzyme levels genetically down to any level (2%, 5%, 10%). In vitro the truncated enzyme has activity. In answer to your question, I am sure you can but I am not sure why one would want to do it.
Aunins:
Can you speculate on whether methylation has a role in productivity of recombinant cell lines in vitro?
Jaenisch:
The old evidence is that a primary cell, which produces all sorts of proteins when put in tissue culture, very soon shows de novo methylation of CPG islands of genes which are tissue specific. So many genes turn off which are not needed in tissue culture. You turn off genes which inhibit cell growth, eg myo D is never methylated in vivo, only in culture. In tissue culture I think de novo methylation is a growth promoting process.
This page intentionally left blank.
ENGINEERING GLYCOSYLATION IN ANIMAL CELLS
J. E. Bailey, E. Prati, J. Jean-Mairet, A. Sburlati, P. Umaña
Institute of Biotechnology, ETH Zürich, CH-8093 Zürich, Switzerland
1. Abstract
Glycosylation can have significant effects on activity, pharmacokinetics, targeting, immunogenicity, and stability of a glycoprotein. Therefore, glycosylation engineering of animal cells which express cloned glycoprotein products is an enabling technology for generating molecular and functional diversity of these products. This review considers potential targets in modifying oligosaccharides on particular glycoprotein pharmaceuticals, strategies available to guide genetic design of a modified oligosaccharide biosynthesis pathway which will achieve the desired end-product, the
current challenges and limitations, technologically and scientifically, in achieving industrially significant results, and progress being made to address these challenges. 2. Introduction
Glycoproteins mediate many essential functions in human beings, other eucaryotic organisms, and some procaryotes, including catalysis, signalling, cell-cell communication, and molecular recognition and association. The function of glycoproteins can be profoundly influenced by their oligosaccharide component(s). Unfortunately, few simple, general principles are available which unify understanding of oligosaccharide structure - glycoprotein relationships (here subsequently referred to more briefly as “structure-function relationships”). Accordingly, the scope of scientific and technological investigation in this field is vast and cannot be comprehensively summarized here.
There are two main results from prior work which are critical in this discussion. 1. The oligosaccharide structures which are assembled starting from particular initiation sites on the polypeptide backbone are functions of the polypeptide amino acid sequence, the host cell in which the glycoprotein is synthesized, and that cell’s environment. 2. With polypeptide sequence, host cell, and environment fixed, the glycoprotein molecules which are synthesized differ with respect to their oligosaccharide structures. 5 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 5-23. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
6
These related yet distinct molecular species are called “glycoforms.” Thus, reference to a
particular glycoprotein is, usually, shorthand for a population of glycoforms. A definition of “glycosylation engineering” is needed here in order to focus this presentation (Further, a definition which reasonably delimits the field under discussion is essential to give that definition any functional utility). Here glycosylation engineering is considered as a subset of metabolic engineering, defined as “the improvement of cellular activitites by manipulation of enzymatic, transport, and regulatory functions of the cell with the use of recombinant DNA technology” [1]. That review included this perspective on glycosylation engineering, presenting several examples in which genetic engineering of the oligosaccharide synthesis pathway achieved altered glycosylation of glycoproteins expressed in mammalian cell culture. A later review took a broader view of glycosylation engineering, including effects of mutations and cell environment on glycosylation [2]. Although environmental effects belong to the field of bioprocess engineering in the current lexicon of our field, some highlights from such bioprocess research are also included here. Another specification is required here: what kinds of glycoproteins will be discussed, and
in what context? Here we focus on cloned, heterologous, secreted glycoproteins produced in animal cell culture, insect cell culture, and, to a lesser degree, in transgenic animals. These glycoproteins, some of which are listed in Table 1, are the backbone of the biotechnology industry which has emerged in the last two decades and which has redefined the scope and significance of animal cell technology in the same period. Of course glycosylation of viruses has major technological relevance, and glycosylation must be critically important, in ways still to be elucidated, in tissue engineering, but these topics must await a future presentation. Further information on the science of glycobiology, as well as introductions to basic concepts in the field, may be found in a number of excellent recent reviews [3,4,5,6,7],
The secreted proteins of interest here are used in many applications as injectable therapeutic agents. This then delimits the set of glycoprotein functional characteristics of greatest importance. Some of the available information on these is summarized next,
7
concentrating specifically on particular glycoproteins which are current or pending products of the biotechnology industry.
3. Oligosaccharide Structure-Glycoprotein Function Relationships
The advent of biotechnology enabled synthesis of human polypeptides in heterologous cells. This new combination of polypeptide and host gave rise to glycoproteins which had not previously existed, but which were under development as potential therapeutic agents. This motivated extensive development of more sophisticated methods for
characterization of glycosylation, and also research to explore the implications of glycosylation on the therapeutic properties of glycoproteins. As summarized in Table 2, this research has revealed that, in particular cases, glycosylation can influence the physical properties, immunological interactions, biological activity, and pharmacokinetics of particular glycoproteins. Unfortunately, it can be very misleading to generalize from an example for a specific glycoprotein to other glycoproteins. Oligosaccharides have different roles on different glycoproteins with different functions. In fact, one group of biochemists believes that oligosaccharides usually have only generalized, physicochemical effects, while another emphasizes evidence of specific biological functions of oligosaccharides. Evidence for both viewpoints exists, prompting the cogent title of one of the foremost reviews of the
subject; “Biological roles of oligosaccharides: all theories are correct” [4].
8
There are a few points which admit generalization: absence of sialic (neuraminic) acid on the termini of complex oligosaccharides results in more rapid clearance, as does the presence of high mannose oligosaccharides. These implications of glycosylation have motivated choice of host cell lines for production of biologicals (to avoid high mannose structures), and also great emphasis on sialylation in process and product development and in product characterization.
4. Why do Glycosylation Engineering?
Glycosylation engineering offers a way to generate glycoproteins which are novel in the sense that they carry different oligosaccharides compared to previously available material. In view of the sensitivity of function of many early products of the biotechnology industry to glycosylation, glycosylation engineering is an obvious strategy for generating “second generation” products. A prominent example is “novel erythropoiesis-stimulating protein” (NESP), moving very rapidly now through clinical trials. This product is a preparation of one or several high-activity glycoforms of EPO [I8]. While such a material can be produced by fractionation of a first-generation product, glycosylation engineering offers an alternative route to obtain novel glycoforms, including those not available from the original production cell line.
Glycosylation engineering provides a means to optimize a new product with respect to function, and also with respect to business position. Novel glycoforms are a possible basis for patent protection of a product. For example, U.S. Patent 5,547,933 [19] claims “A non-naturally occurring EPO glycoprotein product... (with) a higher molecular weight than human urinary EPO..”. Here no glycosylation engineering was involved - glycosylation different from that of human urinary EPO arises simply because the EPO referred to is made in recombinant CHO cells. Nonetheless, by choice of a different host, modification of the host by glycosylation engineering, or by innovative purification strategies, clear opportunities exist for creating new materials which can be patented.
Glycosylation engineering may also be employed to facilitate purification (e.g., by installing a residue or linkage recognized by a particular lectin), to simplify crystallization (in the limiting case, by modifying the amino acid sequence so that it is not glycosylated), or to reduce glycoform heterogeneity in a glycoprotein preparation [2,20].
With these practical benefits as motivations, we next review the factors which influence glycosylation of a polypeptide, which leads us to questions of how glycosylation can differ among glycoforms, or among different glycosylated polypeptides. Each of these types of characteristics, and these different ways of influencing them, provide an avenue for glycosylation engineering to play a role, and for differentiating the glycoprotein produced from presently available preparations.
9 5. Decision Points in Oligosaccharide Biosynthesis
Glycosylation occurs at particular amino acid residues on a polypeptide - known as glycosylation sites - as the polypeptide moves from the endoplasmic reticulum through the Golgi apparatus. However, the oligosaccharide structure attached to a glycosylation site on a given polypeptide can vary over a large set of chemical and structural diversity - beginning with the possibility that the site may have an oligosaccharide attached in some glycoforms but have no oligosaccharide there in other glycoforms (site occupancy). The polypeptide itself, the host cell, and that cell’s environment all can influence substantially the distribution of glycoforms produced. The situation is extremely complicated, making it scientifically and commercially rich in unresolved questions and opportunities. Unfortunately, there is no way at present to predict what types of glycoforms will be produced when an arbitrary polypeptide is expressed in a given host under given conditions (except in the trivial case in which, due to the polypeptide sequence or the host, no glycosylation occurs). Experience is accumulating to allow reasonable hypotheses in some cases about how a change from a given situation will change the glycoform distribution, but, even in this more limited perspective, many uncertainties remain. A summary of many of the ways in which glycoforms can differ, with corresponding examples taken frequently from the set of products listed in Table 1, is provided in Table
3. In some cases, the basic mechanism which determines a particular “decision” in oligosaccharide biosynthesis can be identified - for example cells will not produce bisected glycoforms or glycoforms containing sialic acid in to nonreducing end-galactose residues (found in humans), if they lack, respectively, or Different polypeptides expressed in similar hosts under similar conditions can be glycosylated much differently, clearly indicating that the polypeptide itself exerts a controlling role for its own glycosylation [3,10,23,24]. A particularly interesting and technologically relevant example, which also illustrates this connection at the level of individual amino acid substitutions, is the development of TNK-tPA [25]. A single mutation, T103N, introduced a new glycosylation site carrying complex-type
oligosaccharides, and at the same time changed glycosylation at native site N l 1 7 from a high mannose to a complex pattern. This mutant had a 10-fold lower plasma clearance than wild-type tPA, but only one third of the fibrin binding activity of the wild-type glycoprotein. This activity could be restored to wild-type level by removing the native glycosylation site at position N117. The net effect in the resulting double mutant T103N, N117Q tPA is to shift one site from position 117 to 103 and change
glycosylation pattern from high-mannose to complex type.
the
10
6. Tools and Strategies for Manipulating Glycosylation
6.1. CHOICE OF HOST It is the capability of animal cells to accomplish glycosylation in a manner compatible with human application which has created a special niche for animal cell technology in the biotechnology industry. Commonly used bacterial hosts do not glycosylate their proteins, and yeast glycosylate with high mannose oligosaccharide structures which are not suitable for injection into humans. Similarly, baculovirus expression systems, as well as plants, also synthesize oligosaccharides on glycoproteins which are undesirable for pharmaceutical applications. Even within the sphere of cultured animal cells and whole animals, different cell lines and different animals produce different glycoforms following translation of an identical
polypeptide. A few examples of such phenomena are listed in Table 4. extensive list of examples can be found in Reference 11 .
A more
11
6.2. MUTANTS AND METABOLIC ENGINEERING There are two different classes of genetic manipulation which can influence oligosaccharide biosynthesis. The first is modification of expression level of enzymes and related proteins involved in oligosaccharide biosynthesis which are encoded in the genome of the host cell. There are in turn two alternative technologies for obtaining host cells with such altered expression levels of its homologous proteins. One, which has played a critical role in the development of glycobiology, is screening for mutant hosts which exhibit altered glycosylation. These are typically identified by detection of
the corresponding modification in oligosaccharides displayed on the outer cell surface. Further information on such glycosylation mutants and their application in glycobiology can be found in a recent review [2]. It is reasonable to expect that, at least for some cloned, secreted heterologous glycoproteins, use of glycosylation mutants will result in an alteration of product protein glycosylation. However, to date there are no publications confirming this possibility. A second approach for modifying expression of host cell proteins involved in oligosaccharide biosynthesis involves several different methods based on recombinant DNA technology. By gene activation or by installing additional copies of chosen genes with appropriate transcriptional controllers, particular enzymes can be amplified. Conversely, antisense and other methods can be employed in order to down-regulate expression of targeted host cell genes.
In many potential applications of glycosylation engineering, the oligosaccharide biosynthesis capabilities of the host are extended by introduction into that host of one or more genes encoding heterologous oligosaccharide biosynthesis enzymes, or possibly other proteins including precursor transporters, into a heterologous host. This can be achieved by recombinant DNA methods but not by mutation. A limited number of experiments employing this approach have so far been published. These involve a relatively smallset of heterologous enzymes, in part because the working pool of cloned enzymes for this type of glycosylation engineering, at least in the public domain, is still small. However, these experiments have so far produced positive and encouraging results, in the sense that installation of a heterologous enzyme resulted in the
12
corresponding modification in glycosylation for at least a detectable quantity of a particular glycoprotein which has been analyzed. Table 5 summarizes all such publications known to the authors as of the submission date of this manuscript.
It is by no means guaranteed that genetic manipulation of the activity of a glycosylation enzyme will result in a corresponding change or any change at all in the glycosylation
of particular glycoproteins. Failures in this respect are rarely documented, but there is
one published example. Overexpression of cloned in F9 carcinoma cells (which already express this enzyme) gave no detectable change in the glycosylation of endogenous lysosomal membrane protein 1 (LAMP-1), although the intracellular level of the enzyme was significantly increased [47]. Glycosylation engineering has also been achieved in a transgenic animal [48J. In this case, human was trangenically expressed in the mammary gland of mice. Milk samples from transgenic animals contained soluble, active forms of the
large quantities of a free oligosaccharide product of this
enzyme (2'-fucosyllactose), as well as modified glycoproteins. In contrast, milk from control animals lacked these glycoconjugates. Glycosylation engineering to modify glycoforms of a cloned glycoprotein product can be expected also to influence glycosylation of some set of host cell glycoproteins [49,50], potentially influencing their function. This could disturb growth, productivity, development [51], or viability of the host, complicating achievement of the desired product glycosylation. Engineering global changes in glycosylation capabilities of a cell, such as modifying a yeast to glycosylate like a human ce11, is extremely difficult for this and another reason: oligosaccharide synthesis depends not only on the enzymes directly involved but on synthesis and transport capabilities for nucleoside sugar cosubstrates and their soluble reaction products, requiring that any missing functions in this entire complex system must also be installed to enable the new biosynthetic activity.
As presently understood, oligosaccharide biosynthesis achieves the observed end result by sophisticated organization and segregation of various enzymes, and the reactions they
13
catalyze, into different organelles. Therefore, achieving synthesis of human oligosaccharides in a procaryotic cell seems unattainable, whatever new genes and functions are introduced by metabolic engineering. However, the potential sensitivity of glycoform distribution to synthesis enzyme localization suggests a new avenue for manipulating product glycosylation: The enzyme genes can be engineered to alter targeting of enzymes within the endoplasmic reticulum and Golgi apparatus. Calculated results indicating the conceptual feasibility of this have recently been presented [52], and amino acid sequences implicated in targeting proteins among these compartments are known [53,54], providing essential molecular reagents to undertake such “localization engineering” (!).
6.3. TECHNOLOGIES FOR EFFECTIVE GLYCOSYLATION ENGINEERING Success in metabolic engineering depends critically upon availability of a powerful set of design and implementation tools in order to define potentially effective strategies and in order to execute them. One area of genetic technology development which is potentially very important but still relatively undeveloped is antisense methodology in order to reduce expression of chosen enzymes. Experience with antisense technology and
other applications has shown that it has a greater chance of success if full length antisense messages are used, although even in this case the extent to which expression of the targeted protein will be reduced is unpredictable. Antisense technology is only
now beginning to enter the arena of animal cell technology, as presented elsewhere in this volume. 6.3.1. Antisense Reduction in Cell-Cell-Adhesion for CHO Cells No prior reports have described successful modification of the oligosaccharides synthesized by Chinese hamster ovary (CHO) cells by antisense methods. Here such a
study is summarized. A CHO mammalian cell line that stably expresses FucTVI activity and the cell-surface was previously engineered. This cell line was transfected with an antisense-Fuc-TVI full length gene. The FucTVI activity was measured in three antisense stable cell clones (anti-Fuc-TVI clones) and compared to the and
wild type CHODG44 cell lines (Table 6).
14
The three antisense clones showed different levels of reduced Fuc-TVI activity. The expression level of in the different clones was therefore investigated (Table 7). An monoclonal antibody (CSLEX-1) coupled to IgM-FITC was used for the expression assay.
The
expression in the three antisense clones was lower when compared with the cell line, and null for the wild type CHODG44. As reduced expression should result in by a lower binding capacity to, for example E-selectin, a simple adhesion assay of (transfected and untransfected) cell lines to HUVEC cells (both in the presence and absence of human recombinant which is needed to induce the expression of E-selectin) was performed. The results are shown in Table 8.
15
Anti-Fuc-TVI clones showed the expected reduced E-selectin binding capacity. These results indicate that is definitely possible to regulate the expression of the epitope by antisense technology which specifically targets the fucosyltransferase activity responsible for its synthesis. This antisense technique can be applied to other glycosyltranferases to regulate different points of the glycosylation pathway. Antisense technology of CHO cells, alone or associated with other glycosylation engineering methods, may bring new possibilities for the production of novel glycoproteins.
6.3.2. Mathematical Models of Complex Glycosylation Pathways The network of enzyme-catalyzed reactions which conduct oligosaccharide biosynthesis in animal cells is complicated by two types of general phenomena. First, it is common for a single species or intermediate in this pathway to serve as a substrate for several different enzymes, giving raise to correspondingly different further intermediates or oligosaccharide end-products. Second, certain oligosaccharide biosynthesis enzymes act on large numbers of different biosynthetic intermediates. These two features render intuitive or mental simulation of oligosaccharide biosynthesis very difficult. Therefore, mathematical models which provide a systematic representation of all of the simultaneous and competitive phenomena involved and which can suggest expected consequences from the operation of this network, or, more importantly, from perturbations in it, are indispensable for glycosylation design in the future. A first model for N-linked oligosaccharide biosynthesis has been presented recently, and its results show the types of non-obvious qualitative insight which can be obtained by this
approach [52]. The first step of the pathway has also been recently modelled [26]. This mathematical model incorporates different factors that determine the extent of the oligosaccharyl-transfer reaction and provides useful insights for the engineering of this step.
6.3.3. Vectors for Regulated Multicistronic Expression More sophisticated glycosylation engineering in the future will require coordinated expression of several sense and/or antisense messages, perhaps at a particular time in a production process. Recently, convenient multicistronic cloning and expression vectors for animal cells have been described which can be used in these applications [55].
7. Bioprocess effects on glycosylation
Although it is not the main topic of this review, a few highlights from previous research exploring interactions between the process environment of a recombinant animal cell expression system and glycosylation of product proteins may be of interest. Also, genetic engineering may play a future role in modifying these host cell responses to environmental changes in a way that makes product glycosylation less sensitive to these changes or which enhances the consistency and quality of the final recovered, purified product.
16
Bioprocess effects on glycosylation can be divided into two categories. First, certain conditions in the bioreactor influence activities within the cell, changing glycosylation of proteins secreted by those cells. Second, conditions in the bioreactor, and also in downstream processing, may influence the nature of the end product, including its glycosylation. It should be noted that the possibility of oligosaccharide modification after glycoprotein secretion from the cells has not always been considered explicitly in previous bioreactor studies, so that a rigorous assignment of the phenomena involved as intracellular or extracellular cannot be made in several cases. 7.1. EFFECTS ON GLYCOPROTEIN BIOSYNTHESIS Changes in culture conditions such as and ammonia concentration can cause shifts in the glycoform distribution produced. Several examples which illustrate such phenomena are given in the Table 9. Mechanisms responsible for coupling between external conditions and the internal, compartmentalized, enzyme-catalyzed oligosaccharide biosynthesis reactions which determine glycosylation are not defined, but some reasonable possibilities have been suggested in some situations. For example, because it is a weak base and its unionized form is freely diffusible across cellular membranes, ammonium in the external medium causes changes in intracellular of hybridoma cells [56,57,58]. This is consistent with, for example, associated changes in sialylation of O-linked glycosylation of GCSF, via the relationship of the enzyme Olinked
17
Another bioprocess-glycosylation connection has been elucidated in the elegant study of Jenkins, James, and coworkers on glycoform distributions of cloned human produced by recombinant CHO cells [65]. Glycosylation of shifted significantly as a function time of sampling during a batch cultivation. In terms of
product quality control and process consistency, this work raises profound questions and challenges for the bioprocess engineer. Such questions could be even more acute for long-term cultivations with extended times of product harvest, such as fed-batch and perfusion culture. 7.2. POST-SYNTHESIS EFFECTS
Glycoproteins exit the cell and enter the culture medium where they are exposed to other proteins secreted by the cells, proteins released from lysed cells, and probably serum proteins as well (although medium is changed between cell growth and production phases in several manufacturing processes, this does not completely eliminate serum proteins, as anyone who has tried to wash away serum proteins by extensive treatment of the cells in the laboratory before doing SDS-PAGE analysis knows). Neuraminidase, an enzyme which cleaves sialic acid residues on oligosaccharides, has been detected at potentially significant levels in recombinant CHO cell cultures, and has
been shown to reduce sialylation of secreted glycoprotein products [66]. Activities of several oligosaccharide hydrolases have been detected in insect cell (Sf9) cultures [67]. These findings invite genetic manipulation to reduce expression of these product-degrading enzymes [68].
8. In Vitro Biosynthesis
Oligosaccharide
Fractionation,
Remodeling
and
Obviously the processing pathway to the packaged product does not end with the bioreactor. Different types of technology can be applied downstream to modify glycoforms in the final product. Simplest among these are separation methods which fractionate the product into different glycoforms, allowing selective environment of
preferred molecules. Glycoforms can be fractionated to some extent on the basis of charge or hydrophobicity, while highly specific separations can be achieved using various lectins (e.g., immobilized on a chromatography matrix) which offer exquisite selectivities for a wide variety of particular glycosidic linkages [69]. Many enzymes are known, and some commercially available, which synthesize or which hydrolyze particular glycosidic bonds. These are important tools in current technologies for oligosaccharide analysis, and they are also potentially useful to accomplish in vitro modifications of glycoproteins. In the extreme case many or all of the oligosaccharides on the glycoprotein could be synthesized in vitro. One major barrier to this concept is
18
cost of the enzymes, and especially of the nucleoside sugar donor substrates required for glycosidic bond synthesis. For decades organic chemists have dreamed of replacing microorganisms for synthesis of natural products such as cephalosporin. This remains a dream, but chemistry - including
enzyme catalysis - is a vital contributor in modifying natural products to obtain an optimized pharmaceutical. It seems likely that a similar scenario will unfold concerning glycosylation. 9. Concluding Remarks
By modifying oligosaccharide synthesis processes in the production host, glycosylation engineering interacts with process and polypeptide influences to determine product glycosylation which in turn can influence many practically important functional characteristics of that glycoprotein (Figure 1). The future potential of this technology to contribute to new and improved pharmaceuticals is great. Progress in the field now is limited by lack of a greater number of cloned genes for enzymes and other proteins
involved
in
oligosaccharide
biosynthesis,
by
insufficient
knowledge
about
oligosaccharide structure-glycoprotein function relationships, and by underdeveloped tools for genetic design and manipulation of glycosylation. However, motivated by the scientific and commercial importance of this field, rapid progress in all of these areas is evident, expanding future horizons.
19 10. Acknowledgements The authors’ research in glycosylation is supported by the Swiss Priority Program in Biotechnology (SPP BioTech).
11. References 1. Bailey, J. E. 1991. Toward a science of metabolic engineering. Science 252: 1668-1675. 2. Stanley, P. 1992. Glycosylation engineering. Glycobiology 2: 99-107. 3. Gumming, D. A. 1991. Glycosylation of recombinant protein therapeutics: control and functional
implications. Glycobiology 1: 115-130. 4. Varki, A. 1993. Biological roles of oligosaccharides: all theories are correct. Glycobiology 3: 97-130. 5. Rademacher, T. W., Parekh, R. B., Dwek, R. A. 1988. Glycobiology. Annu. Rev. Biochem. 57: 785-838. 6. Lis, H., Sharon, N. 1993. Protein glycosylation: Structural and functional aspects. Eur. J. Biochem. 218: 1–27.
7. Natsuka, S., Lowe, J. B. 1994. Enzymes involved in mammalian oligosaccharide biosynthesis. Curr. Opin. Struct. Biol. 4: 683-691. 8. Goochee, C. F., Gramer, M. J., Andersen, D. C, Bahr, J. B. 1992. The oligosaccharides of glycoproteins: Factors affecting their synthesis and their influence on glycoprotein properties, p. In: P. Todd, S. K. Sikdar and M. Bier (ed.), Frontiers in Bioprocessing II. American Chemical Society,
Washington, D.C. 9. Jenkins, N., Curling, M. A. 1994. Glycosylation of recombinant proteins: Problems and prospects.
Enzyme Microb. Technol. 16: 354-364. 10. Wyss, D. F., Wagner, G. 1996. The structural role of sugars in glycoproteins. Current Opinion in Biotechnology 7: 409–416. 11. Jenkins, N., Parekh, R. B., James, D. C. 1996. Getting the glycosylation right: implications for the biotechnology industry. Nature Biotechnology 14: 975-981. 12. Dwek, R. A. 1995. Glycobiology: more functions for oligosaccharides. Science 269: 1234-1235.
13. Koenig, A., Rakesh, J., Rakesh, V., Norgard-Sumnicht, K. E., Matta, K. L., Varki, A. 1997. Selectin inhibition: synthesis and evaluation of novel sialylated, sulphated and fucosylated oligosaccharides,
including the major capping of GlyCAM-1. Glycobiology 7: 79-93. 14. Graham, R. A., Burchell, J. M., Taylor-Papadimitriou, J. 1996. The polymorphic epithelial mucin: Potential as an immunogen for a cancer vaccine. Cancer Immun. Immunother. 42: 71-80.
15. Lloyd, K. O., Burchell, J., Kudryashov, V., Yin, B. W. T., Talor-Papadimitriou, J. 1996. Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. Demonstration of simpler and fewer glycan chains in tumor cells. J. Biol. Chem. 271: 33325-33334.
16. Malhotra, R., Wormald, M. R., Rudd, P. M., Fischer, P. B., Dwek, R. A., Sim, R. B. 1995. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nature Med. 1: 237-240. 17. Misiaizu, T., Matsuki, S., Strickland, T. W., Takeuchi, M., Kobata, A., Takasaki, S. 1995. Role of antennary structure of N- linked sugar chains in renal handling of recombinant human erythropoietin. Blood 86: 4097-4104. 18. Fürst, I. 1997. Amgen’s NESP heats up competiton in lucrative erythropoietin market. Nature Biotech. 15: 940.
20 19. Fu-Kuen, L. 1996. Production of erythropoietin. U.S. patent 5,547,933.
20. Davis, S.J., Puklavec, M.J., Ashford, D.A., Harlos, K., Jones, E.Y., Stuart, D.I., Williams, A.F. 1993. Expression of soluble recombinant glycoproteins with predefined glycosylation: applications to the
crystallization of the T-cell glycoprotein CD2. Protein Eng. 6: 229-232. 21. Nishikawa, A., Ihara, Y., Htakeyama, M., Kangawa, K., Taniguchi, N. 1992. Purification, cDNA
cloning, and expression of UDP-N-acetylglucosamine: acetylglucosaminyltransferase I I I from rat kidney. J. Biol. Chem. 267: 18199-18204.
22. Lee, E. U., Roth, J., Paulson, J. C. 1989. Alteration of terminal glycosylation sequences on N-linked oligosaccharides of Chinese hamster ovary cells by expression
sialyltransferase. J. Biol. Chem. 264: 13848-13855. 23. Shao, M. C., Wold, F. 1995. The effect of the protein matrix proximity on glycan reactivity in a glycoprotein model. Eur. J. Biochem. 228: 79-85. 24. Do, K. Y., Fregien, N., Pierce, M., Cummings, R. D. 1994. Modification of glycoproteins by Nacetylglucosaminyltransferase V is greatly influenced by accessibility of the enzyme to oligosaccharide acceptors. J. Biol. Chem. 269: 23456-23464.
25. Keyt, B. A., Paoni, N. F.. Refino, C. J., Berleau, L., Nguyen, H., Chow, A., Lai, J., Peña, L., Pater, C., Ogez, J., Etcheverry, T., Botstein, D., Bennett, W. F. 1994. A faster-acting and more potent form of issue plasminogen activator. Biochemistry 91: 3670-3674. 26. Shelikoff, M , Sinskey, A. J., Stephanopoulos, G. 1996. A modeling framework tor the study of protein
glycosylation. Biotechnology and Bioengineering 50: 73-90. 27. Kumar, V., Korza, G., Heinemann, F. S., Ozols, J. 1995. Human oligosaccharyltransferase: isolation,
characterization, and the complete amino acid sequence of 50-kDa subunit. Arch-Biochem-Biophys. 320: 217-223. 28. Schachter, H. 1986. Biosynthetic controls that determine the branching and microheterogeneity of protein- bound oligosaccharides. Biochem. Cell Biol. 64: 163-181. 29. Moremen, K. W., Trimble, R. B., Herscovics, A. 1994. Glycosidases of the asparagine-linked oligosaccharide processing pathway. Glycobiology 4: 113-125. 30. Kumar, R., Yang, J., Larsen, R. D., Stanley, P. 1990. Cloning and expression of Nacetylglucosaminyltransferase I, the medial Golgi transferase that initiates complex N-linked carbohydrate formation. Proc. Natl. Acad. Sci. USA 87: 9948-9952. 31. Tan, J., D'Agostaro, A. F., Bendiak, B., Reck, F., Sarkar, M., Squire, J. A., Leong, P., Schachter, H. 1995.The human UDP-N-acetylglucosamine:alpha-6-D-mannoside-beta-l,2-N-acetylglucosaminyltransferase II gene (MGAT2). Cloning of genomic DNA, localization to chromosome 14q2l, expression in insect cells and purification of the recombinant protein. Eur. J. Biochem. 231: 317-328.
32. Yoshiada, A., Minowa, M. T., Hara, T., Takamatsu, S., Oguri, S., Iguamatsu, A., Ikenaga, H., Takeuchi, M. 1997. Two novel isoforms of N-acetylglucosaminyltransferase IV. Glycoconjugate J. 14: S46. 33. Shoeribah, M., Perng, G. S., Adler, B., Weinstein, J., Basu, R., Cupples, R., Wen, D., Browne, J. K.,
P. Buckhaults, Fregien, N., Pierce, M. 1993. Isolation, characterization, and expression of a cDNA encoding N-acetylglucosaminyltransferase V. J. Biol. Chem. 268: 15381-15385.
34. Tsuji, S. 1996. Molecular cloning and functional analysis of sialyltransferases. J. Biochem. Tokyo 120: 1-13. 35. Takeuchi, M., Kobata. A. 1991. Structures and functional roles of the sugar chains of human erythropoietins. Glycobiology 1: 337-346. 36. Yan, S. B., Chao, Y. B., van Halbeek, H. 1993. Novel Asn-linked oligosaccharides terminating in are present in recombinant human Protein C expressed in human kidney 293 cells. Glycobiology 3: 597-608.
21 37. Demnan, J., Hayes, M., O'Day, C., Edumnds, T., Bartlett, C., Hirani, S., Ebert, K. M., Gordon, K., McPherson, J. M. 1991. Transgenic expression of a variant of human tissue-type plasminogen activator in goat milk: purification and charaterization of the recombinant enzyme. Biotechnology N.Y. 9: 839843. 38. James, D. C., Freedman, R. B., Hoare, M., Ogonah, O. W., Rooney, B. C., Larionov, O. A.,
Dobrovolsky, V. N., Lagutin, O. V., Jenkins, N. 1995. N-glycosylation of recombinant human produced in different animal expression systems. Bio/Technology 13: 592-596. 39. Sawada R, Lowe J B, Fukuda M. 1993. E-selectin-dependent adhesion efficiency of colonic carcinoma cells is increased by genetic manipulation of their cell surface lysosomal membrane glycoprotein-1 expression levels. J.
Biol. Chem. 268: 12675-12681.
40. Sako, D., Chang, X. J., Barone, K. M. et al. 1993. Expression cloning of functional glycoprotein ligand for Pselectin. Cell 75:1179-1186.
41. Bierhuizen, M. F. A., Maemura, K., Fukuda, M. 1994. Expression of a differentiation antigen and poly-Nacetyllactosaminyl O-glycans directed by a cloned core 2 Chem. 269:4473-4479.
J. Biol.
42. Grabenhorst, E., Hoffmann, A., Nimtz, M. et al. 1995. Construction of a stable BHK-21 cells coexpressing human secretory glycoproteins and human Gal(-l-4)GlcNAc 2,6-sialyltransferase. -2,6 Linked NeuAc is preferentially attached to the Gal(-l-4)GlcNAc(-l-2)Man(-l-3)-branch of diantennary oligosaccharides from
secreted recombinant-trace glycoprotein. Eur. J. Biochem. 232:718-725. 43. Minch, S. L., Kallio, P. T., Bailey, J. E. 1995. Tissue plasminogen activator coexpressed in Chinese hamster ovary cells with contains Biotechnol. Prog. 11: 348-351.
44. Li, F., Wilkins, P. P., Crawley, S., Weinstein, J. et al. 1996. Post-translational modifications of recombinant Pselectin glycoprotein ligand-l required for binding to P-selectin and E-selectin. J . Biol. Chem. 271:3255-3264.
45. Wagner, R., Liedtke, S., Kretzschmar, E. et al. 1996. Elongation of the N-glycans of fowl plague virus hemagglutinin expressed in Spodoptera frugiperda (Sf9) cells by coexpression of human
acetylglucosaminyltransferase I. Glycobiology 6:165-175. 46. Grabenhorst, E., Costa, J., Conradt, H. S. 1997. Construction of novel BHK-21 cell lines coexpressing Golgi resident or soluble forms of human and together with secretory glycoproteins. In: Carrondo M.J.T., Griffits B Moreira J.L.P., eds. Animal Cell
Technology: Kluwer Academic Publishers., The Netherlands: 481-487. 47. Youakim, A., Shur, B. D. 1993. Effects of overexpression of beta-1,4-galactosyltransferase on glycoprotein biosynthesis in F9 embryonal carcinoma cells. Glycobiology 3: 155-163. 48. Prieto, P. A., Mukerji. P., Kelder, B., Erney, R., Gonzalez, D., Yun, J. S., Smith, D. F., Moremen, K. W.,
Nardelli, C., Pierce, M., Li, Y., Chen, X., Wagner, T. E., Cummings, R. D., Kopchick, J. J. 1995. Remodeling of mouse milk glycoconjugates by transgenic expression of a human glycosyltransferase. J.
Biol. Chem. 270: 29515-29519.
49. Bailey, J. E., Umaña, P., Minch, S., Harrington, M., Page, M., Sburlati, A. 1997. Metabolic engineering of N-linked glycoform symthesis systems in Chinese hamster ovary (CHO) cells, in M.J.T. Carrondo, B. Griffiths and J.L.P. Moreira (eds.), Animal Cell Tecnology, Kluwer academic publishers, Dordrecht, pp. 489-494. 50. Minch, S. L. 1996. Engineering of Protein Glycosylation in Chinese Hamster Ovary Cells: Genetic Manipulations, Global Glycoprotein Analysis, and Studies of Environmental Influences. Ph. D. Thesis, California Institute of Technology, Pasadena, California. 51. Livingston, B. D., De Robertis, E. M., Paulson, J. C. 1990. Expression of sialyltransferase blocks synthesis of polysialic acid in Xenopus embryos. Glycobiology 1: 39-44 52. Umaña, P., Bailey, J. E. 1997. A mathematical model of N-linked glycoform biosynthesis. Biotechnol. Bioeng. 55: 890-908. 53. Nilsson, T., Rabouille, C., Hui, N., Watson, R., Warren, G. 1996. The role of the membrane-spanning domain and stalk region of N-acetylglucosaminyltransferase I in retention, kin recognition and structural
22 maintenance of the Golgi apparatus in HeLa cells. J. Cell Biol. 109: 1975-1989. 54. Russo, R. N., Shaper, N. L., Taatjes, D. J., Shaper, J. H. 1992. Beta-l, 4-Galactosyltransferase: A short
NH-2-terminal fragment that includes the cytoplasmic and transmembrane domain is sufficient for Golgi retention. Journal Of Biological Chemistry 267: 9241-9247.
55. Fusseneger, M., Mazur, X., Bailey, J. E. 1997. A novel cytostatic process enhances the productivity of Chinese hamster ovary cells. Biotechnol and Bioeng. 55: 927-939. 56. McQueen, A., Bailey, J. E. 1990. Effect of ammonium ion and extracellular metabolism and antibody production. Biotechnol. Bioeng. 35: 1067-1077.
on hybridoma cell \
57. McQueen, A., Bailey, J. E. 1990. Mathematical modelling of the effects of ammonium ion on the intracellular pH of hybridoma cells. Biotechnol. Bioeng. 35: 897-906.
58. McQueen, A., Bailey, J. E. 1991. Growth inhibition of hybridoma cells by ammonium ion: correlation with effects on intracellular pH. Bioprocess Eng. 6: 49-61. 59. Andersen, D. C, Goochee, C. F. 1995. The effect of ammonia on the O-linked glycosylation of granulocyte colony-stimulating factor produced by Chinese hamster ovary cells. Biotechnol. Bioeng. 13: 98-105.
60. Hayter, P. M., Curling, E. M., Baines, A. J., Jenkins, N., Salmon, I., Strange, P. G., Tong, J. M., Bull, A.
T. 1992. Glucose-limited chemostat culture of Chinese hamster ovary cells producing recombinant interferon-g. Biotechnol. Bioeng. 39: 327.
61. Tachinaba, H., Taniguchi, K., Ushio, Y. et al. 1994 Changes of monosaccharide availability of human hybridoma lead to alteration of biological properties of human monoclonal antibodies. Cytotechnology
16:151-157.
62. Maiorella, B. L., Winkelhake, J., Young, J., Moyer, B., Bauer, R., Hora, M., Andya, J., Thomson, J., Patel, T., Parekh, R. 1993. Effect of culture conditons on IgM antibody structure, pharmacokinetics and
activity. Bio/Technology 11: 387-392. 63. Pels Rijcken, W. R., Overdijk, B., Van den Eijnden, D. H., et al. 1995. The effect of increasing nucleotide-sugar concentrations on the incorporation of sugars into glycoconjugates in rat hepatocytes. Biochem. J. 305: 865-870.
64. Borys M C, Linzer D H, Papoutsakis E T. 1993. Culture pH affects expression rates and glycosylation of
recombinant mouse placental lactogen proteins by Chinese hamster ovary (CHO) cells. Bio/Technology 11:720-724. 65. Hooker, A. D., Goldman, M. H., Markham, N. H., James, D. C., Ison, A. P., Bull, A. T., Strange, P. G., Salmon, I., Baines, A. J., Jenkins, N. 1995. N-glycans of recombinant human change during batch culture of Chinese hamster ovary cells. Biotechnol. Bioeng. 48: 639-648. 66. Gramer, M. J., Goochee, C. F., Chock, V. Y., Brousseau, D. T., Sliwkowski, M. B. 1995. Removal of
sialic acid from a glycoprotein in CHO cell culture supernatant by action of an extracellular CHO cell sialidase. Bio/Technology 13: 692-698. 67. Licari, P. J., Jarvis, D. L., Bailey, J. E. 1993. Insect cell hosts for baculovirus expression vectors contain endogenous exoglycosidase activity. Biotechnol. Prog. 9: 147-152. 68. Ferrari, J., Gunson, J., Lofgren, J., Nayak, N., Krumment, L., Sliwkowski, M., Warner, T. G. 1997. Constitutively expressed sialidase antisense RNA results in increased sialic acid on recombinant
glycoprotein expressed in Chinese hamster ovary cells. Glycoconjugate J. 14: S119. 69. Merkle, R. K., Cummings, R. D. 1987. Lectin affinity chromatography of glycopeptides. Methods Enzymol. 138: 232-259.
23
Discussion
Lupker:
An important thing about glycosylation is the in vivo function and, in this respect, are you aware of groups trying to make knock-out mice for some of the glycosylation enzymes?
Bailey:
Yes, but there was no possibility to cover this approach in this talk. This will show how host changes can be tolerated and we will probably find large sensitivities.
Lupker:
How many genetic diseases exist in humans that concern glycosylation, or are they all lethal?
Bailey:
I do not know the answer to this good question.
Bernard:
You mentioned that we have to be cautious when we produce targets in baculovirus insect cells. Do you have specific examples of proteins that we could not study in vitro function because of the specific glycosylation occurring in insect cells?
Baily:
No, this is another area where the structure/function data is absent. There are a few examples of the polypeptide structure depending upon which glycoform you have. We could question whether deglycosylated polypeptides used for X-ray structure analysis, and subsequent drug design, are the right configurations.
This page intentionally left blank.
SESSIONS ON : BIOSYNTHESIS AND POST-TRANSLATIONAL MODIFICATIONS OF RECOMBINANT PROTEINS, and CELL PHYSIOLOGY AND METABOLIC ENGINEERING OF ANIMAL CELLS
Over the last decade the expression of recombinant proteins in animal cells has evolved from a fine art reserved to specialists to almost a routine business. The focus has changed from the quantitative aspects of expression to the quality of the protein produced with a special emphasis on post-translational modifications such as glycosylation. In addition, considerable interest has now been invested in understanding, modifying and improving metabolic and synthetic pathways in animal cells. Despite the relative ease with which many recombinant proteins can be manufactured by
animal cells today, we should not forget that some proteins are extremely difficult to produce and that, for others production is far from optimal. These problems present the justification for the continuation of fundamental research on gene expression and transfection systems. Of equal importance, as discussed in the papers of the glycosylation chapter, is the effect of manipulating the environment on post-translational modifications in general, and on glycosylation in particular. Among other parameters, the carbohydrate sources and ammonium/glutamine concentrations have been shown to have significant effects. Considerable interest has now been invested in understanding and modifying (or redirecting) metabolic pathways in animal cell lines, when this cannot be achieved by cultural means. The section on metabolic engineering comprises papers dealing with the possibility for modifying the rapid glycolysis and glutaminolysis that generate high levels of waste metabolites by overexpressing the glutamine synthetase gene and thus eliminate the need for glutamine supplementation. Other matters of interest are the modification of glycosylation (novel glycoforms) of proteins by genetic engineering means. This can be achieved either by expressing new sugar transferases in cells, or by eliminating certain transferase activities by an antisense RNA-approach. Cell proliferation and apoptosis are two interlinked fundamental processes which are important for the industrial production of drugs. Therefore, these processes must be fully understood in order to be able to regulate them. On one side, cell growth should be reduced in order to increase the specific productivity. However, this can lead either to increased cell death or, in the case of induced growth reduction (IRF-1 fusion protein -
presence of estradiol leads to a growth reduction) to reduced productivity. By using genetic means, this negative effect can be avoided. The productive cell mass may be reduced by premature cell death (usually apoptotic) caused by culture stresses. Different means to reduce or avoid premature apoptosis were pre-sented, based for instance on the overexpression of bcl-2 or c-jun antisense genes, leading to a prolonged growth phase and often to an increased productivity. These papers indicate 25 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 25-26. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
26
that key cell-cycle control, and apoptosis genes and the proteins they encode provide targets for new approaches to improve large-scale production. Considering that the main reason for choosing an animal cell production system over cheaper and easier alternatives is for their ability to process proteins optimally for bioactivity as therapeutic or diagnostic agents, this area of research is very important. It should enable culture processes to become more efficient resulting in more economical and effective bioproducts. Thus the topics of both sessions on Biosynthesis and posttranslational modifications of recombinant proteins, and on Cell physiology and metabolic engineering of animal cells are very much interrelated, and represent key areas for the development of efficient and reproducible animal cell technology.
B. Griffiths, J. Lupker, M. Al-Rubeai, and J.E. Bailey Chairpersons
GENE EXPRESSION
This page intentionally left blank.
ENHANCED RECOMBINANT PROTEIN EXPRESSION IN INSECT CELLS IN THE PRESENCE OF DIMETHYLSULFOXIDE (DMSO)
LUCIANO RAMOS, JAMES F. KANE, & AMY A. MURNANE
SmithKline Beecham Pharmaceutical, Philadelphia PA, U.S.A.
1. Abstract The use of insect cells to express many recombinant homologous and heterologous proteins is reported throughout the scientific literature. A popular insect promoter is the metallothionein (Mtn) promoter which can be induced by the addition of heavy metals such as In this report we present data from Drosophila melanogaster Schneider 2 (S2) cells that have been stably transfected and express several different proteins under the control of the Mtn promoter. Selection was achieved using the hygromycin B-resistant gene derived from Escherichia coli. Our data show that such stably transfected insect cells expressing several different types of proteins, such as fusion
proteins, soluble receptors and antigens, have enhanced product expression when the cells are treated with 1% dmethylsulfoxide (DMSO) prior to induction with When DMSO is added at least 12 hours before the addition of 750 uM protein expression increased 5 to 8-fold. The addition of DMSO at other times, was not as effective in stimulating expression. Furthermore, DMSO did not affect expression from the D. melanogaster constitutive actin promoter.
2. Materials and Methods Cell lines: Three independent stable cell lines of D. melanogaster cells were selected following transfection with plasmid DNA encoding a fusion protein (S2-F), a soluble receptor (S2-R) or an antigen (S2-A) using procedures previously described (4,5). All of these genes were under the transcriptional control of the D. melanogaster Mtn promoter. Growth Medium: Growth medium is a proprietary SmithKline Beecham serum-free
insect media designated as SB insect media . Experimental conditions: Cells were propagated in 250 ml Bellco spinner flasks or Corning Erlenmeyer disposable 250 ml flasks. Cells were seeded in these flasks by means of dilution into SB insect media to attain a seeding density of about
in a volume of 100 ml per flask. Cultures were incubated at 24°C on a shaker base set at 120 RPM. Cell counts were performed using the ZM Coulter counter and
viability assessed using trypan blue dye exclusion. For production studies, cells were incubated for 3-5 days and induced at a cell density of and incubated for an additional 3-5 days. For experiments where DMSO was used, cultures were treated similarly except that DMSO was added to achieve the desired concentration used in our studies. 29 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 29-33. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
30
Product assay: Quantitation of product expressed by the various cell lines was performed using ELISA based assays
31
32
33
4. Conclusions We have examined three proteins stably expressed in D. melanogaster S2 cells under the transcriptional control of the Mtn promoter. In each case we observed that the addition of 1% DMSO 24 hours prior to induction with (see figs. 1-4) resulted in significant increases in productivity. In addition, there was no negative effect of 1% DMSO on cell viability or growth. While the mode of action of DMSO in D. melanogaster S2 cells is not understood, we propose that the effect is linked to stimulating the specific Mtn promoter used in these studies. This is based on the following observations. First, we have seen DMSO dependent increases in Mtn controlled mRNA. Second, DMSO did not affect expression from the constitutive D. melanogaster actin promoter. Third, DMSO did not effect recombinant protein expression in recombinant CHO containing constitutive promoters. Finally, Waalkes and Wilson observed that DMSO increased metallothionein expression in cultured liver cells (2). 5. References Reid S., and Greenfield P.F. 1992. Improved production of recombinant protein by the baculovirus expression system. In Animal Cell Technology:
Basic & Applied aspects, pp. 419-424. H. Murakami et al. (Eds), Kluwer Academic Publishers. and Wilson M. J. 1987. Increased synthetic capacity for metallothionein in cultured liver cells following dimethyl sulfoxide pretreatment. Experimental Cell Research 169:25-30.
and Swetly P. 1982. Interferon production in human hematopoietic cell lines: Response to chemicals and characterization of Interferon's. Journal of Interferon Research 2:261-270. A., Johansen H., Sweet, R., and Rosenberg, M. 1988. Efficient
expression of foreign genes in cultured Drosophila melanogaster cells using hygromycin B selection. Invertebrate and Fish Tissue Culture, pp. 131-134. Kuroda, Y., Kurstak, E., and Maramorosch K., eds., Springer-Verlag, Berlin. van der Straten, A., Oto, E., Maroni, G., and Rosenberg, M. 1989. Regulated expression at high copy number allows production of lethal oncogene product in Drosophila Schneider cells. Genes & Development 3:882-889. Shea, C., Sant R. G. 1997. Intravesical dimethyl sulfoxide (DMSO) for interstitial cystitis-a practical approach. Urology 49:105-107.
This page intentionally left blank.
STUDIES OF THE HEPATITIS C VIRUS RECOMBINANT PROTEIN PRODUCTION AND ITS EFFECTS ON SF-9 INSECT CELLS METABOLISM CÉLINE. M. CHARON University of Westminster, School of Biological & Health Sciences, 115 New Cavendish Street, London W1M 8JS, UK.
ABSTRACT. The recombinant hepatitis C protein BHC 11 was produced in serum-free medium using the baculovirus expression vector (BEV). Protein synthesis in suspension culture of Spodoptera frugiperda Sf-9 insect cells was achieved in controlled and uncontrolled oxygen environment. The same multiplicity of infections (MOI = 0.1 and MOI = 1) and time of infection were used in each experiment and compared. N-glycosylation of the protein was investigated with different lectins.
1. Introduction
Product productivity depends on different parameters such as, the type of medium used [1], the MOI and the time of infection. The effect of dissolved oxygen tension (D.O.T) on recombinant protein production is controversial. Maintaining a constant level of
D.O.T can improve [4] or decrease product accumulation [4, 6]. In some cases the level of D.O.T was shown to have no effect on transient protein production [3, 5]. The presence of nutrients is also important and the limiting factor for protein synthesis is still unknown. The following experiments compare the protein productivity in small scale culture (100 ml) and larger scale culture (1 L). In the latter the D.O.T was kept at 30%, the pH was monitored and nutrient consumption rates were determined. 2. Materials and Methods
2.1. SUSPENSION CULTURES In small scale culture insect cells were grown in 100 ml SF-900 Gibco medium using 250 ml shaken flasks (128 rpm). Larger scale culture experiments were performed
in a 2L stirred (70 rpm) tank bioreactor (LSL Biolafitte) and maintained under 30% D.O.T. The medium (1 L working volume) was aerated by sparging air. pH remained ~6. 35 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 35-37. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
36
Viable cell density was assessed in a Neubauer counting chamber (BDH) using the trypan blue exclusion test [7]. 2.2. PROTEIN ANALYSIS
The recombinant protein BHC11 (97 kD) was extracted at 24, 48, 72, 96 and 120 hours post infection (hpi). Transient protein expression was studied on western blots and quantified by ELISAs (Murex Diagnostics). N-glycosylation studies were carried out using two biotinylated lectins Galanthus nivalis and Concanavalin A (Vector laboratories) for ECL western blot analysis (Amersham). 2.3. BIOCHEMICAL ANALYSIS Substrates (glucose & glutamine) and product (lactate) were analysed under 30% D.O.T as previously described [2].
3. Results 3.1. PROTEIN PRODUCTION IN UNCONTROLLED OXYGEN ENVIRONMENT
Concentrations of protein BHC11 per unit volume Erleruneyer flask with MOIs of 1 (338 were found at 72 hpi (Figures 1 & 2). Western blot analysis of BHC11 with an MOI = 1 showed accumulation of the product at 48, 72 and 96 hpi.
3.2. PROTEIN PRODUCTION IN STIRRED TANK BIOREACTOR Protein production was studied for each MOI under 30% D.O.T. The volumetric productivity with an MOI of 1, produced at 48 hpi and 72 hpi was 38
37
The specific glucose consumption rate and the specific glutamine consumption rate in the first 48 hours of infection with an MOI of were higher than those recorded with uninfected cells or Sf-9 cells infected with an MOI of 0.1. The lactate concentration remained low (2 mM) in infected and uninfected batch cultures. Glycosylation studies showed that the recombinant protein BHC11 was not Nglycosylated. Western blot analyses also revealed that the recombinant protein BHC11 was more stable when using an MOI of 1 rather than 0.1 (results not shown). Recombinant protein production in batch fermentation under 30% D.O.T was limited compared with non-oxygen limited shaken flask cultures. 4. References 1. Akhnoukh R., Kretzmer G and Schügerl K. (1996): On line monitoring and control of the cultivation of Spodoptera frugiperda Sf-9 insect cells and production by Autographa californica virus vector. Enz. Microb. Technol. 18, 220-228. 2. Charon C. (1995): Infection of the insect cells Spodoptera frugtperda SF-9 with the recombinant baculovirus BHC11 in serum-free medium. In: Animal cell technology: Developments towards the 21st century. Beuvery E.C.,
Griffiths J.B and Zeijlemaker W.P. (Eds). Kluwer academic publishers. Dordrecht, pp 131-135. 3. Hensler W.T and Agathos S.N. (1994): Evaluation of monitoring approaches and effects of culture conditions on recombinant protein production in baculovirus-infected insect cells. Cytotechnology. 15, 177-186. 4. Jain D.. Ramasubramanyan K., Gould S., Lenny A., Candelore M., Tota M, Strader C., Alves K., Cuca G., Tung J.S., Hunt G., Junker B., Buckland B.C and Silberklang M (1991): Large scale recombinant protein production using the insect cell baculovirus expression vector system: antistatin and receptor. In: Spier R.E.,
Griffiths J.B., Meignier B (Eds). Production of biologicals from animal cells in culture. Butterworth - Heinemann Press. Oxford, pp 345-351. 5. Kamen A.A., Bédard C., Tom R., Perret S and Jardin B. (1996): On-line monitoring of respiration in recombinant-baculovirus infected and uninfected insect cell bioreactor cultures. Biotech. Bioeng. 50, 36-48.
6. Reuveny S., Kim Y.J., Kemp C.W and Shiloach J. (1993): Effect of temperature and oxygen on cell growth and recombinant protein production in insect cell cultures. Appl Microb Biotechnol. 38, 619-623 7. Summers M.D and Smith G.E. (1987): A manual of methods for baculovirus vectors and insect cell culture procedures. Texas Agricultural Experiments Station, and Texas A&M University, College Station. Bulletin No
1555. pp 1 0 - 1 8 .
This page intentionally left blank.
THE HUMAN MULTIDRUG TRANSPORTER (MDR1) EXPRESSED IN THE BACULOVIRUS-SF9 INSECT CELL SYSTEM 1, 2 3
SZABÓK , 1BAKOS,É., 1,2WELKER,E., 1VÁRADI,A., GOODFELLOW,H.R., 3HIGGINS,C.F., AND 2SARKADI,B.
1
Inst. of Enzymology, Hung. Acad. Sci., and 2Natl. Inst. of Haematology and Immunology, Research Group of the Hung. Acad. Sci., Budapest, Hungary; 3Inst. of Molecular Medicine, University of Oxford, UK. NIHI, Budapest, Daródczi u. 24., H-1113, Hungary
Introduction Overexpression of the human multidrug transporter (MDR1 or P-glycoprotein) is
responsible for the phenomenon of multiple drug resistance in various cancer cell types. MDR1 is an integral plasma membrane protein which acts as an ATP-
dependent efflux pump to reduce the intracellular concentration of diverse hydrophobic compounds [1]. MDR1 was described as a phosphorylated glycoprotein, but no clear role for phosphorylation in the transporter activity of MDR1 has yet been established [2,3,4,5]. The “linker” region represents the only
documented target for phosphorylation both in vitro and in vivo. We have constructed MDR1 mutants in which the serines and/or threonines in the linker region of the protein were replaced by alanincs (to prevent phosphorylation) or glutamic acid residues (to mimic the charge of permanent phosphorylation). In
one set of mutants the three serine residues phosphorylated in vivo (Ser 661, 667 and 671) were replaced to generate 3A and 3E mutants. In the other set all the eight serines and threonines providing possible additional phosphorylation sites
in the linker region were replaced ( 8A and 8E mutants), in order to investigate the possible role of secondary phosphorylations in this region. The wild-type and mutant transporters, expressed using the baculovirus-Sf9 insect cell system, were tested for their expression level and correct membrane insertion, and characterized by analyzing their ATP and drug affinity in terms of drugstimulated ATPase activity. 39 O. - W. Merten et al. (eds.). New Developments and New Applications in Animal Cell Technology, 39-41. © 1998 Khuwer Academic Publishers. Printed in the Netherlands.
40
Summary of the results The results presented here indicate that phosphorylation of serine residues in the linker region of the MDR1 modulates its interaction with the certain transported hydrophobic substrate molecules. There is no measurable effect of phosphorylation on the ATP-concentration dependence of the multidrug transporter [6]. 1. A similar high expression level of all the phosphorylation site variants could be achieved as that of the wild-type MDR1 protein, and the normal
membrane insertion pattern was also preserved for all these mutants expressed in the baculovirus-Sf9 insect cells system. 2. The maximum level of drug-stimulated MDRl-ATPase activity was similar for the wild-type and the mutant proteins using several MDRl-interacting compounds. 3. The half-maximum activation of the MDRl-ATPase activity of the mutants 3E and 8E, which mimic the phosphorylated MDR1, and the wild-type MDR1, known to be phosphorylated in Sf9 membranes, was achieved at significantly lower concentrations of verapamil, rhodamine 123 and vinblastine
than that for the nonphosphorylatable mutants 3A and 8A. Fig. 1A shows the data obtained by varying the concentration of verapamil for the 3A and 3E mutants. 4. The ATPase activation in the wild-type MDR1 and its phosphorylation mutants was indistinguishable by calcein-AM or valinomycin.
5. The kinetic analysis presented here may be interpreted to mean that MDR1 has multiple drug-interacting sites, which are characteristically modulated
by the phosphorylation of the serine residues in the linker region of this protein. In the non-phosphorylated state these sites show an apparent negative cooperativity or significantly different drug affinities, while in a fully phosphorylated form of the enzyme this phenomenon can not be observed. Fig. 1B shows data from Fig. 1A analyzed using a simple Michaelis-Menten kinetic approach and presented in a linearised (Lineweaver-Burk) plot. Fig. 1C presents a Hill plot analysis of the same data points. 6. The dependence of the MDRl-ATPase activity on ATP concentration was identical in the wild-type and the mutant proteins, and 7. Hill-plots indicated that more than one ATP-binding/interacting sites are present in the enzyme and these sites interact with a positive cooperativity. 8. The 8A and 8E mutants showed a similar behaviour in all the above experiments as their 3A or 3E counterparts, indicating that the phosphorylation of one or more of the targeted 3 serine residues is fully responsible for the druginteraction effects observed, and there is no additional role of serine or threonine phosphorylation in this region in terms of drug-stimulated ATPase activity, even if three serines are already replaced by alanines. Acknowledgements Participation of this work at the meeting was supported by ESACT.
41
References 1. Gottcsman, M.M., and Pastan, I. (1993) Anna. Rev. Biochem. 62, 385-427
2. Germann, U.A., Chambers, T.C., Ambudkar, S.V., Pastan, I., and Gottesman, M.M. (1995) J. Bioenerg. Biomembr. 27, 53-61 3. Gottesman, MM., Hrycyna, C.A.. Schocnlein, P.V., Gemann, U.A., and Pastan, I. (1995) Anna. Rev. Genet. 29, 607-649 4. Germann, U A., Chambers, T.C., Ambudkar, S.V., Licht, T., Cardarelli, C.O., Pastan, I., and
Gottcsman, M.M. (1996) J. Biol. Chem. 271,1708-1716
5 Goodfcllow, H.R., Sardini, A., Ruetz, S., Callaghan, R.. Gros, P., McNaughton, P.A., and
Higgins, C.F. (1996) J. Biol. Chem. 271, 13668-13674 6. Szabó, K., Bakos,É., Welkcr.E., Müller.M., Goodfellow.H.R., Higgins, C.F., Váradi, A., and
Sarkadi, B. (1997) J. Biol. Chem. 272, 23165-23171
This page intentionally left blank.
GLUTAMINE SYNTHETASE TRANSFECTED CELLS MAY AVOID SELECTION BY RELEASING GLUTAMINE
P.BIRD, E. BOLAM, L.CASTELL*, O.OBEID#, N. DARTON and G.HALE. Therapeutic Antibody Centre, Sir William Dunn School of Pathology, University of Oxford Old Road, Headington, Oxford, 0X3 7JT, UK. Tel +44-1865-744845 Fax +44-1865-741291. *Cellular Nutrition Research Group, Dept of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU. #Dept. of Human Nutrition, The Royal London Hospital, Whitechapel, London El 1BB.
1. Abstract Glutamine synthetase (GS) is a popular marker for selection of plasmid expression in mammalian cell lines. Positive selection is maintained simply by omitting glutamine (gln) from culture medium. We have studied the stability of GS transfectants which produce humanised monoclonal antibodies. Spent culture medium of GS transfectants contained up to gln which we conclude is released from the cells. Using a new assay to detect intracellular Ig, cells were detected with low levels of Ig after a short time of culture in medium with as little as
added gln and also in hollow fibre cultures fed with gln free
medium. These variants comprised up to 50% of the cell population and secreted very little antibody. It may be hard to maintain selection pressure in practical large scale cultures particularly in hollow fibre systems where, with a high cell density, the local gln concentrations may be substantial.
2. Introduction The Therapeutic Antibody Centre (TAC) was set up 7 years ago in Cambridge as a centre for the small scale production of therapeutic monoclonal antibodies available for clinical trials under DDX certification. Two years ago the centre moved to a new purpose-built facility in Oxford. In total more than 600g of therapeutic antibody has been produced to treat more than 3000 patients. Seven humanised monoclonal antibodies have been grown in the TAC using hollow fibre based production in seven Acusyst machines (Cellex) and an Acusyst P3X where six hollow fibre devices are incorporated in a single flowpath. Humanised antibodies have been expressed in CHO or NS0 cells using either dihydrofolate reductase or glutamine synthetase for plasmid selection. Glutamine synthetase (GS) is a popular marker for selection of plasmid expression in mammalian cell lines. Positive selection is maintained simply by omitting glutamine (gln) from culture medium (Bebbington et al 1992). The plasmid for transfection is licensed by Lonza. Using this plasmid to transfect NS0, we have produced four different humanised IgG1 antibodies. When these cell lines are grown in
hollow fibre we expect to see an increase in antibody concentration from 0.1-0.4 mg/ml in saturated cell supernatants in small scale culture to 1-4 mg/ml in the Acusyst harvest. Each cell line has a characteristic
product concentration. One of our GS transfectants (cell line 1) showed considerable variation in mean product concentration from day 50-100 post inoculation in three different runs (1.0, 1.7, and 3.1 mg/ml) whilst another (cell line 2) failed to show any significant increase in concentration of product when grown
in hollow fibre (maximum 0.3 mg/ml) compared with small scale tissue culture (0.1 mg/ml). This variability in hollow fibre production by these two cell lines has been examined. We looked for the presence of low or negative antibody producing cells in each cell line by analytical
43 O.- W Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 43-49. © 1998 Kllnver Academic Publishers. Printed in the Netherlands.
44 cloning in medium containing 0 or 1 mM gln. Additionally we developed an assay to detect intracellular immunoglobulin (ICIg) in individual cells by permeabilising the plasma cell membrane with saponin prior
to incubation in FITC conjugated anti- human Ig and assaying individual cell fluorescence on a FACScan. A considerable amount of cell death occurs in hollow fibre cell culture. Our hypothesis was that the death of high Ig producing cells may release intracellular synthesised gln that can be used by lower Ig producing cells that have downregulated both GS and Ig synthesis. Therefore we have measured gln concentrations in small scale tissue cultures and in samples taken from the extracapillary side of hollow fibre cultures of these lines.
3. Methods 3.1. MEDIA. Two types of gln free media were compared. Media 1 was IMDM (Sigma I-2762) with the standard Lonza recommended nucleoside, glutamic acid (glu) and asparagine (asn) additions. Media 2 was a special TAC formulation of IMDM lacking gln but with nucleosides and a higher level of glu (2600 and asn Dialysed fetal calf serum (Gibco ultra low Ig) was added to both media at 5%. The gln content of the FCS was below post dialysis final).
3.2. INTRACELLULAR IMMUNOGLOBULIN (ICIg) ASSAY Actively growing cells were washed into PBS and fixed in 4% formaldehyde/PBS for 15 min and then permeabilised with 0.5% saponin ( Sigma S-2149)/0.5% BSA/PBS for 30 min. Cells from hollow fibre cultures were separated first over Histopaque to enrich for live cells. Fixed cells were incubated in optimal dilution of FITC conjugated sheep anti- human IgG (Fc specific) in permabilising buffer for 30 min. After
washing the cells were resuspended in PBS/BSA/azide to close the membrane pores and fluorescence assayed on a Becton Dickinson FACScan. A sample of line1 cells grown in gln free medium was used as a positive control and non transfected NS0 cells as a negative control in every assay. During analysis of gated 'live' cells, the % positive cells (using a marker to define NS0 as <2% positive), the % strong positive cells (using a marker to define line 1 cells as >95% positive), and the geometric mean of FL1 were recorded. An additional control of staining positive cells with FITC conjugated anti-rat Ig gave similar intensity of FL1 staining as NS0. 3.3. GLUTAMINE ASSAY BY HPLC. Cell culture supernatants samples were stored frozen. Deproteinisation was performed with an equal volume of 10% sulphosalicylic acid. Amino acid derivatives of o-phthalaldehyde were separated on a Hichrom spherisorb reverse phase ODS C18 column as in Mann et al (1988). Peak areas were integrated
and amino acid concentrations calculated from peak areas by reference to the area of an internal standard homocysteine peak.
4. Results and Discussion. 4.1. INTRACELLULAR IG ASSAY. 4.1.1 Assay validation This assay distinguished high Ig producing cells (1.1A: line 1 cells d 236 in culture, from untransfected negative controls (1.1B: NSO cells d 42, by their intensity of green (FL1) fluorescence. Premixing positive and negative cells (1.1C) gave similar % of positive cells and FL1 geometric means to that seen when cells were mixed after staining (LID). Additionally, in a number of cell stability tests a drop in the FL1 geometric mean and % strong positive cells by ICIg analysis has been seen to precede a drop in secreted Ig production by about 10 days, (for example see figure 2) suggesting that
this assay is an early indicator of cell instability.
45
4.2. THE DEVELOPMENT OF LOW IG PRODUCING LINE 1 CELLS IN MEDIA WITH VARYING GLN CONCENTRATIONS. Line1 cells were passaged twice weekly in 1 ml of TAC media with gln added back from Saturated supernatants of passed cells were collected and analysed for Ig concentration by ELISA and percent of strongly positive intracellular Ig cells was also assayed with time (figure 2). At all gln
concentrations tested, low Ig producing cells developed as detected by reduced Ig production and intracellular Ig levels. Only in gln free medium were no low producers detected over 120 days of culture. As little as gln was sufficient to allow low Ig producers to survive in line 1 cultures. (Line 2 cells
developed low Ig producing cells in the complete absence of added gln (data not shown).
46
4.3 GLUTAMINE CONCENTRATIONS IN CELL CULTURES.
4.3.1 In hollow fibre culture Three different hollow fibre cultures of line1 sampled on days 153 and 214 respectively contained 50 - 90 gln in the extracapillary (cell growing) side. Considering that there is continuous dialysis across the hollow fibre it could be that the cells are bathed in higher local concentrations of gln. We have shown that line 1 cells can lose productivity in as little as gln (figure 2) and therefore local production of gln in the hollow fibres may affect productivity.
4.3.2 In flask cultures Supernatant from line 1 cell cultures in TAC medium were collected over a growth period of 15 days. Cell numbers and viability were correlated with gln levels in the supernatant (figure 3). Gln levels rose from 0 to over on day 10 of culture and this increase coincided with the loss of cell viability suggesting that release of cell synthesised gln on cell death is a likely cause of the gln detected in these cultures and also in the hollow fibre cultures. When these cell cultures were repeated in standard media with lower asn and glu concentrations, lower levels of gln(maximum were detected in the media. We are currently trying to find optimal levels of media constituents that allow high Ig production but low gln
accumulation.
47
5. Conclusions A number of factors will affect GS transfectant stability, such as integration site, copy number, and product. GS transfectants exist which retain stability in the presence of gln. Our GS transfectant cell line1
is stable for over 200 days in gln free medium when passaged twice a week in flask culture but not in the presence of or more gln nor in long term hollow fibre culture. We have shown here that GS transfectants can release up to gln into culture medium in association with cell death and that hollow fibre cultures of GS transfectants can also develop high levels of gln on the cell side. We propose
that the loss in productivity of this transfectant in hollow fibre culture results from the level of gln produced locally. This gln related instability may limit the growth of similar GS transfectants in hollow fibre devices. 6. Acknowledgements This work was funded by MRC and Leucosite inc.. We wish to thank Hilary Metcalfe and Sue Bright at Lonza for their helpful discussions and Andy Beevers for his help.
7. References Bebbington, C.R., Renner.G., Thomson, S., King, D., Abrams,D., and Yarranton G.T.. (1992) High level expression of a recombinant antibody from myeloma cells using a glutamine synthetase gene as an amplifiable selectable marker, Biotechnology 10, 169-175. Mann G.E., Smith S.A., Norman P.S.R., and Emery P.W. (1988). Fasting refeeding and diabetes modulate free amino acid concentrations in the rat exocrine pancreas: role of transstimulation in amino acid efflux,
Pancreas 3, 67-76.
48
Discussion
Ozturk:
Your data are very consistent to the original CellTech data which showed that if glutamine was present, the stability decreased. They suggested using methionine sulphoxamine. Have you tried it?
Bird:
Yes, we tried it for cell line 2, but unsuccessfully. Possibly the product is a bit more unstable for cell line 2. Also, as glutamine is
by-passing the need for glutamine synthetase and MSO blocks this enzyme as it is in such low concentrations, the fact that glutamine is around may by-pass that inhibition. Ozturk:
In your hollow fibre system you are getting 3 g/l antibody. Does the membrane cut-off affect productivity as the yield looked very high?
Bird:
We inoculate a 200 ml culture at cells and they grow in the presence of foetal calf serum, so you get a very high cell concentration within the EC side. This is what leads to the very high antibody concentration. The MW cut-off is 10,000 of the kidney dialysis membranes which we use.
Griffiths:
I am wondering whether there is a straight-forward nutritional explanation for the glutamine effects which you observe. Whether an amino acid is essential or non-essential depends upon the cell density. The higher the density, the fewer the amino acids that are
essential. Above 50 million/ml, glutamine ceases to be essential. So at the cell densities you are using, there is no advantage for the cell to have glutamine synthetase. In fact, it maybe a disadvantage, especially with all the asparagine and amides that are present. So it may well be just a question of the advantage that glutamine synthetase has for the cell is completely lost at high densities. Petrie:
Have you observed loss of glutamine synthetase activity also at low density where there is less cell death? Also, have you observed this with other cells, such as CHO and non-NS0 cells?
Bird:
Cell line 1 is a very stable producer in small-scale culture in glutamine-free medium. We have cultured them for nearly 1 year, passaging them twice weekly, and the ICIG levels remain high. Each transfectant will very slightly in its characteristics, but at low cell density there is not a problem. With CHO cells, we have not seen this problem.
49
Berthold:
I always struggle with the naming of cell lines when they are not apparently genetically stable. Assuming that the de-selection of what you see is due to genomic diversity, would it be possible to have alternative strategies to somehow constrain these cell lines to more mono-clonality? Do you have steps to ensure mono-clonality because it is well known, for these cell lines in particular, that the chromosomes are not a set but a histogram, so you have all types of de-selection possibilities?
Bird:
The easy answer is, no, we have not. We can routinely check for low IG producers. We have varied the media to see if we could get lower glutamine levels.
Berthold:
Do you use single-cell cloning from time to time?
Bird:
Yes, we set up each run from a master cell bank containing a minimum number of cell passages before freezing, although of course the hollow fibre runs are long.
Aunins:
I would have thought that you will eventually come to a steadystate even with low producing clones present. Have you run your experiments out to see if you get a steady-state population?
Bird:
This is seen clearly in cell line 2, with or without glutamine present. The percentage of high versus low producers changes very slowly, but you do get to a steady-state where the amount of glutamine produced by the high-producers is just enough and they are growing with a constant division time.
This page intentionally left blank.
STUDY OF DIFFERENT CELL CULTURE CONDITIONS FOR THE PRODUCTION OF A “RESHAPED” MAB IN NSO CELLS.
A.J. CASTILLO1, A. FERNANDEZ1, T. BOGGIANO1, P. PUGEAUD2, I. W. MARISON2. 1) Center of Molecular-Immunology (CM), P.O. Box 16040, Havana City 11600, Cuba, 2) Institute of Chemical Engineering and Bioengineering, Swiss Federal Institute of Technology, CH-1015, Lausanne, Switzerland.
Abstract: The recombinant cell line R3/T16 expresses a “reshaped” Mab against epidermal growth factor receptor (EGF-R) in NS0 myeloma. In this study the ability of two culture media to mantain good levels of growth and production of this cell line under serum reduced conditions have been compared and the effect of supplementation of aminoacids and vitamins at 1% of fetal calf serum was investigated.
Furthermore, production and growth yields of R3/T16 cell line in cultures with different macroporous microcarriers have been compared. Results showed better performances for the immobilized cell cultures in fluidized bed reactor, suggesting that such systems are suitable for a large scale production of this recombinant Mab. Introduccion
themain aims in developing commercial processes is to lower production costs by increasing unit production. To achieve this goal, high density systems capable of volumetric scale-up and long term operation are required. These aims could be obtained using culture systems with cell immobilization in macroporous microcarriers. Immobilization is also reported to improve cell specific production rate [2]. By these reasons overall aims of this study were to optimize a basal medium that could support good levels of growth and production of R3/T16 recombinant cell line at low levels of serum supplement and to test different macroporous microcarriers in order to
There are a number of problems associated with the presence of serum in culture medium used for production, including high cost, regulatory considerations and the difficulty in removing serum proteins when purifying the product of interest. By these reasons the reduction of serum supplement or the use of serum-free medium for the culture of genetically engineered mammalian cells offers many advantages. Previously it has been shown that NSO cells are cholesterol auxothrophs, that renders very difficult their adaptation to serumfree medium. However some authors have reported the use of serum-free media to culture this cell line [1]. One of 51
O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 51-53. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
52
grow this cell line in medium with low concentration of serum supplement.
and other metabolites were measured by RP-HPLC methods (4).
Materials and methods
Results
The R3/T16 cell line is a NSO myeloma that produces an humanized monoclonal antibody against EGF receptor [3]. Protein free media Turbodoma FMX-B1 (FMX Std) and HP 1 (THP1) were obtained from Dr. F. Messi, Cell Culture Technologies and all other basal media and fetal calf serum (FCS) were purchased from Gibco BRL. All other reagents were acquired from Sigma. Previously to culture experiments for
Growth curves were carried out in 6 well plates with a seed cell density of cells/ml using FMX-1 and PFHM-II serum free media supplemented with 8, 3 and 1 percent of FCS. From this study (Fig. 1) we selected Turbodoma medium, due to its best support for cell growth and production at low serum levels, Kinetic studies in T-flasks were carried out in DMEM/F-12 medium supplemented with 8 % FCS (control)
testing different medium supplements,
and in THP1 medium supplemented with
cells were passaged at least 7 days in order to adapt them. For each culture
9 and 1 % of FCS. It was observed an increase in specific glucose consumption
experiment in spinners or Tflasks cells were grown in duplicates. Cultures in well plates were carried out in triplicates. Cytopore I (Pharmacia Biotech) and Cultispher G (Hyclone) microcarriers were tested in spinner flasks (Integra Biosciences). One culture was done in the Cytopilot Mini fluidized bed reactor (FBR) with 200 ml of Cytoline I microcarrier (Pharmacia Biotech). In all cases seed density was cells/mL and culture medium was Turbodoma HP1 supplemented with 1 % of FCS. Cell count was peformed by trypan blue exclusion method. IgG concentration was measured by an anti-human heavy chain ELISA developed at CIM. Aminoacids
and lactate production rates (Table 1), when reducing serum supplement. Glutamine specific consumption rate was higher in THPl medium with respect to control. However growth and production parameters were very similar in all cases, Critical aminoacids were determined and supplemented following the criteria previously described by Stoll et al. [5]. Kinetic studies in T-flasks using THP 1 medium with 1 % of FCS and different supplements were done. Not significative differences were observed for growth and production behaviour (Fig. 2) , as well as for specific consumption and production rates of different metabolites (data not shown) with different medium supplements.
53
very similar in THP1 supplemented both with 9 or 1 % of FCS compared with control medium (DMEM-F12 + 8% FCS). Non positive effect was observed respect to biomass, cumulative product and key metabolic parameters when the adding aminoacids and vitamins, indicating that these metabolites are not limiting steps when this cell line is cultured under serum reduced conditions. R3/T16 cell culture in FBR with Cytoline I microcarriers showed the best performances respect to determined values of Qab. Further experiments with longer culture time are required in order
to investigate full potentialities of this type of system. References 1.- Keen M. J. and Steward T.W. (1995). Adaptation of cholesterol-requiring NSO mouse myeloma cells to high density growth in a fully defined protein-free
Values for overall production rates (Qab) and average IgG concentrations for cultures with different microcarriers are showed in Table 2. Best value for Qab was obtained for cell culture in FBR using Cytoline I microcarriers. Conclusions
Turbodoma culture medium showed better support for cell growth and antibody production at low serum supplement. Growth parameters were
and cholesterol-free culture medium. Cytotechnology 17; 203-211. 2.- Lee G. M. and Palsson B. O. (1990).
Immobiliization
can
improve the
stability
of
hybridoma antibody production in serum-tree medium. Biotechnology & Bioengineering 36; 1049-
1055. 3.- Mateo C., Moreno E., Amour K., Lombardero J., Harris W. and Perez R. (1997). Humanization of a
mouse monoclonal antibody that blocks the epidermal growth factor receptor: recovery of antagonistic activity. Immunotechnology 3; 71 -81. 4.- Stoll T., Pugeaud P., Von Stockar U. and Marison I. W. (1994). A simple HPLC technique for accurate
monitoring
of
mammalian
cell
metabolism.
Cytotechnology 14; 123-128. 5.- Stoll T., Muhlethaler K., Von Stockar U. and
Marison I. W. (1996). Systematic improvement of a chemically-defined protein medium for hybridoma growth and monoclonal antibody production. Journal of Biotechnology 45 (2); 111-123.
This page intentionally left blank.
INCREASING MONOCLONAL ANTIBODY PRODUCTIVITY BY SEMICONTINUOUS SUBSTITUTION OF PRODUCTION MEDIUM FOR GROWTH MEDIUM and K. ŠRÁMKOVÁ Institute of Molecular Genetics, Fundamental Cytotechnology Laboratory, CZ-14220 Praha 4, Czech Republic
Introduction Hybridoma culture in perfusion mode, both in homogeneous suspension and in heterogeneous systems, offers a daily harvest of monoclonal antibody (Mab) synthesized in a relatively small working volume by a high-density cell population over a long period of time [1]. Because high perfusion rates are needed to provide sufficient quantity of substrates and to remove toxic waste products, the simple variant of perfusion culture has some disadvantages. The Mab concentration in the harvest fluid is generally lower than that achievable in an optimized fed-batch culture. The volume of medium consumed per mass unit of the product is relatively high, and the utilization of the substrates is incomplete.
Improvements to the perfusion process have been developed based on addition of nutrient concentrates [2,3], bleeding of homogeneous perfusion cultures [2,4], or separate use of concentrated medium for feeding and buffer solution for dialysis [3]. In this work we report on the development of a semicontinuous process in which an efficient Mab batch production employs cells transferred from a cell growth modul run in perfusion mode. The philosophy of this strategy arises from the notion that optimal medium for Mab production is different from optimal medium for growth. In this process we apply the knowledge of suppression of apoptotic death by addition of some amino acids [5-10] to the cell growth medium. Daily cell bleeds from the growth modul served to set up short-term production cultures in batch mode, in the course of which the Mab concentration rose to multiples of the starting value. Material and Methods Mouse hybridoma ME-750, an IgG2a producer, was cultured in DMEM/F 12/RPMI 1640 (2:1:1) medium supplemented with BME amino acids, 2.0 mM glutamine, 0.4 mM each of alanine, serine, asparagine and proline, 15 mM HEPES, 2.0 g/1 sodium bicarbonate and with the iron-rich protein-free growth-promoting mixture containing ferric citrate [11].The values of the culture parameters were determined as described before [5-11]. The cell growth modul consisted of a strirred reactor with a working volume of 1 liter equipped with a sedimentation cone serving as the cell-retention device. The perfusion-mode hybridoma cultures were carried out at the dissolved oxygen tension of 10% air saturation. The pH was kept at the value of 7.0. 55 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 55-57. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
56
Results and Discussion Upon reaching viable cell density cells/ml the cell growth modul was run in perfusion mode Cell bleed volumes (0.3 -0.4 1) were withdrawn daily when the viable cell
density increased to cells/ml. The cell growth modul was runnig for several weeks under steady-state conditions (viability 90-95%, viable cell density cells/ml, residual glucose 8-10 mM, residual glutamine 1-2 mM, ammonia 4-5 mM, lactate 15-20 mM and Mab concentration 80-110mg/l). Batch cultures were initiated by supplementing the cell bleed withdrawn from the growth modul with a volume of fresh medium and with essential amino acids (Figs. 1 and 2). Our novel strategy changes substantially the functions of perfusion and batch modes in the process (Table 1).
Conclusions
1. A hybridoma perfusion culture can be maintained at steady state (viability >90%, cell density up to cells/ml) for arbitrary time period, thanks to the enrichment of the medium with apoptosis-suppressing amino acids, and to the application of a high cell bleed rate. 2. The perfusion cell growth modul with a working volume of 1.0 1 can serve as a source of cells available daily for initiation of short-term batch cultures. 3. Due to high initial cell density, and substantial exhaustion of nutrients in the growth medium, the batch cultures behave as if initiated at their stationary phase.
57
4. If the medium is sufficiently enriched with the building stones ofthe Mab molecule, i.e. the essential amino acids, and with the main energy source, glutamine, the synthesis of Mabs proceeds at high specific rate. The exhaustion of glutamine, but not of glucose, acts as the stopsignal for Mab synthesis. 5. The Mab concentration in the medium harvested from the batch cultures is several-fold higher than in the medium harvested directly from the perfusion cell growth modul. Acknowledgement. The work was supported by the Contract No. BIO4 CT95-0207 of the Commision of the EC , DGXII/ Contract No. OK120 of the Czech State Budget, and the Grant No. I/68957 of the Volkswagen Foundation. References 1. Griffiths, IB. (1992) Animal cell culture processes - batch or continuous. J. Biotechnol. 22, 21-30. 2. Büntemayer, H., Wallerius, C., and Lehmann, J. (1992) Optimal medium use for continuous high density perfusion processes. Cytotechnology 9, 59-67. 3. Pörtner, R., Lüdemann, I. and Märkl, H. (1997) Dialysis cultures with immobilized hybridoma cells for effective production of monoclonal antibodies. Cytotechnology 23, 39-45. 4. Hiller, G.W., Clark, D.S. and Blanch, H.W. (1993) Cell-retention-chemostat studies of hybridoma cells: Analysis of hybridoma growth and metabolism in continuous suspension culture on serum-free medium. Biotechnol. Bioeng. 42, 185-195. 5. F. (1995) Starvation-induced programmed death of hybridoma cells: Prevention by amino acid mixtures. Biotechnol. Bioeng. 45, 86-90. 6. F., and K. (1997) Unbalanced media for hybridoma cell culture: an alternative reality, in M.J.T. Carrondo et al. (eds.), Animal Cell Technology. From Vaccines to Genetic Medicine, Kluwer Academic Publishers, Dordrecht, pp. 675-680. 7. F., and ChládkováK. (1995) Apoptosis and nutrition: Involvement of amino acid transport system in repression of hybridoma cell death. Cytotechnology 18, 113-117. 8. F. and K. (1996) Cell suicide in starving hybridoma culture: survival-signal effect of some amino acids. Cytotechnology 21, 81-89. 9. F., and K. (1996) Protection of B lymphocyte hybridoma against starvation-induced apoptosis: survival-signal role of some amino acids, Immunol. Lett. 52, 139-144. 10. F., and K. (1997) Amino acid signaling for growth or death, in K. Funatsu et al. (eds.), Animal Cell Technology: Basic & Applied Aspects, Vol.8, Kluwer Academic Publishers, Dordrecht, pp. 131-135. 11. F., Vomastek, T. and J. (1992) Fragmented DNA and apoptotic bodies document the programmed way of cell death in hybridoma cultures. Cytotechnology 9, 117-123.
This page intentionally left blank.
EXPRESSION OF RECOMBINANT HUMAN INSULIN IN CHINESE HAMSTER OVARY CELLS IS COMPLICATED BY INTRACELLULAR INSULIN-DEGRADING ENZYMES
S.C.O. PAK, S.M.N. , M.J. SLEIGH* & P.P. GRAY Department of Biotechnology and the CRC for Biophurmaceutical Research, University of New South Wales, Sydney 2052 Australia; of Molecular Oncology, Westmead hospital; *Peptide Technology Limited, Sydney 2009, Australia
Abstract
To investigate the role of insulin degrading enzymes in heterologous insulin gene expression, Chinese hamster ovary (CHO) cells were transfected with a mammalian expression vector carrying the cDNA for the human pre-proinsulin under the control of the RSV promoter. Stable transfectants were isolated and characterised in regard to insulin transcription, translation, processing and secretion. Levels of insulin expressed by these cells were extremely low, peaking at around cells/24 hours. Analysis of the secreted product indicated inefficient processing with less than 10% of the total product being fully processed. degradation assays revealed insulin degrading activity in the cytosol and in the conditioned medium of CHO cells. In both cases the insulin degrading activity was significantly inhibited by the addition of bacitracin, a peptide antibiotic and an inhibitor of insulin degrading enzyme (IDE). No noticeable effects were seen with the addition of a general protease inhibitor, PMSF. When transfected CHO cultures were supplemented with small quantities of bacitracin insulin expression improved considerably. These results combined support the hypothesis that IDEs are directly involved in inhibiting overexpression of recombinant human insulin in transfected CHO cells. Introduction
Insulin is a potent mitogenic protein naturally synthesised by endocrine islet cells of the pancreas. Although insulin expression has been extensively studies in many different mammalian cell lines, attempts to overexpress insulin in non-endocrine cell lines have largely been unsuccessful (Groskreutz et al., 1994; Moore et al., 1983; Quin et al., 1991; Vollenweider et al., 1992). The reason for this is currently unclear.
Insulin degrading enzymes (IDE) are neutral thiol metalloproteinases that are involved in specifically degrading insulin molecules (reviewed by Duckworth, 1988). When insulin binds to it's receptors on the cell surface a wide range of metabolic/anabolic pathways are 59 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 59-67. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
60
stimulated. This is followed by endocytosis of the receptor-ligand complex to form an intracytoplasmic vesicle called an endosome. The pH in the endosoine rapidly drops to 5.6 resulting in dissociation of the insulin-receptor complex. Although some receptors are degraded, the majority are recycled to the cell membrane. The internalised insulin, on the other hand, undergoes rapid degradation by insulin-specific enzymes that are present in the cytosol. A large number of cells (including the liver, kidney, muscle, pituitary and fibroblast) are known to be rich in IDEs. To investigate the role of insulin degrading enzymes in recombinant insulin expression in non-endocrine cells, CHO cells were transfected with a mammalian expression vector carrying the human preproinsulin cDNA under the control of the RSV promoter. Consistent with previous reports, insulin expression and processing by recombinant CHO cells was extremely poor. Further characterisation revealed considerable insulin degrading activity in the cytoplasm and culture supernatant of CHO cells. In this report we provide evidence to support the hypothesis that intracellular IDEs complicate overexpression of recombinant human insulin in transfected CHO cells. Materials and Methods
Cell Culture. Recombinant CHO cells expressing human insulin were generated by transfecting CHO-K1 cells (ATCC CCL-61) with a plasmid (pRSVIns) carrying the human pre-proinsulin cDNA under the control of the RSV promoter. The basal medium used in this paper is a custom-made preparation from Gibco (USA) which consisted of a 1:1 mix of Dulbecco's Modification of Eagle's Medium (DMEM) and Coon's F12 medium supplemented sodium selenite and is refer to in this paper as serumfree (SF) medium. Recombinant CHO-Ins cells were cultured in serum-free medium supplemented with human apo-transferrin (Sigma, USA) and is referred as SF+Tf. Sample Collection. To assess the recombinant cell lines for the production of insulin, conditioned medium was collected from confluent T-75 cultures. Cells were grown to confluence in 10% FCS medium, rinsed twice with PBS and incubated in 10 ml SF+Tf for 24 hours. Cell lysates were prepared by directly applying 10 ml of lysis buffer [140 mM NaCl, 4 mM KC1, 1 mM NaPO4, 20 mM Tris (pH 7.4), 1% NP-40, PMSF] to the cells. Culture supernatant and cell lysates were clarified by centrifugation and stored at -20 °C until required. Analysis of insulin mRNA in CHO cells. Cytoplasmic RNA from CHO cells were analysed for insulin mRNA by Ribonuclease Protection Assay (Ambion, Inc., Texas) or by Northern blot as previously described (Hunt et al., 1996). Analysis of insulin. Insulin in the cell lysate and in the culture supernatant was measured by an automated Microparticle Enzyme Immunoassay (MEIA) courtesy of Mr Kris Tan (Royal Prince Alfred Hospital, Sydney) and by an immunoenzymetric assay using a
61
MEDGENIX INS-EASIA kit ( M E D G E N I X Diagnostics). Total immunoreactive insulin (IRI) was measured by a radioimmunoassay (RIA).
degrading assay. A confluent monolayer of cells from a T-flask was detached and washed with ice-cold PBS before centrifuging at 2000 rpm for 2 minutes to pellet the cells. The pellet was then resuspended in 3 ml ice-cold Buffer A (10 mM Tris-Cl, 10 mM KC1, 0.06% pH 8.1) and homogenised for 20 minutes on ice. The homogenate was spun at 14,000 rpm for 60 minutes at 4 °C to pellet cellular debris. A small aliquot of the supernatant was removed for determination of protein concentration using a BioRad protein assay kit. A of the cytosolic fraction was preincubated with of Buffer B (125 mM potassium phosphate, 0.25% BSA, pH 7.4) and of a protease inhibitor (PMSF: 100 mM; Bacitracin: 350 units/ml) for 20 minutes at 37 °C. A no protease inhibitor control was also included for comparison. After the preincubation, of insulin [ICN] was added to each tube and incubated at 37 °C for 0, 15, 30, 50 and 80 minutes. Reactions were stopped at the specified times by addition of ice-cold 40% TCA. Following incubation on ice for 30 minutes the tubes were centrifuged for 20 minutes at 14,000 rpm. Supernatant was discarded and the radioactivity in the pellet was measured using a Packard Auto-Gamma 5650 counter. The decrease in the radioactive counts in the pellet indicated the extent of insulin degradation. Conditioned medium for insulin degradation assay was prepared by culturing CHO-K1 cells in roller bottle containing 10% FCS. Upon reaching confluence, cells were rinsed twice with PBS and incubated in 50 ml of SF medium for 24 hours. After centrifugation, culture supernatant was preincubated with or without of 350
units/ml solution of bacitracin for 20 minutes at 37 °C. Assays were then initiated by addition of of insulin [ICN] to each tube. After incubation at 37 °C for 0, 15, 30, 60, 90 and 120 minutes, reactions were stopped and the radioactivity
in the pellet measured as described above. Results and Discussion
Expression of Insulin by CHO-Ins cells To generate stable insulin-expressing cells, of pRSVIns and DNA were co-transfected into CHO cells and exposed to of active G418 for 6 weeks. Individual clones (78) were isolated by limiting dilution and tested for insulin expression by RIA. Consistent with previous studies (Yanagita et al., 1992; Vollenweider et al., 1992), levels of insulin expressed were extremely low with less than 7 ng of cells/24 hours being produced by the best clone (Figure 1, A). In an effort to delineate the factors involved in the low level expression of insulin, cytoplasmic RNA from CHO-Ins cells were analysed by Northern blot. Insulin-specific mRNA was detected in ail the transfected cells but not in the control indicating active transcription of the stably integrated genes (Figure 1, B).
62
Characterisation of secreted insulin
To determine whether CHO cells processed insulin correctly, CHO-Ins conditioned medium was analysed using methods which distinguish mature (fully processed) insulin from partially processed intermediates. Results indicate that over 90% of the total immunoreactive insulin secreted by CHO cells is partially processed, mainly in the form of proinsulin (Figure 2). In an attempt to improve furin processing, site-directed mutagenesis was explored to change the DNA sequence at the C-peptide/A-chain junction of the insulin gene from Leu-X-Lys-Arg to the optimal furin cleavage sequence Arg-X-Lys-Arg. Although cells transfected with the mutated insulin gene processed insulin well, the overall levels of insulin expressed remained below degradation by CHO cell extract To investigate the possibility of intracellular insulin degradation, known amounts of
radiolabelled were incubated with of cytosolic CHO cell extracts over a period of 80 minutes in the presence and absence of protease inhibitors (Figure 3). In the absence of any protease inhibitors, greater than 95% of the added insulin was rapidly
degraded as measured by a decrease in radioactivity of the TCA precipitated intact insulin
(a). In the presence of PMSF, a general protease inhibitor, degradation was only slightly inhibited (b). However, in the presence of bacitracin, a peptide antibiotic and an inhibitor of insulin degrading enzyme (IDE), insulin degradation was almost completely inhibited (c). These results indicate that there is substantial insulin degrading activity in the cytosol of CHO cells and that the majority of that activity is due to IDEs. degradation by CHO culture supernatant
To test for insulin degrading activity in the conditioned medium of CHO cells, insulin degradation by cell-free, conditioned medium was measured at 37 °C in the presence and absence of bacitracin (Figure 4). In the absence of any protease inhibitors, the CHO conditioned medium degraded 80% of the added within 2 hours of incubation (a). On the other hand, when labelled insulin was co-incubated with bacitracin, degradation was significantly inhibited (b). Effect of Bacitracin on recombinant insulin secretion
degradation experiments have indicated that there is significant insulin degrading activity in the CHO cell extract and culture supernatant. To determine whether these enzymes are involved in inhibiting expression of recombinant human insulin in CHO cells, transfected CHO cells were cultured in SF+Tf medium with various concentrations of bacitracin (Figure 5). In the absence of any bacitracin, CHO-Ins cells expressed 0.13 pmoles of cells/24 hours. In comparison, the same cells cultured in the presence of bacitracin showed improved insulin expression proportional
63
to bacitracin concentration. When bacitracin was present at a concentration of 1 mg/ml, insulin expression was shown to improve by around 250%. Conclusion
Recombinant insulin expression has been extensively studied in a number of different mammalian host cell lines. Whilst endocrine cells express insulin well, attempts to overexpress insulin in non-endocrine cells have largely been unsuccessful. Although insulin remains as the most well studied protein, the factors influencing its expression in non-endocrine cells have not been fully established. In an effort to investigate the role of IDEs in heterologous insulin expression, we transfected CHO cells with a plasmid expressing the cDNA for human preproinsulin. Active transcription of the stably integrated insulin gene was confirmed by Northern blot analysis (Figure 1. B). Consistent with previous studies, the levels of insulin expressed were below cells/ 24 hours (Figure 1. A). Analysis of the conditioned medium revealed inefficient insulin processing as indicated by the presence of insulin and proinsulin at a ratio of 1:9 (Figure 2). The inefficient processing was thought to be due to the presence of a suboptimal furin recognition sequence at the C-peptide/A-chain junction of the insulin molecule. Thus to improve insulin processing site-directed mutagenesis was explored to alter the furin recognition sequence. By changing one amino acid, from leucine to arginine, it was possible to improve insulin processing considerably (up to 100% efficiency). However, despite this improvement, the overall levels of insulin secreted did not improve (data not shown).
Insulin-degrading enzymes (IDEs) are enzymes involved in switching off the insulin signal by rapidly degrading internalised receptor-bound insulin. Considerable insulin degrading activity was detected in the cytosol of CHO cells as measured by the degradation of insulin by the CHO cell extract (Figure 3). Analysis of the
cell extract showed presence of IDEs as determined by bacitracin inhibition of insulin degradation. It may be possible that these enzymes are rapidly degrading newly synthesised recombinant insulin and thus prevent the release of intact insulin. Although pulse-chase studies would provide concrete evidence for intracellular insulin degradation, attempts were frustrated by the low levels of insulin expressed by these cells. Instead, evidence for the involvement of IDEs was provided by monitoring insulin expression by cells cultured in the presence and absence of bacitracin. In the presence of bacitracin, intracellular IDEs were inhibited resulting in improved insulin expression in a manner dependent on bacitracin concentration (Figure 5). Investigations are currently under way to identify the sites of IDE binding and cleavage. It is believed that introducing favourable mutations at these sites will reduce intracellular degradation and improved insulin expression. Some evidence for this has already been supplied by Groskreutz and colleagues (1994). These investigators obtained better insulin expression by altering the amino acid at position B-10 from histidine to aspartic acid. By introducing further mutations to the insulin gene it may be possible to engineer an insulin molecule that is completely resistant to IDE degradation.
64
65
References Duckworth, WC (1988) Insulin Degradation: mechanisms, products and significance. Endocrine Reviews 9: 319-345 Groskreuiz DJ, Sliwkowski MX and Gorman CM (1994) Genetically engineered proinsulin constitutively processed and secreted as mature, active insulin. J Biol Chem 269:6241-6245 Hunt SMN, Tail AS, Gray PP and Sleigh MJ (1996) Processing of mutated human proinsulin to
mature insulin in the non-endocrine cell line, CHO. Cytotechnology 21:279-288 Moore H-PH, Walker MD, Lee F and Kelly RB (1983) Expressing a human proinsulin cDNA in a mouse ACTH-secreting cell. Intraccllular storage, proteolytic processing and secretion on stimulation. Cell 35:531-538 Quin D, Orci L, Ravazzola M and Moore H-PH (1991) Intracellular transport and sorting of mutant human proinsulin that fails to form hexamers. J Cell Biol 113:987-996 Vollenweider F, Imiinger JC, Gross DJ, Villa KL and Halban PA (1992) Processing of proinsulin by transfected hepatoma (FAO) cells. J Biol Chem 267:14629-14636 Yanagita M. Hoshino H, Nakayama K and Takeuchi T (1993) Processing of mutated insulin with
tctrabasic cleavage sites to mature insulin reflects the expression of furin in nonendocrine cell lines. Endocrinology 133:639-644
66
Discussion
Barteling:
You are working with human insulin. Did you try to incorporate
hamster-type insulin as the system might work differently? Pak:
We have not tried that but other groups have used rats and insulin from various other species. They have all found similar results.
Ozturk:
What happens if insulin is not added to the cells? Can you select a clone that is insulin independent?
Pak:
The isolation of insulin independent mutants has been tried successfully. However, the growth rates were considerably slower and since the cell line was intended for recombinant biopharmacological production, it was essential to get a fast growing cell.
Sasaki:
You add insulin to stimulate CHO cell growth or to maintain viability. Does bacitracin stimulate cell growth?
Pak:
No, bacitracin at high concentrations will inhibit cell growth. I included it in this talk to demonstrate that insulin-degrading enzymes were involved in preventing insulin expression in CHO cells. We have expressed ILGFI, and that escapes degradation and stimulates cell growth.
Aunins:
I want to clarify a previous answer on insulin mutants. As I understand it, you did your selection in just G418. Did you have insulin present when selecting your clones?
Pak:
It was present.
Ryll:
With insulin being a secreted protein targeted to the Golgi, how do you envisage the intracellular cytosolic activity as being responsible for the degradation?
Pak:
Although the majority of the insulin-degrading activity is found in the cytosol, there are insulin-degrading enzymes in the cell membrane and also in the culture supernatant. Those enzymes were also preventing the accumulation of insulin extracellularly.
67
Bader:
You describe how the insulin is taken up by receptors and goes into an endosome, and is then suddenly degraded by a cytosolic enzyme. How is that possible? Why would insulin not permeate through the membrane? What is your definition of cytosolic?
Pak:
Although insulin is internalised through vesicles, these enzymes have been shown to be permeable and do enter and cleave these molecules.
Meade:
I am interested to know why someone is interested in making insulin in mammalian cells since E. coli produces it so well. We tried to do it in milk and got 20 mg/ml. The animals get in trouble but we had no problems in getting it secreted out. So does it just happen in a tissue culture system rather than in a natural system?
Pak:
Endocrine cells are quite capable of producing insulin but, unfortunately, CHO cells are not endocrine, therefore they lack the necessary functions to easily secrete insulin.
This page intentionally left blank.
HIGH YIELD EXPRESSION OF RECOMBINANT PLASMA FACTORS: USE OF RECOMBINANT ENDOPROTEASE DERIVATIVES IN VIVO AND IN VITRO U. SCHLOKAT1,3, A. PREININGER 1 , M. HIMMELSPACH 1 , G. MOHR 1 , B. FISCHER 2 , AND F. DORNER Departments of Molecular Cell Biology1 and Protein Chemistry2, Biomedical Research Center, IMMUNO AG, Uferstr. 15, 2304 Orth/ Donau, AUSTRIA; for correspondence3: e-mail
[email protected]; fax +43-2212-2716; phone +43-1-20100-4144
1. Abstract Posttranslational proteolytic processing steps are often required to render proteins mature and functionally active. However, upon high yield expression of recombinant forms of these proteins, proteolytic processing becomes severely l i m i t i n g . In this report, the mammalian endoprotease Furin was used in order to achieve complete processing of recombinant von Willebrand Factor and Factor X precursors. Significant processing of rvWF was found to be mediated primarily by naturally secreted 'shed' rFurin accumulating in the cell culture supernatant, rather than intracellularly, upon coexpression. Coamplification of rvWF/rFurin resulted in increases in rvWF yield but, at best, maintenance of rFurin expression, implying that rFurin becomes lethal to its host cell upon overexpression. In order to establish a system allowing for the processing of large quantities of recombinant protein precursor molecules with comparably small amounts of rFurin molecules in vitro, C-terminally truncated, epitope-tagged rFurin derivatives were constructed. The fate of these molecules upon expression was investigated and suitable candidates were purified to homogeneity by a one step procedure. These molecules were used for in vitro processing in solution, in reactions consisting solely of defined components, and allowing for recycling and re-use of the rFurin. Initial attempts towards the development of a downstream processing system employing matrix bound rFurin indicate that complete proteolytic processing of large amounts of precursor molecules by small quantities of rFurin is feasible. 2. Introduction High yield expression of desired biopharmaceuticals is routinely achieved by amplification of the foreign gene/cDNA copies in their host cell. Unfortunately, posttranslational modifications, such as or proteolytic processing, which frequently are required for maturation and/or exertion of functional activity, often become limiting at overexpression. Human von Willebrand Factor (vWF) and Factor X (FX) are glycoproteins circulating in the blood which exhibit pivotal functions in haemostasis: vWF mediates adhe69 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 69-76. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
70
sion of platelets to the subendothelium at the site of injury, is involved in platelet-platelet interactions, and stabilizes circulating Factor VIII. The conversion of FX to FXa is a mandatory reaction in the coagulation cascade ultimately leading to the formation of the fibrin clot. vWF and FX require proteolytic removal of a propeptide for maturation; in addition, processing of the single chain precursor to the light and heavy chains is necessary in order to render FX functionally active. Upon overexpression of recombinant vWF 1 (rvWF) and these proteolytic cleavage reactions become limiting. The mammalian endoprotease Furin 3 has recently been shown to mediate processing of a variety of plasma proteins, e.g. rFIX and rProtein C precursors, C-terminal to the consensus cleavage site arg - x - lys/arg - arg. Here, we describe the construction, expression, and fate of full length and truncated rFurin molecules and their use in order to achieve complete processing of desired precursor molecules in vivo upon coexpression as well as in vitro. 3. Results
3.1. PROTEOLYTIC PROCESSING IN VIVO: CO-EXPRESSION OF RvWF AND WILDTYPE RFURIN CHO cell clones expressing rvWF were established; these cells secreted x day. As shown in Fig. 1, only propeptide free, completely processed rvWF molecules were detectable in the conditioned medium derived from individual cell clones. Upon dihydrofolate reductase/methotrexate mediated amplification, rvWF expression increased to x day at At this expression level, however, propeptide removal by the endogenous proteolytic machinery had become insufficient: approximately 50% of the secreted rvWF molecules still possessed the propeptide (Fig. 1 A).
In an attempt to improve propeptide removal in intermediate yield CHO-rvWF cells, a CHO-rvWF cell clone, secreting x day, was further transfected with a vector mediating human wild-type, full length rFurin expression. Cell clones isolated from this transfection exhibited different degrees of rvWF precursor processing due to their varying degrees of individual rFurin expression (Fig. 1B). A CHO-rvWF/rFurin cell clone exhibiting complete rvWF precursor processing in 24 hour supernatants was further characterized4. Unexpectedly, significant amounts of rvWF precursor molecules were detectable upon frequent media changes, e.g. every 8 hours, but the precursor was absent from subsequent 24 hour supernatants (Fig. 2, top left panel) 5 . In contrast, 8 hour and 24 hour conditioned media derived from CHO-rvWF cells did not reveal any significant changes in the rvWF precursormature rvWF ratio when compared to each other (Fig. 2, top right panel).
In conditioned media derived from CHO-rvWF/rFurin cells, significant amounts of rFurin were identified (Fig. 2, lower left panel). Even though Furin resides, via its trans-membrane domain, mainly in the trans-Golgi network, a naturally secreted form termed 'shed' Furin has recently been identified6-8. This form results from proteolytic cleavage N-terminal to its transmembrane domain. The degree of rvWF propeptide removal correlated well with the amount of 'shed' rFurin in the conditioned media. Subsequent mixing experiments employing conditioned media containing rvWF precursor molecules and shed rFurin confirmed that the 'shed' rFurin mediated
71
rvWF propeptide removal in vitro 5 , contrasting previous reports by others using an experimentally truncated and slightly larger rFurin molecule 9,10. By titration western blotting, rFurin levels were found to exceed endogenous Furin levels by at least a factor of 100 (not shown). Since intracellular rFurin did not noticeably contribute to processing despite this enormous overexpression, the enzyme might either be miscompartmentalized or non functional/silenced, as long as it is located intracellularly, and activated or accessible only once it is extracellular 11.
A variety of attempts to establish CHO-rvWF/rFurin high yield coexpressing clones upon rvWF/rFurin/dhfr triple transfection and subsequent amplification failed. While the rvWF yield could be improved, rFurin expression always uncoupled, resulting in expression of propeptide containing rvWF molecules, although at higher yields (not shown). Presumably, the failure to increase the rFurin yield any further resulted from rFurin becoming lethal to its host cell upon overexpression 12 . The ability to process large amounts of rvWF precursor therefore requires the establishment of an efficient in vitro processing procedure. 3.2. PROTEOLYTIC PROCESSING IN VITRO: USE OF RFURIN DERIVATIVES In order to produce sufficient quantities of rFurin for purification, a variety of C-terminally truncated rFurin molecules were constructed. To test the function of these molecules, they were transiently expressed in 293 HEK cells, as summarized in Fig. 3. Removal of the transmembrane domain that anchors Furin in the membrane of the trans-Golgi network resulted in enhanced secretion of rFurin molecules into the cell
72
culture supernatant. Interestingly, rFurin molecules with deletions affecting amino acids N-terminal to amino acid residue 577, i.e. the 'middle' domain , were strongly expressed intracellularly; however, secreted forms of these derivatives were not detected in the conditioned medium, indicating either blockage of secretion or, alternately, rapid degradation during the secretory process.
Expression of resulted in the secretion of two molecular species, visualized as a double band in western blots. The lower/faster band migrated at a position identical to that exhibited by shed rFurin. Thus, it can be concluded that the cleavage site in rFurin leading to shed rFurin is located in the vicinity of and N-terminal to amino acid 708 (not shown). When permanently expressed in CHO cells, trans membrane domain deleted rFurin molecules generally led to 10 to 20 fold increased amounts of secreted rFurin compared to wt/shed rFurin expression.
In order to facilitate purification, poly-histidine epitopes were added to the C-termini of the deletion mutants and separated from the residual rFurin sequence by spacers of varying length. Interestingly, one construct in which eight histidines were substituted with a threonine/isoleucine rich stretch of amino acids was not secreted any longer. Thus, very few amino acids at the C-terminus may decide upon the molecules' fate and/or intracellular destination. cell clones were established, and from serum free conditioned media was purified to homogeneity on a matrix by a one step procedure as seen in Fig. 4A. The peak functional activity, determined by a fluorogenic Furin specific substrate test5, and the Furin immunoreactive material in a western blot coincided with the 200mM and 500mM
73
imidazole eluates; Furin is the only protein band in these fractions, as visualized by
silver staining.
After dialysis to remove the imidazole, purified and rvWF precursor were mixed in a buffer containing ions. Under these defined minimal conditions, rvWF precursor was successfully processed (Fig. 4B). A mockpurified preparation from unmanipulated CHO cells did not mediate rvWF precursor processing.The polyhistidine tail allows for easy re-purification of the rFurin derivative upon completion of the processing reaction. Thus, this enzyme can be 'recycled'.
In this manner, small quantities of rFurin can be used for the maturation of large amounts of recombinant target molecules. Similarly, both rFX propeptide removal and the processing of the single chain precursor to the heavy and light chains were successfully performed by rFurin derivative in vitro. Strikingly, the rFX propeptide, which does not contain a typical Furin site, is cleaved by a different endoprotease, as determined by expression in Furin deficient CHO cells and subsequent purification2. With the aim of establishing an industrial scale in vitro processing procedure, the histidine tagged rFurin molecules were tested for their functional activity when bound to the resin. Initial experiments employing matrix bound and a Furin specific fluorogenic substrate5 demonstrated successful substrate conversion and, hence, the feasibility of this approach. Optimization of the length and sequence of the spacer between the epitope and the residual rFurin sequence, and choice of resin, e.g. tentacle-gels, will allow proteoly-
74
tic maturation of large amounts of incompletely processed recombinant protein precursors by small quantities of rFurin.
4. Summary
In high yield CHO-rvWF cell clones, removal of the propeptide from rvWF precursors was incomplete. Additional wild-type, full length rFurin expression in these cells improved processing. Unexpectedly, complete rvWF precursor processing was mediated by a naturally secreted form of rFurin, termed 'shed' rFurin, in the conditioned medium. The contribution of intracellular wild-type rFurin was limited despite tremendous overexpression of this enzyme compared to endogenous Furin. Attempts to further improve rFurin expression by amplification did not meet with success, presumably due to toxicity of rFurin to its host cell upon overexpression. In contrast, rvWF amplification could successfully be demonstrated. In order to achieve complete processing of large amounts of rvWF precursor with comparably small amounts of rFurin, the use of rFurin for in vitro processing was
investigated. A variety of C-terminally truncated and, hence, secreted, epitope-tagged rFurin derivatives were constructed and expressed. The extent of the truncation, the type and length of the spacer between the residual rFurin sequence and the epitope, and the amino acids constituting the new C-terminus determined the fate of the
rFurin derivatives upon expression and their individual properties. Using a one step
75
procedure, rFurin derivatives were purified to homogeneity and used in in vitro recombinant target protein precursor processing reactions consisting solely of defined components. Preliminary experiments have demonstrated the feasibility of resinbound rFurin mediated in vitro processing. 5. Acknowledgements We are grateful to Wim van de Yen, John Creemers, and Stephen Leppla for material, Gary Thomas, Nabil Seidah, Anton Roebroek and Wolfgang Garten for discussions, and Carol P. Gibbs for critical reading of the manuscript. 6. References 1. Fischer B, Mitterer A, Schlokat U, DenBouwmeester R, Dorner F (1994). Structural analysis of rceombinant von Willebrand factor: identification of hetero- and homonmultimers. FEBS Lett. 351: 345 - 348. 2. Himmelspach M, Pfleiderer M, Fischer B, Antoine G, Gritschenberger W, Falkncr FG, Schlokat U, Dorner F. Recombinant Human Factor X: High Yield Expression And Maturation By Furin Mediated In Vitro Processing. Submitted. 3. Van de Ven WJM, Voorberg J, Fontijn R, Pannekoek H, van den Ouweland AMW, van Duijnhoven HLP, Roebroek AJM, Siezen RJ (1990). Furin is a subtilisin-likc pro-protein processing enzyme in higher eucaryotes. Mol. Biol. Rep. 14: 265 - 275. 4. Fischer BE, Schlokat U, Mitterer A, Reiter M, Mundt W, Turecek PL, Schwarz. HP, Dorner F (1995). Structural analysis of recombinant von Willebrand factor produced at industrial scale fermentation of transformed CHO cells co-expressing rccombinant furin. FEBS Lett. 375: 259 - 262. 5. Schlokat U, Fischer BE, Herlitschka S, Antoine G, Preiningcr A, Mohr G, Himmelspach M, Kistncr O, Falkner FG, Dorner F (1996). Production of highly homogeneous and structurally intact recombinant von Willebrand Factor multimers by furin mediated pro-peptide removal in vitro. Biotechnol. Appl. Biochem. 24: 257 - 267. 6. Vey M, Schäfer W, Berghöfer S. Klenk HD, Garten W (1994). Maturation of the trans-Golgi Network Protease Furin: Compartmentalization of Propeptide Removal, Substrate Cleavage, and COOH-terminal Truncation. J. Cell Biol. 127: 1829 - 1842. 7. Molloy SS, Thomas L. VanSlyke JK, Stcnherg PE, Thomas G (1994). Intracellular trafficking and activation of the furin proprotein convertase: localization to the TGN and recycling from thc cell surface. EMBO J. 13: 18 - 33. 8. Vidricaire G, Denault JB, Leduc R (1993). Characterization of a secreted form of human furin endoprotease. Biochem Biophys. Res. Comm. 195: 1011 - 1018. 9. Rehemtulla A, Kaufman RJ (1992). Preferred Sequence Requirements for Cleavage of Pro-von Willebrand Factor by Propeptide-Processing Enzymes. Blood 79: 2349 - 2355. 10. Rehemtulla A, Dorner AJ, Kaufman RJ (1992). Regulation of PACE propeptide-processing activity: Requirement for a post-cndoplasmic reticulum compartment and autoproteolytic activation. Proc. Natl. Acad. Sci. USA 89: 8235 - 8239. 11. Anderson ED, VanSlyke JK, Thulin CD, Jean F, Thomas G (1997). Activation of the furin endoprotease is a multiple-step process: requirements for acidification and internal propeptide cleavage. EMBO J. 16: 1508 - 1518. 12. Creemers JWM (1994). Structural and Functional Characterization of the Mammalian Proprotein Processing Enzyme Furin. Ph.D. Thesis at the University of Leuven, Belgium.
76
Discussion
Massie:
The over-expression of furin seems to result in some sort of secretion of the protease in the medium. Do you have any idea why; for instance, is the Golgi saturated or is some other type of event occurring?
Schlokat:
There is a cleavage site. It is not an auto-proteolytic cleavage by furin. If you express wild type furin at some point it is a natural process for furin to be secreted from the cell. In CHO cells even without the expression of any additional furin, just endogenous furin, you have secretion of furin-like activity which mediates the processing of furin-like substrate in the conditioned medium. So it is just part of a natural process.
Massie:
Have you considered using an inducible system to over-express furin at sufficient levels to overcome the toxicity effect?
Schlokat:
It is an alternative but we think it is better to do it just in vitro.
Pak:
My experience is that furin is expressed intracellularly. Could the detection of furin in the supernatant be a result of cell lysis rather than secretion?
Schlokat:
I do not think so as there are such massive amounts of furin in the supernatants, even when you grow cells at low densities where there is no detectable lysis. It is not the wild type furin but a shorter molecule. The trans-membrane domain of the wild type furin molecules is missing. If what you suggest is happening, you would see the whole molecule including the trans-membrane domain. So I do not think it is lysis.
THE ROLE OF CELL CYCLE IN DETERMINING LEVELS OF GENE EXPRESSION IN CHO CELLS
D.R. LLOYD, V. LEELAVATCHARAMAS, D.C. EDWARDS, A.N. EMERY & M. AL-RUBEAI Centre for Bioprocess Engineering, School of Chemical Engineering, University of Birmingham, Edgbaston, Birmingham B15 2TT, U.K.
1. Abstract
Understanding relationships between cell cycle and protein expression is critical as a means to optimising media and environmental conditions for successful commercial operation. Using flow cytometry and centrifugal elutriation together with synchronisation techniques, the possible role of CHO cell cycle dependent features in product expression was evaluated. The production of . was found to be time dependent. Maximum specific productivity was achieved at the mid-exponential phase of batch culture and was always associated with maximum cellular concentration of protein and a high proportion of S phase cells. However, in experiments using sorted S and phase cells the apparent correlation between S phase and productivity was shown not to be causal since there was no significant difference in specific productivity between the different cell cycle phases. 2. Introduction
Growth of mammalian cell cultures is determined by cell cycle duration, cell death rate and the number of dividing (mitotic) cells. The cell cycle state of a culture can be deconvoluted by flow cytometry. Although the duration of the cell cycle or its individual phases may vary between different cell lines, cell cycle events always occur in sequence and checkpoints ensure that if preceding events are not completed correctly, the cell is arrested and will eventually die. Defining the relationship between cell cycle phase and protein expression is crucial to understanding the dynamics of product elaboration which, in turn, must be incorporated in culture protocol design for successful commercial operation. The relationship between cell cycle and protein expression varies with cell line and gene expressed. The aim of this work is to determine the relative effects of cell cycle phase and culture environment on the (specific) productivity of recombinant CHO cells. 77 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 77-79. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
78
3. Materials and Methods
Recombinant CHO cells were grown in stirred batch suspension cultures at 37°C; CHO 320, producing human was grown in RPMI 1640 & 5% FCS & 1 µM methotrexate (MTX); CHO tF70R, producing human tissue plasminogen activator (t-PA), was grown in a proprietary serum free medium (Biopro 1, BioWhittaker, Belgium). Both constructs use the SV40 promoter/enhancer. Cultures examined were either synchronised by late exponential nutrient deprivation or phase enriched fractions separated using a Beckman JE-6B centrifugal elutriation system with a standard chamber.
Product was measured by ELISA; using Genzyme DuoSeT kit product number 803932-00 for and Biopool Imulyse tPA kit product number 101005 for tPA. The DNA content of propidium iodide (PI) stained, RNAse treated, ethanol fixed cells was measured by flow cytometry (Coulter EPICS Elite). Cell cycle analysis was performed using Multicycle software (Phoenix Flow Systems). Cell size was determined either by Coulter principle using a Coulter Multisizer or as relative to flow
cytometric forward angle light scatter (FS). After staining formaldehyde fixed cells with was determined as
FITC conjugated anti-human intracellular the ratio measurement of FITC: FS by flow cytometry.
4. Results 4.1. CHO 320 SYNCHRONIZED BY NUTRIENT DEPRIVATION
Intracellular interferon concentration & specific productivity profiles follow that of percentage of S phase cells but also follow the growth curve. Thus, intracellular interferon concentration and specific productivity are related both to the cell cycle and culture growth phases. 4.2. APPLICATION OF CENTRIFUGAL ELUTRIATION TO THE STUDY OF CELL CYCLE RELATED PRODUCTIVITY
Cultures separated into fractions on the basis of size, allowing preparation of phase enriched samples which all have the same culture history and whose physiology has not been disturbed by nutrient starvation or chemical synchronisation techniques. 4.3. PRODUCTIVITY OF ELUTRIATED FRACTIONS Elutriated CHO tF70R fractions were cultured for 4 hours and the specific productivity/cell/ hour was determined (Figure 1). Preliminary observations that
79
productivity was related to cell cycle phase proved groundless on further investigation.
No fraction was shown to have a specific productivity which was significantly different (p=0.03) from that of any other fraction. Overall, the mean specific productivity was 43 fg/cell/hr. These results also indicate that the SV40 promoter in the construct has not influenced the regulation of any cell cycle dependant protein production mechanism.
5. Conclusions
Gene expression (intracellular product concentration) may be partly cell cycle related because it varies with cell cycle phase and with batch phase; the same was thought to be true of specific productivity. However this work, using centrifugal elutriation, has shown that the cell cycle phase of a population has no significant effect on the specific productivity of that population. The apparent cell cycle association seen previously in batch culture is thus shown to be a coincident effect of batch phase transition from lag to exponential, rather than a causal relationship. Thus it must be the batch phase, possibly due to the environmental conditions (medium condition), which is the major determinant of recombinant CHO productivity. Further work will confirm these observations and clarify the effect of different promoters on cell cycle/size related specific productivity. 6. Acknowledgements This work is supported by the BBSRC UK and EC Framework IV programme.
This page intentionally left blank.
HETEROGENEITY WITHIN DHFR-MEDIATED GENE AMPLIFIED POPULATION OF CHO CELLS PRODUCING CHIMERIC ANTIBODIES No Soo Kim, Sang Jick Kim, and Gyun Min Lee Department of Biological Sciences, Korea Advanced Institute of Science and Technology, 373-1, Kusong-Dong, Yusong-Gu, Taejon 305-701, Korea ABSTRACT Recombinant Chinese hamster ovary (CHO) cells expressing a high level of chimeric antibody were obtained by cotransfection of heavy and light chain cDNA expression vectors into dihydrofolate reductase (dhfr) deficient CHO cells and subsequent gene amplification in medium containing stepwise increments in methotrexate (MTX) level such as 0.02, 0.08, 0.32, and 1.0 µM. In order to determine the clonal variability within amplified cell population in regard to antibody production stability, 20
subclones were randomly isolated from amplified cell population at 1 µM MTX and their antibody production stability was characterized. During 8 weeks of cultivation in the absence of selective pressure, the specific antibody productivity decreased significantly. However, the relative extent
of decrease in was varied among subclones, ranging from 30 % to 80 %, showing that clonal analysis allows one to screen the clone with better stability. Southern and Northern blot analyes showed that this decreased resulted mainly from the loss of amplified immunoglobulin (Ig) gene copies and their respective cytoplasmic mRNAs. Furthermore, since the stability of subclones regarding is not related with either their or Ig gene copies at the beginning of long-term culture,
their stability during long-term culture cannot be predicted based on their initial
or Ig gene copies.
INTRODUCTION The degree of gene amplification, in most cases, is proportional to the level of gene expression (Pensde
et al., 1992). When subjected to successive rounds of selection in medium containing stepwise increments in methotrexate (MTX) concentration, recombinant CHO (rCHO) cells with specific
antibody productivity as high as were obtained by Page and Sydenham (1991). Not only the expression level but the stability of cell lines used is critical for large-scale production of recombinant antibodies. When drug-resistant cells are propagated in the absence of the selective agent, the amplified genes may be maintained or lost. Changes in rCHO populations after extended culture in the presence and absence of selective pressure have been reported (Kaufman et al., 1985; Sinacore et
al., 1995; Weidle et al., 1988; Zettlmeissl et al., 1987). Most of these studies were based on the average cell population. However, CHO cells become quite heterogeneous in regard to
in the course of
dhfr-mediated gene amplification, though they are derived from a single parental clone (Kim et al., 1997). Likewise, their stability during long-term culture may also be heterogeneous. If so, the clonal analysis of the entire cell population allows one to screen the clone with better stability. However, it requires extensive efforts. If the initial properties of clones such as specific growth rate (µ) and gene copy numbers help predict their stability, lots of efforts in screening a stable clone will be saved. MATERIALS AND METHODS Cell line and Cell Culture
Parental CHO cells expressing a chimeric antibody directed against the S surface antigen of hepatitis B virus (HBV) were made by cotransfecting the light and heavy chain expression plasmids into dhfr CHO cells (DG44). Amplified 20 subclones investigated in this study were randomly isolated from
high producer CS 13-1.0 resistant at 1.0 µM MTX using limiting dilution method. For long-term culture in the absence of MTX, 20 subclones were cultivated as monolayer in 6 well tissue culture plates containing 3 mL of with 5 % dialyzed FBS in mixture, humidified at 37°C. The viable cell concentration were determined by the trypan blue dye exclusion method and samples for antibody, nutrient, and metabolic assays were taken every other passage and kept frozen at -80 °C. Chemical and Antibody Assays Glucose and lactate concentration were measured using a glucose/lactate analyzer (Yellow Spring Instruments, Model 2300 STAT) and secreted chimeric antibody was quantified using an ELISA
81 O.-W. Merten el al. (eds.), New Developments and New Applications in Animal Cell Technology, 81-83. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
82 Flow Cytometry Intracellular antibody content was determined using a FACScan flow cytometer (Becton Dickinson). FITC-labeled goat anti-human IgGs specific for heavy chain was used to stain the cells. Southern Blot Analysis Chromosomal DNAs of subclones at the beginning and end of long-term culture were prepared using protocols described in kit manual (NEB). Heavy and light chain cDNAs (1,600 and 900 bp, respectively) were used as templates for heavy and light chain probes, respectively. The probes were labeled by randomly primed incorporation of DIG-labeled deoxyuridine-triphosphate. Prehybridization, hybridization, and subsequent colorimetric detection were conducted as described in the DIG user's guide (BM). The gene copy number was determined by comparison of band intensities on each Southern blot using a UltraScan laser densitomer. Northern and Slot Blot Analysis
For Northern and slot blottings, cytoplasmic mRNA was isolated from each subclone at the beginning and end of culture using NP-40 method. For analyses, 5 µg mRNAs of each subclone were loaded and other procedures were performed as described in Southern blotting. Evaluation of Specific Growth Rate, Specific Antibody Productivity, and Specific Glucose Consumption Rate and Lactate Production Rates Specific growth rate (µ), specific antibody productivity and specific glucose consumption and lactate production rates were evaluated as described earlier. RESULTS AND DISCUSSION
1. Changes in µ and of Subclones during Long-term Culture Clonal analysis shows that CS13-1.0 cells became quite heterogeneous in regard to µ and in the course of dhfr-mediated gene amplification, though they were derived from a single clone. No significant change in µ was observed during long-term culture. However, the of all 20 subclones significantly decreased during the culture. The average of 20 subclones at the end of long-term culture was which is approximately 47 % of the initial average The
antibody production characteristics were varied among the subclones, though the of all 20 subclones decreased during the culture. The of A6, which was most stable, gradually decreased for first 20 days and thereafter was stabilized at The of D1, which was most unstable, gradually decreased throughout the culture and was at the end of long-term culture. 2. Characterization of Subclones by Southern Blot Analyses In order to investigate whether clonal variability with respect to production stability is related to the variation of changes in immunoglobulin (Ig) gene copy numbers of subclones during culture, genomic DNA isolated from 20 subclones at the beginning and end of long-term culture was characterized by
Southern blotting. With heavy and light chain probes, 2.3 kb and 7.1 kb major band were detected, respectively. The relative gene copy numbers of all 20 subclones were summarized in following table. In general, the decrease in of most subclones except for a few subclones was mainly due to the loss of heavy and light chain gene copies during long-term culture. However, the extent of decrease in gene copy numbers was varied significantly among the subclones, suggesting that the initial gene copy numbers of subclones do not help predict their long-term production stability. 3. Characterization of Subclones by Northern and Slot Blot Analyses Northern and slot blotting were carried out in order to quantify the relative heavy and light chain mRNA content of subclones at the beginning and end of long-term culture. In Northern analysis, the major bands of heavy and light chain mRNA were positioned at the similar size of 18s rRNA and below 18s rRNA, respectively. On the whole, a trend obtained in the quantification of the heavy and light chain mRNA content of subclones was similar to that in 4. Characterization of Antibody Production Stability of Subclones by Flow Cytometry
In order to assess the degree of population heterogeneity after long-term culture, the intracellular antibody content of each subclone at the beginning and end of long-term culture was measured by flow cytometry. The changes in intracellular antibody contents of stable A6 and B3 subclones after long-
term culture were insignificant. On the other hand, the intracellular antibody content of unstable D4 and C5 subclones decreased significantly. Accordingly, the changes in intracellular antibody contents of subclones correlate with those in suggesting the potential of flow cytometric measurement of intracellular antibody as a useful tool determining production stability during long-term culture.
83
CONCLUSIONS 1. CHO cells become quite heterogeneous in regard to antibody production stability in the course of dhfr-mediated gene amplification, though they are derived from a single parental clone 2. Clonal analysis enables one to screen the stable clone. 3. The antibody production stability of each clone cannot be predicted based on itsinitial and Ig gene copy numbers. REFERENCES 1. Kaufman. R.J., Wasley, L.C., Spiliotes, A.J., Gossels, S.D. Latt, S.A., Larsen, G.R., Kay, R.M. 1985. Coamplification and coexpression of human tissue-type plasminogen activator and murine dihydrofolate reductase sequences in Chinese hamster ovary cells. J. Mol. Biol. 5:1750-1759. 2. Pendse, G.J., Karkare, S., Bailey, J.E. 1992. Effect of cloned gene dosage on cell growth and hepatitis B surface antigen synthesis and secretion in recombinant CHO Cells. Biotechnol. Bioeng. 40: 119-129. 3. Page, M.J., Sydenham, M.A. 1991. High level expression of the humanized monoclonal antibody Campath-lH Chinese hamster ovary cells. Bio/Technology 9: 64-68. 4. Sinacore, M.S., Brodeur, S., Brennan, S., Cohen, D., Fallon, M., Adamson, S.R. 1995. Population analysis of a recombinant Chinese hamster ovary cell line expressing recombinant human protein cultured in the presence and absence of methotrexate selective pressure, pp 63-67. In: E.C. Beuvery, J.B. Griffiths, and W.P. Zeijlemaker (eds.), Animal cell technology, Kluwer Academic Publishers, Dordrech. 5. Weidle, U.A., Bucke, P., Wienberg, J. 1988. Amplified expression constructs for human tissue-type plasminogen activator in Chinese hamster ovary cells: instability in the absence of selective pressure. Gene 66:193-203. 6. Zettlmeissl, G., Ragg, H., Karges, H. 1987. Expression of biologically active human antithrombin I I I in Chinese hamster ovary cells. Bio/Technology 5: 720-725.
This page intentionally left blank.
IMMUNOFLUORESCENCE DETECTION OF RECOMBINANT MONOCLONAL ANTIBODY AS A TOOL IN THE CHARACTERIZATION OF CHINESE HAMSTER OVARY CELL LINES
CHERYL ANN S. KINNEY, ROBIN E. TRALA, LINDA C. HENDRICKS, and TIMOTHY D. HILL SmithKline Beecham Pharmaceuticals, Biological Process Sciences, PO Box 1539, King of Prussia, PA 19406, USA
1. Abstract A highly sensitive and specific method was developed for direct immunofluorescence analysis of recombinant Chinese Hamster Ovary (rCHO) cells expressing IgG monoclonal antibody (mAb). Fluorescence signal-to-noise ratio using labeled goat anti-human IgG was improved through optimization of fixation, staining and mounting protocols. These improvements enabled measurement of relative cell to cell differences and the detection of non-producing cells when they represented only 2.5% of a mixed cell population. Heterogeneity of fluorescence signal with both intense and low-staining cells was noted for some rCHO cell lines. Low mAb-specific signal was unrelated to cell viability since low-staining cells excluded the viability indicator ethidium monoazide bromide. Furthermore, positive staining of the soluble ER resident protein BiP in dual labeling studies with anti-mAb reagents indicated that low level staining was not an assay artifact related to poor access of fluorescent antibody into secretory compartments. Correlations of signal heterogeneity to long-term culture stability and process performance is under investigation. 2. Introduction CHO cells are a convenient expression system for the generation of protein biopharmaceutical therapeutic agents. Productivity levels for monoclonal antibodies (mAb) achieved in rCHO effectively compete with traditional hybridoma/myeloma cell systems, thus enabling rCHO to serve as an economical antibody production system. In addition, although rCHO contain non-infectious retroviral-like particles, they have been extensively characterized and found free of adventitious viruses, making them a safe substrate for production of biopharmaceuticals. Cell lines developed for industrial processes often vary in productivity and clonal stability. Current methods for evaluating rCHO cells rely on whole population 85 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 85-92. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
86
measurements, such as supernatant titer by HPLC or ELISA, and typically require optimization of growth conditions and qualified assays, while providing no information about homogeneity of cell populations. Immunofluorescence microscopy methods were developed to rapidly profile individual cells within a population, regardless of culture conditions. Through use of immunofluorescence, information critical to selection of the lead process cell line may be available earlier in the development process, before costly development resources are committed. 3. Methods 3.1 CELL LINE
Suspension-adapted host CHO cells (DG-44 clone as described by Urlaub et. al., 19831) and genetically modified recombinant CHO (rCHO) were maintained in SB proprietary medium at a minimum culture viability of 85%. The gene-minus control cell line was generated by transfection with plasmids lacking antibody genes. 3.2. CELL PREPARATION, FIXATION AND PERMEABILIZATION
3.2.1. Slide Preparation
HTC™ coated slides (Cel-Line Assoc., New Field, NJ, 4mm wells) were pre-treated for 2 min at room temperature with 2% (v/v) 3-amino-propyl silane (Sigma Chemical , St. Louis, MO) diluted in acetone, washed 3X in water for injection (WFI), then dried 2hr at 37°C. 3.2.2. Cell Attachment Cells were washed 1X with Dulbecco's phosphate buffered saline (PBS), then cells were added to slide wells and incubated in a humidified environment for 30 minutes at 37°C. PBS was carefully aspirated prior to fixation. 3.2.3. Fixation/Permeabilization
Cells were fixed for 15 minutes at room temperature in 1% buffered paraformaldehyde (ultrapure, Polysciences,Inc.,Warrington, PA), washed twice in PBS, then permeabilized by 2 minute treatment with 0.2% Triton X-100 in PBS, followed by a 5 minute wash in PBS. To reduce background signal associated with free aldehydes, cells were treated for 5 minutes in 0.1M glycine
(J.T. Baker, Phillipsburg, NJ) in PBS, followed by two washes in PBS. To enhance reagent uptake, cells were dehydrated stepwise in ethanol (50%, 70%, 95%, and 100%) at room temperature. Slides were air dried prior to addition of probe.
87
3.3. IMMUNOFLUORESCENCE STAINING
3.3.1. Antibodies and Reagents Cy3-conjugated goat anti-human IgG (Fc specific) was obtained from Sigma
ImmunoChemical, St. Louis, MO. Cy2-conjugated goat anti-human IgG (Fc specific) and Cy3-conjugated goat anti-mouse IgG (H&L) were obtained from Jackson ImmunoResearch, West Chester, PA. Mouse anti-rat Grp78(BiP) was obtained from StressGen Biotechnologies, Victoria, BC. Ethidium monoazide bromide (EMA), a fluorescent photoaffinity label used as a viability indicator, was purchased from Molecular Probes, Eugene, OR. Cy3 and Cy2 are registered trademarks of Amersham International, Inc.
3.3.2. Direct Detection of Intracellular Antibody Cy2- or Cy3-conjugated anti-IgG probes were diluted in PBS containing 1% heatinactivated (65°C, 1hr) fetal bovine serum (FBS). Probe was applied to permeabilized samples on slides and incubated 30 minutes at 4°C in the dark, followed by wash in 1% FBS at 4°C, wash in cold PBS, and final wash at room temperature in WFI. 3.3.3. DNA staining with Ethidium Monoazide Bromide(EMA) EMA is a fluorescent photoaffinity label that after photolysis, binds covalently to nucleic acids in cells with compromised membranes.2 Viability assessment with EMA was performed prior to cell attachment and fixation. Cells were transferred to polypropylene
plates (Costar) on ice and incubated 15 min with 4ug/ml EMA dissolved in PBS, then exposed at 15 cm under a 13 watt fluorescent light source to activate EMA. Following exposure, cells were washed 2X in PBS, and processed for attachment, fixation,
permeabilization and immunofluorescent staining. 3.3.4. Indirect Detection and Dual Labeling Permeabilized cell samples were incubated 30 minutes at 4°C with anti-BiP antibody diluted in PBS containing 1% heat-inactivated FBS, then washed 2X in 1% FBS/PBS. Samples were incubated an additional 30 minutes at 4°C with secondary Cy3-anti-mouse IgG antibody, washed 2X in cold PBS and 1X in room temperature WFI. 3.3.5. Mounting of coverslips Residual WFI was removed from processed slides, then samples were mounted under coverslips using AntiFade reagent (Molecular Probes, Eugene, OR) according to manufacturers instructions. Slides were stored in the dark under low-humidity.
3.4. IMAGE ANALYSIS Images were acquired using a Nikon Optiphot epifluorescence microscope fitted with fluorophore-specific filter sets from Omega Optical (Brattleboro, VT), and captured at
1000X magnification using an IS-2000 CCD camera system and (Alpha Innotech, CA).
software
88
4. Results
Immunofluorescence methods were developed to generate high resolution images of rCHO cell intracellular targets. Fluorescent-labeled antibodies specific for the Fc portion of human IgG were used to detect intracellular mAb in the secretory pathway of CHO cells. Figure 1A and C illustrate the high signal specificity of anti-mAb probes within secretory pathway compartments exemplified by fluorescent staining pattern typical of endoplasmic reticulum and Golgi elements. Non-transfected parental CHO or geneminus rCHO generated by transfection with plasmids lacking mAb genes were tested as negative controls and appeared as faint opaque spheres, lacking any definition of intracellular membranes and requiring extended exposure times for visualization (Fig 1B and D).
89
The limit of detection was determined by mixing up to 50% gene-minus negative control cells with CHO cells expressing mAb (Fig.2). Data demonstrated that the method is highly sensitive, capable of detecting a low level of negative cells (2-3 per 100) within a population, and that fluorescence intensity differences are readily distinguished across a population.
Clonally selected rCHO cells derived from lines genetically engineered to secrete mAb were characterized at the single cell level using anti-mAb immunofluorescence. Subpopulations of cells weak in fluorescence intensity, ranging from 5-50% were observed in various rCHO cell lines (Fig. 3). Low staining cells show structural patterns consistent with higher intensity cells(Fig. 3B). Detection of subpopulations varying in
mAb expression suggests that lines are unstable and /or no longer clonal. Thus, this technique may be useful, particularly early in development, to support cell line selection.
90
To test whether weakly stained or negative rCHO cells represent a non-vital subpopulation of the original culture, a dual labeling method was developed to simultaneously detect intracellular mAb with Cy2-antibody probe, and prefixation viability using EMA, a fluorescent photoaffinity label that, after photolysis, binds covalently to nucleic acids in cells with compromised membranes.2 EMA is excluded from viable cells. Cells weakly stained for mAb (Fig. 4A) were impermeable to EMA (Fig. 4B), indicating lack of mAb-specific fluorescence was not related to viability. In some cases cells were found containing dual label, demonstrating nonspecific adsorption of anti-mAb probe to dead cells (data not shown).
Since recombinant protein is synthesized at very high levels in transfected CHO it was necessary to determine whether low levels of staining were due to poor access of
fluorescently labeled antibody probes to 'saturated' secretory compartments. In addition, since detection of cells which stained weakly for mAb required long exposure times, a reagent was needed to allow visualization of all cells in a field. BiP (IgG heavy chain
binding protein, Grp78) is an ER lumenal protein which functions in post-translational
protein folding 3,4 . BiP was selected as a convenient marker to delineate cells and to test reagent accessibility to ER lumenal targets to determine whether low-/ non-staining cells were an assay artifact. rCHO cells were dual labeled to simultaneously probe mAb and BiP. Cells with low anti-mAb (Fig. 5C) signal had correspondingly high anti-BiP signal (Fig. 5D), demonstating reagent access to secretory compartments.
91
5. Discussion
A highly specific and sensitive immunofluorescence method for intracellular characterization of individual rCHO cells has been developed utilizing Cy2- and Cy3-
labeled antibody probes and the viability indicator EMA. Targets detected include expressed mAb, constitutive BiP and viability status. Preliminary application of this method proved valuable in detecting unexpected heterogeneity of intracellular mAb
across a population of rCHO cells generated by clonal selection. Immunofluorescence offers the ability to rapidly profile cell lines at the single cell level during early stages of process development. Early detection of unstable and/or non clonal lines may allow channeling of costly development resources into cell lines of highest potential. In addition, work is underway to combine this technique with quantitative imaging analysis to allow prediction of cell line productivity very early in the development process.
92
6. References 1
Urlaub, G., Kaas, E., Carothers, A.M., Chasin, L., (l983),Cell, 33:405-412.
2
Haughland, R.P., ed. Handbook of Fluorescent Probes and Research Chemicals, Molecular Probes, Eugene, OR., 6:150.
3
Warren, G., (1987), Nature, 327:17-18. Bole, D.G. et al (1986) Posttranslational Association of Immunoglobulin Heavy Chain Binding Protein with Nascent Heavy Chains in Nonsecreting and Secreting Hybridomas, Journal of Cell Biology. 102:15581566.
4
ELECTROLYZED REDUCED WATER WHICH CAN SCAVENGE ACTIVE OXYGEN SPECIES SUPRESSES CELL GROWTH AND REGULATES GENE EXPRESSION OF ANIMAL CELLS.
S. Shirahata, S. Kabayama, K. Kusumoto, M. Gotoh, K. Teruya, K. Otsubo*, J.S. Morisawa*, H. Hayashi** and K. Katakura
Graduate School of Genetic Resources Technology, Kyushu University, Hakozaki, Higashi-ku, Fukuoka 812-81, Japan; *Nihon Trim Co. Ltd., Meiji Seimei Jusou Building 6F, 1-2-13 Shinkitano, Yodogawa-ku, Osaka 352, Japan; **Water Institute, Nisshin Building 9F, 2-5-10 Shinjuku, Tokyo 160, Japan. Abstract:
Active oxygen species are considered to cause extensive oxidative damage to biological macromolecules, which bring about a variety of diseases as well as aging. Reduced water produced near cathode during electrolysis of water exhibits high pH, low dissolved oxygen, extremely high dissolved molecular hydrogen, and extremely negative redox potential values. Recently we found that strongly electrolyzed reduced water scavenges active oxygen species and protects DNA from oxidative damage (Shirahata, S. et al., Biochem. Biophys. Res. Commun., 234, 269-274 (1997)). Electrolyzed reduced water suppressed the growth of human normal fibroblast TIG-1, human lung adenocarcinoma A549, and human uterine cervix cancer HeLa, indicating that reduced water affects the signaling pathway of cell cycle. The expression of the interleukin-6 gene was enhanced by reduced water as well as ascorbic acid, (+)-catechin and tannic acid when added to the culture of human osteosarcoma MG-63 cells, suggesting that reduced water acts as a reductant to cells. Introduction
Active oxygen species such as singlet oxygen superoxide anion radical hydrogen peroxide and hydroxyl radical (OH) are considered to cause extensive
oxidative damage to biological macromolecules (DNA, membranes, enzymes and so on), which bring about a variety of diseases as well as aging (1, 2). Antioxidative enzymes such as superoxide dismutase, catalase, and glutathione peroxidase can scavenge active
oxygen species. Daily intake of antioxidants such as vitamin C, vitamin E, (+)-catechin is also important to protect cells from oxidative damage. In spite of these
protective mechanism, a chronic state of oxidative stress exists in cells because of an imbalance between prooxidants and antioxidants. Recent heavy environmental pollution
seems to strengthen oxidative stress to our bodies. Water is a most abundant compound on the earth and indispensable for existence of life. More than a half century ago, domestic devices to reform water have been developed in Japan. The principal is to separate reduced water near cathode from oxidized water near anode by semipeamiable membrane during electrolysis of water. Electrolyzed reduced water exhibits alkaline pH and negative redox potential. The devices to reform water are admitted as therapeutic devices by the Japanese ministry of public welfare because reduced water is effective to suppress abnormal fermentation in intestine and hyperacidity, although the action mechanism is unclear. Based upon the interesting clinical improvement of a variety of diseases by intake of reduced water, Hayashi proposed the hypothesis “water regulating theory’ since 1985 (3). Recently we found that electrolyzed reduced water contains high concentration of dissolved hydrogen (DH), scavenges active 93 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 93-96. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
94 oxygen species and protects DNA from oxidative damage (4). We proposed a new hypothesis that active hydrogen in reduce water may scavenge active oxygen. Here we report that electrolyzed reduced water suppresses the cell growth and regulates the gene expression in animal cells. Materials and methods
Electrolysis of water. Ultrapure water produced by an ultrapure system (ULTRAPUR LV-10T, TORAY, Tokyo) was added 0.1 g/l NaCl to elevate electrical conductance (EC) to about 20 ms/m. The water was then electrolyzed with various voltages (0 - 40 V) by an electrolyzing device (Type TI-7000S and TI-7000SL, Nihon Trim Co., Osaka) equipped with platina-coated titanium electrode to produce reduced water which exhibited various RP. Ultrapure water containing NaCl was sent to the electrolyzing device using a water current pump at a rate of 0.5 1/min to 1.0 l/min. Electrolyzing voltage was changed to several to several tens V and currents several to 10 A. RP, EC, dissolved oxygen (DO) and DH were measured using a RP meter (type, HM-14P), a EC meter (CM-14P), a DO meter (DO-14P) and a DH meter (DHDI-1) of Toa Electronics Ltd. (Tokyo) at 25°C. pH was measured using a pH meter (Beckman, Type pHI32) at 25°C. Assay of scavenging effect of reduced water against superoxide onion radical. The scavenging effect of reduced water against was examined by hypoxanthine-xanthine oxidase system using luciferine analog and a chemiluminometer as described previously (4). All reactions were performed in neutralized condition using 40 mM sodium phosphate buffer (pH 7.0). Measurement of growth curve of human normal and cancer cell lines. Normal human fibroblast cell line TIG-1, human lung adenocarcinoma cell line A549 and human uterine cancer cell line HeLa were inoculated into 24-well microplates and cultivated in 10% fetal calf serum-MEM medium containing electrolyzed reduced water at 37°C under an atmosphere of 5% Since strongly electrolyzed reduced water often contains HOCl which was produced near anode, the effects of reduced water on the cell growth were compared with those of HOCl of the same concentration. Tap water must contains more than 0.1 ppm of residual chlorine. The concentration of HOCl was determined by otolidine method. Analysis of the interleukin-6 gene expression in MG-63 cells. Human osteosarcoma MG-63 cells were cutured in 5% FBS-MEM medium at 37°C under an atmosphere of 5% The cells were treated in PBS (+) containing 2.7% reduced water, 0.1 µM ascorbic acid, 0.33 µg/ml (+)-catechin or 40 µM tannnic acid in the presence of for 2 hour. RT-PCR was performed after extraction of mRNA. Results and discussion
Characteristic of electrolyzed reduced water Strongly electrolyzed reduced water exhibited high pH, low DO, high DH and extremely negativeRP values. Marked changes in these values occur in water after electrolysis. For example, the value of RP +350 mV in water before electrolysis changes to -659 mV after electrolysis; 4.08 of pH changes to 10.47; 4.46 mg/1 of DO changes to 3.38 mg/l and 0.0046 mg/l of DH changes to 0.467 mg/l, respectively. It should be noticed that DH value is higher in reduced water than in the original water by two orders of magnitude. Strongly reduced water completely scavenged produced by hypoxanthine-xanthine oxidase system (4). Reduced water was shown to scavenge It prevented singlestrand breakage of plasmid DNA caused by the Cu(II)-catalyzed oxidation of ascorbic acid, suggesting that reduced water can also scavenge OH and The scavenging activity of reduced water against was stable in closed bottle at 4 °C for about a month
95
but lost by opened autoclave or closed autoclave in the presence of tungsten trioxide which is knwon to be a specific adsorbent of active hydrogen.
Suppression of the growth of several human cell lines by electrolyzed reduced water. Electrolyzed water exhibits strong scavenging activity against active oxygen species. In order to examine the effect of reduced water on animal cells, the growth of human normal fibroblast TIG-1, lung adenocarcinoma A549, and human uterine cervix cancer HeLa were examined in the medium containing reduced water. Since reduced water contained
HOCl which was produced near anode, effect of the same concentration of HOCl was examined as control. As shown in Fig. 1, the growth of TIG-1 was suppressed by reduced water and the cells reached confluence at lower cell density in medium containing reduced water than in medium containing no reduced water. The morphology of cells in medium containing reduced water seemed to be normal. One and 0.5 ppm of HOCl slightly stimulated the growth of TIG-1 cells, suggesting that oxidative stress affects the growth of the cells. The growth of lung cancer A549 cells was remarkably suppressed by reduced water. HOCl did not affect the cell growth of A549 cells. The growth of uterine cancer HeLa cells were significantly suppressed by reduced water, but HOCl did not affect the growth of HeLa cells. These results suggested that reductive stress by reduced water may affect the signaling pathway of cell cycle to slower the rate of cell division.
Sensitivity of animal cells to reductive stress may be different depending upon cell types.
96
Induction of the interleukin-6 gene expression in human osteosarcoma MG-63 cells by electrolyzed reduced water and reducing substances.
In order to examine if reduced water regulates some gene expression in animal cells, we examined the expression of the interleukin-6 gene in human osteosarcoma MG-63 cells. Super-induced MG-63 cells produce interferon The expression of interleukin6 gene was examined by RT-PCR method. Treatment of MG-63 cells with reduced water induced the expression of the interleukin-6 gene (Fig. 2). Since reducing substances such as ascorbic acid, (+)-catechin, and tannic acid also induced the expression of the interleukin-6 gene, the effect of reduced water may be due to its reducibiltiy. Here we first demonstarted that electrolyzed reduced water can regulate the growth of animal cells and gene expression. Water can permeate everywhere in the body and penetrates every membrane in eluding the blood-brain barrier. To neutralize the toxic action of active oxygen species, electrolyzed-reduced water may be an ideal and very powerful antioxidant and may be applied for prevention and therapy of various diseases. Further intensive investigation on the effect of reduced water on cell biology, immunology and oncology should be promoted. REFERENCES
1. Sohal, R. S. and Weindruch, R. (1996) Oxidative stress, caloric restriction, and aging.Science 273, 59-63. 2. Feig, D. I., Reid, T. M. and Loeb, L. A. (1994) Reactive oxygen species in tumorigenesis. Cancer Res. 54, 1980s-1984s. 3. Hayashi, H. (1995) Water, the chemistry of life, part IV. Explore 6, 28-31. 4. Shirahata, S., Kabayama, S., Nakano, M., Miura,T., Kusumoto, K., Gotoh, M.,
Hayashi, H., Otsubo, K., Morisawa, S., and Katakura, Y. (1997) Electrolyzedreduced water scavenges oxygen species and protects DNA from oxidative damage. Biochem. Biophys. Res. Commun. 234, 269-274 (1997). 5. Kabayama, S., Osada, K., Tachibana, H., Katakura, Y. and Shirahata, S. (1997) Enhancing effects of food components on the production of interferon from animal cells supressed by stress hormones.Cytotechnology 23, 119-125.
DIFFERENTIAL GENE EXPRESSION OF CYTOCHROME IMMORTALISED HEPATOCYTE CELL LINES
P450
IN
H.T.KELLY1, K.ANDERSON2, E.HILL 1 , H.GRANT2, C.MacDONALD1 Biological Sciences1, University of Paisley and Bioengineering Unit2, University of Strathclyde, Glasgow, UK.
INTRODUCTION Cytochrome P450 isoenzymes and the associated mixed function oxidase system are
important factors in the metabolism and detoxification of xenobiotics in the liver. However these functions are amongst the most labile activities in primary cultures of hepatocytes (Steward et al., 1985; Wortelboer et al., 1990). As an alternative approach to the use of primary hepatocyte cultures for the study of xenobiotic metabolism and toxicity several immortalised rat hepatocyte cell lines have been generated by either calcium phosphate precipitation (MacDonald et al, 1994) or electroporation of SV40 DNA (Yin et al., 1996,). In order to examine the retention of drug metabolising enzyme activity in our immortalised lines we employed the reverse transcriptase polymerase chain reaction (RTPCR) to determine the expression of P450 isoform mRNA, RNA arbitrarily primed polymerase chain reaction (RAP-PCR) to examine differential gene expression of cytochrome P450 and immunoblotting to determine the presence of the P450 protein. METHODS 1.Cell Culture: Hepatocytes were isolated from male Sprague Dawley rats by collagenase perfusion and transfected with SV40 early region DNA by either calcium phosphate precipitation ('C' lines) or electroporation ('LQC' and 'KC' lines) and cultured as described previously (MacDonald et al., 1994; MacDonald and Willett, 1997; Yin et al., 1996). 2.RNA Preparation: Total RNA from freshly perfused hepatocytes and immortalised cell lines was prepared using the total RNA isolation reagent TRIzol (Life Technologies). The RNA obtained was subsequently used for RTPCR and RAP-PCR. 3. First Strand Synthesis: Total RNA (5µg/sample) was converted to cDNA using the Superscript First Strand Synthesis kit and method (Life Technologies). Oligo(dT)12-18 was used to prime the first strand synthesis of all cDNAs prepared in this study. 4. PCR: A 10mM primer mix specific for either 2B1, 2B2 or 3A1 isoforms of CYP450 was used here (Omiecinski et al., 1990). To a thermowell tube (Costar) 5µl of each primer mix was added. In addition 5µl of 10xReaction buffer [500mM KCl, 15mM
100mM Tris HCl (pH9 at room temp.)] (Pharmacia Biotech), 4µl 10mM dNTP mix (10mM dATP, dTTP, dCTP, dGTP), 30.75µl and 0.25µl Taq DNA polymerase (Pharmacia Biotech) were added to each reaction and pulse spun. cDNA solution (5µl) was subsequently added to each tube and the total reaction overlayed 97 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 97-99. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
98
with mineral oil. The reaction was pulse spun and placed in the thermocycler (Techne) to undergo a series of denaturation, annealing and elongation cycles as follows: 1 cycle @ 93°C for 4min, 30 cycles @ 93°C for 1min, 54°C for l.5min and 72°C for 1min and 1 cycle @ 72°C for 5min. The resulting PCR products were resolved on a 1.5% agarose DNA gel and visualised by ethidium bromide staining. A 100bp DNA ladder was used as a sizing marker. 5.RAP-PCR: For the purpose of RNA fingerprinting a RAP-PCR kit (Stratagene ) was used. cDNA synthesis was performed as described above using an 18mer arbitrary primer Al (Stratagene) to replace oligo(dT). To a thin wall tube of 10x reaction buffer, _ mix (25mM each dATP, dTTP, dCTP, dGTP), Taq DNA polymerase RAP-PCR primer Al, of 1:10 cDNA dilution and were added. The reaction was gently mixed, pulse spun and overlayed with mineral oil. RAP-PCR was performed using the following cycling conditions: 1 cycle of 1min @ 94°C, 5 min @ 36°C and 5min @ 72°C; 40 cycles of 1min @ 94°C, 2min @ 50°C and 2min @ 72°C and finally 1 cycle @ 72°C for 10min. To analyse the product of the above reaction was added to of a stop solution containing 95% formamide, 20mM EDTA, 0.05% Bromophenol Blue and 0.05% xylene cyanol FF and the mixture heated to 80°C for
2min. of the reaction was run in a 6% acrylamide sequencing gel in 1xTBE buffer. 6. Western Blotting: All microsomes used in the immunoblotting were prepared from cell homogenates by ultracentrifugation. The samples were separated by electrophoresis, transferred onto nitrocellulose and stabilised in a 3% (w/v) gelatin solution. To immunostain 20ml of relevant primary antibody (a gift from Glaxo/Wellcome) were added for 2h. The protein samples on the nitrocellulose were then washed twice in TTBS (Tween 20 Tris Buffered Saline) and the secondary antibody, goat conjugated with alkaline phosphatase (Biorad), added for 2h. The samples were subsequently washed once in TTBS and once in TBS (Tris Buffered Saline). An alkaline phosphatase detection kit (Biorad) was used for colour development after which the nitrocellulose paper was washed with 3 rinses of water and dried between sheets of blotting paper before being photographed. The immunoblots were analysed using densitometry on a Biorad GS 690 scanning densitometer using Biorad Molecular Analyst software. RESULTS The presence of PCR products specific for the 2B1, 2B2 and 3A1 isoforms of cytochrome P450 was detected in primary hepatocytes using RTPCR. In contrast however larger PCR products, specific for the 2B1, 2B2 and 3A1 primers used here, were identified in both the calcium phosphate transfected and electroporated immortalised hepatocyte cells. Immunoblotting with antibodies specific for 1A1, 2B(1/2), 3A(l-9), 2C6 and 2C11 isoforms of P450 demonstrated that freshly isolated hepatocytes had a higher level of staining for all isoenzyme forms compared with that observed for 24h cultured primary hepatocytes. Immortalised cells, in addition to staining positively for the CYP450
99
isoenzyme proteins examined, also demonstrated multiple stained products smaller than that expected for the proteins studied. Using densitometry analysis the majority of immortalised lines were found to stain positively for CYP1A1, 2B(l/2), 2C6, 2C11 and 3A(1-9) albeit at levels much lower than that observed in the primary cultures. In order to compare the RNA present in both the primary hepatocytes and immortalised cells, arbitrarily primed PCR (McClelland et al., 1995) was used to generate RNA fingerprints of these two hepatocyte populations. Using this technique RAP-PCR products were identified in the immortalised hepatocytes that were absent in the primary hepatocytes. CONCLUSIONS RTPCR analysis demonstrated that mRNAs encoding the cytochromes 2B1, 2B2 and 3A1 are present in our immortalised lines although the product amplified appeared larger than that observed with primary hepatocytes. Cytochrome P450 isoenzyme proteins were detected in both freshly isolated and 24h cultured primary hepatocytes with the levels of isoenzyme lower in the latter cells. In addition to giving the expected protein band, multiple bands were identified for the immortalised cells suggesting cross-reactions had occurred. This was unexpected as monoclonal antibodies were used throughout and no cross reaction was observed with other proteins in freshly isolated or primary rat hepatocytes. These proteins were also smaller in the immortalised cells and some degradation of the cytochrome P450 may have occurred. RNA fingerprinting, using RAP-PCR, identified differences in the RNA transcripts
from immortalised cell lines compared with those obtained from primary hepatocytes. This suggests the occurrence of differential gene expression in our immortalised hepatocytes and highlights RAP-PCR as a useful screening technique for identifying those immortalised lines which retain the most 'normal' phenotype in relation to primary hepatocytes. REFERENCES 1. MacDonald C., Vass M., Willett B., Scott A., Grant M.H. (1994). Expression of liver functions in immortalised rat hepatocyte cell lines. Human Experimental Toxicology 13, 439-444. 2. MacDonald C and Willett B. (1997). The immortalisation of rat hepatocytes by transfection with SV40
sequences. Cytotechnology 23, 161-170. 3. McClelland M., Mathieu-Daudi F., Welsh J., (1995). RNA fingerprinting and differential display using arbitrarily primed PCR. TIG 11, 242-246.
4.Omiecinski C.L., Hassett C., Costa P., (1990). Developmental expression and in situ localisation of the phenobarbital-inducible rat hepatic mRNAs for cytochromes CYP2B1, CYP2B2, CYP2C6 and CYP3A1. Molecular Pharmacology 38, 462-470.
5. Steward A.R., Dannan G.A., Guzelian P.S., Guengerich F.P., (1985). Changes in the concentration of seven forms of cytochrome P450 in primary cultures of adult rat hepatocytes. Molecular Pharmacology 27, 125-132. 6. Wortelboer H.M., de Kruif C.A., van Lersel A.A.J., Falke H.E., Noordhoek and Blaauboer B.J. (1990). The isoenzyme pattern of cytochrome P450 in rat hepatocytes in primary culture, comparing different enzyme activities in microsomal incubations and in intact monolayers. Biochemical Pharmacology 40, 25252534. 7. Yin L., MacDonald C., Grant H. (1996). Electroporation conditions for retention of rat hepatocyte viability. The Genetic Engineer and Biotechnologist 16. 27-34.
This page intentionally left blank.
POST-TRANSCRIPTIONAL CONTROL OF RECOMBINANT GENE EXPRESSION: mRNA RETARGETING AND REGULATION OF EXPRESSION
K.A. PARTRIDGE1, A. JOHANNESSEN2, A. TAULER3, I.F. PRYME2 and J.E. HESKETH1,* 1 Intracellular Targeting Group, Rowett Research Instititue, Bucksburn, Aberdeen, AB21 9SB, UK; 2Department of Biochemistry and Molecular Biology, University of Bergen, Arstadveien 19, 5009 Bergen, Norway; 3 Unit of Biochemistry, Faculty of Pharmacy, University of Barcelona, Diagonal 643, 08028 Barcelona, Spain; *author for correspondence.
1. Introduction Mammalian cell lines are used to produce commercially significant amounts of recombinant proteins in cell factories. There are numerous examples where normally
secreted proteins are being produced in this way (e.g. Lin et al, 1986), as well as a number of commercial vectors for the secretion of heterologous proteins. However such systems have been used only for the production of secreted proteins rather than proteins which are normally intracellular. The ability to secrete intracellular proteins would greatly increase the range of potential products which could be made by cell factories and therefore the secretion of intracellular proteins in mammalian expression systems is an important aim in biotechnological research (James and Simpson, 1996). Secreted proteins are synthesised on the endoplasmic reticulum (ER) and the secretion of an intracellular protein from a cell factory would require as a first step the redirection of the mRNA for synthesis of the protein to the ER.
2. Experimental Approach
Targeting of mRNAs coding for secreted and membrane proteins is achieved by a signal peptide in the nascent polypeptide chain whilst there is growing evidence for targeting of mRNAs coding for intracellular proteins to different cytoplasmic domains by signals in the 3'untranslated region (3'UTR) (Hesketh, 1996). The feasibility of retargeting a mRNA coding for a recombinant intracellular protein to the ER was investigated using stable transfected cell lines expressing gene constructs containing the reporter sequences and luciferase linked to different combinations of 5' and 3' signals. In particular we have studied the effects of adding the 5'albumin signal sequence in combination with either the native globin 3'untranslated region (3'UTR) or the 3'UTR from the c-myc mRNA since the latter is known to contain a signal for perinuclear localisation and association with the cytoskeleton (Veyrune et al, 1996). The subcellular localisation and stability of the transcripts were determined. 101 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 101-103. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
102
3. Results and Discussion
Expression of the exogenous gene in the stable transfected fibroblast cell lines was assessed by Northern hybridisation to detect globin transcripts. The highest levels of globin expression from all four genes was greatest in cells at 70% confluence and all subsequent experiments were carried out at that stage of growth. Detergent/salt fractionation (Vedeler et al, 1991; Veyrune et al, 1996) was carried out to investigate the compartmentation of the transcripts between free polysomes, cytoskeletal-bound polysomes and membrane-bound polysomes. Each cell line was fractionated, polysomes pelleted, and then RNA extracted from the pellets and analysed by Northern hybridisation for abundance of globin transcripts. Globin transcripts with either the native 3'UTR or with the 3'UTR of c-myc were found to be present predominantly in free/cytoskeletal-bound polysomes. In contrast, globin transcripts with the native globin 3'UTR and the albumin signal sequence were found at highest abundance in the membrane-bound polysomes derived from the ER. Globin transcripts with both albumin signal sequence and c-myc 3'UTR showed a markedly lower enrichment of the mRNA in the ER fraction. Reprobing of filters with the 18S rRNA probe allowed correction for RNA loading and quantification of the hybridisation data per unit RNA. This data confirm that the addition of the albumin signal sequence redirects the globin mRNA to the ER (p=0.01). The signal sequence redirected globin with the c-myc attached (p<0.05) but presence of both c-myc 3'UTR and the signal sequence reduced the extent to which redirection occurred (p<0.05).
The data show that the addition of the signal sequence from rat albumin leads to efficient redirection of the globin mRNA with the native 3'UTR to membrane-bound polysomes. The presence of the c-myc 3'UTR reduced the extent of redirection, suggesting that there is competition between 5' and 3' localising signals in the chimaeric mRNA. Measurement of mRNA stability showed that the addition of the signal sequence does not destabilize the mRNA. Translational efficiency was found to be unaffected by addition of the signal sequence or replacement of the native 3'UTR by that of c-myc. Overall the results show that it is possible to retarget a mRNA from free/cytoskeletalbound polysomes to the ER while maintaining stability and translational efficiency but that removal of 3'UTR sequences may be necessary in order to achieve efficient retargeting. This is a prerequisite for secretion of an intracellular protein and is the first step in developing appropriate technology to achieve secretion of intracellular proteins from a cell factory; as such it has important implications for the development of vectors to promote secretion of intracellular proteins from cell factories. Acknowledgements: This work was supported by a grant from the European Union Biotechnology Programme (Bio2-CT94-3069) and the Scottish Office Agriculture, Environment and Fisheries Department. We thank Eli Johannesen and Gill Campbell for excellent technical assistance.
103 References: Hesketh, J.E. (1996) Sorting of mRNAs in the cytoplasm: mRNA localisation and the cytoskeleton. Expt. Cell
Res. 225, 219-236. James, J. and Simpson, B.K. (1996) Application of enzymes in food processing. Crit. Rev. Food Sci. Nutr. 36, 437-463. Lin, F-K., Lin, C-H., Lai, P-H., Browne, J.K., Egrie, J.C., Smalling, R., Fox, J.M., Chen, K.K., Castro, M. and Suggs, S. (1986) Monkey erythropoietin gene: cloning, expression and comparison with the human erythropoietin gene. Gene 44, 201–209. Vedeler, A., Pryme, I.F. and Hesketh, J.E. (1991) The characterization of free, cytoskeletal and membrane-bound polysomes in KrebII ascited and 3T3 cells. Mol. Cell Bioch. 100, 183-193. Veyrune, J-L., Campbell, G.P., Wiseman, J., Blanchard, J-M. and Hesketh, J.E. (1996) A localisation signal in the 3'untranslated region of c-myc mRNA targets c-myc mRNA and beta-globin reporter sequences to the perinuclear cytoplams and cytoskeletal-bound polysomes. J. Cell Science 109, 1185-1194.
This page intentionally left blank.
TRANSIENT TRANSFECTION IN MAMMALIAN CELLS A basic study for an efficient and cost-effective scale up process E.-J. Schlaeger , J.Y. Legendre*, A..Trzeciak, E.A. Kitas, K. Christensen, U. Deuschle
and A. Supersaxo F. Hoffmann La Roche Ltd. PRPN-G, PRPV CH-4070 Basel, Switzerland *UPSA Laboratoires, 128 rue Danton, 92506 Rueil-Malmaison Abstract
The aim of the presented work was to develop a cost-effective and easily scaleable transient transfection system with mammalian cells grown in serum-free suspension culture. For this purpose the cationic polyethylenimine (PEI) and the novel hybrid molecule dioleoyl-melittin (DOM) were used. Both substances are highly efficient transfection reagents for mammalian cells and have been described recently. The transfection complexes were made directly within the cell culture by consecutively adding plasmid and PEI (direct method). Alternatively, the DNA-PEI transfection complexes were performed in fresh medium (1/10 culture volume) and then added to the cells (indirect method). Here we have optimized the PEI-mediated transfection conditions for HEK293 and 293EBNA cells grown in serum-free suspension culture for large scale experiments. In a second part of the investigation the efficiency of gene expression was studied in labscale as well as in fermentor scale by combining DOM with PEI to form transfection complexes.
Our data show the PEI-mediated transfection into EBNA cells can be used as a costeffective transfection system in spinner culture scale up to 2-5L, to produce milligram amounts of recombinant protein. Fermentor scale experiments, however, are less efficient because the PEI- mediated transient gene expression is inhibited by the conditioned medium. Transfection experiments performed in the present of both DOM and PEI exhibited synergistic enhancement of gene expression in EBNA cells. The synergistic enhancement between DOM and PEI at low dose DNA (0, l-0,2µg/ml) was seen in spinner scale as well as in 10L and 23L fermentor Keywords : Transient transfection, HEK293 cells, serum-free, gene expression
Introduction
Efficient gene delivery in gene therapy using non-viral vectors where the DNA is generally complexed with cationic lipids or polycationic polymers has recently become of great interest (1, 2). More recently some of these transfection agents were conjugated with proteins or peptide in order to target then to specific cell types (3, 4). In addition to being important for gene therapy protocols improved non-viral gene delivery techniques are also of significant interest in gene expression in cell culture. 105 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 105-112. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
106
Obtaining stable cell clones is generally a time consuming processs lasting from 4-6 weeks untill 6 months. In order to speed up the whole process of expressing milligram amounts of recombinant proteins we were interested in scaling up the transient gene expression system in suspension culture. Here we have optimized the PEI-mediated transfection conditions of HEK293(EBNA) cells grown in serum-free suspension culture for large scale experiments. In a second part of the investigation the efficiency of gene expression was studied by combining dioleoyl-melittin (DOM), which represents a new class of peptide-based reagent for efficient transfection of mammalian cells, with PEI to form transfection complexes (5,6). Materials and Methods Cell culture Cell line: HEK 293EBNA (Invitrogen) adaptated to growth in suspension Medium: HL serum-free, Ca-free with transferrin, insulin, Primatone RL, Pluronic F68, fructose, maltose) (7 ). Feed solution.: Mixture of gln, glucose, essential and non-essential. amino acids, vitamins, Primatone RL Culture vessel: Spinner flasks (Bellco), 12 L bioreactor, stirred (MBR) Transfection Transfection reagents: Polyethelenimine (Fluka), dioleoyl-melittin (Roche) Reporter gene: Extracellular domain of human TNF receptor p55 (TNFRp55). Plasmid: pREP 7-TNFRp55 (EBV-based expression vectors containing the EBV ori P and the EBNA-1 gene which replicate extrachromosomally in dividing cells, Invitrogen). Transfection assay HEK293(EBNA) cells grown to a cell titer of 0,6-1.0x10e6cells/ml were centrifuged, washed once and resuspended in fresh medium. The cell titer was adjusted to 5-6xlOe5 cells/ml. Preparation of the transfection complexes Direct method: The DNA-PEI transfection complexes were preformed directly in the cell culture by adding DNA and PEI consecutively Indirect method: The DNA-PEI transfection complexes were preformed in fresh medium (1/10 volume) and then added to the cells. The DNA-DOM-PEI transfection complexes were prepared using the indirect method
Incubation The transfected culture was grown for 2-5 days.After the second day the culture was fed once daily with a nutrient mixture of of sugars, amino acids and vitamins.
107
Product analysis The recombinant TNFRp55 were measured by ELISA. Results and Discussions First we adaptated the adherently growing HEK293 cells and the subclone 293EBNA to serum-free growth in suspension culture using HL medium. In order to quickly generate a large set of data on the transient gene expression, experiments were performed in 12 well dishes by transferring 1 ml suspended cells into each well. The transfection complexes were then formed by adding first the plasmids followed by the cationic polymer PEI directly into the culture (direct method). First the PEI nitrogen : DNA phosphate ratio was examined, which is very important for high transfection efficiency (6). The relatively high ratio of 26:1 which was found to be optimal could partially explained by the DNA-PEI complex formation in the culture in the presence of cells. This ratio was subsequently used for gene delivery experiments in spinner culture. Fig. 1 shows the expression levels from an experiment in which 1µg/ml DNA was complexed either by using the direct method or by the indirect method in 1/10 volume of fresh medium. Two clear results were obtained. First the expression levels in EBNA cells were significantly higher compared to 293 cells if the direct method was used. This could be due to the higher growth rate observed during the post-transfection time, (see the final cell density). In contrast, the 293 cell titer is lower after 3 days incubation. Secondly, the transient expression of TNFRp55 displays a significantly lower titer if the indirect method was used, indicating that the conditions of the separately prepared DNA-PEI complexes is suboptimal.
108
In an additional experiment the scaleability of the direct method was investigated using 1 µg/ml plasmid. In Table 1 we demonstrate scaleability of the spinner culture system. No difference in expression levels were observed if increased culture volume up to 2L was used in corresponding spinner flasks. From this finding it is evident that milligram amounts of recombinant proteins can be produced in a cost-effective way using this simple indirect method of DNA-PEI complex formation.
A lot of effort was invested to reduce the DNA concentration in transient transfection experiments further. From previous experiments we know that the transient gene expression was always slightly if PEI (Mw 25kDa) was used instead of PEI (800kDa) higher compared to data obtained with PEI Mw 800 kDa. Therefore, studies were performed using both 25 and 800 kDa PEI to determine the optimal ratios of PEI: DNA with respect to plasmid concentration and the method used for complex formation. The results clearly shows that in the presence of 1µg/ml DNA the ratios of PEI:DNA is different depending on the method and DNA concentration, see Table 2. While the direct method again shows the ratio of 26:1 the indirect complex formation shows a N : P ratio of 13: 1. The latter finding confirms results described in the literature (6). Highly remarkable is the fact that at low DNA concentration
(0,2µg/ml) high expression levels were measured if the amount of PEI was increased . The optimal ratio of PEI: DNA was found to be 33 : 1. Table 2 shows the TNFRp55 titer of transient transfection experiments with different DNA concentrations and different molecular weights of PEI ( 25 and 800 kDa), using the direct and indirect method.
109
Before each transfection experiment 293EBNA cells were transferred into fresh medium. This step is very important for the DNA uptake process as is shown in the next experiment. EBNA cells were washed and diluted into fresh medium, followed for 48 hrs. incubation. During culturing the medium become conditioned. After 24 and 48 hrs. incubation cells were adjusted to a cell titer of 5×10e5 c/m1 with
the corresponding spent medium and transfected using the indirect method with DNAPEI complex formation in 1/10 culture volume with fresh medium. In the control sample, cells from the 48 hrs. time point were carefully transferred into fresh medium and then transfected as described. The results in Fig.2 clearly demonstrate that transient gene expression is strongly inhibited by condioned medium depending on the age of the culture. However, the cells are still competent for DNA uptake as illustrated by the control result. The inhibition ot transient transfection by conditioned medium presents a serious problem in large scale experiments. To overcome this difficulty we have used the combination of two transfection agents dioleyl-melittin (DOM) and PEI. DOM is highly toxic in serum-free suspension culture if the described DNA-DOM ratio of 1 : 10 was used. By lowering the DNA concentration from 1µg/ml to 0.1-0.2 µg/ml the toxic effect is drastically reduced but no TNFRp55 could be measured. However, if PEI was also added to the DNA-DOM complexes (here we used the 25 and the 800 kDa polymer) a significantly increase of the expression levels was observed as shown in Fig.3. This clearly demonstrates a synergistic enhancement of transient transfection efficiency in the presence of DOM and PEI. In a set of experiments we optimized the ratios of DNA-DOM-PEI. Conditions could be found which show high transfection efficiency at low DNA concentration. Furthermore, the inhibitory effect of conditioned medium could be significantly reduced by using DOM and PEI together. From this it is evident that if no medium exchange is performed in a large scale transient transfection experiment DOM and PEI must both be used and the culture must be diluted with fresh medium to give the correct cell titer.
110
In a last experiment we show a transient gene expression experiment using a 12L bioreactor. EBNA cells were transferred into fresh medium and used to inoculate the fermentor. If the cell titer of 5-6x10e5 c/ml was achieved then 1L of fermenter volume was replaced by 1L freshly prepared transfection complexes (DNA-DOM-PEI). The released 1L portion was transfected under identical conditions and incubated in a spinner flasks. The results of this fermentor scale experiments is illustrated in Fig. 3. About 16 milligram TNFRp55 was produced within 5 days post-transfection.
Conclusions PEI-mediated gene transfer into HEK293EBNA cells can be used as a simple transfection system to produce milligram amounts of protein in a cost effective way during 3-5 days in serum-free medium. Transient transfection is inhibited in conditioned culture. The combination of DOM and PEI significantly reduces the inhibitory effect and yields higher expression values >Furthermore, the action of both agents together are extremely useful in fermentor scale transfection at low DNA concentration.
111
References
1. X Gao and L Huang (1995) Cationic liposome-mediated gene transfer, Gene Therapy 2, 710-722. 2. Barthel F., Remy J.-S., Loeffler J.-P. and Behr J.P. (1993) Gene Transfer Optimization with Lipospermine-Coated DNA, DNA and Cell Biology 12, 553-560. 3. Gottschalk S., Sparrow JT., Hauer J, Mims MP., Leland FE, Woo SLC and Smith LC. (1996) A novel DNA-peptide complex for efficient gene transfer and expression in mammalian cells, Gene Therapy 3, 448-457. 4. Kircheis R., Kichler A., Wallner G., Kursa M., Ogris M., Felzmann T.
Buchberger M. and E. Wagner (1997) Coupling of cell-binding ligands to polyethelenimine for targeted gene delivery, Gene Therapy 5. Legendre JY., Trzeciak A., Bohrmann B., Deuschle U., Kitas E.A. and Supersaxo A. (1996) Dioleoylmelittin as a Novel Serum-Intensitive Reagent for Efficient Transfection of Mammalian Cells, Bioconjugate Chem. 8, 57-63 6. Boussif O., Lezoualc'H F., Zanta M., Mergny M., Scherman D., Demeneix B. and Behr J.-P. (1995) A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethelenimine, Proc. Natl. Acad. Sci.. USA 92,72977301. 7. Schlaeger E.-J. (1996) The protein hydrolysate, Primatone RL, is a cost-effective multiple growth promotor of mammalian cell culture in serum-free media and displays anti-apoptosis properties, J. Immunol. Methods 194, 191-199.
112
Discussion
Wurm:
What is the transfection efficiency in the reactor?
Schlaeger:
I do not know as I only looked for the accumulation of TNF receptor. From earlier experiments 30-60% of the cells were transfected.
Mueller:
Some time ago NC2 precipitation of DNA was used to transfect cells and those reactions were very strongly pH dependent. I would expect the same in your system. Have you looked for pH dependence on your precipitation efficiency?
Schlaeger:
No. The whole system works very well on the plate, and we have used different types of medium, but the pH was constant at about 7.3. I do not believe that there is any difference in the complex formation with pH. The system is good in that it is simple, but we have a problem with the conditioning medium in the 60 1 fermenter because of the number of passages.
Merten:
I know that DOM is still produced in your laboratory. Will it become available on the market as it would be useful in large-scale applications?
Schlaeger.
You can buy the 2 molecules separately but you have to do the conjugation yourself. It has been given to various companies for testing, but I do not know what the decision was.
LARGE SCALE TRANSIENT GENE EXPRESSION IN MAMMALIAN CELLS E.-J. Schlaeger, K. Christensen, G. Schmid, N. Schaub, B. Wipf, and A. Weiss F. Hoffmann-La Roche Ltd., Pharmaceutical Division - PRP Department PRPN-G, CH-4070 Basel, Switzerland
Keywords: transient transfection, plasmid production, plasmid purification
• The aim of this work was to develop a fast, robust and costeffective integrated process for the production of mg
amounts of protein for research purposes. The process consists of 3 distinct parts: Plasmid production, plasmid purification and large-scale transient transfection of mammalian cells grown in serum-free suspension culture.
• We investigated plasmid amplification using various E. coli strains cultivated in different complex media followed by the establishment of plasmid production conditions in 10 L fermenters
• The efforts in the area of plasmid purification were geared towards the development of a fast and cost-effective method that generates material suitable for our PEImediated transfection protocol
• Different plasmid preparations were tested in PEI-mediated transient transfection experiments with HEK293 (EBNA) cells grown in serum-free suspension culture at lab and bioreactor scale 113 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 113-116. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
114
Process flow diagram for the purification of plasmid DNA for transient transfection
Alkaline Lysis and 2-Propanol Precipitation
115
Cell culture Cell line: Medium: Culture vessel: Plasmid: Reagent:
HEK293(S), 293EBNA (Invitrogen) HL-0%FCS w heparin Spinner flaks (Bellco), 12L bioractor (MBR) pREP7, pC1,(soluble human TNFRp55) pGL3-CMV(luciferase) Polyethylenimine (PEI), Fluka, Aldrich Dioleolyl-melittin (DOM), Roche
Transfection assay: Log cells(5xl0e5c/ml) in HL w/o heparin Formation of DNA-PEI transfection complexes: indirect method: The complexes were performed in fresh medium (1/10 volume) an then added to the cells. Incubation: 3-5 days, spinner flask, 100rpm, (feed) Test: sol. human TNFRp55 ELISA
116
Summary • We established an E. coli fermentation process for plasmid production in 10 L bioreactors yielding between 50-150 mg of unpurified plasmid depending on the plasmid and the host strain. The E. coli strain
•
was selected to give a high yield of monomeric supercoiled pREP7-TNFRp55 DNA.
•
A standard alkaline extraction method was scaled up and a 1-step chromatographic procedure yielded plasmid DNA suitable for our transfection protocol.
•
Transient gene expression with different plasmid preparations exhibited high transfection efficiencies.
•
We developed a cost-effective large scale transient transfection process to produce mg amounts of recombinant protein using HEK293 (EBNA) cells grown in serum-free suspension culture.
Synergistic enhancement of transient expression by dioleoylmelittin (DOM) and polyethylenimine (PEI) in mammalian cells in suspension culture E.-J. Schlaeger , J.Y. Legendre*, A. Trzeciak, E.A Kitas, K. Christensen, U. Deuschle and A. Supersaxo F. Hoffmann La Roche Ltd. PRPN-G, PRPF, CH-4070 Basel, Switzerland *UPSA Laboratoires, 128 rue Danton, 92506 Rueil-Malmaison, France Abstract
Dioleoyl-melittin, which is a conjugate of dioleoyl-phosphatidyl-ethanolamine-N-{3-(2pyridyldithio)propionate} with the amphipatic peptide melittin { Gly-Cys} 1 represents a new class of peptide-based reagent for efficient transfection of mammalian cells. In this work we investigated the transfection efficiency of dioleoyl-melittin (DOM) combined with polyethylenimine (PEI) using HEK293(EBNA) cells grown in serumfree suspension cultures. Gene expression was monitored using the luciferase reporter gene and the human soluble TNF receptor p55 gene (TNFRp55) inserted into different vectors. Our data clearly show that DOM together with PEI exhibited synergistic enhancement for gene expression in EBNA cells. At the optimal DNA-DOM-PEI
weight ratio the efficiency of transfection increases significantly compared to corresponding PEI and DOM transfection at low DNA concentration. In summary, our data show that dioleoyl-melittin and polyethylenimine act synergistically in transfecting 293(EBNA) cells grown in serum-free suspension culture. Keywords : HEK293, serum-free culture, transient transfection, bioreactor
Introduction
Efficient gene delivery in gene therapy by using non-viral vectors has recently become of great interest (1 ). Substantial work has been done to improve DNA uptake where the DNA is generally complexed with cationic lipids or polycationic polymers. More recently some of these transfection agents were conjugated with proteins or peptide in order to target it to specific cell types (2,3). In this context we were interested in dioleylmelittin (DOM) which is a novel peptide-based gene transfer agent as described recently (4 ). The authors described that the highest expression levels for gene delivery experiments were found by using the ratio DNA:DOM of 1:10. If we transferred the weight ratio of DNA: DOM to our transfection system it became clear that if lµ g/ml DNA was used in a transfection experiment the corresponding amount of DOM is highly toxic especially in serum-free suspension culture. Therefore, it was very important to minimize the cell toxicity by reducing the plasmid concentration. In this work we investigated the transient transfection efficiency of dioleoyl-melittin (DOM) combined with polyethylenimine (PEI) at low DNA concentration using HEK293(EBNA) cells grown in serum-free suspension cultures. 117 O. - W. Merten et al. (eds.), Mew Developments and New Applications in Animal Cell Technology, 117–120. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
118
Materials and Methods Cell culture Cell line: HEK 293EBNA (Invitrogen) serum-free HL medium (5). Culture vessel: Spinner flaks (Bellco), 12 L bioreactor, stirred (MBR) Transfection Transfection agents: Polyethelenimine (PEI), dioleoyl-melittin (DOM) Reporter gene: Extracellular domain of human TNF receptor p55 . Plasmid: pREP7-TNFRp55 (EBV-based expression vectors (Invitrogen) Transfection assay HEK293(EBNA) cells were centrifuged, washed once and resuspended into fresh medium. The cell titer was adjusted to 5-6xl0e5 cells/ml. Preparation of the transfection complexes The DNA-PEI transfection complexes were prepared in fresh medium (1/10 volume) and than added to the cells (6). The DNA-DOM-PEI transfection complexes were prepared in fresh medium (1/10 volume) and then added to the cells.
Incubation: The transfected culture was grown for 2-5 days.After the second day
the
culture was fed once daily . Product analysis: The secreted TNFRp55 were measured by ELISA.
Results
and
Discussions
Before establishing data for a scaleable transient gene expression system we first adaptated the adherently growing HEK293 cells and the subclone 293EBNA to serumfree growth in suspension culture using HL medium . In a set of experiments we tested the expression levels of DOM-mediated transient transfection by using different DNA and DOM concentrations. The results clearly indicate significantly toxic effects on cells if more than DNA and DOM is used. However, lowering the DNA concentration further caused a significant drop in efficiency ( data not shown). From our experience with PEI-mediated transient gene expression we tried to combine both transfection agents in order to improve the gene delivery system in suspension cell culture. Fig. 1 shows the time course of a transfection experiment in which 0.25 DNA was incubated with DOM in the absence and in the presence of PEI. Using the DNA-DOM complexes high cell viability was observed (> 85%). However, 3 days post-infection only background expression levels were measured. Similar results were obtained if DNA-PEI transfection complexes were used. Quite different results were obtained in the sample where PEI was added with the DNA-DOM complex. A high yield of TNFRp55 was accumulated in the culture medium. The conclusion of this simple experiment clearly indicates that DOM and PEI act synergistically in transfecting 293EBNA at low plasmid concentration. This result was subsequently confirmed on several occasions. The concentrations of DNA, DOM and PEI were optimized in order to improve transfection efficiency.
119
After establishing lab-scale data on transient gene expression we scaled up this technique. First we applied the transfection conditions in spinner culture up to 2L volume without lost of expression levels, demonstrating the possibility of production of several mg recombnant protein. Finally transient gene expression was performed in a 12 L bioreactor. Figure 2 shows the results. About 2,5L cells were grown up to a cell titer of 1,2×l0e6 cells/ml, transferred into fresh medium by a centrifugation step and used to inoculate the fermentor giving a final volume of 11L.
120
Conclusion
The results of this study clearly show that DOM together with PEI exhibited synergistic enhancement for gene expression in EBNA cells at low DNA concentration. At the optimal DNA-DOM-PEI weight ratio (0.2-0.15-0.5) the efficiency of transfection increases significantly (up to 10-fold) compared to corresponding DNA-PEI and DNADOM transfection. No toxic effect was observed. Therefore, the combination of DOM and PEI exhibits a cost effective transient gene expression system with high transfection values and is extremely useful for large scale production of milligram amounts of recombinant proteins at low plasmid concentration.
References 1. X Gao and L Huang (1995) Cationic liposome-mediated gene transfer, Gene Therapy 2, 710-722. 2. Gottschalk S., Sparrow JT., Hauer J, Mims MP., Leland FE, Woo SLC and Smith LC. (1996) A novel DNA-peptide complex for efficient gene transfer and
expression in mammalian cells, Gene Therapy 3, 448-457. 3. Kircheis R., Kichler A., Wallner G., Kursa M., Ogris M., Felzmann T. Buchberger M. and E. Wagner (1997) Coupling of cell-binding ligands to polyethelenimine for targeted gene delivery, Gene Therapy 4. Boussif O., Lezoualc’h F., Zanta M., Mergny M., Scherman D., Demeneix B. and Behr J.-P. (1995) A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethelenimine, Proc. Natl. Acad. Sci.. USA 92,72977301. 5. Schlaeger E.-J. (1996) The protein hydrolysate, Primatone RL, is a cost-effective multiple growth promotor of mammalian cell culture in serum-free media and displays anti-apoptosis properties, J. Immunol. Methods 194, 191-199. 6. Legendre JY., Trzeciak A., Bohrmann B., Deuschle U., Kitas E.A. and Supersaxo A. (1996) Dioleoylmelittin as a Novel Serum-Intensitive Reagent for Efficient Transfection of Mammalian Cells, Bioconjugate Chem. 8, 57–63
TRANSIENT EXPRESSION OF A SOLUBLE AND SECRETED FORM OF HETERODIMERIC T-CELL RECEPTOR IN HEK-293
M. JORDAN* , C. L. BLANCHARD°,1. BERNASCONI°, I. LUESCHER° and F. M. WURM*
* Center of Biotechnology UNIL-EPFL, Swiss Federal Institute of Technology, 1015 Lausanne, Switzerland °Ludwig Institute for Cancer Research, University of Lausanne, 1066 Epalinges, Switzerland
1. Abstract Biologically active human T-cell receptor (TCR) was expressed as a secreted recombinant protein in 293 cells.
Correct
chain pairing was facilitated by
complementary charged peptides (leucine zipper) at the C terminus. Two plasmids, coding for the chains were constructed and prepared using commercially available purification kits. After optimizing transfection conditions for secretion of heterodimeric TCR in 12 well plates, transfections were performed in spinner flasks. The transfection efficiency was determined with a co-transfected expression vector and correlated with TCR levels as determined by ELISA. Product was isolated by affinity chromatography. Biological activity, i.e. ligand binding was tested. Transiently produced recombinant soluble TCR showed similar affinity to the ligand as receptors purified from cell membranes. 2. Introduction For determination of the structure of TCR, mg amounts of soluble protein are desirable. Before a quantitative ELISA with a purified standard was available, relative amounts of heterodimers were detected by an ELISA using antibodies against both chains. Biological activity was measured using ligand. Stable expression in CHO cell lines gave poor signals in both assays, indicating that the formation of heterodimers is not very efficient and that TCR might be difficult to express at high levels. This article describes the transient expression of TCR in the human kidney cell line 293 T. 3. Materials and Methods Plasmids and vectors: The chain were cloned seperately into the pCI-neo expression vector (Promega). In order to have a soluble and secreted version of TCR the transmembrane domain and cytoplasmic tail were deleted. In addition, a leucine zipper 121 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 121-123. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
122
sequence was introduced into each chain, which should facilitate formation of heterodimers. The Qiagen kit was used to purify mg amounts of plasmids. Transfections in plates: Exponentially growing 293 T cells were seeded at 10-20 hours before transfection in DMEM/F12 medium supplemented with 2% FCS1. Per 10 ml of medium, . of 250mM containing a total of DNA was mixed with HEPES buffer (1.5mM 140mM NaCl, 50 mM HEPES, pH = 7.05). The transfection cocktail was added to cells after 1 minute and the plates were incubated for 4 hours at . Precipitate was removed at this point by exchanging the medium. Transfections in spinner flasks: For 1 L spinner flask, cells were seeded in 500 ml of fresh medium at Immediately before the precipitate was formed 15 ml of 250mM was added into the spinner flasks to increase the calcium concentration. Subsequently, 20 ml of transfection cocktail was added2. After 4 hours, the culture was diluted by adding 500 ml of fresh medium. Protein was harvested after 2 - 3 days. 4. Results and Discussion IS OPTIMAL FOR HETERODIMER EXPRESSION Expression of TCR was first optimized in 12 well plates to identify an optimal ratio of the two chains, encoded by two different expression vectors. Ratios of 1:9 through 9:1 were tested (Fig. 1). ELISA data as well as photo-affinity labeling tests indicated that the is limiting and that at an excess of expression vector significantly improves transient expression.
4.2. T-FLASKS VERSUS SPINNER FLASKS TCR was transiently expressed in T-flasks or in 1 L spinner flasks. The ratio of chain expression vectors was 1:2 . For the spinner experiment, cells were adapted for one month to grow in suspension containing single cells and small aggregates (less than 10 cells per aggregate). Transfections of this adapted population in plates showed that the cells still grew adherent and there was no change in transfection efficiency. The expression of TCR in the spinner flasks was comparable to the T flasks (Table 1). In other experiments no difference could be found between 12 well plates and T-flasks.
123
4.3. DOES AN INTERNAL CONTROL CORRELATE WITH PRODUCT TITERS? Although the transfection procedure is well defined, the problem of variation in transfection efficiency between different experiments remains. For the transient expression of proteins such variation can cause a problem, in particular when there is no quantitative assay available for the protein to be expressed. To minimize variation
and to guarantee at least a reasonable transfection efficiency before efforts for product isolation are started, we included in one series of transfections in 100 ml spinner flasks as an internal standard 10 % of pCMV The cells were fixed 24 hours after transfection and stained for 4 hours with X-gal. Positive cells were counted in the microscope and compared with the relative ELISA-signal (Fig.2). Although none of the assays were optimized for a high accuracy, the internal marker seems to correlate with the levels of produced TCR. Such an internal standard, co-transfected with any protein has a clear advantage, because it allows detection with one assay all the variations in transfection efficiency, which would directly affect the product yield.
5.
Conclusions
Different chains seem to be expressed at different efficiency, even when both chains are cloned into the same expression vector. For two chain proteins the levels of transient expression can be improved by optimizing the ratio of the two vectors used for co-transfection. Transfections in spinner flasks resulted in the same level of expression as transfections in T flasks or in 12 well plates. Co-transfection of a marker (10% or less of total DNA) correlates with the product level for a particular protein and generally can be used as a control for reproducible transfection efficiencies. 200 µg of recombinant TCR was purified from 2.5 L of supernatant harvested 2 days after transfection.
References 1
Jordan, M., Schallhorn, A. and Wurm, F.M. (1996) Transfecting mammalian cells: optimization of critical parameters affecting calcium-phosphate precipitate formation. Nucleic Acids Res. 24, 596-601
2
Jordan, M., Koehne, C. and Wurm, F.M. (1997) Calcium phosphate mediated DNA transfer into HEK293 cells in suspension: control of physicochemical parameters allows transfection in stirred media. Cytotechnology, in press
This page intentionally left blank.
MEASURABLE PARAMETERS OF CELLS AND PRECIPITATE PREDICT TRANSFECTABILITY WITH CALCIUM PHOSPHATE
M. Jordan and F. Wurm Center of Biotechnology UNIL-EPFL, Swiss
Federal Institute of
Technology, 1015 Lausanne, Switzerland
1. Abstract Transient expression of proteins in mammalian cells at 1 - 100 L scale has the potential to become a powerful technique for the rapid production of research proteins. We have shown that the calcium phosphate technique is compatible with routine handling in bioreactors and that the yield of proteins is comparable to that seen in standard transient transfections 1 . However, although the reproducibility of the method is
excellent within triplicates, there can be dramatic variations in transfection efficiencies with different batches of cells, solutions, plasmid preparations etc. In addition, expression levels of novel proteins may differ from those seen with proteins like tPA or hGH. There is a need therefore, to monitor the transfection procedure itself and to predict protein expression through defined and quantitative assays. We suggest two
tests: the first assesses, through OD-measurements of the transfection cocktail, the quality of the DNA-carrier complexes. The second employs a commercially available vector encoding a strongly fluorescent green fluorescent protein (GFP). Transfection with this vector provides, within a day, a quantitative signal. Together, these assays
allow a fast assessment of transfections with calcium phosphate for optimization purposes. Moreover, co-transfecting GFP with the vectors of interest allows, to a certain degree, prediction of transfectability and expression of the desired protein. 2. Introduction
Transfection efficiency depends on physical and biological parameters, some of them not known or difficult to control. For the calcium phosphate technique in particular, physical parameters of the precipitation buffers are most critical 2 . The effect of such parameters on the precipitation of DNA can be studied by a turbidity assay described earlier3. Here we suggest a modified protocol without the addition of DNA, to test and to compare new batches of transfection solutions rapidly. Transfectability of cells is more difficult to control. Even with the same cell line, transfection results can vary several fold depending on the actual status of the cell population. It is desirable therefore, to include an internal standard in order to monitor 125 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 125-128. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
126
the actual transfection efficiency. Such an internal standard should be applicable for various cell lines and different methods applied. In addition, it should allow comparison of transfection efficiencies at various scales. 3. Materials and Methods
Turbidity assay: One volume of 250 mM (without any DNA) is quickly mixed with one volume of HEPES buffer HEPES, pH = 7.05). After 1 minute, the absorption at 320 nm is measured. GFP measurements:The plasmid pEGFP-Nl (Clontech) is transfected in multiwell plates using the calcium phosphate method. Fluorescent signals are directly measured from 12 well plates containing cell culture medium (CytoFluor II, extinction at 485/20, emission at 530/25). Since plastic and cell culture medium significantly contribute to the signal, a control measurement immediately taken after the transfection when fresh medium had been added, is to be subtracted from the derived values. Alternatively, cells were counted and resuspended in PBS. cells per well (96
well quartz plate) typically resulted in good signals much above the background from negative cells.
4. Results and Discussion 4.1. CONTROL OF NEW BATCHES OF SOLUTIONS
Although many parameters have been described to optimize the solutions needed to form the precipitate, only a transfection experiment with a known reference solution proves equivalency. It is obvious that this can be tricky. A more direct method is the quantification of the turbidity of the forming precipitate itself. There is no absorption at
320 nm in the absence of "precipitate" particles. When the phosphate concentration in the precipitation buffer is increased, the physical nature of the precipitate changes and the turbidity increases in a typical mode (Fig. 1.). For transfections, an absorption of 0.13 - 0.145 was found to be optimal for precipitates formed in the presence of 25µg of DNA per ml of precipitate. Once this
value is known for a transfection protocol, the turbidity can be used as a quick assay assessing the capacity of the used solutions to generate an efficient DNA-carrier complex with calcium
phosphate.
127 4.2. GFP SIGNAL IS PROPORTIONAL TO DNA AMOUNT ADDED PER WELL
Preliminary results with showed that an internal standard correlates with product titers, but too many variations were seen with this assay. We investigated the use of GFP protein, eliminating lysis of cells, enzymatic reaction etc. A major drawback of GFP is that signals are relatively weak, which makes detection not very sensitive. Second generation GFP's overcame this limit. We tested the sensitivity by transfecting different amounts of GFP plasmid into 293 cells and measured the signal directly in the 12 well plates (Fig. 2). Even at the lowest amount of DNA, 200 ng per well, the signal was clearly above the background level. Up to a dose of 1 µg per well, signal intensity increased linearly with the amount of DNA, yet became saturated above 2.5 µg per well.
4.3. GFP SIGNAL INCREASES FOR 70 HOURS AFTER TRANSFECTION
3 – 5 hours after the addition of precipitate to the cells, first positive cells can be
identified in the microscope. The quantification of fluorescence however is difficult at time point earlier than 12 hours. Intensities of signals increase for the first 3 days and stay almost constant for a few more days (Fig. 3). The plateau after 3 days was seen at all the DNA concentrations tested. It appears therefore that such a plateau does not reflect a saturation of intracellular GFP accumulation, but a loss of expression after a certain period of time. A similar behaviour can also be observed for transient expression of
secreted proteins.
128
5. Conclusions The turbidity at 320 nm quantitatively describes the precipitate. Solutions can be quickly tested without the addition of DNA. The EGFP-N1 vector in combination with an efficient transaction method results
within a day after transfection in fluorescent signals detectable directly from growing cells. Since the signal derives directly from the expressed protein, any pretreatment of samples or incubation steps can be avoided. Expression of GFP appears not to interfere with the expression of other proteins, when representing 10% or less of plasmid quantity of the transfection cocktail. Even at this low molar ratio, the product concentration is high enough to produce easy detectable
fluorescent signals. Signals increase for about 70 hours and reflect GFP expression with a high accuracy. Intracellular accumulation of GFP shows a trend typical for the expression of secreted
proteins, such as tPA or rDNase (data not shown). The fluorescent signal might not only correlate with transfection efficiency, but with protein expression in general as well.
References 1
2
3
Jordan, M., Koehne, C. and Wurm, F.M. (1997) Calcium phosphate mediated DNA transfer into HEK293 cells in suspension: control of physicochemical parameters allows transfection in stirred media. Cytotcchnology in press Jordan, M. and Wurm, F.M. (1995) High level transient expression in mammalian cells: identification and optimization of physico-chemical parameters of the calcium phosphate transfection method, in E.C. Beuvery et al. (eds.) Animal Cell Technology: Developments towards the 21st Century, Kluver Academic Publisher, Dordrecht. 49-55 Jordan, M., Schallhorn, A. and Wurm, F.M. (1996) Transfecting mammalian cells: optimization of critical parameters affecting calcium-phosphate precipitate formation. Nucleic Acids Res. 24. 596-601
GLYCOSYLATION
This page intentionally left blank.
INFLUENCE OF Na-BUTYRATE ON THE PRODUCTION AND SIALYLATION OF HUMAN INTERFERON- BY 2,6-SIALYLTRANSFERASE ENGINEERED CHO-CELLS D. LAMOTTE1, L. MONACO2, N. JENKINS3 & A. MARC1 1 LSGC-CNRS, BP 451, 54001 Nancy Cedex - France 2 DIBIT, via Olgettina 60. 20132 Milano - Italy 3 De Montfort University, L91 9BH Leicester - UK 1. Introduction Mammalian cells are widely used for the production of recombinant drugs because of their ability to perform extensive post-translational modifications. However, they exhibit low production yields in comparison with procaryotic cells. Nevertheless, the use of stimulating agents such as sodium butyrate in medium formulation can enhance the synthesis of recombinant glycoproteins 1,2 . Some conflicting results demonstrated that Na-butyrate addition affects the cell's glycosylation machinery. For some, sodium butyrate may reduce the sialyltransferase synthesis 3,4 . Conversely, an increase in the specific activity of sialyltransferases in CHO cells was pointed out as a result of sodium butyrate addition 5 . Although the CHO-derived glycan structures are similar to those present on natural human proteins, they are not identical6. In CHO cells, sialic acids are exclusively added to terminal galactose via Since it is known that the absence of linkages can dramatically enhance clearance of a drug from bloodstream 6 , we have recently expressed the cDNA coding for the rat into the CHO 320 producing (IFN) line and allowed the presence of on IFN7. Here, we report the effect of 1 mM sodium butyrate on cell growth, IFN production and sialylation. Experiments were performed in controlled bioreactor cultures with parental and engineered CHO cells, in order to determine the influence of Na-butyrate on the IFN sialylation. 2. Materials & Methods The producing IFN CHO cell line (CHO 320) was supplied by the Wellcome Foundation Laboratories. The engineered producing IFN CHO cell line (CHO C5) was constructed as described in ref. 7. Cultures were performed with a serum-free medium based on RPMI-1640 supplemented with BSA, insulin and salts. The culture conditions were similar to those described in ref. 8. Sodium butyrate was added from a stock solution (500 mM in PBS - Sigma B2503) 24 or 36 hours further the seeding of the bioreactor. IFN purification and HPLC resolution and detection of sialic acids to discriminate between and are described in ref. 7.
131 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 131-133. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
132
3. Results 3.1. INFLUENCE OF Na-BUTYRATE ON GROWTH AND IFN PRODUCTION
Since preliminary shake-flask cultures have shown that the 1 mM Na-butyrate concentration is optimal for enhancing the IFN production without compromising the cell viability, bioreactor cultures were performed with 1 mM Na-Butyrate. 1 mM Na-butyrate concentration restricted the maximal viable cell density and increased the final IFN concentration by 90-130 % (fig. 1). Butyrate exposure resulted in a major increase in the maximal specific IFN production rate reaching 45 and 150 for CHO 320 and CHO C5 respectively (data not shown). For both cell lines, the production of the IFN occurred exclusively during the growth phase. 3.2. INFLUENCE OF Na-BUTYRATE ON IFN SIALYLATION IFN was purified from culture supernatants at the end of the growth phase of the batch cultures (80-100 hours of culture) performed with and without butyrate addition. The percentages of sialic acids and the molar ratio of total sialic acids to IFN molecules were determined (table 1). In control conditions, transfection of the cDNA into CHO 320 cells to produce C5 resulted in 68% of total sialic acids linked in the and nearly double the overall IFN sialylation, in comparison with the IFN from the parental cell line.
133
The effect of adding butyrate was determined for the two cell lines. As expected, 100 % of sialic acids on IFN from CHO 320 were still in the in the culture performed with Na-butyrate. Conversely, 82 % of sialic acids were in the conformation on IFN secreted by CHO C5 line with Na-butyrate compared to 68% without butyrate. Furthermore, the overall degree of IFN sialylation was twofold higher for CHO C5 cells subjected to butyrate, whereas it was not enhanced by butyrate exposure in the CHO 320 cell line. Therefore, the increase in the overall degree of sialylation on IFN produced by CHO C5 cells with butyrate results
predominantly from an increase in the molar ratio of total (+130%) rather than sialic acids (+15%).
sialic acids
4. References 1. Chevalot I., Dardenne M., Cherlet M., Engasser J.-M. and Marc A. (1995) Effect of sodium butyrate on protein production in different culture systems, in Beuvery E.C., Spier R. and Griffiths B. (eds.), Animal Cell Technology: Developments towards the 21st century, Kluwer Academic Publishers, Dordrecht, pp. 143-147 2. Oster T., Thioudellet C., Chevalot I., Masson C., Wellman M., Marc A. and Siest G (1993) Induction of recombinant gamma-glutamyl transferase by sodium butyrate in transfected V79 and CHO Chinese hamster cells, Biochem Biophys Res Comm 193, 406-412.
3. Shah S., Lance P., Smith T.J., Berenson C.S., Cohen S.A., Horvath P.J., Lau J.T.Y. and Baumann H. (1995) n-butyrate reduces the expression of in Hep G2 cell. J Biol Chem 267, 10652-10658. 4. Li M., Andersen M.L. and Lance P. (1995) Expression and regulation of glycosyltransferases for N-
glycosyl oligosaccharides in fresh human surgical and cultured cell lines, Clin Sci 89, 397-404. 5. Chotigeat W., Watanapokasin Y., Malher S. and Gray P.P. (1994) Role of environmental conditions on the expression levels, glycoform pattern and levels of sialyltransferase for hFSH produced by recombinant CHO cells, Cytotechnology 15, 217-221. 6. Jenkins N., Parekh R.B. and James D.C. (1996) Getting the glycosylation right: implications lor the biotechnology industry, Nature Biotechnology 14, 975-981. 7. Monaco L., Marc A., Eon-Duval A., Acerbis G., Distefano G., Lamotte D., Engasser J.-M., Soria M and Jenkins N. (1996) Genetic engineering of in recombinant CHO cells and its effect on the sialylation of recombinant interferon-gamma, Cytotechnology 22, 197-203. 8. Lamotte D., Eon-Duval A., Acerbis G., Distefano G., Monaco L., Soria M., Jenkins N., Engasser J.-M and Marc A. (1997) Controlling the glycosylation of recombinant proteins expressed in animal cells by genetic and physiological engineering, in Carrondo M.J.T., Griffiths B. and Moreira J.L.P. (eds.), Animal Cell Technology: From Vaccines to Genetic Medicine. Kluwer Academic Publishers, Dordrecht, pp. 761-765.
This page intentionally left blank.
ELEVATED INHIBITS THE POLYSIALYLATION OF THE NEURAL CELL ADHESION MOLECULE IN CHO MT2-1-8 CELL CULTURES
JAMES A. ZANGHI1,3, THOMAS P. MENDOZA1, RICHARD H. KNOP2, WILLIAM M. MILLER1,# 1
Department of Chemical Engineering, Northwestern University, 2145 Sheridan Road, Evanston, IL 60208-312 2 Division of Medical Oncology, Evanston Hospital, 2650 N. Ridge Avenue, Evanston, IL 60201-1794 3 Present location: Institute of Biotechnology, Swiss Federal Institute of Technology, ETH Hönggerberg, HPT, CH-8093 Zürich, Switzerland. Email:
[email protected] # Corresponding author. Phone: (847)491-4828. Email: wmmiller@nwu. edu
Animal cells are important for the production of complex glycoproteins for use in therapeutics and diagnostics. Conditions during culture, such as the depletion of nutrients and accumulation of metabolites, may adversely affect the glycosylation process or increase the deterioration of glycoproteins after secretion (1, 2). Glycosylation has a critical role in protein quality by regulating its physiochemical and biological properties such as specific activity, thermal stability, solubility, clearance rate from blood stream, and immunogenicity (1). We and others have shown that ammonia, a metabolic waste product of animal cells, can specifically inhibit protein glycosylation (3, 4, 5, 6). Using the neural cell adhesion molecule (NCAM) as our model cell surface glycoprotein (Fig. 1), we showed that ammonia inhibits the NCAM polysialylation in Chinese hamster ovary (CHO) and small cell lung cancer (SCLC) cells in a dosedependent and reversible manner (6). The response was very strong, with a 90% decrease in CHO cell PolySia surface content following an exposure to 10 mM for 4 days.
A possible explanation for ammonia inhibition of sialylation or polysialylation is decreased (poly)sialyltransferase activity due to perturbations in the trans golgi pH
where the enzymes reside. The weak base readily diffuses across biological membranes, while its conjugate acid is virtually impenetrable so that the base accumulates in acidic compartments in the cell, including the trans golgi, resulting in collapse of the pH gradient (7, 8, 9, 10).
Carbon dioxide is another important waste product of animal cells, though problematic only under specific conditions such as high density culture systems where significant differences between the mass transfer coefficients of oxygen and carbon dioxide leads to a buildup of dissolved 135 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 135-140. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
136
By neglecting follows (13):
in water may be summarized as
Analogous to ammonia, freely diffuses across cellular membranes while the conjugate base is essentially membrane impermeable. For this reason, cells exposed to elevated at constant pH experience an initial decrease in pH. While the trapping effect observed for ammonia is less likely to occur with because of specific transporters such as the antiporter and symporter (14), the decrease in intracellular pH may or may not return to the original value (15, 16). We therefore hypothesized that elevated may also disrupt intracellular pH and other ion gradients, and thus inhibit polysialylation in a manner analogous to ammonia.
Elevated inhibits CHO cell growth and protein production (12, 17, 18). Kimura et al. (18) showed that CHO cell growth inhibition was more severe when osmolality was allowed to increase with while an increase in osmolality alone had no effect. In addition, it was shown that elevated had no effect on recombinant tissue plasminogen activator (tPA) glycosylation with the exception of an increase in Nglycolylneuraminic acid (Neu5Gc; balance N-acetylneuraminic acid, Neu5Ac) (19). A similar observation was reported by Grampp (20). Here we examined the effects of elevated as well as pH and osmolality, on CHO MT2-1-8 cell NCAM polysialylation. The experiments were conducted with the same CHO MT2-1-8 cell line, culture medium and set-up as that previously published for the studies with tPA (18, 19, 21, 22) (Fig. 2). This allows a direct comparison of the effects of on the glycosylation of the more robust tPA molecule and the hyper-sensitive NCAM
137
polysialic acid. Cells were cultured for 1-5 days under an atmosphere of 38 (control, 5% , 90, 140, or 195 torr and subsequently analyzed by flow cytometry using anti-NCAM and -PolySia mAbs. We separately measured the effects of osmolality and pH on NCAM polysialylation by adjusting the NaCl or NaOH concentration in the
medium, respectively.
The results of the experiments are summarized in Table 1 (23). At normal levels, both increasing pH and osmolality inhibited polysialylation. The effect was most pronounced at a pH above 7.4 and when the osmolality exceeded 400 mOsmol/kg. As increased the effect was much greater, with PolySia content decreasing until no immunoreactivity remained (i.e. anti-PolySia mAb fluorescence was identical to background fluorescence) after four days exposure to 140 at pH 7.5. At moderately elevated levels (90 torr), PolySia was unaffected or only slightly inhibited at pH 7.2 but was significantly reduced at pH 7.5. In all cases, NCAM was not affected, suggesting that the increase in pH, osmolality and were specific to polysialic acid.
138
Kimura et al. showed that increasing osmolality exacerbates the growth (18). In addition, increases with increasing pH which may disrupt exchangers in the cell membrane or other cell functions. Cell counts prior to flow cytometry confirm that there was a synergism between increased pH and elevated At pH 7.5, CHO cell growth was completely inhibited inhibition caused by elevated
at 195 torr, and there was considerable cell death at 250 torr This contrasts the results obtained at pH 7.2, where 195 torr and 250 torr decreased cell growth by 24% and
44%, respectively (18). In addition, at values of 195 and 250 torr, there were gross changes in morphology, including larger cell size and decreased adherence to the culture flask only at the higher pH. An increase in increases the buffering capacity of the medium, thus requiring more acid or base to change the pH.
As
illustrated in Fig. 3, small changes in pH will greatly affect the amount of NaOH added to the cell culture at elevated which will also affect osmolality. For ammonia, an increase in extracellular pH results in greater accumulation of ammonia in the cell and greater inhibition of both cell growth and sialylation (4, 6, 24, 25). It is clear the carbon dioxide has a similar effect. The increased buffering capacity at elevated
will likely reduce proton gradients within the cell, especially in acid
organelles where pH can be a low as 5.0, and increase the energy required to maintain the ATPase activity needed to pump protons from the organelles. If exchangers are
present in membranes of these organelles, then elevated may directly disrupt intracellular pH gradients by way of Either way, changes in pH may result in a decrease in the activity of pH-sensitive enzymes within these organelles and may explain the observed decrease in NCAM polysialylation.
In addition to the relevance to biotechnology, the regulation of PolySia by factors in the extracellular environment can have broad implications.
NCAM
polysialylation is developmentally regulated and mediates a variety of cell-cell adhesive interactions including cell migration during morphogenesis (26) and malignant growth
(27). Conditions present in large scale, high density culture systems such as elevated ammonia and carbon dioxide levels are also present within fast-growing solid tumors
139
such as SCLC.
The data provide evidence of a link between the tumor microenvironment and metastasis through the regulation of NCAM polysialylation. Acknowledgments. We thank Merck, Sharp & Dohme for sponsoring the oral presentation of this work at the 15th ESACT meeting. We also acknowledge the organizing committee for making this possible through a bursary. We thank Albert Schmelzer for his laboratory assistance.
This research was supported by NSF grants BCS-9058416 and BES-9402030 (W.M.M.) and the Jean Ruggles Romoser Research Endowment (R.H.K).
References 1. 2. 3. 4.
C. F. Goochee, T. Monica, Bio/technol. 8, 421-426 (1990). D. C. Anderson, C. F. Goochee, Curr. Opin. in Biotechnol. 5, 546-549 (1994). D. C. Anderson, C. F. Goochee, Biotechnol. Bioeng. 47, 96-105 (1995). M. C. Borys, D. I. H. Linzer, E. T. Papoutsakis, Biotechnol. Bioeng. 43, 505-514 (1994).
5.
M. Gawlitzek, U. Valley, M. Nimtz, R. Wagner, H. S. Conradt, in Animal Cell Technology:
Developments towards the 21st Century. E. C. Beuvery, Ed. (Kluwer Academic, Netherlands, 1995). 6. J. A. Zanghi, T. P. Mendoza, R. H. Knop, W. M. Miller, J. Cell Physiol. submitted (1997). 7. W. F. Boron, P. de Weer, J. Gen. Physiol. 67, 91-112 (1976). 8. R. T. Dean, W. Jessup, C. R. Roberts, Biochem J. 217, 27-40 (1984). 9. C. de Duve, et al., Biochem. Pharmacol. 23, 2495-2531 (1974). 10. R. G. Anderson, R. K. Pathak, Cell 40, 635-643 (1985). 11. S. S. Ozturk, Cytotechnol. 22, 3-16 (1996). 12. D . R. Gray, S. Chen, W. Howarth, D. Inlow, B. L. Maiorella, Cytotechnol. 22, 65-78 (1996). 13. W. W. Umbreit, in Manometric and biochemical techniques W. W. Umbreit, R. H. Burris, J. F. Stauffer, Eds. (Burgess Publishing, Minneapolis, 1972) pp. 20-29. 14. I. H. Madshus, Biochem. J. 250, 1-8 (1988).
15. 16.
R. Krapf, C. A. Berry, R. J. Alpern, F. C. J. Rector, J. Clin. Invest. 81, 381-389 (1988). L. Simchowitz, A. Roos, J. Gen. Physiol. 85, 443-470 (1985).
17.
D. Drapeau, Y.-T. Luan, J. C. Whiteford, D. P. Lavin, S. R. Adamson, Paper presented at the Annual
Meeting of the Society of Industrial Microbiology, Orlando, FL (1990). R. Kimura, W. M. Miller, Biotechnol. Bioeng. 52, 152-160 (1996). R. Kimura, W. M. Miller, Biotechnol. Prog. 13, 311-317 (1997). G. E. Grampp, et al., Paper presented at the Cell Culture Engineering IV meeting, San Diego, CA (1994). 21. R. Kimura, PhD Thesis, Northwestern University (1996). 22. J. A. Zanghi, PhD Thesis, Northwestern University (1997). 23. J. A. Zanghi, T. P. Mendoza, A. Schmelzer, R. H. Knop, W. M. Miller, Manuscript in preparation. (1997). 24. C. Doyle, M. Butler, J. Biotechnol. 15, 91-100 (1990). 25. I. Lüdemann, R. Pörtner, H. Märkl, Cytotechnology 14, 11-20 (1994).
18. 19. 20.
26.
G. M. Edelman, Ann. Rev. Biochem. 54, 135-169 (1985).
27.
E. P. Scheidegger, P. M. Lackie, J. Papay, J. Roth, Lab.Invest. 70, 95-106 (1994).
140
Discussion
Ozturk:
It is very difficult to separate the effects of pH and bicarbonate and because they are all coupled together. So I was wondering if it is possible to decouple the bicarbonate and
Zanghi:
Constant pH and osmolality was maintained and we varied the but the bicarbonate level went up. It may be possible to alter the pH and together and maintain the bicarbonate concentration.
Ozturk:
Bicarbonate maybe more important than the
Zeng:
Have you measured, or calculated, the
Zanghi:
The
itself. data?
was measured using a blood-gas analyser in all cases
INFLUENCE OF CULTIVATION CONDITIONS ON GLYCOSYLATION PATTERNA FED-BATCH AND CONTINUOUS CULTURE STUDY
NATASCHA A. SCHILL, MORRIS Z. ROSENBERG, REBECCA L. DABORA Biogen Inc., 14 Cambridge Center, Cambridge MA 02142, USA
1. Introduction
Glycosylation is a post-translational event taking place in the Golgi apparatus of eukaryotic cells. The glycosylation pattern of a protein may have a significant effect on
its physical, chemical and biological properties. Therefore, process development for a potential therapeutic glycoprotein is only successful if it can be demonstrated that the product is consistently glycosylated from batch to batch. One of the most critical process steps with respect to glycosylation pattern of a protein is the cell culture
process (e.g. Jenkins et al. 1996). From the literature it appears as though factors
affecting glycosylation are different from protein to protein; both environmental and kinetic variables were reported to influence the glycosylation pattern of proteins. This paper discusses the influence of different process variables on the glycosylation pattern of a recombinant fusion protein which contains eight N-linked glycosylation sites. The carbohydrate groups contribute approximately 30% to the total molecular mass of the protein. The protein is produced by a recombinant CHO cell line in fed-
batch mode. It was observed that minor changes in cultivation methods, timing of feed addition or time of product harvest, could lead to a significantly different glycosylation pattern of the protein. To identify the process variables influencing glycosylation of this fusion protein, the study included fed-batch and continuous cultivations. Results suggest that only specific productivity affects the glycosylation pattern of this recombinant fusion protein. 2. Materials and methods A CHO derived cell line was used in the study. It grew in serum-free low protein medium. Methotrexate (MTX) was always present in the medium to maintain selective
pressure. All fed-batch and continuous cultures were performed in bench-scale reactors controlled at 36 C, pH 7.2 and 50% air saturation. Appropriate amounts of fusion protein were purified in a one column step, and glycosylation pattern was analyzed by IEF (isoelectric focusing), asialo-FACE (fluorophore assisted carbohydrate 141 O.-W. Merten et al. (eds.). New Developments and New Applications in Animal Cell Technology, 141-147. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
142
electrophoresis), OGS assay (Oxford Glyco-systems), and SEC (size exclusion chromatography). 3. Results and Discussion 3.1. FED-BATCH CULTIVATION Changes in protein glycosylation pattern during a typical fed-batch cultivation were
followed by analyzing samples taken during exponential, stationary and death phase. Results from IEF, SEC and OGS analysis show that the glycosylation pattern of the fusion protein changed over the course of the fed-batch culture. Between days 6 and 8 the IEF banding pattern shifted towards more acidic pH (see Figure 1), suggesting an increase in the sialic acid attached to the carbohydrate groups of the fusion protein. Indeed, analysis of sialic acid content confirmed that the sialic acid content of the fusion protein increased by 20% during the cultivation. In addition to changes in sialic acid content it was noted that the antennary structure was also altered. Figure 2 shows the antennary structure of the fusion protein at different cultivation times, as measured
by OGS analysis: biantennary structures decreased, whereas tetraantennary structures increased with cultivation time. The observation that the cells only started to produce a more completely glycosylated protein after the exponential growth phase suggested that one or more process variables
could be responsible for this. Throughout the cultivation specific growth rate specific productivity (qP), growth phase, nutrient composition, ammonium concentration, and culture osmolality changed. Because the culture environment is
altered steadily with time during fed-batch or batch cultivation, these methods are not amenable to identifying critical process parameters affecting glycosylation microheterogeneity. However, continuous culture experiments allow the control of the culture environment independent of time. This technique is thus suitable for a thorough investigation of the relationship of each of these growth variables with the glycosylation pattern of the fusion protein. 3.2. CONTINUOUS CULTURE EXPERIMENTS
During long-term continuous cultures selective pressure was maintained with methotrexate (MTX) to avoid a loss in fusion protein gene copy number. During the experiment the following groups of variables were tested for their influence on product quality: 1) environmental variables, i.e. asparagine concentration, glutamine
concentration, and ammonium concentration; and 2) kinetic variables, i.e. specific growth rate and specific productivity. The glycosylation pattern was determined by
IEF, SEC, asialo-FACE, and OGS analysis. None of the environmental variables tested in pulse and/or shift-experiments affected
the protein glycosylation pattern, although concentrations were increased one to three fold for the amino acids, and seven fold for the ammonium concentration.
143
Steady states at dilution rates of 0.35/d and 0.20/d were established to investigate the influence of specific growth rate on glycosylation pattern. Analysis by IEF, OGS and
SEC showed that glycosylation pattern was similar for both steady states although the difference in growth rate was nearly 2-fold. Thus, the glycosylation pattern of the fusion protein was independent of specific growth rate. Interestingly, glycosylation pattern resembled the pattern obtained at the end of fed-batch cultivations
The glycosylation pattern did change significantly during a transient increase in ferric citrate concentration (Figure 3), which resulted in an increase in both specific growth and specific productivity. Coincident with these changes were observed an increase in the amount of aggregation from 5.6 to 13.9 percent, and a decrease in terminal sialylation as evidenced by the disappearance of the more acidic bands on an IEF gel (not shown). Figure 4 shows that the change in ferric citrate concentration also resulted in a decrease in tetraantennary glycoforms, with a corresponding increase in the fraction of biantennary structures. The observation that the complexity in antennary structure and sialic acid content decreases when the specific productivity increases, agrees with the results obtained during the fed-batch cultivation discussed above. For example, Figure 5 illustrates the relationship between sialic acid content and specific productivity as observed during fed-batch and transient continuous cultures. This strongly suggests that the specific productivity is affecting the glycosylation of the fusion protein. 3.3. CHANGES IN INTRACELLULAR PROTEIN GLYCOSYLATION DURING FED-BATCH CULTIVATION
There are two possible explanations for the observed relationship between glycosylation pattern and specific productivity: 1) at high specific productivities the glycosylation enzymes are saturated and can not glycosylate all proteins flowing through the Golgi apparatus; or 2) the residence time of the protein in the Golgi apparatus is too short to ensure complete glycosylation. The following experiment was performed to investigate which of the two explanation is most likely for the fusion protein of interest. A typical fed-batch experiment was performed in duplicate reactors, where samples were taken throughout the cultivation to analyze intracellular fusion protein quantity and quality. Figure 6 shows a SDS PAGE Western blot of the intracellular fusion protein at
different time points of cultivation. The intensity of the protein band on the SDS PAGE Western blot increased with cultivation time indicating an increase in intracellular fusion protein concentration. This suggests that the fusion protein is accumulating in the Golgi apparatus over the course of the fed-batch cultivation. As a consequence, an increasing fraction of the product would be exposed to the glycosylation enzymes for a longer period of time, and therefore, become more completely glycosylated. That intracellular fusion protein becomes more fully glycosylated with cultivation time is supported by the following three analysis: 1) the molecular mass of the intracellular fusion protein appears to increase with cultivation time as evidenced by a shift to a
144
higher molecular mass of the protein band on the SDS PAGE Western blot (Fig. 6); 2) the mass of glycan per gram of protein increased with cultivation time as shown by the carbohydrate structure analysis (not shown); and 3) a clear shift towards more acidic pH with cultivation time was observed on the IEF Western blot (not shown), suggesting an increase in sialic acid content.
In summary, these results show that for studied cellular system, glycosylation is inversely related to the specific productivity of the cell. Results further indicate that the residence time of the protein in the Golgi apparatus is crucial for the extent of glycosylation. However, this hypothesis would need confirmation by a pulse/chase type experiment, which allows flow rates through the Golgi apparatus to be measured. 4. Conclusions
This project focused on the relationship between cultivation conditions and glycosylation pattern of a recombinant fusion protein produced by a CHO derived cell line. During the investigation it was found that the glycosylation pattern changed
during fed-batch cultivation: sialic acid content and antennary complexity increased
with cultivation time although ammonium concentration and most likely glycosidase activities - two factors which reportedly can decrease sialic acid concentration increased simultaneously. Continuous cultures were performed to identify which environmental and kinetic variables impact the glycosylation process. A change in glycosylation pattern was only found when the specific productivity during a continuous culture was increased transiently by an increase in ferric citrate concentration. This indicated that it is a kinetic variable which influences the glycosylation of the studied fusion protein. Further experiments focused on the glycosylation of intracellular fusion protein and support the hypothesis that specific productivity, or rather the residence time of the protein in the Golgi apparatus, is crucial to the extent of glycosylation. Notably, concentration, molecular weight, and sialic acid content of the fusion protein increased with cultivation time, suggesting that a prolonged residence time in the Golgi apparatus leads to more complete glycosylation.
5. References Jenkins N., Parekh R.B. and James D.C. (1996) Getting the glycosylation right: implications for the biotechnology industry. Nature Biotechnol. 14: 975-982.
145
146
147
Discussion
Franek:
What are your ideas on the mechanism of how ferric citrate influences the sialylase?
Schill:
I do not think it is ferric citrate which influences glycosylation. In continuous culture, we chose to decrease the ferric citrate concentration as we did not want to limit the cultures by glucose or another energy source. It is not the effect of the ferric citrate, but rather of increasing the specific productivity.
Kempken:
In principle, you could use a very low perfusion rate and could verify a glyco-pattern that is similar to the end of a batch culture. You could then use a very high perfusion rate and verify a pattern that you have in an early stage of a batch fermenter.
Schill:
We established two steady-states. The higher one was close to the exponential growth rate. To establish a steady-state you need to allow 7 residence times to stabilise the system, and with mammalian cells this can take months. So the restriction to doing this is time.
Kempken:
I agree, but you might then find a compromise between your required product structure and the productivity of the system.
Schill:
Specific productivity is not linked to the specific growth rate in this system.
Butler:
In establishing your steady-states, do you know what your limiting nutrient was and, if so, have you considered that the limiting nutrient might affect the interpretation of the data?
Schill:
I think ferric citrate was the limiting factor in the cultures, but it was still at measurable levels, ie not that low. We do not know the affinity of the cell for ferric citrate, which could be higher as normally transferrin is used as a transport factor.
This page intentionally left blank.
EFFECTS OF DIFFERENT PRODUCTION SYSTEMS ON GLYCOSYLATION PATTERN OF MURINE MONOCLONAL IgA SCHWEIKART, F.1; LÜLLAU, E. 2 ; JONES, R.1 ; HUGHES, G.J.1 1 Dept. of Medical Biochemistry at the Medical Center, Faculty of Medicine, University of Geneva, 1 rue Michel-Servet, CH-1211 Geneva 4, Switzerland; 2 Biomedical Research Institute, Glaxo Wellcome Research and Development SA, 14 chemin des Aulx, CH-1228 Plan-les-Ouates, Switzerland
Introduction
Immunoglobulin A is one of the key components in mucosal immune defence in mammals. Monoclonal IgA was produced under
protein free conditions by a murine hybridoma cell line (ZAC3) in a 0.5 1 hollow fibre (HFR), a 2.15 1 continuous stirred tank (CSTR) and a 2 1
fluidized bed reactor (FBR). The IgA was directed against the LPS-antigen of vibrio cholerea. IgA from the three different production systems was purified by DEAE anion exchange, hydroxyapatite and size exclusion chromatography [1]. The glycosylation pattern of the alpha chain was examined by two different approaches outlined in Fig. 1. Approach 1 gives information on glycosylation at specific sites by analysing selected peptides from a peptide map. The heterogeneity of the glycostructures at a given site can be examined. In a second approach HPLC profiling of the total oligosaccharide content was performed after PNGase F cleavage of the whole IgA and labelling of the released oligosaccharides. This was followed by analysis of the separated, derivatized oligosaccharides by matrix-assisted laser desorption time of flight mass (MALDI-TOF) spectrometry. This gives quantitative information about relative amounts of certain structures.
Murine IgA glycosylation Mouse has 4 potential N-glycosylation sites. Only two of them were originally found to be glycosylated [3]. One is located in domain and the other in the 149 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 149-152. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
150 tailpiece of domain (329NVS). The other potential sites for N-glycosylation are 99NCS (domain ) and 314NFT (domain ). Glycosylation at a third site has been
described for an chain expressed in an another myeloma cell line[4]. Myeloma IgA's were shown to contain no N-acetylgalactosamine and therefore no O-linked oligosaccharides [2, 5]. The light chains contain no N-linked glycosylation sites in the constant region. Results
All IgA’s examined carry a large variety of different Nlinked oligosaccharide structures. The glycosylation of
the chain varies according to the IgA production system. IgA chain from all three bioreactors is shown to carry N-linked oligosaccharides only at position 38NVS (domain ) (Fig.2). The expected site in the tail piece (329NVS, domain ) is surprisingly not glycosylated : the corresponding tryptic peptide was found in a nonglycosylated form in the peptide map
and it could be identified by Edman sequencing and precise mass assignment. A MALDI-TOF mass spectrometric analysis of the glycosylated tryptic peptide (peak 1) is shown in Fig. 3. The spectrum
reveals a great variety of structures all of which could be independently confirmed by following the second approach. Here, by achieving a monoisotopic resolution, a more detailed and accurate analysis of the oligosaccharide structures could be made. N-linked oligosaccharides Some m/z values
and the corresponding proposed structure are indicated. After
treatment of the glycopeptide with PNGase F an average mass of 4291 could be determined (not shown); the nominal mass of the peptide moiety
appeared with a mass difference of 16, presumably due to the oxidised
A small portion of the peptide
in the position
37. This mass difference makes a differentiation between e.g. NeuAc~NeuGc or Hex~Fuc in the glycosylated peptide impossible. More detailed information are only available by following the approach 2.
151
were released and labelled with PMP (Fig.4). The UV-profiles (Fig. 5) represent the compositions of
chain oligosaccharides derived from IgA's produced in the three
bioreactor systems. The proportion of di- and oligosialylated structures decreased in the following order: CSTR>FBR>HFR; the HFR derived IgA contained almost no sialylated oligosaccharides. The proportion of
monosialylated structures decreased in the same order but to a lesser extent. Selected HPLC-fractions were analysed by MALDI-TOF mass spectrometry. The monosaccharide compositions were deduced from the very accurate monoisotopic mass determination of the whole PMP-labelled
oligosaccharide.
The
error
in
mass
determination varied between 0.005 and 0.02%. By measuring mass differences after digestion with exoglycosidases a further confirmation of several structures could be obtained. High mannose structures were deduced after treatment; sialylated structures either by direct
measurement of Cl-methylated compounds or after sialidase treatment. At least 21 different oligosaccharide structures could be deduced. A further 20 additional, less abundant oligosaccharide structures could be detected. HFR IgA contained more of a GlcNac bisected hybrid structure (peak 1, 2) than FBR IgA. In CSTR IgA no such structure could be detected. IgA's from all reactor systems contained a quite high proportion of high mannose structures (HFR peak 3,4; CSTR peak 5,6). Otherwise mainly complex oligosaccharides of the biantennary type and only low amounts of triantennary complex structures were found. N-Glycolylneuraminic acid was present on a large number of oligosaccharides from CSTR derived IgA. Many of the oligosaccharide
structures were fucosylated. The large number of different structures suggests that many of them are incompletely
processed or truncated. Although ammonium in the cell culture medium is known to be
152 an important factor influencing the sialylation level of expressed glycoproteins, in these studies no significantly higher or longer-lasting ammonium concentration was observed during the fermentation in the three production systems. Our work indicates that different production systems profoundly influence the glycosylation pattern of a glycoprotein. Although these systems were operated under conditions as similar as possible (protein free, pH, they represent quite different environmental conditions for the cells. Given that specific oligosaccharide structures can inhibit bacterial adhesion
at mucosal surfaces [6], the different glycosylation patterns seen with different production systems may influence the efficacy of antigen-specific IgA when used for therapeutic intervention [7]. References [1]
Lüllau, E., Schweikart, F., Huser, M., von Stockar, U. and Hughes, G. J., Biotech. Bioeng., submitted
[2]
The numbering of amino acid residues was taken over from that used in the SWISS-Prot entry P01878 Robinson, E. A. and Appella, E., Proc. Natl. Acad. Sci. USA.77, 4909-4913 (1980)
[3] [4]
Taylor, A. K. and Wall, R., Mol. Cell. Biol., 8, 4197-4203 (1988)
[5]
Lipniunas, P. et al., Arch. Biochem. Biophys., 300, 335-345 (1993)
[6]
Boren, T., Falk, P., Roth, K. A., Larson, G. and Normark, S., Science, 262, 1892-1895 (1993)
[7]
Weltzin, R., Hsu, S. A., Mittler, E. S., Georgakopoulos, K. M. and Monath, T. P., Antimicrob. Agents Chemother., 38, 2785-2791 (1994)
Acknowledgement
This work was supported by research funds from the Swiss National Science Foundation, SPP Biotechnology Priority Program
IDENTIFICATION OF ALTERED GLYCOSYLATION AS THE MAJOR DIFFERENCE BETWEEN INTRACELLULARY ACCUMULATED AND SECRETED PROTEIN PRODUCED IN BACULOVIRUS-INFECTED INSECT CELLS. GRYSSELL RODRIGUEZ1*, HARALD. S. CONRADT2 and VOLKER JÄGER 1 . 1
Cell Culture Technology Dept., 2Protein Glycosylation Dept., Gesellschaft für Biotechnologische Forschung mbH, Mascheroder Weg 1, D-38124 Braunschweig, Germany. * Permanent address: Centro de Inmunología Molecular, POBox 11600 Habana, Cuba. Introduction
The baculovirus expression vector system (BEVS) has become widely used for the production of recombinant proteins due to its ability to express large amounts of foreign gene products inserted under the transcriptional control of the polyhedrin or p10
promoters. Another advantage is that insect cells perform most of the post-translational modifications of proteins observed in higher eukaryotes. However, the intracellular
accumulation of substantial amounts of protein can be observed frequently for numerous recombinant proteins. Recombinant human a glycoprotein bearing
two N-glycosylation sites, was selected as a model protein. Isolated from human cerebrospinal fluid, serum, plasma and urine its biological significance as a prostaglandin-D synthetase remains disputed (3). This work is focussing on the comparison of intracellularly accumulated and secreted produced by IPLB-SF21AE and High Five™ insect cells and the identification of the intracellular accumulation of recombinant protein, apparently associated to the glycosylation process. Results and Discussion Comparison and characterization of intra- and extracellular in insect cell lines
SDS-PAGE analysis (Figure 1) revealed that
protein expressed
protein from insect cells runs
slightly faster than the protein secreted by recombinant BHK21 cells or isolated from hemofiltrate of patients. This difference in the electrophoretic mobility implies smaller N-glycan structures than those found in protein from recombinant BHK21 cells or hemofiltrate (1,3). Two insect cell lines, High Five and Sf21, were infected with a recombinant baculovirus for expression of For both cell lines the pattern of intracellular protein was characterized by three bands at the same positions than those of the secreted protein (Figure 2). In addition, intracellularly accumulated protein revealed a band with a higher molecular
weight of 28 kDa, which was of increasing intensity with time post infection. 153 O.-W. Merten el at. (eds.), New Developments and New Applications in Animal Cell Technology, 153-155. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
154
Another band with a molecular weight of about 24 kDa was detected in protein from Sf21 cells. In our opinion this band corresponds to an intermediate stage in the processing of the secreted protein inside the cell, but not to an intracellularly accumulated form., because the intensity did not alter after infection. The extracellular protein produced by both cell lines was represented by three bands with molecular weights of about 25.6 kDa, 22.7 kDa and 21 kDa. From 4 days post infection onward, after the majority of cells had died due to viral infection, a smeary band appeared near to 28 kDa. This smear was proved to become finally a clear band (data not shown). The presence of this band in the supernatant, at the same position than the intracellular band with 28 kDa, suggests an accumulation of the corresponding protein inside of the cell, which is released into the supernatant only after cell lysis.
Oligosaccharide processing, limiting step in the protein secretory pathway
The intracellular accumulation of substantial amounts of recombinant protein has been reported frequently for baculovirus-infected insect cells (2, 4, 5). A detailed carbohydrate analysis of both intracellular and secreted IgG was carried out recently (5). In contrast to the secreted glycoprotein, the N-glycans of intracellular IgG from insect cells included more than 50% of high mannose type structures, indicating a significant level of incomplete oligosaccharide processing for a fraction of the intracellular immunoglobulins. It
was hypothesized that these intracellular immunoglobulins may not reach the subsequent cellular compartments in which carbohydrate trimming takes place, probably due to retention or slow secretory pathway processing of some immunoglobulins in the
endoplasmatic reticulum or Golgi apparatus of baculovirus-infected cells. Using protein as a model we wanted to check if glycosylation was playing a crucial role in the protein accumulation. For that purpose it was checked if glycosylation was responsible for the differences in the SDS-PAGE patterns between intra- and extracellular protein.
155
Both protein fractions, intra- and extracellular were digested with N-Glycosidase F enzyme. After enzymatic digestion, the electrophoretic pattern of recombinant intra- and extracellular protein changed dramatically. All bands except the lowest one representing the non-glycosylated form of protein disappeared and the remaining band became more intensive (Figure 3). These results clearly demonstrate that the different bands from intracellular protein correspond to different glycosylation stages of the same peptide, and provide an evidence about a possible bottle neck in the secretion of protein, apparently due to a problem
during the glycosylation process.
Conclusions SDS-PAGE/western blotting of protein from supernatant as well as from lysed virusinfected insect cells (IPLB SF21 AE, BTI Tn5Bl-4) revealed the presence of an intracellularly acumulated species, which was demonstrated to have a molecular weight different to those observed in the supernatant. Enzymatic digestion with N-Glycosidase F has proved that the difference between the intra-and extracellular protein pattern was due to different glycosylation stages of the recombinant protein. The results suggest the presence of a bottle neck in the glycosylation pathway of baculovirus-infected insect cells secreting protein. Acknowledgements We want to acknowledge the financial support from ESACT for G. Rodriguez to participate in this conference. References 1.
Grabenhorst, E., Hoffmann, A., Nimtz, M., Zettlmeissl, G. and Conradt, H.S. (1995) Construction of stable BHK-21 cells coexpressing human secretory glycoprotein and human Gal
GlucNAc-R
3.
sialyltransferase NeuAc is preferentially attached to the Gal Gluc NAc ) Man of diantennary oligosaccharides from secreted recombinant protein. Eur. J. Biochem. 232, 232-718. Hasema, C.A and Capra, J.D. (1990) High-levels production of a funtional immunoglobulin heterodimer in a Baculovirus Expression System. Proc. Natl. Acad. Sci. USA. 87, 3942-3946. Hoffmann, A.,Nimtz, M., and Conradt, H.S. (1997) Molecular characterization of protein in
4.
human serum and urine: a potencial diagnostic marker for renal disease. Glycobiology 7, 499-506. Hsu, T.A, Eiden, J.J., Bourgarel, P., Meo, T. and Betenbaugh, M.J. (1994) Effect of co-expressing
2.
chaperone BIP on funtional antibody production in the baculovirus system. Protein Expr. Purif. 5, 95-603. 5. Hsu, T.A., Takahashi, N., Tsukamoto, Y., Kato, K., Shimada, I., Masuda, K., Whiteley, E.M., Fan, J.-Q., Lee, Y.C and Betenbaugh, M.J. (1997) Differential N-Glycans patterns of secreted and intracellular IgG produced in Trichoplusia ni cells. J. Biol. Chem. 272, 9062-9070.
This page intentionally left blank.
HOW AMMONIUM DOMINATES THE METABOLISM IN VITRO CULTIVATED MAMMALIAN CELLS
OF
Aziz Çayli1, Manfred Wirth2 and Roland Wagner1 1 Cell Culture Technology Department, 2Department of Gene Regulation and Differentiation, Gesellschaft für Biotechnologische Forschung mbH, Mascheroder Weg 1, D-38124 Braunschweig, Germany
Introduction
The accumulation of ammonium ions during cultivation of mammalian cells used for the production of recombinant biopharmaceuticals affects growth rate and productivity (Backer et al. 1988; Butler and Spier, 1984; Glacken, 1988; Ito and McLimans, 1981; Jensen and Liu, 1961) and the quality of the synthesized product, particularly with regard
to glycosylation pattern (Gawlitzek et al., 1995, 1997, Maiorella, 1992; Thorens and Vasselli, 1986). Recently we have reported that the intracellular content of UDP-activated N-acetyl hexosamines (UDPGNAc) is substantially elevated under higher ammonium
concentrations in the medium (Ryll et al, 1994). Ammonium ions are channeled into the pathway of UDPGNAc formation at the amination step of fructose-6-phosphate (Frc6P) to form glucosamine-6-phosphate (GlcN6P). UDPGNAc is then formed by a bifurcated pathway whereby UTP and N-acetyl glucosamine-1-phosphate (GlcNAclP) condense to UDPGlcNAc which subsequently is transformed to UDPGalNAc. We could show that 15N of UDPGNAc, a precursor of carbohydrates in glycoproteins, is found in the N-glycans (Valley, 1996) resulting in the formulation of the hypothesis, that the effects of ammonium ions on protein glycosylation are mediated via the ammonium-induced elevation of the UDPGNAc pool (Grammatikos et al., 1998, Ryll et al., 1994). Here, we present the glucosamine-6-phosphate isomerase (GPI) as the key enzyme responsible for ammonium incorporation. Moreover, we propose two strategies to inhibit its activity. Firstly, a strategy based on metabolic engineering by antisense RNA expression and secondly a strategy based on process control by the addition of an inhibitor to the culture. Results The enzyme. The glucosamine-6-phosphate isomerase has been identified as the key enzyme accepting ammonium ions and elevating the intracellular UDPGNAc content. GPI
was extracted from BHK21 cells and purified to homogeneity by affinity chromatography (Calcagno et al, 1984). The enzyme is a hexamer with a molecular weight of approximately 180 kd. Sequence analysis of the amino terminus revealed a high similarity to the human form of the enzyme. The reaction is reversible but the equilibrium is far on the side of Frc6P. We could show that the enzyme exclusively accepts but no glutamine. Glutamine is used by the glucosamine-6-phosphate synthase (GPS) which catalyzes the 157 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 157-161. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
158
same reaction and which is controlled by an end product inhibition of UDPGNAc (Fig. 1). We assume that GPI is cut out for the role to control the stationary intracellular concentrations of intermediate metabolites of the UDPGNAc pathway by regulating GlcN6P in vivo where never high ammonium concentrations are reached. However, under in vitro conditions in the presence of high ammonium concentrations, this regulation system causes serious problems on the synthesis of UDPGNAc followed by an effect on the expression of carbohydrate structures. The inhibitor. GPI was characterized with respect to effectors to be used as modulators in cultivation processes of mammalian cells. Mannose-6-phosphate (Man6P) was shown to be a strong inhibitor whereas glucose-6-phosphate, glutamine and N-acetyl-glucosamine6-phosphate (GlcNAc6P) act as activators. By using mannose in appropriate concentrations in combination with glucose as carbon source we have shown that the formation of higher UDPGNAc concentrations could be prevented in the presence of ammonium in the culture medium indicating that mannose which is intracellularly transformed to Man6P is an efficient inhibitor in bioprocesses to control N-glycan expression of glycoproteins and glycolipids.
Antisense strategy. Due to the fact that synthesis and regulation of UDPGNAc can be exclusively performed by the GPS alone we planned to inhibit GPI by antisense RNA expression. Two different plasmids were constructed using human cDNA and directed to
159
the 5´- and 3´-end of the enzyme under the control of the SV40 early promotor (Table 1). In addition a further plasmid harboring the 5´-end in sense direction with the same promotor was used as control.
As a result the transfected cell lines showed a significant decrease in the GPI enzyme activity (Fig. 2). Plasmid 1 and 2 revealed an enzyme expression of only 30 and 50% of the control, respectively. Cotransfection of both plasmids, however, resulted in 90% of repression. Only 10% of the expression found in the control cells could be detected.
160
Conclusion Glucosamine-6-phosphate isomerase has been identified as the ammonium accepting enzyme resulting in an elevated UDPGNAc content under high ammonium concentrations. GPI was efficiently inhibited using two different strategies: The addition of mannose to culture media and the genetic modification of the cells using antisense RNA expression. References Backer, M.P., Metzger, L.S., Slaber, P.L., Nevitt, K.L., Boder, G.B. 1988. Large Scale production of monoclonal antibodies in suspension culture. Biotechnol. Bioeng. 32: 993-1000. Butler, M., Spier, R.E. 1984. The effects of glutamine utilisation and ammonia production on the growth of BHK cells in microcarrier cultures. J. Biotechnol. 1: 187-196
Calcagno, M., Campos, P.J., Mulliert, G., Suastegui, J. 1984. Purification, molecular and kinetic properties of glucosamine-6-P isomerase (deaminase) from Escherichia coli. Biochim. Biophys. Acta. 787: 165173 Gawlitzek, M., Valley, U., Wagner, R. 1995. Effects of Ammonia and Glucosamine on the Glycosylation Pattern of Recombinant Proteins Expressed from BHK-21 Cells. In: Animal Cell Technology
'Developments towards the 21st Century'; Beuvery, E.C., Griffiths, J.B., Zeijlemaker, W.P., Eds.; Kluwer Academic Publishers: Dordrecht, The Netherlands, pp. 379-383
Gawlitzek, M., Valley, U., Wagner, R. 1997. Ammonium ion/glucosamine dependent increase of oligosac charide complexity in recombinant glycoproteins secreted from cultivated BHK-21 cells. Biotechnol. Bioeng, in press Glacken, M.W. 1988. Catabolic Control of Mammalian Cell Culture. Bio/Technology 6: 1941-1050.
Ito, M., McLimans, W.F. 1981. Ammonium Inhibition of Interferon Synthesis. Cell Biol. Int. Rep. 5: 661-666.. Jensen, E.M., Liu, O.C. 1961. Studies of Inhibitory Effect of Ammonium Ions in Several Virus-Tissue Culture Systems. P.S.E.B.M. 107: 834-838. Maiorella, B.L. 1992. In Vitro Management of Ammonia's Effect on Glycosylation of Cell Products Through pH Control. US Patent, Number 5,096,816. Ryll, T., Valley, U., Wagner, R. 1994. Biochemistry of Growth Inhibition by Ammonium Ions in Mammalian Cells. Biotechnol. Bioeng. 44: 184-193 Thorens, B., Vassalli, P. 1986. Chloroquine and ammonium chloride prevent terminal glycosylation of immunoglobulins in plasma cells without affecting secretion. Nature 321: 618-620.
Valley, U. 1996. UDP-N-acetyl-hexosamines as central metabolites in growth and potein glycosylation of recombinant BHK cells. Thesis, Technical University Braunschweig.
161
Discussion
Singhvi:
Do you have any idea of the rates of UDP molecules that go by the two different pathways of synthetase and isomerase? Would this be reduced by inhibiting the isomerase and by how much?
Cayli:
Normally the disproportionately high level of UDPGNAC is due to the activity of isomerase because in animal cell culture we do have 4-5 mM ammonium. These high ammonium levels drive the reaction to UDPGNAC. I do not have any data on the synthetase activity. I guess if the isomerase was inhibited, the concentration of UDPGNAC should be very low.
Konstantinov:
You mentioned that you had tried mannose in your culture medium. Could you comment on whether this affected glycosylation?
Cayli:
There are 2 steps: first, adding mannose to the culture medium and measuring UDPGNAC; second, the analysis of the glycostructures. We have just measured the UDPGNAC pool in the cell because it is much quicker. We just optimised the mannose level in the medium and just checked the decrease of UDPGNAC in the cells. We have no data yet on the structures of the proteins.
Konstantinov:
You need mannose for glycosylation. So I was wondering, if you add it to the medium whether it helps glycosylation by a different mechanism?
Cayli:
We have no data on the effect of pure mannose on protein glycosylation. So what you say is possible.
This page intentionally left blank.
STUDY OF HUMAN RECOMBINANT GM-CSF PRODUCED IN DIFFERENT
HOST SYSTEMS USING MONOCLONAL ANTIBODIES
M. ETCHEVERRIGARAY, M. OGGERO, M. BOLLATI, R. KRATJE Instituto de Tecnología Biológica (INTEBIO). Facultad de Bioquímica y Ciencias Biológicas. Universidad Nacional del Litoral Ciudad Universitaria - C.C. 530 - (3000) Santa Fe. ARGENTINA
Abstract GM-CSF is a glycoprotein that activates growth and differentiation of hemopoietic progenitor cells, usefull to reverse or prevent chemotherapy secondary leukopenias. In spite of the differences in the chemical structure, due to the variable glycosydic content of the forms produced in bacteria, yeast and mammalian cells, all of them have biological activity. Independently, antigenicity of non glycosylated recombinant human proteins may have relevance in the choice of the host system for the production of factors for clinical use. To study the undesirable immune response in the results of the therapy, we used the following strategy: i) To obtain the glycosylated hormone, CHO dhfr - cells were manipulated by
genetic methods to produce human GM-CSF under the control of the adenovirus major late promoter. ii) A panel of GM-CSF MAbs was produced from hybridoma cells obtained in our lab. We analyzed the specificity of the MAbs taking into account their neutralizing
capacity. Some of them neutralized the in vitro biological activity of the hormone, with different affinities for GM-CSF from several sources. Patients under treatment with the commercial non-glycosylated GM-CSF develop antibodies and undesirable responses. Competition experiments between the neutralizing MAbs and these human antibodies would demonstrate the importance of the immune response in the choice of the host system for its production. Introduction
Granulocyte macrophage colony stimulating factor (GM-CSF) was expressed in different systems: bacteria, yeast and mammalian cells. All of them have biological activity. Despite
the fact that the low levels that can be achieved by recombinant mammalian cells are disappointing for the production of GM-CSF, there are important reasons to support and improve this host system. It was observed that the therapeutical administration of nonglycosylated or partially glycosylated GM-CSF produces activation of the immune system [1,2] and development of undesirable responses that undoubtly cause the inefficacy of the treatment together with many disagreeable side effects. The recognition of antibodies specificity in patients sera under treatment with GM-CSF may be important in the choice
of the appropriate host system for the production of this hormone. Materials and Methods
Expression vectors for CHO cells were obtained from Genargen S.R.L., Buenos Aires, Argentina. CHO dhfr - cells were transfected by lipofection to produce human GM-CSF 163 O.-W. Merten et al. (eds.). New Developments and New Applications in Animal Cell Technology, 163-165. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
164
under the control of the adenovirus major late promoter. The vector contained the gen for dihydrofolate reductase (dhfr) to allow the selection of stable transfectants. Among the several cell lines achieved, the clone was selected for further experiments, taking into account its higher productivity [3]. Non-glycosylated GM-CSF was the E. coli derived GM-CSF International Standard (NIBSC, 88/646, UK), and the E. coli derived GM-CSF purchased from Schering-Plough Co., Ireland, that was used as internal standard previously valorized against the International Standard. Glycosylated GM-CSF was the CHO derived hormone prepared in our lab. The GM-CSF MAbs obtained in our lab are shown in Table I.
To test the biological activity of E. coli and CHO derived GM-CSF, we used the factordependent cell line TF-1 (ATCC CRL-2003). The proliferation assay was optimized in our lab for GM-CSF valoration. TF-1 cell proliferation was determined measuring dehydrogenase-enzyme´s activity as marker for the biological activity, using a commercial colorimetric kit (Cell Titer 96™, Promega, USA). MAbs were evaluated for their ability to inhibit the proliferation of GM-CSF stimulated TF-1 cells, i.e. to neutralize in vitro GM-CSF activity. For this purpose we used either six different MAbs: ascites 2E11, 8B10, 15G5 and 32H6, and purified 1B8 and 7E10 MAbs by protein A affinity chromatography . Serial dilutions of the antibodies were tested both with glycosylated and non-glycosylated GM-CSF. The results were expressed as neutralization percent. Results and Discussion
The isotype MAbs IB8 and 7E10 were purified with 82% and 70% recovery, respectively. The MAb 32H6 was heated at 56°C for 30 minutes. The IgM isotype ascites were used without previous treatment. Fig. 1 shows an example of the different behaviour of neutralizing and non-neutralizing antibodies. The neutralizing effect of the purified MAbs 7E10 and IB8 is shown in Fig. 2. The behaviour of MAb 7E10 may be related with heteroclytic antibodies [4], i.e. antibodies of higher affinity with a related molecule than with the immunogen (Table II). In contrast, the other antibodies that reacted with the glycosylated hormone correspond to cross-reactive antibodies, being E. coli derived GM-CSF the immunogen. It must be taken into account
165
that antibodies present in patients´ sera may be of both types and play an important role in the development of undesirable responses: loss of response in future treatments and crossreaction with the own hormone. The choice of host systems for the production of clinicals has to consider not only the biological activity of the product but also the immune system, wich plays, in this case, an important role and once it is stimulated there is no possibility
to abolish its effect. References: 1- Wadhwa, M., Bird, C., Fargerberg, J., Gaines-Das, R., Ragnhammar, P., Mellstedt, H. and Thorpe R. (1996). Clin. Exp. Immunol. 104:351
2- Gribben, J. G., Devereux, S., Thomas, N. S. B., Keim, M., Jones, H. M., Goldstone, A. H. and Linch, D. C. (1990). The Lancet 335:434 3- Bollati, M., Kratje, R. and Etcheverrigaray, M. (1997). Encuentro de Investigadores Jóvenes. UBA. Argentina.
4- Mäkelä, O. (1965). J. Immunol. 95:378
METABOLIC ENGINEERING
MODIFICATION OF HYBRIDOMA CELLS METABOLISM
J.J. Cairó, C. Paredes and F. Gòdia* Departament d'Enginyeria Química. Facultat de Ciències. Edifici C. Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona. Spain. E. Prats, F. Azorín, LI. Cornudella Departament de Biologia Molecular i Cel.lular. Centre d'Investigació i Desenvolupament. CSIC. Jordi Girona Salgado, 18-26. 08034 Barcelona. Spain.
* To whom correspondence should be addressed.
SUMMARY Two different genetic modifications of hybridoma cells are studied. First, cells are
transfected with the glutamine synthetase gene, and important modifications in their physiology can be observed, that are reflected on the corresponding analysis of the intracellular metabolic fluxes. For the modified cell line the need for glutamine feeding in the culture has been eliminated and the ammonium production suppressed. Moreover, the glucose uptake rate has been reduced to half with respect to the parental strain, while maintaining a similar growth pattern. Second, antisense RNA techniques were employed to inhibit partially the expression of two glycolytic enzymes in order to create some rate limiting steps in the glycolytic pathway. The preliminary results obtained with the glucose transporter and enolase genes show the potential of such approach.
INTRODUCTION. Typical batch cultures of hybridoma cells have a number of drawbacks : low cell concentration, low level of product expression, limited viability of the cells and complex nutrient requirements. The design of more efficient processes for monoclonal antibody production and the development of optimized operation strategies1 has to be based in a much better knowledge of the cell metabolism. Many authors have 167 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 167-174. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
168 demonstrated that the metabolism of several cells can be redirected to the obtention of desired products by using the metabolic engineering approach 2 . Hybridoma cell cultures typically produce lactic acid, ammonia and some amino acids when metabolizing the carbon and energy sources, glucose and glutamine. The byproduct generation from its metabolism represents a poor exploitation of these substrates and can inhibit cell growth due to lactate and ammonium accumulation 3 . In order to overcome the high glutamine uptake rate, the generation of high levels of ammonium as well as the high glycolytic flux and the lactate generation two approaches have been performed. First approach consists in the expression of the glutamine synthetase in a hybridoma cell line. Second approach is based on the use of antisense RNA techniques to partially inhibit the glucose transporter and the enolase gen. Antisense control of gene expression has become widely used method for specifically interfering with gene function 4 . MATERIALS A N D METHODS Cells : KB-26.5 murine hybridoma, producing an
against antigen
of red cells.
Medium : DMEM supplemented with 2% foetal calf serum. Viable cell number : haemocytometer, viability as trypan blue exclusion. Batch and continuous cultures : Spinner flask, 250 ml working volume, 40 rpm, 37°C, Continuous cultures at a dilution rate of
, average cell population
cell/ml. Glutamine and Glucose feeding decreasing stepwise one at a time 5 .
Glucose and Lactate : YSI 2700 Ammonium concentration : flow injection analysis system 6 . Glutamine and other amino acids concentrations : HPLC. Glutamine Synthetase : pCMGS.gpt 7 kindly provided by Celltech. Selection in glutamine free medium. Clone selected by serial dilution. Antisense constructions : 450 bp fragment downstream the ATG codon of both glucose transporter gene GLUT1 and enolase gene. Fragments were cloned in antisense orientation into the BamHI site of plasmid pcDNA3. Selection by resistance against Neomycin. Transfection : lipofection method. Stoichiometric model : As described in [8]. RESULTS A N D DISCUSSION Hybridoma cell line KB-26.5, like all tumoral cells, can be considered as an energetically efficient system, since is able to take energy from different sources (glucose and glutamine), but this efficiency exists as long as cells are in their ideal surroundings, as in body tissue. The body provides the cells with an extremely controlled environment, in which the inefficiency observed when cells are in culture does not exist. Glucose and glutamine concentrations in batch and fed-batch cultures are usually much
169 higher than the physiological ones found in tissues, and cells will consume tar greater amounts of both substrates, due to the high transport and glycolysis and glutaminolysis rates, and produce excessive amounts of lactic acid and ammonium. This point was corroborated in continuous culture experiments performed in two different ways: maintaining a constant glucose concentration in the feed medium while decreasing the glutamine concentration stepwise, and maintaining glutamine concentration constant while decreasing glucose stepwise. The results of this series of experiments are summarized in Figure 1a and 1b. It can be observed that as the glutamine concentration found in the medium increases (so, more excess of glutamine is provided to the cell metabolism), higher amounts of glutamine are consumed and ammonium produced. The same behaviour can be observed for glucose and lactate. Thus, when excessive amounts of glutamine are added to the hybridoma culture, glutamine is not efficiently used for cell growth, but rather to produce glutamine-related by-products such as ammonium, alanine and proline. On the other hand, as glucose level in the exhaust medium increases, more lactate is produced. Thus, as this cellular level was the same, it seems that there is not a real need to consume those great amounts of glucose and glutamine in order to keep the cell growing.
In order to overcome the high glutamine uptake rate and the generation of high levels of ammonium, the glutamine synthetase gene has been expressed in the KB-26.5 cell line. The physiological consequences of this expression can be seen in Figure 2. Transfected cell line show a lower growth rate than the original one but
170 specific production rate of ammonium is zero. Similarly specific glucose uptake rate is reduced to a half of that of the untransformed cell line, and the Lactate/Glucose molar yield has slightly decreased.
To elucidate which are the metabolic reasons tor this physiological change a stoichiometric model was constructed to estimate the intracellular fluxes. In brief it
consists in the derivation of a mass balance for each considered metabolite including the transport rates across membranes and their production or consumption rates by the
intracellular reactions considered. All these data makes possible the estimation of the intracellular fluxes by means of a least squares procedure.
The simplified results obtained in the estimation of the corresponding intracellular fluxes are presented in Figure 3. For the non modified hybridoma cells, the glucose and glutamine high consumption rates generate high amounts of lactate and ammonium as it has been stated before. A possible explanation of these results could be a low efficiency in the shuttle system for mitochondrial reoxidation of the large amounts of NADH produced in the glycolytic pathway. As a consequence NADH should be regenerated via lactate dehydrogenase using pyruvate as a substrate rather than through the electronic transport chain. Thus, the pyruvate amount that can be incorporated into TCA cycle is very small and the rapid glutaminolysis rate collapses and unbalances the
TCA cycle. Simultaneously the great amount of ammonium generated from glutamine and other amino acids deamination overflows the cell capacity and it is excreted as tree ammonium, alanine and proline. Moreover as alanine is produced in large amounts the availability of pyruvate for the cell metabolism decreases (alanine is formed from
pyruvate and glutamic acid).
171
The results obtained with the transfected cell line show similar trends with
respect to N A D H regeneration via lactate production. The main difference is found in the glycolytic flux, that in the transfected cell has been reduced to half of that for the parental strain (Figure 2). The effect of the glutamine synthetase expression on the ammonium excretion could he explained as a result of a change in the way that the cells use in order to eliminate the excess of ammonium ions generated from glutamate metabolism, not requiring neither ammonium excretion nor animation of pyruvate to alanine. Last factor could be the reason for the reduction of the glycolytic flux as a consequence of a lower need for pyruvate in the transfected cell line. The carbon circulation w i t h i n the TCA cycle is not collapsed by glutamic acid. On the other hand, it can be seen from Figure 3 that the exchange between mitochondrial and cytoplasmic malate has been inverted for the transfected cells when compared to the parental ones. In order to overcome the high glucose uptake rate and the generation of high levels of lactate, an antisense R N A approach has been used. It is generally assumed that the mechanism of inhibition by nuclear-derived antisense R N A entails sequence-specific hybridization of antisense RNA transcript to the target m R N A in the nucleus that blocks protein synthesis 4 . Under optimal conditions an antisense RNA
172
approach could inhibit absolutely protein translation. Thus under suboptimal conditions it can be used to decrease the amount of the target protein. If that protein is an enzyme its is possible to lower the flux through the enzymatic reaction that it catalyses lowering the amount of enzyme. In the present work this possibility has been used in order to create a rate-limiting step in the glycolytic pathway. Two points in the glycolytic pathway were chosen as a target; first the transporter protein for glucose (GLUT 1) and second the enzyme enolase. This enzyme catalyses the conversion from 2phosphoglyceric acid to phosphoenolpyruvic acid. The physiological consequences of this approach can he seen in Figure 4. Both cell lines show higher growth rates than the control. This fact can he explained by the fact that integration in the genome occurs randomly and there will he some random effect or by the fact that cells carrying antisense construct have some advantage over non-carrying ones. Specific glucose uptake rate has decreased about 20% for enolase construction and 45% for glucose transporter construction. From these values it is likely to suppose that both constructions are able to generate a rate-limiting step in the glycolytic pathway. The molar yield for lactate/glucose remains almost unchanged showing that these approach does not affect to the cytosolic NADH regeneration.
CONCLUSIONS
When glucose and glutamine are added in excess to the culture medium they are consumed at high rates, with low efficiency for the cells, and generation of by-products. The use of the glutamine synthetase gene allows the reduction of ammonia production and unexpectedly decreases glycolysis rate to one half. Some potential decrease of the glycolysis rate could he introduced generating a rate-limiting step by means of antisense RNA techniques. Further work is required to corroborate these results, assess the stability of the transformed cells and the consequences in product formation.
173 Acknowledgements CellTech Therapeutics kindly provided the glutamine synthetase gene. This work was supported by CICYT (project BIO94-0288) and was carried out in the framework of the Centre de Referencia de Biotecnologia. References 1 .Bibila, T.A., Robinson, D.K. (1995) In Pursuit of the Optimal Fed-Batch Process for Monoclonal Antibody Production, Biotechnology Progress 11, 1-13. 2.Bailey, J.E. (1991) Toward a Science of Metabolic Engineering, Science 252,1668-1675.
3.Ozturk, S.S., Riley, M.R., Palsson, B.O. (1992) Effects of ammonia and laclate on hybridoma growth, metabolism, and antibody production. Biotechnology and Bioengineering 39,418-431. 4.Pestka S. (1992) Antisense R N A . History and Perspective in R. Baserga and D.T. Denhardt (eds.), Annals of the New York Academy of Sciencies, Vol 660. New York Academy of Sciencies. New York pp. 251-262. 5.Sanfeliu A., Paredes C., Cairó J . J . , Gòdia F. (1997) Analysis of Glucose and Glutamine Metabolism of
Hybridoma C e l l s by Continuous Culture Experiments, in M.J.T. Carrondo, B. Griffiths and J.L.P. Moreira (eds.), Animal Cell Technology. From Vaccines to Genetic Medicine, Kluwer Academic Publishers, Dordrecht, pp. 785-789.
6.Campmajó, C., Cairó, J . J . , Sanfeliu, A., Martínez, E., Alegret, S., Gòdia. F. (1994) Determination of ammonium and L-Glutamine in hybridoma cell cultures by sequential flow injection analysis. Cytotechnology
14,177-182. 7.Bebbington.C.R., Rentier, G., Thompson, S., King, D., Abrams, D., Yarranton, G.T. (1990) High level expression of a recombinant antibody from myeloma cells using a glulaminc synthetase gene as an amplifiable selectable marker. Bio/Technology 10,169-175.
8.Sanfeliu, A. (1995) Producció d’ Anticossos Monoclonals Mitjancant el Cultiu in vitro d’ Hibridomes en Bioreactors : Anàlisi de la Fisiologia i Metabolisme C e l . l u l a r , Ph. D. Thesis, Universitat Autònoma de Barcelona.
174
Discussion
Franck:
How do the changes in metabolism influence the specific productivity of the antibody?
Godia:
We do not have quantitative data to answer your question. We focus on genetic modification and metabolic pathway changes, rather than productivity.
Singhvi:
Why did you choose the two enzymes for your anti-sense targets? Was it random or based on preliminary work?
Godia:
The rationale was that the glucose transporter was a clear target as it is at the beginning of all processes. We also knew, by means of DNA probes, which was the glucose transporter active in our cell line and we could make it more easily than other ones. For the inulase we tried to select one enzyme that was well down the glycolytic pathway and so it would not affect the initial steps.
Cayli:
What kind of gene did you use for your anti-sense construct? Is it from the hybridoma or another cell line? Also, are your anti-sense clones stable?
Godia:
I cannot tell how stable the clone is because we have only had it for one month but we have to check for this. We obtained the gene from a cDNA library using the oligonucleotide primers and by PCR.
CLONING AND EXPRESSION OF A CYTOSOLIC SIALIDASE FROM CHO CELLS IN A GLUTATHIONE S-TRANSFERASE (GST)-ENCODING EXPRESSION VECTOR
M. BURG and J. MÜTHING University of Bielefeld, Faculty of Technical Sciences, Institute of Cell Culture Technology, P.O.Box 100131, 33501 Bielefeld, Germany
1. Introduction Many proteins, produced by recombinant DNA technology for clinical and therapeutical purpose, are glycosylated in their native state. Sialic acids, which are terminally linked to the oligosaccharide chains, play an important role in determining the in vivo fate of a glycoprotein in the circulatory system concerning its activity [1] or hepatic clearance rate [2]. Recent publications revealed cytosol-derived sialidase activity in cell-free supernatant of Chinese hamster ovary (CHO) and hybridoma cells [3] in bioreactor cultures with potential for glycoprotein desialylation [4]. Detailed studies published by our laboratory showed the effect of CHO cell derived sialidase towards sialylated oligosaccharides of recombinant human antithrombin III [5,6] (Fig. 1). In continuation of this work, we attempted to clone and express the cytosolic sialidase of CHO cells in E. coli strains. In order to distinguish sialidases of the CHO donor cells from the E. coli host, we used an expression vector encoding for glutathione S-transferase (GST). A fragment with almost the entire open reading frame was generated for subsequent cloning. 175 O. - W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 175-179. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
176
2. Materials and Methods
POLYMERASE CHAIN REACTION (PCR) EXPERIMENTS Reverse transcriptase PCR (RT PCR) Single strand cDNA was synthesized by reverse transcription of CHO-K1 total RNA with oligo (dT) primers using the GeneAmp® RNA PCR kit (Perkin Elmer). Double strand cDNA fragments with almost the entire open reading frame of the cytosolic sialidase and in frame restriction sites were amplified using the primers shown in Fig. 2 and a mixture of Klen
Therm DNA polymerase
and Accu Therm DNA polymerase (Gene Craft). The samples were subjected to a temperature cycle step of 94°C (40 sec) and 68°C (2 min) for a total of 35 cycles, followed by a 7 min extension
step at 72°C after the final cycle. SUBCLONING The Original TA Cloning® kit (Invitrogen) was applied to subclone the PCR product in the pCR® 2.1 vector by direct insertion and transformation of E. coli F’. The generated plasmids, isolated with the Quantum Prep Plasmid Miniprep kit (BioRad) from the cultivated subclones, were tested by restriction analysis. The inserted fragment was cut off the ligated vector, isolated by gel extraction and used for further cloning experiments.
CLONING AND EXPRESSION The pGEX-2T plasmid vector of the GST Gene Fusion System (Pharmacia) was employed for cloning experiments. This vector encodes for GST at the amino terminus of the generated protein. The plasmid encoding the cytosolic CHO cell sialidase was constructed by inserting a BamHI-EcoRI cDNA fragment into the multiple cloning site of the vector. E. coli M15 harbouring pREP4 was transformed with the products of ligation. The clones were screened by restriction analysis and two were sequenced by the dye termination method with an EBI 377 (Perkin Elmer) sequencer from both insert directions and with two additional internal nested primers (worked out by IID Biotech Bioservice GmbH) for double strand sequencing of the whole insert. The clones were
177
induced by IPTG and the expression was assayed by SDS-PAGE running the total protein extracts on 8-25 % gradient gels (Pharmacia). 3. Results AMPLIFICATION OF A cDNA FRAGMENT BY RT PCR We amplified a cDNA fragment of the cytosolic sialidase derived from CHO cells encoding different restriction sites for cloning by using the designed primer sequences.
Fig. 3 A (lane 2) shows the generated RT PCR product on a 2% agarose gel. The fragment was used for the subsequent cloning experiments.
INSERTION OF THE RT PCR PRODUCTS IN THE pCR® 2.1 VECTOR To eliminate enzymatical modifications the product was subcloned in the pCR® 2.1 vector. Several M15 pREP4 transformands were produced and plasmid isolations of the
subclones (scl) scl1, scl2 and scl3 were tested by restriction analysis. The insert is flanked by a BamHI and a EcoRI restriction site and encodes for one ScaI site (Fig. 3 B). The sc12 contains the successfully ligated plasmid pMBU4-2 (Fig. 3 B, lane 2).
CLONING AND EXPRESSION OF THE CYTOSOLIC SIALIDASE FROM CHO
CELLS IN pGEX-2T The BamHI-EcoRI fragment (Fig. 3 C, lane 1) was cut off the pMBU4-2 plasmid and cloned into the pGEX-2T plasmid vector, which encodes for GST. The screening of the transformands revealed four clones (cl1, cl2, cl6 and cl8) with the constructed plasmid
178
encoding the CHO cell sialidase sequence, identified by its PstI restriction sites (Fig. 4). Sequencing of the clones cll and cl2 ruled out base replacements or amplification errors. SDS PAGE of the total protein extracts after induction revealed a new protein at about 70 kDa (Fig. 5). This correlates with the molecular weight of a fusion protein
composed of the GST (29 kDa) and the cloned cytosolic CHO cell sialidase (43 kDa).
4. Discussion Regarding the published cDNA sequence of the CHO cell derived cytosolic sialidase [7]
and with reference to the cloning and expression data of the cytosolic sialidase of rat cells [8], we successfully cloned a CHO cell sialidase cDNA fragment with the almost entire open reading frame in a pGEX-2T expression vector. The GST-sialidase fusion protein was found to be expressed in four M15 pREP4 clones, identified by SDS-PAGE. Next we will purify the GST-sialidase fusion protein by affinity chromatography on Gluthatione Sepharose 4B (Pharmacia), cleave the cytosolic sialidase from the GST by thrombin digestion (using the thrombin specific recognition site encoding by the pGEX
179
plasmid), and utilize the isolated sialidase to produce specific antibodies against cytosolic CHO cell sialidase.
5. References [1] Chavin, S. I., Weidner S. M., (1983) Blood clotting factor IX, J. Biol. Chem. 259: 3387-3390 [2] Briggs, D. W., Fisher, J. W., George, W. J., (1974) Hepatic clearance of intact and desialylated erythropoietin, Am. J. Physiol. 227: 1385-1388 [3] Gramer, M. J., Goochee, C. F., (1993) Glycosidases activities of the 293 and NS0 cell lines, and of an antibody-producing hybridoma cell line, Biotechnol. Bioeng. 43: 423-428 [4] Gramer, J. M., Goochee, C. F., Chock, V. Y., Brousseau, D. T., Sliwkowski, M. B., (1995) Removal of sialic acid from a glycoprotein in CHO cell culture supernatant by action of an extracellular CHO cell sialidase, Biotechnology 13: 692-698 [5] Munzert, E., Müthing, J., Büntemeyer, H., Lehmann J., (1996) Sialidase activity in culture fluid of chinese hamster ovary cells during batch culture and its effect on recombinant human antithrombin III integrity, Biotechnol. Prog. 12: 559-563 [6] Munzert, E., Heidmann, R., Büntemeyer, H., Lehmann, J., Müthing, J., (1997) Production of recombinant human antithrombin III on 20-L-bioreactor scale: corellation of supernatant, neuraminidase activity, desialylation, and decrease of biological activity of recombinant
glycoprotein, Biotechnol. Bioeng., in press [7] Ferrari, J., Harris R., Warner, T.G., (1994) Cloning and expression of a soluble sialidase from chinese hamster ovary cells: sequence alignment similarities to bacterial sialidases, Glycobiology 4: 367-373 [8] Miyagi, T., Konno, K. , Emori, Y., Kawasaki, H., Suzuki, K., Yasui, A., Tsuik, S., (1993)
Molecular cloning and expression of cDNA encoding rat skeletal muscle cytosolic sialidase, J. Biol. Chem. 268: 26435-26440
6. Acknowledgements
This work was financed by the Deutsche Forschungsgemeinschaft (DFG), Graduiertenkolleg ,,Zelluläre Grundlagen biotechnischer Prozesse“. We would like to thank the ESACT for a bursary, which enabled MB to attend the 15th ESACT Meeting.
This page intentionally left blank.
Construction of a novel CHO cell line coexpressing human glycosyItransferases and fusion PSGL-1 - immunoglobulin G B. Vonach, B. Hess and C. Leist. Novartis Pharma AG, Biotechnology Development and Production, CH-4002 Basel, Switzerland.
Introduction The sialyl Lewisx (sLex) determinants serve as ligands in the selectin-mediated adhesion of leukocytes to activated endothelium or platelets. The most frequently used mammalian host cell lines (CHO, BHK) for the production of recombinant glycoproteins are incapable to produce sialyl Lewisx oligosaccharides. Therefore, we have constructed CHO cell lines expressing human N-acetyl-Dglucosaminyltransferase and 1,3-fucosyl-transferase III. Stable clones were obtained which were subsequently transfected with a plasmid encoding human PSGL1-lgG. The recombinant PSGL-1 molecule was recognized by specific antisialyl Lewisx antibodies that only bind to the correctly glycosylated protein. Furthermore, the recombinant PSGL-1 bound to P-selectin, its natural ligand, showing that it was properly glycosylated.
Expression of recombinant human glycosyltransferases Plasmids used:
pGNT-his, coding for the N-acetyl-D-glucosaminyltransferase and the enzym histidinol-dehydrogenase pFucTIII-zeo, coding for the 1,3-fucosyltransferase III and zeocine resistance pPSGL-1-lgG1-hyg, coding for the P-selectin glycoprotein ligand 1immunoglobulin G1 (Fc region) fusion protein and hygromycin resistance CHO SSF3 cells were first cotransfected with pGNT-his and pFucTIII-zeo. pGNThis expressed the dominantly acting hisD gene of Salmonella typhimurium encoding the enzym histidinol-dehydrogenase. The presence of this gene allowed the cells to survive in media without histidine supplemented with 1mM Lhistidinol. Positive transfected clones were picked and grown in 96-well plates until analysis. 181 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 181-183. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
182 Immunostaining and FAGS analysis The presence of the sLe x determinant on the surface of cotransfected cells (CHO SSF3 /GNT/FucTIII) was verified by immunostaining using a specific mouse anti-sialyl-Lex IgM (Becton Dickinson) and an anti-mouse-lgM-peroxidase conjugated antibody (Jackson Dianova). The specificity of the reaction was shown by the absence of signal in untransfected cells, indicating that these CHOSSF3 cells normally lack the enzyms N-acetyl-D-glucosaminyltransferase and fucosyl-transferase III. When analysing cotransfected cells a brown DAB (Diamino-benzidin tetrahydrochloride)/ cobalt and nickel chloride precipitate was clearly detectable by microscopy (enlargement:20x). The presence of membrane-bound expressed sialyl Lex was checked on the surface of cotransfected CHO cells (CHO SSF3/GNT /FucTIII) by FACS analysis. The cells were treated with the specific mouse anti-sLex IgM followed by the fluorescence dye DTAF. Untransfected cells were used as negative control. The samples were analyzed by flow cytometry on a FACStar Flow Cytometer (Becton Dickinson). The fluorescence of the positive clone was above 97% indicating that the newly constructed cell line was almost pure (Fig.1).
Expression of PSGL-1-lgG1 in the newly constructed cell line
CHO SSF3/GNT/FucTIII cells were transfected with the plasmid pPSGL-1-lgG1hyg, coding for the P-selectin glycoprotein ligand 1 - immunoglobulin G fusion protein. The recombinant PSGL-1 molecule was recognized by specific anti-sialyl Lewisx antibodies that only bind to the correctly glycosylated protein.
183
We also evaluated binding of recombinant PSGL-1-lgG to P-selectin, the natural ligand. The immobilized P-selectin only bound minor amounts of recombinant PSGL-1-lgG purified from the supernatant of B5 cells (only transfected with the plasmid pPSGL-1-lgG1-hyg) (Fig.2). However, the binding was significantly increased when adding recombinant PSGL-1-lgG purified from the supernatant of H4 cells (transfected with the plasmids pGNT-his, pFucTIII-zeo and pPSGL-1lgG1-hyg). There was no detectable difference between the proteins obtained from cells grown in the absence or presence of fetal calf serum.
Conclusion The CHO SSF3 cell line used as host for our DNA transfections has been previously adapted for growth in suspension cultures in serum-free media. The recombinant CHO SSF3 cells efficiently returned to growth in serum-free suspension culture after extended culture in monolayers using serumsupplemented media. This indicated that the preadapted cell phenotype was stable after transfection and selection of heterologous genes. Furthermore, the recombinant PSGL-1-lgG protein expressed by CHO SSF3 previously cotransfected with plasmids encoding both the N-acetyl-D-glucosaminyltransferase and 1,3-fucosyltransferase presented a "human-like" glycosylation pattern, which was specifically recognized by anti-Lewisx antibodies. The recombinant PSGL-1 bound to P-selectin, its natural ligand, showing that it was properly glycosylated. The transfection of mammalian cell lines with plamids encoding human glycosyltransferases of defined specificity provides a tool to generate novel stable host cell lines for the production of recombinant proteins with tailored glycosylation pattern.
This page intentionally left blank.
PRODUCTION OF DEFINED GLYCOSYLATION VARIANTS OF SECRETED HUMAN GLYCOPROTEIN THERAPEUTICS BY COEXPRESSION WITH HUMAN RECOMBINANT GLYCOSYLTRANSFERASES IN BHK-21 CELLS
Schlenke, P., Grabenhorst, E., * Costa, J., Nimtz, M., and Conradt, H.S. Dept. of Protein Glycosylation, GBF, Mascheroder Weg 1, D-38124 Braunschweig, Germany, *IBET, ITQB, Apartado 12, 2780 Oeiras, Portugal
1. Abstract To investigate the stability of a BHK-21 A cell line transfected with human EPO (huEPO) and the human 2,6-sialyltransferase ST6N (huST6N), the cell line was cultivated over a time period of 18 days in a 2.5 L perfused bioreactor in protein- and serum-free medium and under physiological stress after addition of ammonium. The stability of gene expression and the activity of the newly introduced huST6N and the endogenous 2,3-sialyltransferase ( 2,3-ST) were analyzed during the different cultivation conditions by RT-PCR and in vitro assays. Furthermore, the purified secreted huEPO was analyzed by western blot and the liberated N-glycans were characterized by HPAEC-PAD analysis. The results confirmed the stability of the cell line with respect to the expression of the newly introduced human proteins even under physiological stress. The elevated ammonium concentration led to reversible changes on the EPO N-glycans. 2. Introduction When expressed from mammalian host cell lines, the glycan moieties found on recombinant human glycoprotein therapeutics depend on the cell line used for production, the polypeptide and the culture conditions. Several common motifs found on proteins from natural sources like the terminal 2,6-sialylation of N-glycans which is characteristic for human serum proteins or the Lex or sLex structures are not synthesized from the most frequently used host cell lines BHK or CHO because these cell lines do not express the specific glycosyltransferases. The differences in the glycan structures between recombinant proteins and the natural human counterparts are of relevance for glycoproteins produced for clinical applications because these motifs are involved in numerous biological phenomena, e.g.: in-vivo half-live, inflammatory processes, antigenicity. We have shown that it is possible to alter the glycosylation potential of host cell lines by rransfection with plasmids encoding glycosyltransferases not expressed from the parent cell line (1,2). By coexpression of human glycoproteins with glycosyltransferases it is possible to obtain stable cell lines producing reproducible human-type glycosylated products. In addition, coupled with analysis of the resulting products by mass spectrometry, the system offers a reliable approach to investigate the in vivo substrate 185 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 185-190. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
186
specificity of glycosyltransferases. By using this system together with in vitro assays the substrate specificity of the human fucosyltransferase III was elucidated (3). To investigate the stability of a BHK-21A cell line transfected with huEPO and the human 2,6-sialyltransferase, the cell line was cultivated in a 2.5 L perfused bioreactor in protein- and serum-free medium with or without addition of ammonium and ammonium/mannose. It is known that ammonium which accumulates during cell culture due to amino acid metabolism and degradation of glutamine affects the glycosylation of proteins (8,9). The BHK-21A cells used for the reactor experiment differ from BHK-21B cells by the high amount of terminal GalNAc structures found on the N-glycans (1). Due to the fact that the endogenous 2,3-sialyltransferases is unable to act on these structures, Nglycans produced from this cell line are undersialylated. This would result in a rapid hepatic clearance of the corresponding proteins in humans. We could show that the transfection of the BHK-21A cell line with the huST6N increases the sialylation state of the coexpressed recombinant huEPO because the human enzyme was shown to be able to act in vivo on terminal Gal as well as on terminal GalNAc structures (2). 3. Material and Methods Cell line and culture conditions: A BHK-21A cell line transfected with huEPO and huST6N was cultivated in a 2.5 L perfused bioreactor for 3 days in protein- and serumfree standard medium (SMIF 6, Gibco-BRL), followed by a cultivation period of 5 days in SMIF 6 supplemented with 15 mM After return to standard conditions for 3 days the perfusion was started with standard medium supplemented with 15 mM and 4 mM mannose. The process was finished after a cultivation period of 3 days in standard medium (see Fig. 1). Total cell number and viability was determined as described (4). During the different culture conditions, the supernatant and cells were harvested for further investigations. EPO purification, characterization and analysis of N-glycans: Western analysis of the secreted protein was performed before and after removal of the N-glycans by PNGase Ftreatment. The secreted EPO was purified from the concentrated cell culture supernatants by immunoaffiniry chromatography (2). After the purity of the preparation was verified by SDS/PAGE and Coomassie staining, the protein was digested with trypsin and the resulting peptides were separated by RP-HPLC. The N-glycans were liberated from the peptides by PNGase F and separated by RP-HPLC. The native and desialylated oligosaccharides were desalted and analyzed by HPAEC-PAD as described previously (5). PCR analysis: Total cellular RNA was prepared by Tri-Reagent followed by cDNA synthesis using standard protocols (6). The cDNA samples were normalized with respect to the signals obtained after actin PCR, electrophoretic separation of the PCR products in agarose gels and densiometric analysis of the resulting bands. The normalized cDNA samples were used for PCR analysis with primers corresponding to the endogenous 2,3-ST (E. Grabenhorst, unpublished results) and the newly introduced huST6N,
187 resulting in PCR fragments of 774 bp and 699 bp, respectively. Analysis of the PCR products was performed as described. Preparation of cell extracts and sialyltransferase assay: After harvesting, cells were washed with PBS, spun at 1000 x g and resuspended at a concentration of cells/ml in ice-cold extraction buffer (10 mM MES/NaOH, pH 6.5, 2% Triton CF-54, 1 mM PMSF, 10 µg /ml aprotinin, 10 µg /ml leupeptin) and stored at -70 °C. Prior to analysis the samples were thawed and incubated for 1h on ice. Sialyltransferase activity was tested with an 8-methoxycarbonyloctyl glycoside type II acceptor in reaction mixtures containing in a volume of 100 ': 50 mM MES/NaOH buffer, pH 6.5, 27 cell extract, 90 nmol acceptor, 5 nmol of CMPNeu5Ac (60.000 cpm/nmol), 20 mM , 100 mM NaCl and 0.2 nmol ATP. The mixture was incubated at 37 °C for 5h, diluted to 1 ml with ice-cold and applied to Sep-Pak cartridges. After washing with 15 ml of water the products were eluted with 1.5 ml of methanol. The eluat was dried under vacuum and resuspended in 700 sialidase buffer (50 mM Na-acetate pH 5.0, 5 mM , 0.02% ). Aliquots
of 200 were incubated for 4h at 37 °C with a) 10 mU Vibrio Cholerae sialidase (removes 2,6 and 2,3 linked sialic acid), b) 5 mU Newcastle disease virus sialidase (removes only 2,3 linked sialic acid) and c) without sialidase. Subsequently, the reactions were stopped by the addition of water and the mixtures were applied to the Sep-Pak cartridges as described. After elution with 1.5 ml of methanol the incorporation
of
Neu5Ac onto the acceptor was determined by liquid scintillation counting.
4. Results and Discussion By cotranfection of mammalian host cell lines with plasmids encoding glycoprotein therapeutics and glycosyltransferases not expressed from the parent cell lines, it is possible to obtain therapeutics with human-type glycosylation characteristics (1,2). In order to investigate the stability of a genetically engineered BHK-21A cell line transfected with huEPO and the huST6N, the cell line was cultivated over a time period of 18 days in a perfused 2.5 L bioreactor. During the cultivation in protein- and serumfree medium and under physiological stress induced by the addition of 15 mM ammonium with or without 4 mM mannose to the standard medium, the cellular growth rate and viability was determined. Furthermore, the stability of gene expression and the activity of the newly introduced huST6N and the endogenous α2,3-ST was investigated using RT-PCR analysis and in vitro sialyltransferase assays, respectively. The secreted huEPO was characterized by immunoblotting after purification by affinity chromatographie. The liberated N-glycans were analyzed by HPAEC-PAD. Cell growth: Ammonium is known as a harmful substance accumulating during cell culture. Several authors described a reduction of the cell density due to elevated ammonium concentrations (see ref. 7 for review). The degree of growth reduction by
ammonium varies between a wide range and probably reflects the different sensitivity of the cell lines used for the studies as well as differences in the cell culture conditions. In the present study, no significant effect of the elevated ammonium concentration on cell
188
growth rates or the viability of the BHK-21 A cell line (82-95%) was observed (see Fig. 1). RT-PCR analysis: RT-PCR analysis of the transcripts encoding the newly introduced huST6N and the endogenous 2,3-ST revealed a stable expression of the corresponding genes during the cultivation period even under high ammonium concentration. The analysis indicated a constant transcription rate of both, the huST6N and the 2,3-ST, which was not affected by the culture conditions. Northern analysis revealed a l0fold stronger signal for the huST6N compared to the endogenous enzyme (not shown).
Sialyltransferase assay: Similar to the transcription rate of the sialyltransferases, the enzyme activity detected in cellular extracts remained stable during the production process. A total sialyltransferase activity between 0.18 and 0.34 cells was determined. With the acceptor substrate used for the assay, the human sialyltransferase showed a significantly higher activity as the endogenous enzyme (about 83% of the total activity).
Immunoblot: Western blotting analysis of the supernatants collected during the different culture conditions confirmed a stable secretion rate of the recombinant EPO during the cultivation process. The analysis revealed a reversible increased mobility of the protein in SDS-PAGE when produced under elevated ammonium concentration. Removal of the N-glycans from the protein by PNGase F-treatment eliminated the
differences indicating a variation in N-glycosylation being responsible for the observed differences in mobility of EPO after addition of ammonium. The protein part as well as
the ratio of O-glycosylated and non O-glycosylated protein remained unaffected during the different culture conditions. Glycan analysis: Differences in the oligosaccharide structures produced under elevated ammonium concentrations were also observed by HPAEC-PAD analysis of the separated native and desialylated N-glycans. Predominantly tetraantennary structures that were highly sialylated were detected when synthesized under standard conditions. On the contrary, stress conditions (application of ammonium with or without mannose) led to a decrease in sialylation state and to the formation of partially agalacto tetraantennary structures as shown by MALDT-TOF MS analysis of the glycans (data not shown). The oligosaccharide structures observed during standard conditions were regained after switching from the stress conditions back to the standard conditions again. These results clearly indicate the stability of the genetically engineered BHK-21 A cell line during the production process with respect to the expression of the recombinant proteins even under high ammonium concentrations. As expected, the addition of ammonium to the culture medium led to changes in the N-glycan structures found on the secreted EPO. Thorens and Vassalli (8) reported the complete inhibition of sialic acid
transfer to terminal galactose residues of immunoglobulins secreted by plasma cells in the presence of 10 mM Similar to the results obtained in the present study, no influence of ammonium on the secretion rate was observed. The detection of truncated glycan structures on the recombinant huEPO produced under elevated ammonium concentrations is consistent with results published by Borys et al. (9). The authors described the inhibition of glycosylation of mouse placental lactogen-I expressed from CHO cells by increasing levels of ammonium in a pH-dependent manner. Their results
189
indicated that ammonium has the potential not only to affect the terminal sialylation but the entire glycosylation process, resulting in truncated structures. The reversibility of the effects observed after the addition of ammonium confirmed the stability of the BHK21A cell line investigated. The results revealed that it is possible to obtain stable cell lines by transfection of BHK21 cells with glycosyltransferases not expressed from the parent cell lines. These cell lines can be used for the production of human-type glycosylated therapeutics.
5. References 1. Grabenhorst, E., Hoffmann, A., Nimtz, M., Zettlmeissl, G., Conradt, H.S.: Construction of stable BHK-21
cells coexpressing human secretory glycoproteins and human Eur. J. Biochem. 232 (1995), 718-725
--sialyltransferase,
2. Schlenke, P., Grabenhorst, E., Wagner, R., Nimtz, M., Conradt, H.S.: Expression of human α2,6sialyltransferase in BHK-21A cells increases the sialylation of coexpressed human erythropoietin, In: Animal Cell Technology, Kluwer Academic Publisher, Dordrecht, (1997), 475-480 3. Costa, J., Grabenhorst, E., Nimtz, M., Conradt, H.S.: Stable expression of the golgi form and secretory
variants of human fucosyltransferase III from BHK-21 cells, J. Biol. Chem. 272 (1997), 11613-11621 4. Gawlitzek, M., Valley, U., Nimtz, M., Wagner, R., Conradt, H.S.: Characterization of changes in the glycosylation pattern of recombinant proteins from BHK-21 cells due to different culture conditions, J. Biotechnol. 42 (1995), 117-131
190 5. Nimtz, M., Martin, W., Wray, V., Klöppel, K.-D., Augustin, J., Conradt, H.S.: Structures of sialylated oligosaccharides of human erythropoietin expressed in recombinant BHK-21 cells, Eur. J. Biochem. 213 (1993), 39-56 6. Sambrook, J., Fritsch, E.F., Maniatis, T.: Molecular cloning: a laboratory manual, 2 nd edn, Cold Spring Harbor Laboratory, Cold Spring Harbor NY (1989) 7. Schneider, M., Marison, I.W., Stockar, U.v.: The importance of ammonia in mammalian cell culture, Minireview, J. Biotechnol. 46(1996), 161-185 8. Thorens, B. & Vassalli, P.: Chloroquine and ammonium chloride prevent terminal glycosylation of immunoglobulins in plasma cells without affecting secretion, Nature 321 (1986) 618-621 9. Borys, M.C., Linzer, D.I.H., Papoutsakis, E.T.: Ammonia affects the glycosylation pattern of recombinant mouse placental lactogen-I by Chinese Hamster Ovary cells in a pH-dependent manner, Biotechnol. Bioeng. 43 (1993), 505-514
Discussion Handa-Corrigan:
How stable is your protein in terms of processing and freezing and thawing?
Schlenke:
You can freeze it several times without affecting the activity.
ANTISENSE RNA FOR THE ELIMINATION OF NEUGC RESIDUES FROM RECOMBINANT GLYCOPROTEINS
A. GREGOIRE, A. VISVIKIS*, A. MARC, J-L. GOERGEN Laboratoire des Sciences du Génie Chimique, CNRS-INPL, BP 172, F 54505 Vandoeuvre-lès-Nancy * Centre du Médicament - Fac. Pharmacie, 30 rue Lionnois - 54000 Nancy
1. Abstract
In order to inhibit the CHO CNAH translation, responsible for the conversion of NeuAc to NeuGc residues, fragments of different sizes from the mouse cnah cDNA have been cloned as antisense fragments. It appeared that the different antisense species tested were able to inhibit the CNAH translation in vitro. However, when decreasing the amount of the antisense fragments by half, different efficiencies were found according to the
fragment's length or its sequence. 2. Introduction
CHO cells have become one of the most favoured way for the production of complex recombinant proteins destined for human therapy (1,2,3). While, in rodent cells, the CMP-N-acetylneuraminic-acid-hydroxylase (CNAH) converts CMP-N-acetylneuraminic acids (CMP-NeuAc) to CMP-N-glycolylneuraminic acids (CMP-NeuGc) (4), in adult human cells this enzyme is absent and thus NeuGc-bearing proteins can produce a strong immune response when injected (5). The recent cloning of the mouse cnah gene (6) can be used, in an antisense strategy, to stop the production of NeuGc residues bearing proteins in CHO cells. In this study, different pieces of the mouse cnah cDNA have been used to generate antisense RNAs, which have then been tested for their ability to inhibit the CNAH expression in vitro. 3. Materials and Methods Plasmid constructions : Classical molecular biology techniques were performed according to Sambrook et al., 1989 (7). The 400nt antisense fragment is a XbaI/SacI fragment isolated from the pBSCNAH (plasmid containing the mouse cnah cDNA, kindly given by T. Kawano) and subcloned in the pGEM3Z vector. The 800nt antisense fragment was amplified by PCR, using the Eurogentec TAQ DNA polymerase, and cloned into the pCR2.1 vector issued from the "TA cloning kit" (Invitrogen). In vitro transcription & translation : In vitro transcription reactions were performed using the "Riboprobe in vitro Transcription System". In vitro translation reactions were performed using the "Rabbit Reticulocyte Lysate System" and chemiluminescent detection was possible due to the "Transcend™ non-radioactive Translation Detection System" (Promega). 191 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 191-193. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
192
4. Results & Discussion
4.1 ANTISENSE RNA PRINCIPLE AND STRATEGY
Since initial experiments (8, 9) showed that artificial antisense oligonucleotides may be used to interfere with gene expression, there has been a growing body of literature on antisense nucleic acids. As a first attempt, the lack of generally applicable rules for the
design of efficient antisense led us to test, in vitro, the ability of different antisense RNAs to inhibit the translation of the mouse cnah mRNA. We thus tested the efficiency of antisense RNAs of different lengths by cloning fragments from the mouse cnah cDNA. Three different antisense RNAs could then be produced : a full length (FlAs of ca. 1700nt), a 800nt and a 400nt, schematically represented on fig.l.
4.2 TRANSCRIPTION AND TRANSLATION INHIBITION TESTS The mouse cnah cDNA and the antisense fragments were transcribed by either T7 or T3 RNA polymerase and the RNAs were loaded on an agarose gel (fig. 2). The RNA lengths could be verified by comparison with 4 control RNAs of 250, 1525, 1065 and
2346nt. The band intensity reflected the amount of RNA obtained, allowing an estimation of the sense and antisense RNAs quantities necessary for the in vitro translation tests.
As shown in fig. 3, lane CNAH, a 66Kda protein was synthetised during the translation reaction in the tube containing the cnah mRNA. The next step was then to inhibit
CNAH expression adding antisense RNAs in the reaction. The first in vitro translation antisense experiments were performed with a same amount of sense and antisense RNAs. In presence of any of the antisense RNAs, no band corresponding to the CNAH protein
appeared (fig. 3A, Lanes FlAs, 800As and 400As), indicating that the 3 antisense RNAs
193 are able to stop the cnah mRNA translation. With one half of antisense RNA, the full length and the 400nt antisense fragments were still very efficient (fig. 3B, Lanes FlAs and 400As), whereas a decreased inhibition was observed when the 800nt antisense RNA was present (fig. 3B, Lane 800As). The 800nt antisense RNA is less efficient than the shorter 400nt piece, probably because : (i) of a particularly stable secondary structure adopted by the 800nt RNA; (ii) the 800nt RNA begins to hybridize to the cnah mRNA just at the ATG codon, which is not the case for the 2 other antisense RNAs beginning their hybridization earlier on 5' (fig. 1).
5. Conclusion
We were able to inhibit the in vitro mouse cnah mRNA translation by RNA antisense technology. Three different mouse antisense RNAs were tested, and all of them efficiently inhibited the CNAH translation. However, probably due to the region it hybridizes to the mRNA, the 800nt antisense was less efficient. The shorter and most efficient antisense (400As) will then be tested for its translation inhibition ability in vivo in CHO cells. 6. References 1. Archer, R., Wood, L. (1992) in R.E. Spier, J.B. Griffiths, C. Macdonald (eds.),: Animal Cell Technology: Developments, Processes and Products , Butterworth-Heinemann, pp. 403-408.
2. Lubiniecki, A., Arathoon, R., Polastri, G., Thomas, J., Wiebe, M., Garnick, R., Jones, A., van Reis, R.,
Builder, S. (1989) in R.E. Spier, J.B. Griffiths, J. Stephens, P.J. Crooy (eds.), Advances in Animal Cell Biology and Technology for Bioprocesses., Butterworth-Heinemann, pp.442-449.
3. Cole, E.S., Lee, K., Lauziere, K., Kelton, C., Chappel, S., Weintraub, B., Ferrera, D., Peterson, P., Bernasconi, R., Edmunds, T., Richards, S., Dickrell, L., Kleeman, J.M., McPherson, J.M., Pratt, B.M. (1993) Biotechnology 11, 1014-1024. 4. Kawashima, I., Ozawa, H., Kotani, M., Suzuki, M., Kawano, T., Gomibuchi, M., Tai, T. (1993) J. Biochem. 114, 186-193. 5. Muchmore, E.A., Milewski M., Varki, A., Diaz, S. (1989) J. Biol. Chem. 264, 20216-20223. 6. Kawano, T., Koyama, S., Takematsu, H., Kozutsumi, Y., Kawasaki, H., Kawashima, S., Kawasaki, T., Suzuki, A. (1995) J. Biol. Chem. 270, 16458-16463. 7. Sambrook, J., Fritsch, E.F., Maniatis, T. (1989) Cold Spring Harbor Laboratory Press. 8. Paterson, B.M., Roberts, B.E., Kuff, E.L. (1977) Proc. Acad. Sci. USA 74, 4370-4374. 9. Zamecnik, P.C., Stephenson, M.L. (1978) Proc. Natl. Acad. Sci. USA 75, 280-284.
This page intentionally left blank.
CELL PROLIFERATION
PROLIFERATION CONTROL APOPTOSIS
This page intentionally left blank.
INTRACELLULAR FATTY ACID COMPOSITION AFFECTS CELL YIELD, ENERGY METABOLISM AND CELL DAMAGE IN AGITATED CULTURES M.BUTLER, N.HUZEL, N.BARNABÉ, L.BAJNO AND T.GRAY Department of Microbiology, University of Manitoba, Winnipeg, Canada R3T 2N2
Abstract Continuous passage of cells in serum-free media requires the presence of micronutrients and growth factors to compensate for the lack of serum. Fatty acid supplementation is essential to ensure an adequate composition of the structural lipid components of the cell. We have shown that the unsaturated fatty acids, oleic and linoleic independently enhance cell yield and Mab productivity. The cellular content of the fatty acids gradually increased during continuous culture passage with no evidence of regulatory control. Most of the fatty acid accumulated in the polar lipid fraction and the unsaturated/ saturated fatty acid ratio of all cellular lipid fractions increased significantly. This caused a substantial decrease in the rate of glutamine metabolism and an increase in the rate of glucose metabolism. The changes in energy metabolism were reversed when the cells were removed from fatty acidsupplemented medium. The most plausible explanation for this effect is an altered rate of transport of glutamine via the cell membrane. An observed change in the phospholipid composition of the membrane also caused a significant protective effect on the cells in agitated cultures. The life-span of fatty acid-loaded cells showed a improvement compared to controls in cultures stirred at high rates of agitation. Introduction The unsaturated fatty acids, linoleic acid and oleic acid have been shown to be essential for the repeated passage of hybridomas in serum-free cultures. In previous reports (1,2) we showed that linoleic or oleic acid enhances significantly the cell yield and monoclonal antibody productivity of a B-lymphocyte hybridoma (CC9C10). However, continued culture passage with the unsaturated fatty acids leads to a lipid-loaded state in which cells maintain a high capacity for growth but a decreased capacity for antibody production. A similar differential effect of fatty acids on product secretion and cell growth has been reported previously for the secretion of cytokines from human peripheral lymphocytes (3) and for recombinant protein productivity from BHK cells (4). The mechanism of growth-promotion of these fatty acids may be related to their importance in the synthesis of cellular membranes (5,6) which may have a significant effect on membrane fluidity (7). We now present data to show that the fatty acids cause significant changes in the phospholipid composition of the cell membrane. This may lead to altered rates of transport 197 O.-W. Merten et al. (eds.). New Developments and New Applications in Animal Cell Technology, 197-203. ©1998 Kluwer Academic Publishers. Printed in the Netherlands.
198
of key energy substrates into the cell and reduced fragility under conditions of culture agitation. Materials and methods
Cell line: The murine B-lymphocyte hybridoma (CC9C10), which secretes a monoclonal antibody against insulin, was obtained from the ATCC (No HB123). The cells were adapted to a serum-free medium over several passages and grown for at least 10 passages in this medium prior to the described experiments. Insulin was one component of the serum-free formulation. However, substitution with a recombinant analogue of insulin-like growth factor was equally effective with respect to growth promotion. Growth yields in the
presence of either insulin or recombinant IGF were enhanced by 20%. Culture: The basal medium consisted of DMEM: Ham‘s F12 (1:1 v/v) supplemented with a
serum-free mixture of hormones and micronutrients (1). The cultures were also supplemented, where indicated, with fatty acid-free bovine serum albumin complexed with a specific concentration of oleic or linoleic acid. Total cell concentrations were determined by a Coulter counter. Viable cell concentrations were determined by counting a cell suspension diluted 1:1 v/v with 0.2% trypan blue using a Neubauer
haemocytometer.
Results 1. The effect of fatty acids on growth and antibody production Cells were adapted from a serum-supplemented to a serum-free medium and grown for at least 10 passages before there was a noticeable decrease in cell yield. The original cell yields were restored by the addition of oleic or linoleic acid to the serum-free cultures at 25-50 µM. Cell yields were enhanced by as much as 300%. The doubling time in the presence of the fatty acids was around 17 h. Ten other fatty acids were tested for growth promotion in the serumfree medium but none produced similar effects to these unsaturated fatty acids. Cultures of hybridomas grown over several passages in media supplemented with linoleic acid (25 µM), oleic acid (25 µM) or an equimolar mix of oleic/ linoleic (25 µM) showed a consistent enhancement of cell yield compared to fatty acid-free control cultures. Growth yields were greatest in cultures containing an oleic/ linoleic acid mix >linoleic acid >oleic acid >control. The effect of growth enhancement was reversible. When cells that had been passaged continuously in the presence of fatty acids were re-introduced into unsupplemented medium, the growth advantage over control cultures was lost within 2 to 3 passages. The Mab yield increased significantly to 90 µg/ml at the first passage of growth in the presence of fatty acids. However, the yield of Mab gradually declined over the subsequent 3 passages of growth with fatty acid until there was no difference in Mab yield (60 µg/ml) from the control culture. The effect of removing the fatty acids was to temporarily restore the higher Mab yield of the cells previously grown in fatty acid. However, this advantage was eroded after 4 passages in the absence of fatty acids.
199
2. Metabolic state of cells grown with fatty acids
The results of the growth experiments suggest a model set out in Table 1. Initially (state 1) the cells were starved of critical fatty acids following continuous growth in serum-free medium without a fatty acid supplement. State 2 arises following a brief exposure to linoleic (or oleic) acid (25-50 µM). State 3 arises from prolonged exposure to fatty acids and can be partially reversed to state 2 following the removal of fatty acids from the growth medium.
The fatty acid composition of each of these states is significantly different. In state 1,82% of cellular fatty acids could be accounted for by palmitic, oleic and stearic acids. The linoleic acid concentration was low (<5%). In state 2 the linoleic content increased to 70% and in state 3 to 90%, whilst the content of the other fatty acids decreased progressively over this period to 5%. Further evidence of metabolic differences between cells in these 3 states comes from the analysis of energy metabolism. We have shown by radioactive incorporation experiments that the oxidative metabolism of glucose increases (x2) and the oxidative
metabolism of glutamine decreases (x8) as cells progress from state 1 to state 3. Cells in state 3 grown in the absence of fatty acid revert to state 2 and demonstrate a partial reversal of this oxidative pattern. In all states the rate of fatty acid oxidation was low in relation to the total
utilisation of fatty acid and in relation to glucose and glutamine oxidation (8).
200
3. Regulation of fatty acid uptake It would appear that the cells have a requirement for linoleic and/or oleic acid but are unable to regulate the rate of uptake to maintain optimal intracellular metabolism (state 2 in Table 1). In order to verify this , we determined the rate of incorporation of radioactively labelled fatty acids from the media into 3 intracellular lipid fractions (Fig. 1). The pattern of fatty acid utilisation was determined for cells grown in the presence or absence of linoleic acid for at least 5 passages. Most of the fatty acid was incorporated into the polar lipid fraction (>74%). This fraction included the phospholipids derived from cell membranes. There was no significant difference in the total incorporation of linoleic acid between control and fatty acid-grown cells. This suggests that there is no regulatory mechanism to prevent an over-accumulation of fatty acid into the cell. A similar result was obtained with respect to the incorporation of oleic acid into these lipid fractions.
4. Uptake of energy substrates in the presence of fatty acids The metabolic profile of cells grown in linoleic or oleic acid was found to be significantly
different from control cells. The possibility that the changes were associated with an altered membrane permeability to substrate uptake was investigated by short-term radioactive uptake
experiments. The rates of cellular uptake of glucose and glutamine were determined from radioactive incorporation into cells over a 3 min incubation period. In separate incubations glucose was added at concentrations up to 100 mM and glutamine in concentrations up to 20 mM (Fig. 2).
Hyperbolic curve fitting indicated Michaelis-Menten-type kinetics of substrate uptake with respect to concentration. This data shows a significant difference in glutamine uptake between the linoleic acid-grown and control cultures but no significant difference for glucose uptake.
201
The kinetic parameters of substrate uptake were determined by statistical analysis using the soft-ware program, HYPER (Table 2). The was no apparent difference in the Km values for glucose transport in the linoleic acid-grown cells. However, the Km for glutamine uptake in linoleic acid-grown cells at 23±5 mM was almost an order of magnitude higher than the value of 2.7±0.5mM for control cells. At the glutamine concentration (6 mM) used in the standard growth medium the glutamine uptake rate was 2.5-fold lower in linoleic acid-grown cells compared to control cells. This indicates that the incorporation of the unsaturated fatty
acids into the membrane lipids caused a significant decrease in the transport of glutamine.
5. The effect of culture agitation on fatty acid grown cells Suspension cells agitated in spinner flasks are susceptible to shear damage caused by gas entrainment. We determined that a measurable rate of loss of cell viability occured in spinner flasks at an agitation rates between 470 - 630 rpm (tip speed 120-165 cm/sec). At the higher value (630 rpm) the viable cell concentration decreased to zero after 1.5 h, whereas at the lower value (470 rpm) the viable cell concentration decreased to half the original value within 1-3 h. Fig 3a shows the time-dependent decrease of viable concentration of linoleic acidgrown and control cells over a period of 5 h. This is a representative of a series of curves generated within the agitation range from which we determined the half-life of the viable cell population. Fig. 3b shows that the half life values determined for the linoleic acid-grown cells were significantly higher than those of control cells up to 550 rpm. At the higher agitation rates the half-lives were extremely short and no significant difference was found for the values for the two cell types. At 470 rpm the determined half-life for linoleic acid-grown cells was x3 the equivalent value of control cells. This result indicates that the effect of the fatty acid is to improve the robustness of the cells significantly in agitated culture.
202
Cells were inoculated at 5xl05 cells/ml into 200 ml medium contained in a spinner flask which was agitated at a selected speed for 5 h. The viable cell concentration was determined at intervals during this period. (A) The change in viable cell concentration for cultures agitated at 470 rpm. (B) The half-life of the viable cell population at various agitation speeds. Values are means ±SEM for n=3 Conclusions Supplementation of a serum-free culture of a hybridoma with the unsaturated fatty acids, oleic and linoleic causes :- a substantial growth enhancement (300%) - an initial enhancement of Mab yield (60%) - a significant reduction in glutamine uptake (60%) - an increased tolerance to culture agitation For maximal productivity of the hybridomas, the fatty acid composition of the cell requires to be finely balanced between a lipid-starved and lipid-loaded state. As there appears to be no regulatory mechanism for fatty acid uptake, the lipid-balanced state of the cells in culture must be maintained by a controlled feeding regime References 1. Butler, M. and Huzel, N. (1995) J. Biotechnol. 39, 165-173 2. Butler,M., Huzel,N. and Barnabé,N. (1997) Biochem J. 322, 615-623. 3. Karsten, S., Schafer, G. and Schauder, P. (1994) J. Cell Physiol. 161, 15-22 4. Schmid, G., Zilg, H., Eberhard,U. and Johaiinsen, R. (1991) J. Biotechnol. 17, 155-167 5. Rockwell, G.A., Sato, G.H. and McClure, D.B. (1980) J. Cell Physiol. 103, 323-331 6. Rintoul, D.A, Sklar, L.A. and Simoni, R.D. (1978) J. Biol. Chem. 253, 7447-7452 7. Calder, P.C., Yaqoob, P., Harvey, D.J, Watts, A. andNewsholme, E.A. (1994) Biochem. J. 300, 509-518 8. Butler, M. and Huzel, N. (1997) ESACT 14, 657-662.
203
Discussion
Grammatikos:
How do you add the fatty acids to the medium?
Butler:
We attached the fatty acids to de-lipidated BSA.
Grammatikos:
When you incorporated linoleic acid into cells you showed a much
lower arachidonic acid level. It is known, theoretically, that linoleic acid can lead to increases in arachidonic acid. Can you speculate on your result - is it just not processed to arachidonic acid?
Butler:
The figures may have been misleading. I quoted moles percent to show that the proportion of linoleic acid goes up dramatically. The amount of arachidonic remains about the same.
Jordan:
Do you have air bubbles in the bioreactor at 470 rpm?
Butler:
We were not sparging; it was a spinner flask, so we had a vortex and head space.
This page intentionally left blank.
LIPID REQUIREMENTS OF A RECOMBINANT CHINESE HAMSTER OVARY CELL LINE (CHO) JEFFREY T. MCGREW, CHERYL L. RICHARDS, PAULINE SMIDT, BRADLEY DELL, AND VIRGINIA PRICE Immunex Corporation, Department of Cell Sciences, 51 University Street, Seattle, WA 98101 USA
1. Abstract
We have tested the effect of a wide variety of lipid supplements and precursors on the growth of a recombinant Chinese Hamster Ovary (CHO) cell line. This cell line is adapted to grow in protein-free media and grows slowly in the absence of any exogenous lipid
source. Several exogenous lipid sources stimulated robust growth including Intralipids. Intralipid (Kabi Pharmacia) is a filterable lipid emulsion consisting of 10% soybean oil, 1.2% egg yolk phospholipids, and 2.25% glycerin in water. Soybean oil consists of a mixture of neutral triglycerides. In order to determine if the growth promoting activity could be due to one of these components, purified triglycerides and phospholipids were tested alone and in combination. We found that the growth promoting activity required
both triglycerides and phospholipids. We also found that the phospholipid growth factor lysophosphatidic acid stimulated CHO cell growth. 2. Introduction
Growth of mammalian cells in culture typically requires the addition of exogenous lipids. The requirement for lipids can be met with serum, partially purified serum fractions, lipid rich albumin, or protein-free lipid emulsions. Exogenous lipids become incorporated in the cell membranes and play a nutritional role for cell growth [1]. Lipids are also involved in signaling intracellularly and extracellularly [2]. Previous studies demonstrated that addition of exogenous lipids to Chinese Hamster Ovary (CHO) cells improved growth and
production of recombinant proteins [3,4]. For manufacturing purposes lipid supplements should be chemically defined, filterable, and easy to prepare [5]. In addition, a lipid supplement would preferably not be derived from serum thus avoiding adventitious contaminants. The objective of this study is to identify commercially available lipid supplements that support robust growth of CHO cells and are suitable for manufacturing.
3. Results and Discussion 3.1 GROWTH OF CHO CELLS IN RESPONSE LIPIDS Table 1 shows the results of a growth stimulation assay of several lipids and lipid precursors. Consistent with previous results, both Ex-cyte and cholesterol rich lipids stimulated growth of CHO cells [4]. Intralipid, a protein-free lipid emulsion also supported robust growth of CHO cells. Figure 1 shows the stimulation of cell growth in response to increasing concentrations of Intralipid. Intralipid is an emulsion of 10% soybean oil,
1.2% egg yolk phospholipids. 205 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 205-207.
© 1998 Kluwer Academic Publishers. Printed in the Netherlands.
206
Since Intralipid supported cell growth, we sought to determine if either soybean oil or phosphatidyl choline, the primary component of egg yolk phospholipids, would stimulate
CHO cell growth independently. Soybean oil or phosphatidyl choline on their own supported little, if any, cell growth (data not shown). An emulsion was prepared consisting of soybean oil, phosphatidyl choline, and F68. This emulsion did stimulate some cell growth, but not as much as Intralipid (data not shown).
207
Intralipid is a potentially useful lipid supplement for manufacturing. It is chemically well defined and relatively inexpensive. The mean particle size of Intralipid is 0.37 microns which is larger that the pore size of a 0.2µ filter [6]. Since emulsion particles should be somewhat flexible, we pressure filtered Intralipid prior to adding it to media and found that Intralipid easily penetrated a 0.2µ filter. If, however, Intralipid was added to media prior to filtration, we found that the filter would clog suggesting that the particle size of the emulsion increases in the presence of media. Filtering Intralipid prior to adding it to media did not influence performance of CHO cells in shake flask or bioreactor cultures (data not shown). 3.2 LYSOPHOSPHATIDIC ACID STIMULATES GROWTH OF CHO CELLS Lysophosphatidic acid (LPA) is a simple phospholipid that stimulates growth of many cell types when added to cells extracellulary [2]. LPA bound with albumin is a component of
serum, and many of the growth factor effects of serum can be accounted for by LPA [2]. Since some serum-free media does not contain any polypeptide growth factors, LPA in or produced from lipid supplements could potentially account for some of the growth stimulatory effects of exogenous lipids. LPA was added in increasing concentration to CHO cells in the presence of fatty acid free-BSA as a lipid carrier (Figure 1B). LPA stimulated modest growth of CHO cells with a saturating concentration of about 20 µg/ml. In Figure 1B, a saturating concentration of Intralipid supported indicating the lysophosphatidic acid was not as potent as Intralipid. This suggests that some of the
effects of exogenously added lipids may be due to growth factor like properties rather than a nutritional properties. LPA also stimulated growth of cells in the absence of BSA, but less than that in the presence (data not shown). 4. References 1. Schimd, G. (1991) Lipid metabolism of animal cells in culture-A review, in Production of Biological from Animal Cells in Culture: Research, Development and Achievements. R. E. Spier et al., (Eds.) Butterworth Oxford, pp61-65
2. Moolenaar, W.H.: Lysophosphatidic Acid, a Multifunctional Phospholipid Messenger, J. Biol. Chem. 270 (1995), 12949-12952 3. Darfler, F. J. : Preparation and use of lipid microemulsions as nutrition supplements for culturing mammalian cells, In Vitro Cell Dev. Biol. 26 (1990), 779-783 4. Jenkins, N., Castro, P., Menon, S., Ison, A., and Bull, A.: Effect of lipid supplements on the production and glycosylation of recombinant interferon-g expressed in CHO cells, Cytotechnology 15 (1994), 209-215 5. Seamans, T.C., Gould, S.L., Distefano, D.J., Silberklang, M., and Robinson, D.K.: Use of Lipid Emulsions as Nutritional Supplements in Mammalian Cell Culture, Ann. N.Y. Acad. Sci. 245 (1994) 240-243 6. Mehta, R.C., Head L.F., Hazrati, A.M., Parr, M., Rapp,R.P., DeLuca,P.P.:Fat emulsion particle -size distribution in total nutrient admixtures, Am. J. Hosp. Pharm. 49 (1992) 27492755
This page intentionally left blank.
SUSTAINED EXPRESSION IN PROLIFERATION CONTROLED BHK-21 CELLS Keywords: BHK-21, IRF-1, proliferation control, growth regulation, expressions
PETER P. MÜLLER, SABINE KIRCHHOFF AND HANSJÖRG HAUSER GBF - National Center for Biotechnological Research, Mascheroder Weg 1, 38124 Braunschweig, FRG Tel.: ++49 (0)531 6181 250
Fax.: ++49 (0)531 6181 262 E.mail:
[email protected]
Abstract
We have established proliferation controled BHK cell lines employing IRF-1 (Interferon
Regulatory Factor 1), a transcriptional activator that inhibits cell growth. The activity of IRF-1 has been made hormone dependent by fusing IRF-1 to the hormone-binding
domain of the estrogen receptor. The growth rate of cells expressing the IRF-l-estrogen receptor fusion protein can be reduced by adding estradiol to the medium. Productivity of
constitutively expressed proteins decreases when growth is downregulated. Expression during both, unrestricted growth and the growth controled phase is obtained by using two separate transcription units. Long-term stability of the regulation has been achieved by coupling the expression of IRF-1 with a selection marker on a dicistronic mRNA construct. The results demonstrate that stable proliferation control and sustained expression can be achieved in a biotechnologically relevant cell line.
Introduction Cell culture processes are initiated from a small number of cells that are expanded
manyfold to achieve high densitiy. In an ideal continuous culture process initial cell growth is rapid, followed by a production phase in which proliferation is downregulated. After reaching an optimal high cell density proliferation is no longer required, only the production is of interest. Proliferation of most cell lines is lower at a high densities, however, not sufficiently low for continuous culture. In a proliferation inhibited state, protein synthesis and metabolic activity of the cell could be devoted largely to the
production of the desired recombinant protein. Advantages of a proliferation inhibited production phase would be
- lower release of intracellular hydrolizing enzymes, leading to a higher uniformity and stability of the product, - higher consistency of the product by keeping the cells in an identical state of proliferation during the whole production period, - genetic drift is reduced due to the reduced proliferation, resulting in a higher stability of the production - reduced media consumption as a consequence of lower metabolic turnover.
Understanding molecular processes that control cell proliferation and progress in the technology of genetic manipulation of mammalian cells (Hauser, 1997) has allowed us to
209 O.-W. Merten et al. (eds), New Developements and New Applications in Animal Cell Technology, 209-214. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
210 influence the proliferation of cell lines which are of biotechnological interest. IRF-1 overexpression inhibits the proliferation of a number of cell lines (Kirchhoff et al.,
1993, 1995, 1996). To demonstrate the feasability of growth control in a biotechnologically relevant cell line, IRF-l-estrogen receptor fusion protein encoding
gene has been transfected into a producer BHK cell line. Upon estrogen addition to the growth medium, cell proliferation is reduced to various degrees depending on the estrogen concentration. After three days in the presence of low estrogen concentrations (30nM) inhibition is about five- to tenfold. After five days of IRF-1 activation the cells are still viable as determined by trypan blue staining (Kirchhoff, unpublished). Cell morphology as examined by microscopic observation shows membrane blebbing as well as the accumulation of granula within the cytoplasm in most of the cells. Whereas native
BHK-21 cell nuclei are not uniformely sized and often show a typical kidney form, IRF-1 activity leads to a rounded nuclear morphology. Indications for apoptosis were not
detected (Kirchhoff, unpublished). IRF-1 does not lead to a cell cycle specific arrest. Instead, there is a slow-down of all cell cycle phases (Kirchhoff et al., in preparation). The slight accumulation of the cells in Gl phase cannot account for the drastic inhibition of cell proliferation. The most likely cause is interferon secretion induced by IRF-1 imposes the weak Gl arrest. A proportional
extension of other cell cycle phases could explain the reduced proliferation. IRF-1 activation leads to reduced gene expression, depending on the promoter used.
Productivity of a recombinant immunoglobulin decreases after three days of growth arrest (Kirchhoff et al 1996). Since IRF-1 is a DNA sequence specific transcriptional activator,
transcription from promoters containing IRF-1 binding sites is enhanced in IRF-1 proliferation controled cells. Both constitutive expression during unrestricted growth and during the controled growth phase are obtained by employing two separate expression
constructs, one with a constitutive promoter and a second one with an IRF-1 inducible promoter. Since growth control imposes a strong selection pressure, stability of the
regulatory control is essential. Long-term stability of this regulatory system has been obtained by tightly coupling expression of the IRF-1 fusion gene to a selection marker on a dicistronic construct.
Material and Methods DNA constructs Constructions were carried out by standard procedures (Sambrook et al., 1989). The IRF-1 fusion with the human estrogen receptor fragment has been described (Kirchhoff et al., 1993). An EcoRI-NheI restriction fragment from the plasmid pMC-2P carrying
an IRES element from Polio Virus and the pac gene as a selection marker has been inserted downstream of the IRF-1-hER gene to create a dicistronic expression cassette (Dirks et al., 1994). The dicistronic transcript is driven by the constitutive MPSV
promoter. Luciferase is constitutively expressed from the SV40 promoter or IRF-1 inducible expressed from a from a synthetic promoter that contains IRF-1 binding sites. Cell culture and gene transfer BHK-21 (ATCC CCL10) cells maintained in Dulbecco’s modified Eagle’s medium (DMEM) with 10% fetal calf serum were stably transfected by calcium phosphate coprecipitation method. 5 µg plasmid, 5 µg of high molecular weight DNA and 0,5 µg of selection plasmid pSV2pac (Vara et al., 1986) or pAG60 (Colbère-Garapin et al. 1980) per cells was used. Cells from a stable cell clone were transfected with the expression plasmid encoding the fusion protein IRF-1-hER and single cell clones were
isolated and expanded. Clones were cultured in the presence of 5 µ g/ml puromycin and 800 µ g/ml G418 (Gibco). Luciferase activity was measured using the Luclite kit
(Packard) and normalized against LDH activity. Other procedures were performed as described earlier (Kirchhoff et al., 1996).
211 Results 1. Establishment of stable proliferation control in BHK cells
No obvious phenotype on cell growth was found in cells constitutively expressing 1RF1 fusion protein in the absence of estrogen. Nevertheless, long-term cultivation of such cell clones leads to a loss of estrogen dependent growth regulation. Possibly subtle growth advantages of cells that have lost the 1RF-1 fusion gene expression lead to overgrowth by these non-expressing cells. To stabilize the growth regulatory system we coupled the expression of the IRF-1 fusion gene to the expression of a puromycin resistance marker gene on a dicistronic construct (Fig. 1). The regulation has been stable in all experiments and no reversion of the growth controled phenotype has been
observed. This selection pressure has been required during cloning and manipulation of cells, but could be relieved during actual production periods.
2. Recombinant gene expression in proliferation controled cells
Recombinant genes are commonly expressed from strong constitutive promoters. Cell growth and expression from the highly active MPSV promoter determined 3, 4 and 5 days after inducing growth restriction showed that productivity is not significantly
altered during this period but decreases from 40 % to 60 % during the fourth day and to about 20 % at the fifth day (Kirchhoff et al. 1996). The concentrations of estrogen used
do not significantly influence the productivity from these constructs whereas cell growth is further reduced at higher estrogen concentrations. To improve expression in growth controled cells we have made use of the fact that IRF-1 activates transcription of promoters with IRF-1 inducible elements (Kirchhoff et al., 1993, Tamura et al., 1995). Although basal expression is low, induced expression levels are in the same range as from strong viral promoters. That these promoters are inducible by estrogen in BHK-21 cells that express the IRF-1 fusion protein shows that
it functions at the same time to reduce the growth rate and activate transcription of IRF-1 dependent promoters. Both, constitutive expression and sustained expression during growth restriction is achieved when cells contain two different expression constructs, one driven by the constitutively active SV40 promoter and a second construct with an IRF-1 inducible promoter (Fig. 2).
212
Discussion
We demonstrate the feasability of IRF-1 mediated proliferation control by i) controling cell growth in the biotechnologically relevant BHK-21 cell line using an estrogen activatable IRF-1 fusion protein ii) stabilizing the growth regulatory system by coupling the expression of the IRF-1 fusion protein to the expression of a selectable marker gene on a dicistronic mRNA, and iii) expression of a recombinant protein could be sustained
during both unrestricted growth and the growth control phase by expression from two separate constructs that are driven by a constitutively active promoter and and IRF-1
inducible promoter, respectively. Carvalhal et al. (this volume) show that high viability in 1RF proliferation controled cultures can be maintained. The combination of genetic
manipulation with cultivation techniques moves this regulatory system from an academic interest oriented research project towards an applicable biotechnology project.
Acknowledgements We thank H. Conradt, L. Kongerslev, K. Scharfenberg, R. Wagner, D. Wirth and M. Wirth for suppport and discussions. The work was supported financially by an EC-grant BIO4-CT95-0291.
213 References Colbère-Garapin, F., Horodniceau, F., Khourilsky, P. and Garapin, A.C. (1981). A new dominant selective marker for higher eukaryotic cells J. Mol. Biol. 150, 1-13. Dirks, W., Schaper, F. Kirchhoff, S., Morelle, C, and Hauser, H.. (1994). A multifunctional vector family for gene expression in mammalian cells. Gene 149, 387-388 Hauser, H., (1997) in Mammalian cell biotechnology in protein production (Hauser, H. and Wagner, R., eds.). Walter de Gruiter, Berlin, 3-27. Kirchhoff. S., Schaper, F., and Hauser, H. (1993). Interferon regulatory factor 1 (IRF-1) mediates cell growth inhibition by transactivation of downstream target genes. Nucleic Acids Res. 21: 2881-2889. Kirchhoff. S., Koromilas, A., Schaper. F., Grashoff, M., Sonenberg, N. and Hauser, H. (1995). IRF-1 induced cell growth inhibition and interferon induction requires the activity of the protein kinase PKR., Oncogene 1 1 , 439-445 Kirchhoff. S., Kröger, A., Cruz. H., Tümmler, M., Schaper, F. and Hauser, H. (1996). Regulation of cell growth by IRF-1 in BHK-21 cells. Cytotechnology 22, 147-156. Sambrook, J., Frisch, E. F., and Maniatis, T. (1989). Molecular Cloning: A laboratory manual. Cold Spring Harbor Press (New York) Tamura, T., Ishihara, M., Lamphier, M S., Tanaka, N., Oishi, I , Aizawa, S., Matsuyama, T., Mak, T W., Taki, S. and Taniguchi, T. (1995). An IRF-1 dependent pathway of DNA-damage-induced apoptosis in mitogen-cativated T lymphocytes. Nature 376, 596-599. Vara J, Portela A, Ortin J and Jimenez A (1986). Expression in mammalian cells of a gene from Streptomyces alboniger conferring puromycin resistance. Nucleic Acids. Res. 14: 4617-4624.
214
Discussion
Massie:
When your cell cycle growth slows down and you look at viability, do you see any induction of apoptosis?
Müller:
We have tried to find signs but there is no indication that the cells died of apoptosis. The cells accumulate a lot of intracellular vesicles and grow larger. After prolonged exposure to estradiol they burst.
Massie:
Do you think that this is a side-effect of estradiol, or regulation of other genes by your transcription factors?
Müller:
I think that it is an effect of over-activation of IRF-1 because cells which lose expression of IRF-1 fusion protein do not show any effect to the action of estradiol.
Al-Rubeai:
Have you looked at these vesicles?
Müller:
We do not know what is in them.
Konstantinov:
I think that your system is flexible but complex. What is its advantage compared with a simple decrease of temperature in the fermenter?
Müiler:
Can tell me how decreasing the temperature can adjust the growth of stromophilia to the growth of haemopoetic stem cells? You need to control the growth specifically of one particular cell line. You cannot just change the overall conditions by taking away one
limiting medium component, or by changing the temperature.
Kostantinov:
Some groups have successfully shown modulation of BHK cell metabolism by adjusting the temperature.
Müller:
You can do that within a certain range.
CELL GROWTH INHIBITION BY THE IRF-1 SYSTEM A.V. CARVALHAL1 ; J.L. MOREIRA1; P. MÜLLER2, H. HAUSER2; M.J.T. CARRONDO1,3 1 - IBET/ITQB, Apartado 12, 2780 Oeiras, Portugal 2 - GBF, Mascheroder Weg 1, 38124 Braunschweig, Germany 3 - Lab. Eng. Bioq., FCT/UNL, 2825 Monte da Caparica, Portugal
1. Abstract A genetic approach, based on the growth regulatory protein interferon-regulated-factor-
1 (IRF-1), activated by the addition of estradiol, has been applied to regulate BHK cell growth. With the addition of 100 nM of estradiol 48 hours after inoculation, growth inhibition occurs within 24 hours but is followed by a significant decrease in cell viability, whereas rec-protein specific productivity is not significantly altered. Viability decrease is not due to estradiol effect and is independent upon the culture system. In order to define strategies to extend the stationary growth phase, several parameters have been studied: estradiol concentration, time post inoculation for estradiol addition and time span of estradiol exposure. When the time of contact between the cells and estradiol is reduced the cell viability increases, achieving similar values of the control, without the estradiol, and leading to a stationary growth phase extension.
2. Materials and Methods Cell line and medium: BHK clones were obtained from Dr H. Hauser (GBF, Braunschwig, Germany) and grown in DMEM supplemented with 10% (v/v) FBS, 4.5g/l of glucose, 5 mg/1 of puromycin and 5 mg/1 of vitamin Kl. Culture system: The cells were grown in T-flasks and inoculated with a seeding density of . Cell concentration and viability were measured by the trypan blue dye exclusion method. Estradiol was directly added to the culture medium using a 100 fold stock solution and, unless indicated, the final concentration was 100 nM. Estradiol removal from the culture medium (whenever indicated) was performed by replacing the total supernatant by fresh medium. 215 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 215-217. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
216
3. Results and Discussion 3.1. IRF-1 OVEREXPRESSION INDUCTION EFFECT ON: 3.1.1. Cell growth Estradiol addition to the culture medium 48
hours after inoculation leads to an effective growth inhibition (Figure 1A) but this is followed by a significant decrease in cell viability (Figure 1B) (up to 50% five days after estradiol addition). This decrease is faster than the normal pattern of a static batch culture, as can be seen by the control test, where no
estradiol was added. The results presented in Figure 1 are independent on the clone under test and the culture method (static or stirred cultures).
3.1.2. Rec-protein productivity Rec-protein productivity is not significantly affected by the estradiol addition (specific productivity of 130 ± 20 I.U.).
3.2. PARAMETERS AFFECTING CELL GROWTH INHIBITION In order to eliminate the cell viability decrease 48 hours after estradiol addition, the effect of several parameters on cell growth inhibition were evaluated.
3.2.1 Estradiol concentration There is a clear difference in cell growth pattern between 10 nM and 100 nM: cell growth inhibition is more efficient when 100 nM is used. However, in both cases a similar sharp decrease in cell viability is observed, similar to Figure 1B and independent upon estradiol concentration.
3.2.2. Time post inoculation for estradiol addition 100 nM estradiol was added at two different times, 48 or 96 hours after inoculation; at the end of the exponential phase (96 hours), a similar pattern to the control was observed (the cell viability pattern did not decrease differently from the control).
217
3.2.3. Time of contact between the cells and the estradiol In the previous reported experiments there is no estradiol removal after its addition. However, as presented in Figure 2B, cell viability increases when the time of contact between the cells and estradiol is reduced to 72 hours. The recovery of viability is due to the removal of estradiol and not to the exchange to fresh medium (data not shown). Similar results were obtained with the producer clone (data not shown).
If the media is changed again 3 days after estradiol removal by fresh estradiol-free medium, the cells
start to grow again (Figure 2A), clearly indicating that the cell growth inhibition process can be reversed.
4. Conclusions
• The induction of IRF-1 overexpression leads to a clear growth inhibition by the addition of estradiol (100 nM) at the beginning of the exponential growth phase, but is followed by: . decrease in cell viability (faster than in the control); . no significant change in rec-protein specific productivity.
• The significant decrease in cell viability can be avoided when the time of contact between the cells and estradiol is reduced.
• IRF-1 control proliferation system can be reversed by the removal of the estradiol from the medium. References Kirchhoff S , Schaper F; Hauser H (1993), Nuclei Acids Res 21:2881-2889. Kirchhoff S; Kroger A; Cruz H; Tümmler M; Schaper F; Köster M; Hauser H (1996), Cytotechnology 22:147156.
Acknowledgements The authors acknowledge and appreciate the financial support received from the European Commission (B1O4-CT95-0291) and from Junta Nacional de Investigação Cientifica-Portugal (BIC 1788). The authors are grateful to Ms. Maria do Rosário Clemente for technical support.
This page intentionally left blank.
CORRELATION BETWEEN BHK CELL SPECIFIC PRODUCTIVITY AND METABOLISM H. J. CRUZ1, J. L. MOREIRA1, E. M. DIAS1, C. M, PEIXOTO1, A. S. FERREIRA1 & M. J. T. CARRONDO1,2
1 - IBET/ITQB, Ap. 12, 2780 Oeiras, Portugal 2 - Lab. Eng. Bioq., FCT/UNL, 2825 Monte da Caparica, Portugal
1. Abstract
A rBHK21 clone producing an antibody/cytokine fusion protein was used to study the dependence of cell metabolism on the glucose and glutamine levels in the culture
medium. Results indicate that glucose and glutamine consumptions and lactate and ammonia productions show hyperbolic behaviors. The estimated values for were 1.39 ± 0.11 mM for lactate production as a function of glucose and 0.59 ± 0.17 and 0.15 ± 0.04 mM for ammonia production as a function of glutamine, at glucose concentrations of 0.05 and 1.0 respectively. At very low glucose concentrations the glucose to lactate yield decreased markedly, showing a metabolic shift towards lower glucose fermentation. At very low glutamine concentrations, the glutamine to ammonia yield increases, showing a more efficient glutamine metabolism. The cell specific productivity can be increased significantly by manipulating nutrient concentrations. 2. Introduction
The metabolism of transformed cells shows new properties like high glycolysis and glutaminolysis rates, glucose and glutamine being the main nutrients utilized by mammalian cells [1]. Mammalian cells grown in culture excrete lactic acid and
ammonia in quantities that may inhibit cell growth and thus decrease final product
liters. High glucose and glutamine concentrations lead to overflow metabolism while limiting concentrations provoke the use of more efficient energy pathways and reduce formation of inhibitory by products [2]. 3. Materials and Methods Cell lines and cell growth systems rBHK 21A cells were obtained from Dr. Hansjörg Hauser (GBF, Braunschweig, Germany). Cells were grown in DMEM with 5% PCS. Studies were performed in static flasks containing 10 ml of medium and as inoculum. Metabolite analysis Glucose- Sigma # G20, glutamine- Sigma # GLN-2, Lactate- Boehringer Mannheim # 139084, Ammonia- Boehringer Mannheim # 1112732. 219 O. - W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 219-221. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
220
4. Results and Discussion 4.1. GLUCOSE METABOLISM The results obtained from the glucose uptake as a function of glucose concentration show a hyperbolic behavior, with value of 1.64 ± 0.17 mM (similar to the reported 2 mM in chick embryo fibroblast cultivation [3]) and (the range of values obtained includes those found in the literature [4]: 12 nmol at 20 mM of glucose). For the lactate production a similar behavior to that found for glucose was obtained, with lactate production being very low under low glucose concentrations The values obtained for are higher than those found in the literature [4] but are consistent with the ones obtained in the glucose uptake assay. The glucose to lactate yield decreases dramatically at very low glucose levels. This clearly indicates a metabolic shift from a high lactate to a low lactate producing metabolism- more efficient pathways are involved. This shift is observed for glucose below 1.64 mM or which is comparable with results obtained for hybridomas [5]. 4.2. GLUTAM1NE METABOLISM The glutamine uptake has a hyperbolic behavior with and mM for glucose 0.05 and respectively. These values are lower than those found in the literature that range from 2 mM in normal rat kidney cells to 4.5 mM in extracts of Ehrlich ascite cells [6]. The values obtained for were for glucose and respectively. These values are comparable to those in the literature: 3.0 to 4.9 nmol cells at 3 mM glutamine [4] and 5.7 nmol cells for MDCK cells in medium with fructose instead of glucose [7]. The glutamine consumption being higher at the lower glucose concentration shows the interactive and complementary nature of both these main nutrients for animal cells. The ammonia production showed a similar behavior to that found for glutamine uptake, with and at glucose 0.05 and respectively. Reported results showed that ammonia production of MDCK cells can be reduced by maintaining the glutamine concentration at less than 1.0 mM [7]. The values obtained for were and at glucose 0.05 and 1.0 respectively. The glutamine to ammonia yield increases at very low glutamine, meaning that a more efficient glutamine metabolism is occurring [2]; although the yields are higher, the overall ammonia production will be lower at low glutamine concentrations.
221
4.3. PRODUCTIVITY
A significant variation (approximately 2 fold) in the cell specific productivity is observed with the glucose concentration. With glutamine the same behavior is observed at glucose but at glucose the trend is to increase productivity with decreasing glutamine. 5. Conclusions
Significant reductions in the glucose consumption were observed for low glucose concentrations; the same occurred with lactate production. Lactate showed a significant decrease in yield from glucose at very low glucose concentrations, showing that a shift towards a more efficient glucose metabolism occurred. Significant reductions in the glutamine consumption were observed for low glutamine
concentrations; the same occurred with ammonia production. Ammonia showed an increase in yield from glutamine at very low glutamine concentrations which shows higher efficiency in glutamine metabolism. Glutamine consumption and ammonia production increased significantly with the decrease in glucose concentration. The cell specific productivity can be significantly increased by manipulating nutrient concentrations. Acknowledgements The authors acknowledge the financial support received from the European Commission (B1OTECH PL933069) and Junta Nacional de Investigação Cientifica e Tecnológica- Portugal (PBICT/BIO/20333/95 and PRAXIS XXI/BD/2764/94) and thank Dr. Sadettin Ozturk for the revision and discussion of this work.
References 1. McKeehan WL (1982) Mini-review: glycolysis, glutaminolysis and cell proliferation. Cell Biol Int Rep 6: 635-649. 2. Ljunggren J & Häggström L (1994) Catabolic control of hybridoma cells by glucose and glutamine fed batch cultures, Biotechnol Bioeng 44: 808-818, 3. Fagon JB & Racker E (1978) Determinants of glycolytic rate in normal transformed chick embryo fibroblasts. Cancer Res 38: 749-758 4. Neermann J, Wagner R (1996) Comparative analysis of glucose and glutamine metabolism in transformed mammalian cell lines, insect and primary liver cells. J Cell Physiol 166: 152-169, 5. Zhou W, Rehm J & Hu WS (1995) High viable cell concentration fed-batch cultures of hybridoma cells through on-line nutrient feeding. Biotechnol Bioeng 46: 579-587. 6. Xie L & Wang DIC (1994) Fed-batch cultivation of animal cells using different medium design concepts and feeding strategies. Biotechnol Bioeng 43: 1175-1189. 7. Glacken MW, Fleischaker RJ & Sinskey AJ (1986) Reduction of waste product via nutrient control: Possible strategies for maximizing product and cell yields on serum in cultures of mammalian cells. Biotechnol Bioeng 28: 1376-1389.
This page intentionally left blank.
EFFECT OF GROWTH ARREST IN BHK METABOLISM: ON LINE MONITORING BY AND NMR SPECTROSCOPY
P.M. ALVES 1, A.V. CARVALHAL1, J.L. MOREIRA1, H. SANTOS1, M.J.T. CARRONDO1,2 1
Instituto de Biologia Experimental e Tecnológica/Instituto de Tecnologia Quimica e Biológica, Apt. 12,2780 Oeiras, Portugal. 2 Faculdade de Ciências e Tecnologia/Universidade Nova de Lisboa, 2825 Monte da Caparica, Portugal.
1. Introduction
Controlling proliferation of cell growth has been successfully applied recently [1]. Nevertheless, the physiological and metabolic behaviour of the cells after growth arrest is not well understood. Nuclear magnetic resonance (NMR) techniques are potentially very attractive to
explore cell metabolism due to their unique non-invasive characteristics. With a suitable perfusing system it is possible to monitor biochemical processes in real time under physiological conditions and various metabolic manipulations can be simulated. The low-sensitivity of the NMR method requires high cell densities in the detection zone; basement membrane gel (BMG) threads are a good strategy for cell immobilization because their matrix can support a high cell number and allow protection from shear damage [2]. The aims of this work were: on line monitoring of cells energetic status by NMR spectroscopy and on line monitoring of glucose uptake and lactate production by NMR spectroscopy, after estradiol addition to a BHK cell line growth regulated by the IRF-1 (interferon-regulated-factor-1) system. 2. Materials and Methods 2.1 Cell line and growth systems
BHK-21 cells genetically modified to depend on estradiol addition to regulate growth were obtained from Dr Hansjörg Hauser (GBF, Braunschweig, Germany). Cells were immobilized in BMG threads as described before [2]. An inocullum of cells was used for 1.5 ml of BMG. After immobilization, the threads were placed in 14 cm culture dishes containing 50 ml of Dulbecco’s modified Eagle’s medium (DMEM) with lg/1 glucose and supplemented with 10% fetal bovine serum (FBS). Cells were mantained for 2 days in a humidified atmosphere of 10% CO2/90% air at 37 °C. 2.2 On line NMR For NMR measurements the immobilized cells were transferred to a 10 mm tube fitted with a perfusion apparatus [2]. Cells were perfused at 1.5 ml/min with DMEM 223 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 223-225. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
224
containing
glucose (1 g/1) and estradiol (100 nM). The media was oxygenated with and mantained at 37 °C.During the experiment, the medium was changed or supplemented with glucose in order to avoid nutrient limitations and inhibition of cell metabolism by waste products. NMR spectra and NMR spectra were obtained using a 10 mm broad band probehead on a Brucker DMX500 NMR spectrometer. 3. Results and Discussion
3.1. Effect of Growth Inhibition on Cell Energetic Status Growth inhibition was successfully achieved after estradiol addition as no increase on NTP levels was observed during the following 100 hours (figure la).
During the first 24 hours after estradiol addition, NTP drops steadily. After that period a slight decrease was observed and NTP levels almost reach a plateau (figure 1b). This behaviour is consistent with the induction of growth arrest as an adaptation of cells energetic state to the new metabolic conditions is expected. As can be seen in the spectra (figure la), GPC/NTP, PC/NTP and PE/NTP ratios were affected with the time-course of the experiment, which indicates that phospholipid content of the cells is changing. The effect of estradiol on membrane fluidity is well reported [3] and further studies are necessary to confirm the integrity of cell membrane after long periods in contact with estradiol. 3.2. Effect of Growth Inhibition on Glucose and Lactate Metabolism
Using labelled substrates, as glucose, it is possible to monitor the distribution of the label within various metabolites during the time-course of an in vivo NMR experiment. As can be seen in the spectra (Figure 2), labelling from glucose was
225
incorporated mainly in lactate. Following time trajectories for labelling from glucose into lactate it is possible to compare glucose uptake and lactate production rates along time after estradiol addition.
For the first 12 hours, a higher rate for glucose consumption and lactate production was observed as compared to the following 80 hours and to the rates obtained before growth inhibition (data not shown). This can be due to the fact that cells are adapting their metabolism immediately after growth arrest. This is in agreement with the decrease in the NTP levels observed in the
spectra. An interesting result is that the glucose uptake rate slightly increases again after the re-feed done at time 60h, with no significant increase in lactate production rate. Further experiments have to been performed in order to evaluate the importance of this behaviour.
4. Conclusions and Perspectives
• BHK cells can be immobilized in gel threads (BMG) and perfused inside a NMR tube for long periods of time (up to 100 hours) without significant losses in cell viability. • Estradiol addition is efficient to induce growth arrest (NTP does not increase with time) and no significant changes in glucose metabolism were observed. Differences in phospholipid content of the cells were detected after growth inhibition. • Work using different labelling -glucose and other labelled precursors is in progress in order to evaluate metabolic fluxes in BHK before and after growth arrest. Further studies are necessary to elucidate the effect of estradiol on phospholipid metabolism. References:
1 Kirchhoff, S., Kröger, A., Cruz, H., Tümmler, M., Schaper, F., Köster, M. and Hauser, H. (1996) Regulation ofcell crowth by IRF-1 in BHK-21 cells, Cytotechnology 22,147-156.
2 Alves, P.M., Flögel, U., Brand, A., Leibfritz, D., Carrondo, M.J.T., Santos, H. and U. Sonnewald (1996) Immobilization of primary astrocytes and neurons for on-Line monitoring of biochemical processes by NMR, Dev. Neurosci. 18, 478-483. 3 Schwarz, S.M. (1988) Estrogen modulates ileal basolateral membrane lipid dynamics and Na+-K+ATPase activity. Am. J. Physiol. 254(5), G687-G694 Ackowledgments: The authors acknowledge the financial support received from European Comission BIO4-
CT95-0291, Fundação para a Ciência e Tecnologia PBICT/BIO/20333/95 and PRAXIS XXI/BD/2721/94.
This page intentionally left blank.
CELL SURVIVAL IN CHO CELL CULTURES GROWN IN A DEFINED PROTEIN FREE MEDIUM
ABSTRACT
Animal cells, primarily hybridomas, important for diagnostic and pharmaceutical production have been shown to die almost exclusively via apoptosis when entering the stationary phase. Recently similar reports have been presented for CHO (Chinese Hamster Ovary) cells grown in batch cultures under optimal conditions for high product yield 1. Experiments performed in small scale using a defined protein free medium, with the sole
addition of recombinant insulin, enabled us to investigate the importance of physiological parameters and their effect on cell survival. We show here that a CHO cell line engineered to produce a recombinant therapeutic protein is capable of inducing the apoptotic programme under batch culture conditions in a 2 L reactor, as
measured by the TUNEL assay (DNA end-labeling). Cells are arrested in the Gl phase of the cell cycle though insulin is present in excess and no apparent depletion of nutrients is at hand. Proliferation ceases and viability
decreases although the concentration of inhibiting metabolites is low. INTRODUCTION
Animal cells in culture are constantly exposed to environmental changes. There are several factors determining
the health status of the cells in a bioreactor: the availability of growth and survival factors, the availability of nutrients, the accumulation of both toxic and beneficial metabolites, variations in pH and DO levels and the physical shear forces encountered by the cells 2. If exposed to sudden toxic insult animal cells die by necrosis, morphologically characterised by swelling and the flocculation of nuclear chromatin, with subsequent cell lysis. Cells which experience mild environmental perturbations in culture conditions respond by undergoing an active, energy dependent programmed cell death called apoptosis. Apoptosis is characterised morphologically by cell shrinkage, condensation and fragmentation of the nucleus and biochemically by cleavage of DNA into nucleosomal fragments as a result of induction of transglutaminases, proteases and nucleases 3. A number of agents are reported to induce apoptosis in vivo and in vitro. Hormone and growth factor deprivation and loss of matrix attachment triggers apoptosis in different cell systems. Damage related inducers such as heat shock, viral infections, activation of oncogenes, or the tumour suppressor
as well as exposure of cells to nutrient
deprivation, free radicals and high concentrations of antimetabolites results in cell death4 .
METHODS
Batch growth studies were performed both in spinners and in a controlled 2 L stirred tank bioreactor (Belach bioteknink AB, Sweden). pH and dissolved oxygen (DO) were monitored and controlled at optimal levels. pH was controlled on line through additions of
on demand and oxygenation by bubble free
aeration using air and pure oxygen. The reactor culture was characterised in respect to consumption of nutrients (glucose and amino acids), the growth factor (insulin RIA) and formation of metabolites (lactate and ammonia).
Glucose and lactate was determined with a YSI 2700 analyser; amino acids with Waters PicoTag method and ammonia using an Orion electrode. Temperature was maintained at 37° C. Cells were grown in a proprietary defined serum free medium supplemented with 10 mg/L recombinant insulin, (nucellin-Zn, Eli Lilly Inc.).
227 O.-W. Merten et al. (eds.). New Developments and New Applications in Animal Cell Technology, 227-229. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
228 Cell count and viability were assesed using a particle counter (CASY, Schärfe system, Germany) and by Erythrosin B dye exclusion with a Bürker chamber. Cell cycle distribution analysis were performed using the method of Vindeløv. Apoptosis was measured by several independent methods: cells were harvested twice daily and fixed according to the protocol for the TUNEL reaction, (Boehringer Mannheim), and analysed with an Epics Elite flow cytometer. Different modified protocols for DNA fragmentation were employed according to ”Techniques in Apoptosis”, T. G Cotter and S. J. Martin, 1996. Additional experiments were performed in 100 ml stirred spinner cultures where the effect of decreased concentrations and consecutive supplementations of the growth factor were investigated, as well as different inoculum densities during batch growth.
RESULTS
The proliferation of CHO cells in batch culture stops after 100 h of culture at a cell density of approximately 2,5X106 cells/ml (Fig. 1). Practically all cells are viable throughout the growth phase. The cessation of growth is immediately followed by rapid cell death which obviously occurs almost exclusively by apoptosis as measured by TUNEL whereas no DNA fragmentation could be detected in the viability ranges examined. At this time (100 h) neither the level of glucose were limiting nor were the accumulated levels of lactate and ammonium inhibiting
(Fig. 2). The consumption and accumulation patterns of the amino acids show that only a few of them were used to any great extent (Fig. 3). The consumption of aspartate and asparagine was most significant and it seems likely that the cells are using these amino acids for their energy metabolism. Almost no uptake of the dipeptide
glycyl-glutamine (gly-gln) occured and the concentration in the medium did not change until the viability dropped. At this point both glutamine and glycine were accumulated in the culture medium which indicates an
extracellular cleavage of the dipeptide probably due to the release of proteases from the dying cells. The uptake of serine may also have contributed to the accumulation of glycine. Alanine was the sole additional amino acid which accumulated extracellularly. The concentrations of the remaining amino acids, (ser, glu, met, cys, val, leu, ile, pro, lys, arg, thr, his, tyr, phe and trp) were not affected significantly during the growth phase. Analysis of insulin concentrations in the medium showed that nucellin-Zn levels were high during almost the entire culture period and dropped to lower levels only during the last day, i.e. long time after cell death was initiated (Fig 1). Cell cycle distribution analysis from cells grown in spinner cultures (Fig. 4) revealed that the cells arrest in G1 phase of the cell cycle long before the viability is negatively affected and while the insulin still is plentiful. Insulin concentrations below 2,5 mg/L resulted in a reduced growth rate and decreased viability whereas total omission of the growth factor caused a rapid cell death. To investigate whether the insulin present was bioactive, additional nucellin-Zn (10 mg/L) was added intermittently to the spinner cultures at 4 time points after the commencement of the cultures. No improvement of the survival, nor any augmentation of the proliferation could be observed in this test indicating that a sufficient amount of nucellin-Zn is present (Fig. 5). Using different inoculum densities with the medium containing 10 mg/L nucellin-Zn, we could obtain an increasing amount of maximal total cell concentration, which would indicate an autocrine growth factor effect.
References 1
”Apoptosis in CHO cell cultures, examination by flow cytometry”, A Moore et al, Cytotechnology 17: 1-17, 1995.
2
”Cell death (apoptosis) in cell culture sytems”. T G. Colter and M Al-Rubcai. TIBTECH vol 3 pp 150-155, April 1995
3
”The genetic regulation of apoptosis”, A. H. Wyllie, Current Opinion in Genetics and Development, 5: 97-104, 1905.
4
”Apoptosis in the pathogcnesis and treatment of disease”, C. B. Thompson, Science vol 267, pp 1456-1462, March 1995.
229
This page intentionally left blank.
ENHANCED APOPTOSIS IN INSECT CELLS CULTIVATED IN SIMULATED MICROGRAVITY N. COWGER and K. O’CONNOR Tulane University, Chemical Engineering Department, and Molecular & Cellular Biology Program, New Orleans, LA 70118
Abstract
There is a shift from necrosis to apoptosis when batch cultures of Spodoptera frugiperda are grown in the low turbulence environment of NASA’s High-Aspect Rotating-Wall Vessel (HARV) versus a shaker flask. The NASA vessel was developed for the cultivation of animal cells in an environment which simulates microgravity on earth. Fluorescence microscopy with the DNA stains acridine orange and ethidium bromide showed 33% of S. frugiperda cells were apoptotic in the HARV when the viability was
50%, while cells grown in shaker flask had no more than 11% apoptotic cells at the same viability. We believe that the shift to apoptosis in the HARV is primarily the result of reduced hydrodynamic forces. Background
The HARV bioreactor used in our research was developed by NASA in 1990 for the cultivation of animal cells in an environment which simulates the effects of microgravity here on earth. As described in our earlier publications [1,2], the combination of endover-end mixing, bubble-free aeration and solid-body rotation greatly reduces the magnitude of hydrodynamic forces within the HARV relative to conventional bioreactors. Since its introduction, the HARV has mostly been applied as a tool for tissue engineering studies [1]. In addition, our laboratory chose to study the usefulness of the HARV for insect-cell suspension culture. Our work with insect cells was the first application of simulated microgravity to a non-mammalian and a freely suspended cell line. Insect cells were chosen primarily because their reported sensitivity to hydrodynamic forces made them amenable to the quiescent environment of the HARV. Our previous studies [2] have revealed profound differences in the growth profile and metabolism between S. frugiperda cells grown in the HARV compared to those in shaker flask. The shaker was selected as a control vessel since it is one of the most gentle forms of conventional cultivation. Our studies showed less nutrients consumed and less wastes produced in HARV insect-cell cultures. The metabolic differences are evidence for the use of alternate metabolic pathways in the HARV culture. In the quiescent HARV, the 231 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 231-233.
© 1998 Kluwer Academic Publishers. Printed in the Netherlands.
232
energy required for cell repairs may be redirected to other metabolic processes. Earlier studies [3] also showed changes in morphology and DNA fragmentation indicative of increased apoptosis in the HARV culture. It is only recently that apoptosis has been documented [4] during routine subculturing of S. frugiperda cells with no viral infection present. Methods The cultivation conditions for IE1FB2 cells, a subclone of Sf9 S. frugiperda, were as presented previously [3]. In the fluorescence microscopic protocol [5], cell samples were stained with acridine orange and ethidium bromide and viewed on an Olympus BX60 microscope with UPlanFl objective at 40x magnification.
Results and Discussion Figure 1A shows representative growth curves for S. frugiperda cells. Though maximum cell densities were virtually identical in the two vessels, stationary phase in the HARV was much extended and the death rate constant in the HARV was a factor of 20 to 90 times less than for the control culture [3]. The increased longevity of insect cells in the HARV is not an artifact from experimental conditions, such as feeding interval and cell density, and most likely results from the HARV’s combination of reduced shear and lower accumulation of waste.
Fluorescence microscopy was performed to quantify the subpopulations appearing in the two cultures during death phase. The protocol used relies on the differential uptake of the DNA-binding dyes acridine orange and ethidium bromide. Cells are classified as viable, early apoptotic, late apoptotic, or necrotic based on their staining characteristics and morphology. From Figures 1B and 1C, it can be seen that apoptosis is dominant for the HARV culture, while necrosis is the controlling mechanism for shaker cells. When the viability is 50%, up to 33% of total cells are apoptotic in the HARV. In comparison, cells grown in shaker flask had no more than 11% apoptotic cells at the same viability. Thus, necrotic cells at this stage represented approximately 17% of the population in the HARV and 40% in the shaker.
233
In a previous publication [6], we discussed some of the factors which may influence cell death. One pertinent example is that the intensity of a mechanical stress may affect the relative occurrence of apoptosis and necrosis, as shown in a study [7] where animal cells were subjected to different agitation rates in a stirred-tank bioreactor. In our studies, since there was less turbulence in the HARV than in the shaker flask, a higher percentage of apoptosis relative to necrosis may have been favored in the microgravity vessel. Other cultivation conditions have been shown to enhance apoptosis, for example, glutamine, serum, or glucose deprivation, and ammonia toxicity. These do not appear relevant to the HARV culture, particularly since it is characterized by reduced glucose utilization and reduced ammonia accumulation relative to the control culture.
Conclusion
Knowledge of death mechanisms in insect-cell cultures could potentially impact commercial processes by offering a means of control over the culture to improve productivity. During long-term cultivation of Spodoptera frugiperda insect cells in simulated microgravity, there is an apparent shift to apoptosis relative to a shaker control. Our work with HARV cultivation has further shown significant effects on the metabolism, morphology, and growth profiles of insect cells. We believe, first, that these phenomena were primarily the result of reduced hydrodynamic forces in the HARV, and second, that these results would not have been readily achieved with conventional means. Acknowledgments This work was funded by a grant from NASA (NAG 9-826). We are also grateful to Dr. Carol Burdsal and Dr. Kyriakos Popadopoulos for the use of their microscopes. References
1.
2. 3. 4
Clejan. S., O’Connor, K.C., Cowger, N.L., Cheles. M.K.. Haque, S., and Primavera, A. (1996) Effects of
simulated microgravity on DU 145 human prostate carcinoma cells. Biotechnol. Bioeng 50. 587-597 Francis, K.M., O’Connor. K.C., and Spaulding, G.F. (1997) Cultivation of fall armyworm ovary cells in simulated microgravity. In Vitro Cell Dev. Biol. 33, 332-336. Cowger, N.I., O’Connor. K.C., and Bivins. J.E. (1997) Influence of simulated microgravity on the longevity of insect-cell culture. Enzyme Microb. Technol. 20, 326-332. Palli, S.R., Sohi. S.S., Cook, B.J., Primavera. M., and Retnakaran. A. (1997) Screening of 12 continuous cell lines for apoptosis, in K. Maramorosch and J. Mitsuhashi (eds.), Invertebrate Cell Culture: Novel Directions and Biotechnology Applications, Science Publishers, Inc., Enfield, New Hampshire, pp. 5360.
5.
Duke. R.C. and Cohen. J.J. (1992) Quantitation of apoptotic index and cell viability using fluorescent dyes, in J.E. Coligan, A.M. Kruisbeek, D.H. Margulies. E.M. Shevach, and W. Strober (eds.), Current
Protocols in Immunology, Greene Publishing Associates and Wiley-lnterscience, New York. pp. 3.17.13.17.3. 6.
7.
Cowger, N.L. and O’Connor. K.C. (1997) Application of simulated microgravity to insect-cell culture, in K. Maramorosch and J. Mitsuhashi (eds.), Invertebrate Cell Culture: Novel Directions and Biotechnology Applications, Science Publishers, Inc., Enfield, New Hampshire, pp. 131-138. Al-Rubeai, M., Singh. R.P., Goldman. M.H., and Emery, A.N. (1995) Death mechanisms of animal cells in conditions of intensive agitation. Biotechnol Bioeng. 45, 463-472.
This page intentionally left blank.
MODULATION OF APOPTOSIS BY BCL-2 EXPRESSION FOLLOWING AMINO ACID DEPRIVATION AND IN HIGH CELL DENSITY PERFUSION CULTURES
R. P. Singh*, D. Fassnacht**, A. Perani*, N. H. Simpson*, C. Goldenzon*, R. Pörtner** and M. Al-Rubeai* * School of Chemical Engineering, University of Birmingham, Edgbaston, Birmingham, B15 2TT, U.K. and **Technical University of HamburgHarburg, Bioprozess und Bioverfahrenstechnik, Dnickestr. 15, D-21071, Hamburg, Germany. Key words: Apoptosis, Hybridoma, Bcl-2, Amino Acids, Perfusion Culture 1. Introduction
A number of studies have now demonstrated that cell death during commercial cell cultures proceeds by the active, genetically determined mechanism called apoptosis, rather than the passive accidental form of cell death known as necrosis (Al-Rubeai et al., 1990; Franek and Dolnekova, 1991; Mercille and Massie, 1994; Singh et al., 1994; Perreault et al., 1994). Suppression of apoptosis significantly improves the robustness of the cells, thus raising culture productivity. However, there are still major gaps in our knowledge in terms of the role of specific components of the culture environment in terms of the induction and suppression of apoptosis. Studies conducted thus far have demonstrated that the deprivation of glutamine, threonine and cysteine results in the induction of high levels of apoptosis (Mercille and Massie, 1994; Perreault and Lemieux, 1994; Singh et al., 1994). However, it is not clear whether this is a feature specific to these particular nutrients, or an effect which is seen following the deprivation of any of the amino acids found in culture medium. In order to answer this question, we have identified the mechanism of cell death following deprivation, individually, of all amino acids. We then went on to investigate the effect of over-expression of the anti-apoptosis gene bcl-2 under these conditions. Finally, the impact of bcl-2 overexpression on antibody productivity in the extremely stressful environment of high cell density perfusion culture systems was studied.
2. Materials and Methods 2.1 CELL LINES AND CELL MAINTENANCE
The cell lines used in this study were TB/C3.bcl-2 and TB/C3.pEF derived from the murine hybridoma TB/C3 which was transfected with the expression vector pEF bcl-2235 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 235-241. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
236
MC1neopA and the control vector pEF-MC1neopA respectively (see Simpson et al., 1997). Cells were maintained at 37°C in RPMI 1640 medium (Gibco, UK.) supplemented with 5% (v/v) Foetal Calf Serum (FCS) (Sigma, UK.). Bcl-2 expression levels were monitored by immunostaining of the Bcl-2 protein followed by flow cytometric analysis as previously described ( Simpson et al., 1997). The medium used for the fixed bed culture was a 1:1 mixture of Iscove's MDM and Ham's F12 supplemented with 2 mmol 1 -1 L-glutamine, 2 g 1-1 NaHCO3, 0.01% PEG and 50 mmol 1 -1 ethanolamine supplemented with 1% (v/w) of a protein-free iron-rich supplement (IR) containing 20 mmol 1-1 ferric citrate. 2.2 AMINO ACID DEPRIVATION: EXPERIMENTAL PROCEDURE
48 Hours Deprivation. Cells taken from the mid exponential phase of batch cultures were centrifuged for 5 minutes at 1000 rpm. They were washed once in phosphate buffered saline (PBS) and then resuspended in the Select-Amine basal medium with 5% dialysed FCS containing all amino acids except the one under investigation at a target viable cell number of 2xl0 5 /ml in a 15 ml volume. The cells were then dispensed in 5 ml aliquots into 3x5 ml plastic wells on 12 well plates, giving triplicate cultures for each experiment. The Plates were incubated for 48 hours at 37°C in a humidified 5% CO2/air incubator. Prior to analysis, the cells were trypsinized using a trypsin EDTA solution (Sigma UK), centrifuged at 1000 rpm and resuspended in the original 5 ml of culture medium (to ensure that any floating dead or viable cells in the original culture medium were included in the analysis). Levels of apoptosis, necrosis and viability were assessed by fluorescence microscopy as previously described in Simpson et al., 1997. Time Course Study Following Deprivation of Individual Essential Amino Acids. Cells
were prepared as described above at a target cell number of 2xl0 5 /ml in 90 ml of selectamine medium (containing all amino acids except for the one under study). The cells were dispensed in 5 ml aliquots into 18x5 ml wells. At regular intervals, 2 wells were “sacrificed” and cells removed by trypsinization and assessed for viable cell number, viability and levels of apoptosis and necrosis as described above. This allowed for the analysis of the cultures at 9 time points during the course of the culture. 2.3 PERFUSION CULTURES
Fixed-bed Reactor. The fixed bed reactor (Meredos, Germany) used in this study consists of a 100 ml fixed-bed in which the cells are immobilised on porous carriers and a 1 litre conditioning vessel. During operation, the medium was constantly pumped from the conditioning vessel through the fixed-bed and back. Bubble aeration took place in the conditioning vessel to supply the cells with oxygen. The maximum superficial flow velocity in the fixed-bed was kept below 1.1 mm s-1 in order to prevent cells from being washed out of the fixed-bed. The pH was measured and controlled
237
automatically by adding CO2 to the air. The medium in the conditioning vessel was agitated using magnetic stirrer and the temperature maintained at 37°C.
Porous glass bead carrier with a diameter of 3 to 5 mm (Siran, Schott, Germany) were used. The fixed bed was inoculated with 1xl06 cells (ml fixed-bed)-1 which corresponds to a cell density of 1xl05 cells (ml suspension)-1. Monoclonal antibody titre was measured by an IgG ELISA as described in Simpson et al., 1997. Hollow Fibre System (Tecnomouse). Hollow fibre studies were carried out using a Tecnomouse bioreactor (Integra Biosciences, UK) with two OxyCell hollow fibre
cassettes, one for each cell line. Temperature was controlled at 37°C and the cultures were aerated with 5%CO2/air. Medium was recirculated through the cassette at a flow
rate of l00ml/hr from a 2 L reservoir bottle. Samples were harvested from the extracapillary space at weekly intervals and assayed for levels of mouse IgG using a sandwich enzyme-linked immunosorbent test as described previously (Simpson et al., 1997). Glucose levels were determined using a Reflolux II® system (Boeringher, Germany) The medium bottle was replaced at regular intervals such that the glucose concentration remained above 3 mM. 3. Results and Discussion 3.1 INDUCTION OF APOPTOSIS BY AMINO ACID DEPRIVATION: INFLUENCE
OF BCL-2 EXPRESSION
The percentage of viable, necrotic and apoptotic cells in the control cell line cultures was determined following 48 hours of deprivation of each amino acid. The majority of cell deaths in each case occurred by apoptosis. However, there were clearly two distinct groups of amino acids. Deprivation of essential amino acids exhibited the greatest loss of viability, with over 70% of all cells being apoptotic. Deprivation of the non-essential amino acids had the least effect on viability , although apoptosis still accounted for most of the dead cells.
The effect of bcl-2 expression on the viability of the culture was also assessed. For most amino acids, the viability of the bcl-2 cultures was greater than 70 % after 48 hours, representing a substantial improvement in viability over control cultures. Time course studies were then conducted to examine the death profile following deprivation of each essential amino acid. As illustrated by the 3 examples given in Figure 1, the cultures could be divided into two phases: an initial high viability phase, followed by a rapid death phase. Both of these phases were significantly extended during the bcl-2 cultures. However, the specific level of protection offered varied from one amino acid to the next, which is clearly illustrated by comparing threonine to
238
239
isoleucine. In the former, the viability fell constantly between 40 and 80 hours, whereas in the latter, there was a significantly lower fall in viability. Development of fed batch culture processes is an iterative process which relies on feeding of exhausted nutrients and is therefore dependent on intensive monitoring of nutrient levels. However, in many cases the exhaustion of a particular amino acid willresult in the induction of apoptosis before feeding has commenced. The use of bcl-2 transfected cell lines should prevent this from happening, thus considerably speeding up the process of feeding strategy development by removing the need to constantly having to re-initiate the culture from the beginning.
3.2 INFLUENCE OF BCL-2 ON ANTIBODY PRODUCTIVITY IN HIGH CELL DENSITY PERFUSION CULTURES
The high cell numbers achieved in perfusion culture systems normally lead to an exacerbation of nutrient and oxygen limitations. Therefore, it is expected that bcl-2 transfected cells would have a significant survival advantage in the relatively stressful
240
environment encountered in such systems. In order to investigate this possibility, growth of bcl-2 transfected and control cell lines was studied in fixed bed and hollow fibre perfusion systems. Direct estimation of viability is impossible, although a flourometric technique was applied to the estimation of the free DNA concentration in the culture medium from the fixed bed reactor. This revealed a higher concentration of free DNA in the control cell line culture, indicating a significant level of cell death when compared to the control cell line. The difference in the antibody productivity of the two cell lines in each culture system is shown in Figures 2 and 3. In both systems, the antibody titre in cultures using the bcl-2 transfected cell line was approximately 100% higher than that of the control cell line cultures. This increase must reflect the reduction,, in the bcl-2 transfected cultures, of the amount of perfused medium required to generate replacement cellular biomass. 4. References Al-Rubeai, M., Mills, D., Emery, A. N. (1990) Electron Microscopy of hybridoma cells with special regard to monoclonal antibody production. Cytotechnology. 4:13-28.
Franek, F. and Dolnikova, J. (1991) Nucleosomes occurring in protein-free hybridoma cell cultures. Evidence for programmed cell death. FEBS Letters 248:285-287. Mercille, S. and Massie, B. (1994a). Induction of apoptosis in nutrient-limited cultures of hybridoma cells. Biotechnology and Bioengineering: 44, 1140-1154. Perreault, J. and Lemieux, R. (1994). Essential role of optimal protein-synthesis in preventing the apoptotic death of cultured b-cell hybridomas. Cytotechnology. 13, 99-105. Simpson, N., Milner, A. N. and Al-Rubeai, M. (1997) Prevention of hybridoma cell death by bcl-2 during suboptimal culture conditions. Biotechnology and Bioengineering 54, 1-16. Singh, R. P., Al-Rubeai, M., Gregory, C. D., and Emery, A. N. (1994). Cell death in bioreactors: a role for apoptosis. Biotechnology and Bioengineering 44, 720-726.
5. Acknowledgements
This work is supported by the EC Framework IV Programme
241
Discussion
Massie:
What is the stability of the clones expressing bcl-2, not only in terms of the expression of the genes but also the phenotype following passaging?
Singh:
We have passaged the cells for 6 months and found very high levels of stability in bcl-2 expression, even in the absence of geneticin. The same is true for antibody productivity.
Massie:
I assume that there is no selection pressure in the perfusion system?
Singh:
No.
Massie:
A question concerning the relative amounts of apoptotic cells in batch culture in the bcl-2 transfectant: do you still see cells dying by apoptosis in a typical batch culture?
Singh:
Yes, we do see the classical apoptosis morphology but at a lower level. This may reflect the rate of apoptotic death and progression of cells into a secondary necrotic state, so it becomes more difficult to clearly identify them morphologically as apoptotic.
Massie:
Do you think that there is a relationship between the level of bcl-2 and protection? Can you saturate the dominant effect of protection which bcl-2 confers on hybridoma cells?
Singh:
I think that you probably can but we have not reached that point with these cells. Clearly, in the amino acid deprivation experiments, the cells are still dying of apoptosis.
Ryll:
You found that cells over-expressing bcl-2 have reduced amino acid uptake rates. Is that something one would expect? Did you do this with just on clone that you selected, or is it a population? If it was a clone, you could have selected for reduced amino acid uptake by chance.
Singh:
There are mixed populations, not clones, for that precise reason. The cells are under starvation conditions, so one would expect the
cells to adapt by down-regulating metabolic activities. This is evidenced by the utilisation rates.
This page intentionally left blank.
EFFECT OF BCL-2 EXPRESSION ON HYBRIDOMA CELL GROWTH DURING STRESSFUL CONDITIONS D. FASSNACHT1, S. ROSSING1, F. M. AL-RUBEAI3, R. PORTNER1 1 Technische Universitat Hamburg-Harburg, und Bioverfahrenstechnik, D-21071 Hamburg, Germany 2 Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, CZ-14220 Praha 4, Czech Republic 3 Centre for Biochemical Engineering, School of Chemical Engineering, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK
1. Abstract Two transfected hybridoma cell lines TB/C3-bcl2, (overexpressing the Bcl-2 protein) and TB/C3-pEF (control cell line), were compared to assess the potential of Bcl-2 in preventing apoptosis. The conditions examined were batch cultures, growth in diluted media, and long-term fermentations in a high cell density fixed-bed reactor. The membrane intact index (percentage of cells with intact membranes determined by trypan blue staining) of the TB/C3-bcl2 cell line decreased much slower than that of the control cell line during the dying phase of the batch cultures. No significant difference in the consumption (glucose, glutamine) and production rates (lactate, ammonia, antibodies) was notable in the exponential phase of the experiments. When comparing the cell lines in diluted media the advantage of the Bcl-2 overexpressing cell line was again a higher membrane intact index at increasing dilution steps. Comparing both cell lines in a fixed-bed reactor at various dilution rates revealed a significant difference in antibody production. TB/C3-bcl2 produced twice as many antibodies as the control cell line for all steady-states. But no difference in the consumption (glucose, glutamine) and production (lactate, ammonia) rates was observable. 2. Cell Line and Culture Conditions Both mouse hybridoma cell lines produce an IgG antibody against an antigenic determinant in the hapten domain in the Fc region of human IgG. These cell lines were transfected with the Bcl-2 (pEF bcl2-MClneopA) and control (pEF-MClneopA) plasmids by Simson et al. (1997). 243 O.-W. Merten et al. (eds.). New Developments and New Applications in Animal Cell Technology, 243-245. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
244
For growth, a 1:1 mixture of Iscove’s MDM and Ham’s F12 supplemented with L-glutamine, 0.01% PEG and ethanolamine was used as basal medium. This basal medium was either supplemented with 1% (v/w) of a protein-free iron-rich supplement (IR) containing ferric citrate and Dolníková, 1991) or 3% (v/w) horse serum (HS). The total amount of glutamine in both media was and for glucose. For the batch experiments, cultivation took place in stationary flasks. The flasks were inoculated with exponentially growing cells at an initial cell density of Growth curves were obtained by removing a doublet of flasks each day for counting and analyses. A fixed-bed reactor (meredos, Germany) was used for continuous fermentation. The reactor consists of a 100 ml fixed-bed in which the cells are immobilised on porous carriers and a 1 litre conditioning vessel. The carrier used was Siran (Schott, Germany) which proved especially suitable for hybridoma cells (Pörtner et al., 1997). pH was measured and controlled automatically by adding CO2 to the air. The medium of the conditioning vessel was heated to 37 °C by an electrical heater. No separate heating was required for the fixed-bed because it was integrated in the conditioning vessel. This also assured a convenient handling of the whole system.
3. Results 3.1. BATCH EXPERIMENTS The main aspect of comparing the two cell lines in batch cultures was to verify the effect of Bcl-2 during ideal growth conditions (exponential phase) as well as in sub-optimal conditions (death phase). These experiments were performed with two different medium supplements: 3% HS and 1% IR to clarify if the medium supplement has an effect on the behaviour of the cell lines. The two cell lines grew in both media to the same maximal cell density of approx. (Fig. 1). In the HS medium, Bcl-2 seemed to prolong the exponential phase and to delay the dying of the cells for 48 hours compared to the TB/C3-pEF cell line. The growth of both cell lines in the IR medium did not only show the delay of the death phase but also a significant reduction in the specific death rate for the TB/C3-bcl2 cell line. Fifty percent of the TB/C3-bcl2 cells in
245
the IR medium still had intact membranes after 9 days of cultivation whereas no viability was detected in all other experiments after this time. There was no significant difference in glucose and glutamine consumption as well as lactate and ammonia production for the exponential phases of the experiments. This was also true for the antibody titre, which reached a concentration of approx. 50 mg l-1 in all experiments. 3.2. GROWTH IN DILUTED MEDIA These experiments were carried out in diluted media in order to compare the two cell lines under nutrient limitation. Both hybridoma cell lines reached a viable cell density of 6.105 to 7.105 cells ml-1 in the undiluted IR medium after 72 hours. The membrane intact index was close to 90%. The reduction of the content of nutrients, achieved by medium dilution, resulted both in a lower relative viable cell density and in a lower membrane intact index. The TB/C3-bcl2 cell line displayed higher resistance to the starvation stress. At the verge of starvation-induced death, i.e. in 40% to 50% medium, the membrane intact index clearly documented the superiority of the TB/C3-bcl2 cell line. Here the membrane intact index was approx. 15% higher than that of the control line. 3.3 FIXED-BED REACTOR Both cell lines were also compared in the fixed-bed bioreactor at various dilution rates. Comparing the results of the cell lines revealed a significant difference in antibody
production. TB/C3-bcl2 produced twice as many antibodies as the control cell line for all steady-states. But no difference in the consumption (glucose, glutamine) and production (lactate, ammonia) rates was observable. For details of the results, please refer to R. P. Singh et. al ‘Manipulation of apoptosis by Bcl-2: Enhancement in survivability after amino acid deprivation and in intensive culture systems’. 4. Conclusions
The overexpression of Bcl-2 did not have an influence on the metabolism of cells growing under ideal conditions (exponential phase of batch cultures). But the Bcl-2 overexpressing cell line survived much better when induced to stressful conditions such as the late exponential phase in batch experiments, growth in saline diluted media or during continuous fermentations in fixed-bed reactors at low dilution rates. References F., and Dolníková, J, 1991. Hybridoma growth and monoclonal antibody production in iron-rich protein-free medium: Effect of nutrient concentration. Cytotechnology 7: 33-38 Pörtner, R., Rössing, S., Koop, M., Lüdemann, I. 1997. Kinetic studies on hybridoma cells immobilized in fixed bed reactors. Biotechnology and Bioengineering 55: 535-541 Simpson, N. H., Milner, A. E., Al-Rubeai, M. 1997. Prevention of hybridoma cell death by Bcl-2 during sub-optimal culture conditions. Biotechnology and Bioengineering 54: 1-16
This page intentionally left blank.
INHIBITION OF c-jun EXPRESSION IN F-MEL CELLS CAUSES CELL CYCLE ARREST AND PREVENTION OF APOPTOSIS
YON HUI KIM 1 , TAKEHIKO IIDA 1 , EDWARD V. PROCHOWNIK 2 , EIJI SUZUKI 1
1. Department of Chemistry and Biotechnology, Graduate School of Engineering, The University of Tokyo, Bunkyo-ku, Tokyo 113, Japan
2. Division of Pediatric Hematology/Oncology, Children's Hospital of Pittsburgh, Pittsburg, PA 15213-2583, USA ABSTRACT
We are able to provide an evidence that will support the suppression of cell proliferation to withdrawal from the cell cycle and suppression of onset apoptosis with conditional expression of c-jun antisense transcript in F-MEL cells. F-MEL cells were transfected with c-jun antisense gene located downstream of a glucocorticoid-inducible MMTV promoter, and named as c-jun AS cells. By treating the c-jun AS cells with dexamethasone (DEX) in DMEM supplemented with 10% serum, the growth could be suppressed for duration of 16 days with high cell viability of 92%. When DEX-treated c-jun AS cells were serum deprived, the cell viability remained at high of 86% for upto 10 days, the onset of apoptosis was suppressed, and the internucleosomal cleavage of DNA was not detected upto 8 days. In contrast, when wild type F-MEL cells were serum deprived, the cell viability is low (50%.) and the onset of apoptosis is induced within 2 days, and internucleosomal cleavage of DNA was detectable.
1. INTRODUCTION Biologically active proteins such as cytokines, vaccines, and antibodies are produced by mammalian cell culture. The protein production of such cultures usually increases with increase in cell integration, the viable cell number integrated with respect to culture time. Viable cells in the late logarithmic growth phase and the following non-growth viable phase are major contributors to cell integration. Cells often produce protein at a rate higher in the non-growth viable phase than in the logarithmic growth phase (Suzuki and Ollis, 1990). However, cells tend to die quickly after reaching the maximum cell density due to adverse conditions caused by over-growth. Hence the viable non-growth culture period may be as short as only two to three days (Duval et al., 1990; Vomastek and Franek, 1993). Therefore, preventing cell death which starts in the late logarithmic growth phase (Vomastek and Franek, 1993) and maintaining them viable in batch culture for longer time
period should increase protein production of the culture. The cells die due to depletion of nutrients such as amino acids (Franek and Chladkova-Sramkova, 1995) and glucose (Marcille and Massie, 1994; Singh et al., 1994), limitation of growth factors such as serum components(Singh et al., 1994), or accumulation of toxic metabolites (Glacken et al., 1988; Tohyama et al., 1990). The over-growth inevitably leads to some of these cell death inducing conditions. Cell death may follow two distinct patterns: necrosis and apoptosis. Apoptotic cell death follows a well-defined sequence of events characterized by cell shrinkage, nuclear 247 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 247-254. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
248
condensation, and fragmentation of the cell into discrete membrane enclosed bodies. In the early apoptotic death process, an endogenous endonuclease is activated and cleaves DNA within the internucleosomal spacer regions. Hence, a characteristic ladder pattern consisting of multiplies of 180 bp fragments is seen when the DNA from apoptotic cells is electrophoresed on an agarose gel. Reportedly, the cell death in the late logarithmic growth and stationary phases of batch culture is mostly apoptosis (Mercille and Massie, 1994). Proto-oncogene c-jun known as the immediate early response' gene is rapidly induced in response to mitogenic stimuli, and it plays a critical regulatory role in the commitment of the cell to proliferate (Ryseck et al., 1988, Smith and Prochownik, 1992). A nuclear phosphoprotein c-Jun is a major component of the AP-1 trans-acting transcriptional activator complex that promotes transcription of various genes required for progression of the cell cycle (Turner and Tjlan, 1989). The selective inhibition of c-jun expression caused exit from the cell cycle, in other words, it blocked cell growth (Smith and Prochownik, 1992; Soprano et al., 1992). The possibility of c-Jun being the inducer for natural cell death, apoptosis, was reported (Colotta et al., 1992; Estus et al., 1994; Rampalli and Zelenka, 1995; Anderson et al., 1995). Interleukin (IL)-6- and lL-2-dependent mouse cell lines underwent programmed cell death alter the growth factor deprivation; in this death process, c-jun gene was rapidly induced; and the antisense oligonucleotides directed against c-jun reduced this c-jun induction, while improving survival of the cells after the growth factor deprivation (Colotta et al., 1992). The antisense oligonucleotides for c-jun prevented HL-60 cells from apoptosis induced by ceramide (Sawai et al., 1995). Using this understanding that the c-jun gene plays an important role in the progression of the cell cycle and induction of apoptosis or programmed cell death. The objective of the present work is to establish a cell line in which growth can be switched on and off without induction of apoptosis. And we were successful in creating a cell line c-jun AS that can be induced by glucocorticoid hormone to block cell proliferation and at the same time suppress apoptosis even under growth factor deprivation. This growth and apoptosis controllable cell line can be utilized to keep high viability in batch, fed-batch, or perfusion culture. The cell line will be also suitable to culture for which use of any serum components is prohibited. 2. MATERIALS AND METHODS Cell Line and Cell Culture Conditions Friend murine erythrolcukemia (F-MEL) cells were supplied by Riken Cell Bank. FMEL cells and all the cells derived from F-MEL cells in the present work were cultured in Dulbecco's modified Eagle's medium (DMEM) (Nissui, Tokyo), supplemented with 10% fetal bovine serum (v/v) (JRH, Biosciences), 4 mM glutamine, 100 mg/ml kanamycin, 0.2% NaHCO3 (complete medium), unless otherwise specified. The cells were maintained in the logarithmic phase of growth in 25-cm2 plastic T-culture flasks (Sumitomo Bakelite. Tokyo) at 37°C in a 5% CO2-95% air humidified incubator. For the induction of the transfected sense or antisense c-jun transcripts, cells were cultured in the complete or serum deprived medium supplemented with dexamethasone (Sigma) at a concentration of 1x10 -6 M. Viable cell count was performed by the trypan blue dye exclusion method employing a hemocytometer.
249
Transfection, S e l e c t i o n , and Gene A m p l i f i c a t i o n pMS-G c-jun AS dhfr vector contains an antisense fragment of c-jun gene downstream of a glucocorticoid-inducible murine mammary tumor virus (MMTV) promoter and a dhfr (dihydrofolate rcductase) gene. The antisense c-jun gene is the inversely inserted sequence that consists of 287 bp of 48 bp of coding sequence derived from the extreme end of the coding region, and 929 bp of c-jun cDNA. pMS-G c-jun dhfr vector contains a complete sense c-jun cDNA instead of the antisense cjun gene (Smith and Prochownik, 1992). For transfections, 2 x 1 0 6 F-MEL cells were pelleted at 500 g for 10 min, washed twice in phosphate-buffered saline (PBS), and resuspended in 200 ml of PBS. 20 mg of BamHI-linearized pMS-G c-jun AS dhfr DNA or pMS-G c-jun dhfr DNA plus 2 mg of NdeI-linearized pSV2neo plasmid DNA in a total volume of 50 ml of sterile water were added to the cell suspension. Transfection was accomplished by electroporation with a homemade apparatus at settings of 650 voltage with 10 pulses at resultant time of 250 msec. The cells were grown for 24 h in the complete medium, and then G-418 was added to a final concentration of 0.4 mg/ml. G-418 resistant clones were detected within 4 to 8 days. Pooled G-418 resistant clones were then cultured in the complete medium containing methotrexate (MTX) at a final concentration of 50 nM for amplifying the sense or antisense c-jun gene together with the dhfr gene for several months. For cloning the cell , the dilution plating techniques were applied using 96-weIl plates. Detection of c-Jun Protein by Western B l o t t i n g
To assess the effect of c-jun antisense transcript induction on c-jun protein levels, the c-jun AS cells were cultured in the complete medium containing 10 -6 M dexamethasone for 48 h. The 5x10 5 cells were harvested, pelleted at 2500 g for 10 min, washed twice in phosphate-buffered saline (PBS) and resuspended in lysis buffer (1% Triton x-100, 0.15 mM NaCl, 10 mM Tris, pH 7.8) at 4°C for 30 min. The cell lysates were boiled in sodium dodecyl sulfate (SDS) sample buffer for 5 min, and electrophoresed on a 10% SDSpolyacrylamide gel, and then electroblotted onto nitrocellulose filter overnight. The blotted nitrocellulose filter was blocked with 0.5% skim milk in TBST for 3 h at room temperature. At size of 39-kDa, c-jun protein was detected by rabbit polyclonal antibodies to c-jun /AP-1 protein (Medac, Diagnostika) to which peroxidase-conjugated goat antirabbit Ig polyclonal antibody (Bio Source International, Inc. Tago Products) bound. The cJun-specific band was then visualized by use of the ECL Western blotting system (Amersham, Life Science). F-MEL cells and the c-jun AS cells were cultured free from DEX, and treated in the same manner for Western blotting. DNA Fragmentation Assay by Electrophoresis 1x106 cells were pelleted and lysed by vortexing vigorously in 0.5 ml of TE buffer (10
mM Tris-HCl, pH 7.4 and 1 mM EDTA) containing 0.2% Triton X-100, and centrifuged for 10 min at 13,000g at 4°C. DNA was extracted after addition of 0.1 ml of 5 M NaCl and 0.7 ml of isopropanol. The supernatant was vortexed, placed at -20°C overnight, and then centrifuged for 10 min at 13,000 g at 4 °C. The DNA pellet was dissolved in TE buffer and treated with RNase prior to electrophoresis on a 2% agarose gel. To visualize the fragmented DNA bands, the gel was stained with 1 mg of ethidium bromide per ml.
250
3. RESULTS and DISCUSSION Blocking Cell-Growth by Antisense c-Jun Expression F-MEL cells were transfected with the linearized pMS-G c-jun AS dhfr vector carrying the antisense c-jun gene as described in Materials and Methods. The vector contains a glucocorticoid-inducible MMTV promoter and dhfr gene. The dhfr gene was applied for amplifying the vector by culturing cells with methotrexate (MTX), an inhibitor of dihydrofolate reductase. MMTV promoter was used for turning on or off the transcription of the antisense gene depending on the presence or absence of a synthetic glucocorticoid, dexamethasone (DEX). The transfected cells were selected with G418, and then cultured in MTX for amplifying the antisense gene (generally 50 to 200 copies/cell) (Prochownik and Kubowska,1986). The obtained cell line was named c-jun AS. First we assessed the effect of c-jun antisense transcript induction on c-jun protein levels. We exposed the c-jun AS cells to 10-6 M DEX for 48 h. The cells were harvested and subjected to SDS-polyacrylamide gel electrophoresis and electroblotted onto nitrocellulose. Control lysates were prepared from the wild type F-MEL cells. Rabbit polyclonal antibodies to c-Jun and AP-1 proteins was used to detect c-Jun. Next we examined whether we can block the growth of the c-jun AS cells and maintain the cells in
viable state. The c-jun AS cells in logarithmic growth phase in the complete medium were collected and resuspended in 10 ml of the fresh complete medium at day 0 in each of 25 cm 2 T-flasks. For inducing the antisense c-jun to block the cell growth, DEX was added to the medium at 10-6 M on day 0. The viable cell density and viability are shown in Fig. 1-a and -b, respectively. For comparison, we cultured in the same manner the wild type F-MEL cells and those transfected with the complete sense c-jun gene. The growth of the c-jun AS cells was almost blocked two days after DEX addition. After that the viable cell density was kept almost unchanged for 14 days. A viability greater than 86% was maintained for 16 days. In the absence of DEX, the c-jun AS cells grew to the over-growth condition and then started dying. The wild type F-MEL cells also grew to over-growth , and then started dying either in the presence or absence of DEX. Jointly these results indicated that the c-jun AS cell line was a desired cell line, that is, a viably growtharrestable cell line. Suppressing Apoptosis by Antisense c-Jun Expression
At least two groups reported that antisense oligonucleotides directed for c-jun gene suppressed apoptosis (Colotta et al., 1992; Sawai et al., 1995). This suggested that the cjun AS cell line is possibly free from apoptosis when cultured in the presence of DEX. Use of oligonucleotides is limited to research purpose, because they are expensive and not stable in culture. Contrarily, the antisense c-jun transcripts in the c-jun AS cells can be induced with relatively inexpensive DEX when necessary. Therefore, we examined the
apoptosis resistance of the c-jun AS cells by applying serum-deprivation, one of typical apoptosis inducing conditions. The logarithmically growing c-jun AS cells in the complete medium were collected, and washed three time in PBS. Then the cells were placed in the serum-deprived medium, and cultured in the presence or absence of DEX. The wild type FMEL cells were also subjected to the same procedure. The viable cell density and viability are shown in Fig.2-a and -b, respectively. Under serum-deprivation, the viability of the
251
wild type F-MEL cells decreased to 50% in 3 days, while that of the c - j u n AS cells was maintained above 80% for 8 days. In the absence of DEX, the c-jun AS cells, of which c-jun expression was partially
suppressed by the antisense c-jun expression due to the leakiness of MMTV promoter, survived and grew well under serum-deprivation (Fig.2-a and -b). This meant that we could unexpectedly establish a F-MEL cell line that can grow without any serum component. We interpreted this result as c-jun expression in the c-jun AS cells cultured in the absence of DEX was high enough to drive cell cycling and too low to induce apoptosis. We examined emergence of the ladder pattern, a land mark of apoptotic cells, on electrophoreses of DNA extracted from the cells of the above experiments. The c-jun AS cells cultured with DEX under serum-deprivation were collected on day 4, 6, 8, 10, and 12.
DNA samples extracted from the cells were treated as described in Materials and Methods for detecting DNA fragmentation. The wild type F-MEL cells cultured under the serumdeprivation were similarly examined. The clear DNA ladder was detected for the wild type F-MEL cells on day 4, but not for the c-jun AS cells treated with DEX (Fig.3). Jointly with the result of Western blotting for detection of c-jun protein, this result indicated that suppression of c-jun expression inhibits apoptosis. A cell line c-jun AS that can be reversibly and viably growth-arrested was established by transfecting F-MEL cells with inducible antisense c-jun gene. The cell line is resistant to apoptosis induced by scrum-deprivation , or by cell cycle arrest. The c-jun AS cells can grow even under serum-deprivation when cultured free from dexamethasone, while the wild type F-MEL cells die quick. Jointly with several other reports on the relation between apoptosis and c-jun expression, our result strongly suggested that c-jun expression is required for onset of at least some types of apoptosis. References Anderson, A. J., Pike, C. J. and Cotman, C. W. 1995. Differential induction of immediate early
gene proteins in cultured neurons by b-amyloid (Ab): association of c-Jun with Ab - induced apoptosis. J. Neurochem. 65: 1487-1498. Colotta, F., Polentarutti, N., Sironi, M. and Mantovani, A. 1992. Expression and involvement of c-fos and c-jun protooncogenes in programmed cell death induced by growth factor deprivation in lymphoid cell lines. J. Biol. Chem. 267: I8278-18283. Duval, D., Demangel, C., Geahel, I., Blondeau, K. and Marcadcd, A. 1990. Comparison of various methods for monitoring hybridoma cell proliferation. J. Immunol. Meth.
134: 177-185. Estus, S., Zaks, W. J., Freeman, R. S., Gruda, M., Bravo, R., and Johnson, E. M. Jr. 1994.
Altered gene expression in neurons during programmed cell death: identification of c-jun as necessary for neuronal apoptosis. J. Cell Biol. 127: 1717-1727. Franek, F, and Chladkova-Sramkova, K. (1995) Apoptosis and nutrition: Involvement of amino acid transport system in repression of hybridoma cell death. Cytotechnology 18: 113-117.
Glacken, M. W., Adema, E, and Sinskey, A. J. 1988. Mathematical descriptions of hybridoma culture kinetics: I. initial metabolic rates. Biotechnol. Bioeng. 32:491-506. Mercille, S. and Massie, B. 1994. Induction of apoptosis in nutrient-deprived cultures of
hybridoma and myeloma ells. Biotechnol. Bioeng. 44: 1140-1154. Rampalli, A. M. and Zelenka, P. S. 1995. Insulin regulates expression of c-fos and c-jun and
suppresses apoptosis of lens epithelial cells. Cell Growth Differ. 6: 945-953. Ryseck. R. P., Hirai, S. I., Yaniv, M. and Bravo, R. 1988. Transcriptional activation of c-jun
during the G0/G1 transition in mouse fibroblasts. Nature 334: 535-537. Sawai, H., Okazaki, T'., Yamamoto, H., Okano, H., Takeda, Y., Tashima, M., Sawada, H.,
Okuma, M., Ishikura, H., Umehara, H., and Domae, N. 1995. Requirement of AP-l for ceramide-induced apoptosis in human leukemia HL-60 cells. J. Biol. Chem. 270: 27326-
27331.
252 Singh, R. P., Al-Rubeai, M., Gregory, C. D., and Emery, A. N. 1994. Cell death in bioreactors: a role for apoptosis. Biotechnol. Bioeng. 44 : 720-726. S m i t h , M. J. and Prochownik, E. V. 1992. I n h i b i t i o n of c-jun causes reversible p r o l i f e r a t i v e
arrest and withdrawal from the cell cycle. Blood 79: 2107-2115. Soprano, K. J., Cosenza, S. C., Yumet, G., and Soprano, D. R. 1992. Use of antisense oligomers to study the role of c-jun in G1 progression. Ann. N. Y. Acad. Sci. 6 6 0 : 231 -239. Suzuki, E. and Ollis, D. F. 1990. Enhanced antibody production at slowed growth rates: experimental demonstration and a simple structured model. Biotechnol. Prog. 6 : 231 -236. Tohyama, N., Karasuyama, H. and Tada, T. 1990. Growth autonomy and t u m o r i g e n i c i t y of i n t e r l e u k i n - 6 - d e p e n d e n t B cells transfected w i t h i n t e r l e u k i n - 6 cDNA. J. Exp. Med. 1 7 1 : 389400.
Turner. R. and Tjlan, R. 1989. Lcucine repeats and an adjacent DNA b i n d i n g domain mediate the formation of f u n c t i o n a l cFos-cJun heterodimers. Science 2 4 3 : 1689-1694
Vomastek, T. and Franek, F. 1993. Kinetics of development of spontaneous apoptosis in B cell hybridoma cultures. Immunol. Lett. 35 : 19-24.
253
254
Discussion Handa-Corrigan:
Dexamethasone is a gluco-corticoid and most clinicians look at this molecule as giving cells the ‘kiss of life’. The change in the biochemistry of the cell is quite acute as the cell will start producing glucose, rather than utilising it, and revert to using amino acids and fatty acids instead of glucose. So when we add dexamethasone to cells we find that there is a slowing of the growth rate and they live slightly longer. In your study, what happened to the parent cell line in the presence of dexamethasone?
Kim:
The F-MEL cells were not affected at all by dexamethasone in any respect.
Hauser:
Can you use the system with cells that have endogenous dexamethasone receptors? This would be a problem for changing to other cells. You would probably have to change to another inducible system. Also, have you tried to get a stable expression of your growth anti-sense regulator, and can your cells sustain stability with this type of regulator?
Kim:
It is a problem in that sometimes dexamethasone does induce apoptosis in some cell lines. So there is a limit to this model. A year ago I did have a stability problem but, as I selected more and more, I now have very strong expression even without dexamethasone. So I believe that it is very strong, once selected.
Hatzfeld:
Did you try adding for short cultures oligonucleotide anti-sense?
Kim:
No, I have not tried oligonucleotides.
HIPPOCAMPAL CELLS
IN
CULTURE AS A MODEL TO
STUDY
NEURONAL APOPTOSIS
I. FIGIEL, J. JAWORSKI and L. KACZMAREK Nencki Institute of Experimental Biology Pasteura 3, Warsaw 02-093, Poland
1. Abstract
Glutamate toxicity (excitotoxicity) has been well documented and proposed to play a role in a broad spectrum of neurological diseases. There is a growing interest in defining glutamate-mediated neurotoxic mechanisms, but the high degree of complexity of the intact nervous system hampers a detailed analysis. Thus, cell cultures may provide a useful alternative. We have applied a culture of hippocampal granule cells of postnatal rats to study glutamate-evoked toxicity. These cells are known to be particularly resistant to excitotoxic insult in the brain in situ. However, we have found that granule neurons grown in culture die when they are exposed to high concentrations of glutamate. Moreover, the dying cells display morphological and biochemical features characteristic of apoptosis, a mode of cell death typical of physiological neuronal elimination during development. To further investigate molecular correlates of this phenomenon we have developed an improved calcium phoshate coprecipitation procedure to transiently introduce DNA into cultured neurons. Using this technique we have been able to investigate direct involvement of particular transcription factors in the regulation of glutamate excitotoxicity. The results of our study may be helpful to understand the molecular mechanisms of neuronal apoptosis.
2. Introduction
Glutamate is the major excitatory neurotransmitter, that, in addition to interneuronal communication, can also be neurotoxic. In the past several years there have been many studies on isolated neuronal populations treated with glutamate, which have lead to the hypothesis that toxicity is caused by an influx of calcium through receptor-controlled ion channels, which in turn triggers a cascade of events leading to neuronal cell death (Choi and Rothman, 1990; Randall and Thayer, 1992). However, details of the complex process are still uknown. Recently it has been suggested that excitotoxicity may have an apoptotic character, i.e., may belong to programmed cell death phenomena (for review see: Dragunow and Preston, 1995). 255
O.-W. Merten et al. (eds.). New Developments and New Applications in Animal Cell Technology, 255-258. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
256
Since apoptosis is supposed to be an active process, it is believed that it should involve gene expression. Regulation of gene expression is brought about by transcription factors. Activation of glutamate receptors causes an increase in expression of AP-1 (activator protein-1) transcription factor (Morgan and Curran, 1991; Kaczmarek 1994; Kaminska et al., 1994). Major components of AP-1 are Fos (cFos, Fos B, Fra-1, Fra-2) and Jun (c-Jun, Jun B, Jun D) proteins. Possible role of AP-1, and more specifically c-Fos and c-Jun proteins, in active cell death has been initially supported by results of experiments carried out on non-neuronal cells (Colotta et aI., 1992). In the studies on the central nervous system, Smeyne et al. (1993) using c-foslacZ transgenic mice expressing β-galactosidase under control of c-fos regulatory element, observed that c-Fos expression is associated with apoptotic cell death following kainate injection. Dragunow et al. (1993), on the other hand, reported a prolonged increased in c-Jun immunoreactivity in a model of status epilepticus coupled to neurodegeneration. Recently, Estus et al. (1994) and Ham et al. (1995) have demonstrated that c-Jun is induced in sympathetic neurons undergoing programmed cell death after NGF withdrawal, and moreover, blocking of AP-1 activity with either microinjection of specific antibodies or introduction into the cells of dominant negative mutant of c-Jun prevented neuronal death, whereas overexpression of c-Jun promoted the neuronal death. Hence, it is expected that identification of genes as well as their regulatory mechanisms involved in control of apoptosis should be of great value for both understanding the process and development of therapeutic strategies. 3. Experimental approach and results
In our studies we have employed cultures of hippocampal dentate gyrus, a brain area known to be rather resistant to excitotoxic insult. Dentate granule neurons were
obtained from 5-day-old rat pups and cultured as previously described (Figiel and Kaczmarek, 1997). Cells grown for 6 days in vitro were exposed to glutamate. Unexpectedly, in our culture conditions, we have observed an extensive neuronal loss after treating the cultures with 0.5 mM glutamate. Generally, we noted somal rounding, thining and fragmentation of dendrites. In some cases cell body became enlarged, the nucleus vacuolated, and eventually the cell body detached from the substrate. We have used the specific DNA stain, Hoechst 33258, in order to assess changes of nuclear structure following exposure to glutamate. Several features indicative of apoptosis, such as the condensation of the nuclear chromatin and fragmentation of the nucleus, were observed (Fig. 1) These apoptotic-like morphological changes were acompanied by DNA fragmentation, as revealed by the method of TdT-mediated dUTP-digoxigenin 3’ end labeling (TUNEL) (Gavrieli et al., 1992).
We have also employed immunocytochemistry to investigate expression of c-Fos and c-Jun, two AP-1 transcription factor components, in the control and glutamatetreated cells. We found that following glutamate treatment the level of c-Fos protein was significantly increased in comparison to control (untreated) cultures. However the pattern of this immunoreactivity was almost identical, regadless of the concentration of
glutamate. Moreover, there was much higher number of neurons expressing c-Fos, than the number of dying cells identified with an aid of the aforementioned approaches. On the contrary, c-Jun expression was found only in dying cells.
257
To test the hypothesis that c-Jun contributes to the induction of neuronal apoptosis, we employed calcium phosphate transfection developed by M.E. Greenberg (Xia et al., 1995) with modifications. PS65T-C1 plasmid (Clontech, GenBank accession #U36202) encoding red shifed variant of GFP under control of CMV promoter was used for optimalization of transfection. Preliminary results are shown in Fig.2.
4. Conclusions
In conclusion, we have demonstrated that excitotoxicity produced by glutamate in cultured hippocampal dentate neurons induces cell death by an apoptotic mechanism. Results of our studies based on transient expression of c-jun dominant negative mutant may show the correlation between cell death and c-Jun induction.
5. References Choi, D. and Rothman, S.M. (1990) The role of glutamate neurotoxicity in hypoxic-ischaemic neuronal death Annu. Rev. Neurosci. 13, 171-182. Colotta, F., Polentarutti, N., Sironi, M., and Mantovani, A. (1992) Expression and involvement of c-fos and c-jun protooncogenes in programmed cell death induced by growth factor deprivation in lymphoid cell lines, J. Biol. Chem. 267, 18278-18283. Dragunow, M. and Preston, K. (1995) The role of inducible transcription factors in apoptotic nerve cell death, Brain Res. Rev. 21, 1-28. Dragunow, M., Young, D., Hughes, D., Mac Gibbon, G., Lawlor, P., Singleton, K., Sirimanne, E., Beilharz, E., and Gluckan, P. (1993) Is c-Jun involved in nerve cell death following status epilepticus and
258 hypoxic-ischaemia brain injury? Mol. Brain Res. 18, 347-352. Figiel, I. and Kaczmarek, L. (1997) Cellular and molecular correlates of glutamate-evoked neuronal programmed cell death in the in vitro cultures of rat hippocampal dentate gyrus, Neurochem. Int. 31, 229-240. Gavrieli, Y., Sherman, Y., and Ben-Sasson, S.A. (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation, J. CellBiol. 119, 493-501. Ham, J., Babij, C., Whitfield, J., Pfarr, C.M., Lallemand, D., Yaniv, M., and Rubin, L.L. (1995) A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death, Neuron 14, 927-939. Kaczmarek, L. (1994) Glutamate-evoked gene expression in brain cells - Focus on transcription factors,
Amino Acids 7, 245-254.
Kaminska, B., Filipkowski, R.K., Zurkowska, G., Lason, W., Przewlocki, R., and Kaczmarek, L. (1994) Dynamic changes in composition of the AP-1 transcription factor DNA dinding activity in rat brain following kainate induced seizures and cell death, Eur. J. Neurosci. 6, 1558-1566. Morgan, J.I. and Curran, T. (1991) Stimulus-transcription coupling in the nervous system: involvement of the inducible protooncogenes fos and jun, Annu. Rev., Neurosci. 14, 421-451. Randall, R.D. and Thayer, S.A. (1992) Glutamate-induced calcium transient triggers delayed calcium overload and neurotoxicity in rat hippocampal neurons, J. Neurosci. 12, 1882-1895. Smeyne, R.S., Vendrell, M., Hayward, M., Baker, S.J., Miao, G.G., Schilling, K., Robertson, L.M., Curran, T., and Morgan, J.I. (1993) Continuous c-fos expression precedes programmed cell death in vivo, Nature 363, 13-23. Xia, Z., Dickens, M., Raingeaud, J., Davis, R.J., and Greenberg, M.E. (1995) Opposing effects of ERK and JNKp38 MAP kinases on apoptosis, Science 270, 1326-1331.
DEVELOPMENT OF CARBOXY SNARF-1-AM AND ANNEXIN V ASSAYS FOR THE DETERMINATION OF APOPTOSIS IN HETEROGENEOUS CULTURES
A. Ishaque & M. Al-Rubeai Centre for Bioprocess Engineering, School of Chemical Engineering, University ofBirmingham, Edgbaston, Birmingham, U.K.
1. Abstract Accurate identification and quantitation of apoptosis is essential for developing efficient strategies for optimisation of culture survivability and productivity. Flow cytometry in conjunction with several fluoroprobes is increasingly used to identify apoptotic cells. We have examined the possibility of using carboxy SNARF-1-AM, a pH sensitive fluoroprobe and FITClabelled annexin V, a probe specific to phosphatidylserine exposed on the outer surface of apoptotic cells. Intracellular acidification was shown to precede the occurrence of apoptosis thereby proving to be an early indicator of cellular deterioration and cell death. Annexin V in combination with propidium iodide enabled identification of viable, transient apoptotic and necrotic cells in heterogeneous cultures. Metabolic activity (pHi), and cell death population dynamics (viable/ apoptotic/ necrotic fraction) were therefore effectively and reliably determined using flow cytometry. key words: flow cytometry, apoptosis, pHi and annexin-V.
2. Introduction
The presence of dead cells significantly limits the productivity of hybridoma cells in culture. Cell death via apoptosis represents the predominant mode of cell death in culture prosesses, especially in the batch culture of hybridoma cells (Singh et al., 1996). Therefore, monitoring the development of early apoptotic cell state will significantly facilitate the control and optimisation of bioreaction processes. Flow cytometry is the best method for detecting and analyzing apoptosis in heterogeneous culture, revealing information on the state of cells in a near on-line mode and time scale (Al-Rubeai et al., 1991). In the present study Annexin-V (AV) (a naturally occurring phospholipid which has a high affinity for phosphatidylserine exposed on the surface of early membrane intact apoptotic cells) conjugated to FITC was used in a simple flow cytometric assay for the identification of apoptosis.
FITC-AV in combination with the DNA binding dye
propidium iodide (PI) entered plasma membrane damaged cells to identify necrotic cells. Cell death population dynamics (viable/apoptotic/necrotic cells) were therefore assessed in batch culture of hybridoma cells using the AV-assay. Intracellular acidification may represent a signal for the integration of a number primary signals
to enhance the development of apoptotic cell death. This hypothesis was tested by determining the intracellular pH of hybridoma cells, using a pH sensitive fluoroprobe carboxy-SNARF-1-AM, undergoing apoptotsis either spontaneously in batch culture or by induction after exposure to campothecin. 259 O. - W. Merten et al (eds.), New Developments and New Applications in Animal Cell Technology, 259-261. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
260 3. Materials and methods
Transfected control hybridoma cell line (Pef), and hybridoma cells transfected with the antiapoptotic protein bcl-2 were cultured at 37 °C in RPMI 1640 basal medium supplemented with 5% (v/v) foetal calf serum. Cultures were maintained in 50 ml or 250 ml Duran-bottles stirred by magnetic followers.
Pef and bcl-2 cells undergoing spontaneous apoptosis in batch culture were double stained with FITC-AV and PI. Cells were washed in PBS (1%) and then resuspended in binding buffer (10 mM Hepes/NaOH, pH 7.4, 150 mM KCl, ImM MgCl 2 and 1.8 mM CaCl2). FITC-AV was added to give a final concentration of 2.5 The mixture was incubated in the dark at room temperature for 10 mins. PI (1mg/ml) was added 5 mins before flow cytometric analysis.
Pef and bcl-2 hybridoma cells induced to undergo apoptosis by campotheicn treatment or from the death phase of batch culture were loaded with carboxy-SNARF-1-AM (1 mM in DMSO), to give a final concentration of 10 in a HEPES-buffered medium. Cells were incubated for 30 min at 37 °C and then analysed by a Coulter Epic Elite flow cytometer, with excitation at 488 nm to produce an acidic emission signal at 575 nm and a basic emission signal at 635 nm. The ratio of basic and acidic forms gave an indication of the pHi. All cells were correspondingly assessed for cell viability by fluorescent microscopy using a mixture of acridine orange and PI. 4. Results
4.1. FITC-AV staining of hybridoma cells in batch culture AV/PI staining of control (Pef) hybridoma cells allowed the transition from viable to necrosis via apoptosis to be followed in batch culture (fig.l). At 72 hrs the viable population [AV(-ve)/PI(-
ve)] moved into an early apoptotic compartment [AV(+)/PI(-)]. The emergence of early apoptotic cells coincided with fluorescent microscopy results. At 84 hrs of culture the entire apoptotic population migrated to a necrotic cell gate [AV(+)/PI(+)]. Bcl-2 transfected cells migrated
directly from [AV(-ve)/PI(-ve)] to [AV(+)/PI(+)] compartments during batch culture, therefore by-passing apoptotic cell death demonstrated by phosphatidylserine externalization on cells with intact plasma membranes. 4.2. Carboxy-SNARF-1-AM staining of hybridoma cells exposed to campothecin Exposure of hybridoma cells to the DNA topisomerase I inhibitor campothecin (CAM) led to the
appearance a subpopulation of cells with a lower fluorescent ratio than the untreated cells. The apoptotic population had a reduced forward scatter which was due to cellular shrinkage. In the CAM treated cells a population with lower ratio (acidic and apoptotic ) appeared 3 hrs before the maximum proportion of apoptotic cells could be detected by fluorescent microscopy.
261
4.3. Carboxy-SNARF-1-AM staining of hybridoma cells in batch culture Carboxy-SNARF-1-AM staining of Pef hybridoma cells growing, in batch culture showed an increase in pHi during exponential growth (48 hrs), probably due to an increase in the percentage of S-phase cells. Decrease in pHi at the decline phase was, however, a manifestation of both an increase in G1-cells and apoptosis. The reduction in pHi occurred prior to the identification of
apoptosis by fluorescent microscopy. In hybridoma cells over expressing bcl-2 in batch culture there was an initial slight increase followed by a continuous but slow decline in pHi with time which coincided with an accumulation of cells in G1-phase of the cell cycle 5. Conclusion
Acidification and phosphatidylserine externalization demonstrate early events in apoptotic cell death. Intracellular acidification is linked to cell growth inhibition and to apoptosis. Monitoring acidification and phosphatidylserine externalization by flow cytometry provide earlier identifications of apoptosis compared to other techniques and therefore can be used to control bioreaction processes.
6. Acknowledgments This work is funded by the E.C. Framework IV Programme 7. References 1. Al-Rubeai M., Emery A.N. & Chalder S. Flow cytometric study of cultured mammalian cells. J.Biotechnol. 1991, 19:67. 2. Singh R.P., Al-Rubeai M , Emery A.N. Apoptosis: Exploiting novel pathways to the improvement of cell culture processes Genetic Engineer and Biotechnologist 1996, 16:227-251.
This page intentionally left blank.
SESSION ON INTEGRATED BIOPROCESSING IN ANIMAL CELL TECHNOLOGY
This area still represents the main line of activity of many of the ESACT members and thus it provides the organisers with a large choice, so that, as in the earlier meeting in Vilamoura, it was considered that no invited speaker was required. Indeed, as in the past, the meeting organising committee had a very difficult task in choosing only ten oral presentations out of the sixty two submitted abstracts. In order to decrease the unfairness of the process and to balance out the oral and poster sessions, there was an attempt to balance presentations along three topics of research and development: 1- Physical environment, cells and products - at the cross roads between the physical environment which is becoming more controllable and the cell physiology, yielding more reliable production: 2- Monitoring and control - even though sensors (on line and off line) have not
yet delivered as much as is expected of them, the relevance of this area for quality assurance and economic production is becoming more firmly established; 3- Integrated processes and scale-up - an area which plenty of congress organisers want to present but which is only slowly yielding results for public discussion, as companies and teams become more assured of what they are doing and risk presenting.
From the overall presented papers, a few can be briefly described to give the flavour of the session.
Konstantin Konstantinov (Bayer, Berkeley, CA, USA) presented a production process model for high-density perfusion cultures showing that dynamic, profit based optimisation of feeding is essential for the efficient manufacturing of therapeutic proteins; it is only to be expected that other protein manufacturers will add depth to this trend setting process of economically pushing animal cell technology. The use of the single round infective Semliki Forest Virus which targets a broad range of host cells for the transient expression of proteins at high level was described by Horst Blasey (GlaxoWellcome, Geneva, Switzerland) for the production of 15mg of the 5HT3 receptor protein in an 11.5 litre batch reactor. Stephanos Grammatikos (Karl Thomae, Biberach, FRG) provided industrial credibility for the use of intracellular ribonucleotide pools to indicate the metabolic status of the cell. Monitoring of nucleotide ratios such as UTP to UDP-N-acetylhexosamine in very large scale (up to 10000 1) can be used to predict the behaviour of a culture up to two days before any hint of physiological changes is given by traditional cell number/cell viability estimations - optimisation and economic modelling are envisaged. At the other extreme, Nicolas Kalogerakis (NYSU, Buffalo, NY, USA) described a dielectrophoresis-based cell separation/filter being worked out on a very small scale using microfabrication tools which is under test for separating viable 263 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 263-264. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
264
from non viable cells in perfusion systems, and speculated on the inherent capability of this filter for the preferential removal of apoptotic bodies from bioreactor effluent streams. Pedro Cruz (IBET, Oeiras, Portugal) described the importance of optimising the conditions in the bioreactor in order to obtain high quality virus like particles from baculovirus infected insect cells. The use of sonoperfusion to keep single mammalian cells inside continuously stirred tank reactors was described (A. Miller, Mons, Belgium). The effect of bioreactor parameters on less commonly described receptor production (CD 13 in HL60 cells) was presented by T. Papoutsakis (U.S.A.). Given the increasing relevance of fed batch production, feeding and monitoring strategies have been presented for the more common industrial cell types (CHOs, insect cells). Control of proteolytic activities during fermentation were described for both mammalian and insect cells. Indeed, the winner of the poster prize (courtesy of Promega) was Ernesto Chico for work performed at GBF with insect cells; for these cell types, L.
Häggström (Royal Inst. Technol., Stockholm, Sweden) used osmotic shock to increase growth rate and final cell density. Amongst the various control strategies described, a couple of imaginative imaging processes were presented by groups in Stuttgart and Berkeley, whereas the group of R. Kemp (U. Wales, UK) presented a viable cell monitor based on a dielectric spectroscope and proposed on line heat flux measurement for animal cell culture modelling in what might be an upscaleable fed batch system.
The recurrent utilisation of internal settlers in continuous culture was elegantly presented by the group of A. Marc (Nancy, France) for the production of properly glycosylated gamma interferon. Different groups evaluated fluidized bed systems for production of therapeutic proteins (M. Biselli, Jülich, Germany; J. Shiloach, NIH, MD, USA; H. Katinger, Vienna, Austria) while the advantages of temperature control namely to temperature lower than 37° C, were presented by G. Kretzmer (Hannover, Germany) and the Californian teams at Bayer and Genentech.
Different options for the purification of proteins were presented, ranging from the expanded bed adsorption (again from Genentech, J.T. Beck) as well as the direct protein sequestration concepts put forward by A. Lydiatt (Birmingham, UK); even though regulatory issues might hinder the use of such concepts they deserve more work to prove
their feasibility. Integrated approaches and the influence of the chromatographic steps used upon structure and activity of proteins were also covered (S. Fletcher, Sidney, Australia; H. Vogel, GBF, Germany) whereas displacement chromatography was tested for DNA preparation (R. Freitag, ETH Lausanne, Switzerland).
Appropriately for systems meant for production of proteins, different processes of virus clearance and validation and other safety issues (General safety issues) were also covered in what was a very holistic and expert dominated session. M. Carrondo Chairperson
PHYSICAL ENVIRONMENT
CELLS AND PRODUCTS
This page intentionally left blank.
DIAUXIC CELL BEHAVIOR ENABLES DETOXIFICATION OF CHO CELL CULTURE MEDIUM DURING FED BATCH CULTIVATION
Holger Lübben and Gerlinde Kretzmer, Institut für Technische Chemie, 30167 Hannover,Germany
Introduction
In fed batch cultures usually the feeding of the main substrates as glucose and glutamine leads to an increase in cell count and product concentration, but very often a dramatic decrease in cell viability due to the enormous toxification of the cell culture broth with lactate and ammonia at high cell density is observed. Especially the excretion of large amounts of lactate is known to be responsible for the growth inhibiting effect, finally ending in abrupt cell death. Using a special feeding technique the recombinant CHO celline SSOA2 producing human antithrombin III is
able to grow on its waste product lactate as a carbon source and completely detoxifies the cell culture broth from this major metabolite demonstrating a functional gluconeogenesis of mammalian cells in vitro. Inducing the diauxic cell behaviour a new way for extended cultivation spand, increased biomass and product titre as well as optimal viability is generated. Material and Methods
Different feeding techniques have been applied : In the first experiments a pulsewise feeding of different substrates has been applied (glucose and glutamine, asparagine and glutamine). The pulses were given at small portions to the cultivation (1g/L for glucose and 100 mg/L glutamine) in order to prevent excessive metabolisation as have been described earlier. Later on a continuous feeding technique of glutamine and asparagine was developed. The intension was to keep the glutamine concentration constant at 200 mg/L during the feeding phase. Although asparagine is a key substrate and essential for the occurrence of the lactate consuming ability it was not possible to measure the asparagine concentration on-line. For that reason the feeding mix consists of a molar ratio of 4:1 glutamine to asparagine, respectively 0.1 m gln and 0.025 m asn. This ratio is equal to the ratio of the specific consumption rates. The nutrient flow rate was controlled either manually (210 mg/L.d) or by means of on-line FIA analysis (PID-controller). Gluconeogenesis is not very common in mammalian cell culture. In this metabolic state previously excreted metabolites as pyruvate, citrate and lactate are remobilized 267 O.-W. Merten et al. (eds.). New Developments and New Applications in Animal Cell Technology, 267-271. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
268
(Figure 1). To enable several steps in the gluconeogenetic pathway, energy in form of ATP is required. Without the amino acid precursors for energy production no gluconeogenesis is possible. The functionality of TCA cycle is maintained by anaplerotic input of glutamine via 2-oxoglutarate and aspartate via oxaloacetat. The following figure illustrates a hypothesised mechanism of the pathway during the gluconeogentic phase. The proposed reactions are in accordance with the biochemical literature and the experimental measured data.
Huge amount of excreted succinate (1g/L) was observed and could not be explained by a simple mass balance of the reactions that fill the TCA cycle. For explanation reasons some of the reactions in the TCA must be reversed to some extend. At oxaloacetate two directions are hypothesised. First: A part of oxaloacetate enables the gluconeogenetic pathway by reversed reduction to malate, hence leaving the mitochondrium. Another part is needed for maintaining the flux within the TCA for further oxidation of acetyl-CoA. The excretion of succinate is thought to be due to the reversed function of the mitochondrial malate dehydrogenase. Excreted succinate is supposed to originate from
269
glutaminolysis, but also, in order to close the carbon balance, from lactate which maintains the TCA cycle running via acetyl-CoA.
Results and discussion
The application of various feeding techniques induces different metabolic behaviour. Applying a pulsewise feeding of glucose and glutamine an excessive metabolisation of both nutrient sources was observed, although just small portions were given to the culture. The velocity of glucose and glutamine consumption is enormous. Glycolysis and TCA are completely unbalanced. As a consequence high excretion rates of TCA metabolites (citrate and succinate) as well as lactate were observed. Already in the beginning of the feeding phase cell growth is inhibited due to the large lactate production and consequently no further recombinant product was obtained. Obviously the relation between productivity and growing is due to the genetic construction. A combination of glucose and glutamine feeding is not a successful way for process optimization. In order to prevent an ongoing lactate production in the feeding phase a pulsewise feeding of glutamine and asparagine was established. In this case the cells change their metabolic behaviour. As far as glucose has been depleted they switched from glycolysis to gluconeogenesis. This diauxic behaviour is well known in procaryontic systems and is here indicated by the consumption of the excreted waste
270
product lactate and a reduced growth rate (0.715.d-1 during glucose metabolization vs. 0.308.d-1 in the lactate consuming phase). The ability to use lactate as a carbon source resulted in a prolonged exponential growth, mainly by reducing the inhibition of cellular growth by lactate. The cell count as well as the product titre is increased (40% more biomass; 30% more ATIII). See Figure 3. Although the glutamine demand in the gluconeogenetic phase is reduced (qGln= 0.061 (mg/(106ce.d)] compared to 0.176[mg/(106ce.d)] in the glucose consuming phase), a manual feeding of 100 mg/(L.d) was not sufficient because of the increasing cell number. For this reason a continuous feeding of asparagine and glutamine was applied to prevent the limitation of these amino acids. Due to the availability of these anaplerotic amino acids the specific growth rate in gluconeogenetic phase was increased up to 0.44.d-1 and a further optimization was achieved (cell count: 4.11.106ce/ml, product concentration: 36.45mg/L). The re-metabolisation of lactate is almost complete and results in a high viability up to 160 hours. The results of different feeding techniques on cell growth and productivity are summarised in Table 1.
271
Conclusions For aims of process optimisation an increased cell and product concentration could not
be achieved by simple glucose and glutamine feeding due to the growth inhibiting tension of their waste products lactate and several organic acids. The experiments pointed out that any significant accumulation of lactate has to be avoided. By applying an intelligent feeding technique we could induce a so far not often seen remetabolisation of the toxic waste product lactate for biosynthesis purposes and therefore denote this phase as gluconeogenesis. The induction of the gluconeogenitic phase was achieved by a continuous feeding of TCA-cycle anaplerotic amino acids glutamine and asparagine. The utilisation of waste products diminishes the growth inhibiting effect. As a consequence of the removement of lactate a prolongation of cell growth was achieved, because of the occurrence of a second exponential phase when the cells grow on lactate as a carbon source. Although in this phase the growth rate was decreased the overall number of cells was improved. Increased biomass correlates with an increase of product titre.
This page intentionally left blank.
EFFECTS OF POLYSACCHARIDE DERIVED FROM TEA ON GROWTH OF
HUMAN CELL LINES IN SERUM FREE CULTURE
H.KAWAHARA, M.MAEDA-YAMAMOTO, K.OSADA, K.TSUJI National Research Institute of Vegetables, Ornamental Plants and Tea, MAFF, 2769 Kanaya, Shizuoka 428, JAPAN
1. Introduction
Serum free culture of mammarian cells is more advantageous method that culture environment can be designed freely for various bio-assay than usual culture method
containing serum. We try to investigate various effects of food components on cell function
of human immune cell lines. In such a case, if culture medium containing serum is used, it is difficulte to prove the function of those components because of unknown elements in serum [1]. Serum free culture is supposed that it is effective for our system. Growth factors such as insulin, trasferrin, ethanolamin, sodium selenite for serum free culture were known well [2]. However, every cell llines don't always grow in serum free culture containing such growth factors. In this report, we studied that tea polysaccharides added in serum free media effect on cell growth of human immunological cell lines.
2. Materials and Methods 2.1. CELL LINES AND MEDIA
Human immunological cell lines (Burkitt lymphoma RAJI, human T lymphoma PEER, human eosinophil cell line EoL-1, human basophil cell line KU812, human chronic granulocytic leukemia K-562) were cultured in ERDF basal medium containing 10%FBS.
Each cell lines was sure of growing in ERDF medium supplemented with
insulin,
273 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 273-275.
© 1998 Kluwer Academic Publishers. Printed in the Netherlands.
274
10µg/ml transferrin, 20µM ethanolamine, 25nM sodium selenite(ITES). Cells were cultured in ITES-ERDF serum free medium for 2 days before testing. Each cell lines was sure of growing in ITES-ERDF medium. Cell numbers were measured by trypan blue dye exclusion method. 2.2. PURIFICATION OF HEMICELLULOSE FROM JAPANESE GREEN TEA Hemicellulose from the Japanese green tea (Camellia Sinensis var. 'yabukita') was obtained as follows. The extract from powdered green tea with acetone was mixed with 0.5N NaOH and 0.1%NaBH 4 . After shaking the mixture for 2 hours at room temperature, it was centrifuged at 5000xg for 30 min. The supernatant was obtained and adjusted to pH4.5 with acetic acid solution. Then, adding 7% trichloroacetic acid to the solution, it was centrifuged. The supernatant was dialyzed against water for 3 days, and the solution was mixed with ethanol to separate the polysaccharides fraction. After centrifugation, the
precipitate was dissolved in water and lyophilized. The lyophirized powder was dissolved in distilled water again, the solution was added to culture medium. 2.3. PREPARATION OF pH OF CULTURE MEDIUM ERDF basal medium adjusted to six point of pH6.0, 6.5, 7.0, 7.3, 7.5, 8.0 were applied to this experiment. Acidified or neutralized medium of pH range from 6.0 to 7.3 was performed with gas. Basic medium at pH7.5 or 8.0 was prepared by adding 1N NaOH to the medium.
3. Result and Discussion
We acquired several kinds of polysaccharides from tea by using various purification methods. In these extracts, the polysaccharide having the highest activity of cell growth was named TH, and used following experiments. We tried to add the TH at various concentration to ITES-ERDF medium. Figure 1 shows the maximum dose of TH for 5 kinds of cell lines. When the TH was added
275
to ITES-ERDF medium at 10µ g/ml of final concentration, all kinds of cell lines except KU812 could grow in this serum free media. If TH over 10µg/ml was added to ITESERDF medium, the viability of cell was significantly decreased on microscopic observation. As shown in Figure 2, though lag of the cell growth was slightly prolonged by adding TH, saturated cell density of ITES-ERDF-TH was about 2 times higher than that of ERDF containing only ITES. We investigated that the effect of pH of serum free culture medium on viability of the cells. As shown in Figure 3, the viability of the cells cultured in ITES-ERDF-TH was kept on the higher level than that of the cells cultured in ITES-ERDF. Specially, on the higher pH than pH7.4, addding the TH to ITES-ERDF medium is more effective than the culture medium without TH. These results suggested that the TH had a effect to stabilize something change of medium with cultivation rather than to stimulate the cell growth like a growth factor.
4. References 1.Shinmoto,H., Kobori,M., Tsushida,T., and Shinohara,K. (1995) Protein-free culture of human macrophage like UM cell line, in E.C.Beuvery, J.B.Griffiths and W.P.Zeijlemaker (eds.), Animal Cell Technology, Kluwer Academic Publishers, Dordrecht, pp. 1147-1151. 2.Murakami,H. (1989) Serum-free media used for cultivation of hybridomas, Monoclonal Antibodies: Production and Application, Alan R. Liss, Inc. pp. 107-141.
This page intentionally left blank.
METABOLIC DEMANDS OF BTI-TN-5B1-4 (HIGH FIVE™) INSECT CELLS DURING GROWTH AND AFTER INFECTION WITH BACULOVIRUS ERNESTO CHICO1, 2 and VOLKER JÄGER1 1 Gesellschaft für Biotechnologische Forschung mbH Mascheroder Weg 1 D-38124 Braunschweig, Germany. 2 Center of Molecular Immunology POBox 16040 Habana 11600, Cuba. Introduction • Because of its high productivity BTI-Tn-5Bl-4 (High Five™) cell line has become an attractive alternative to Spodoptera fugiperda cells for recombinant protein production using the Baculovirus expression system. • In this work we present the main metabolic demands of this cell line and discuss the major challenges for growing these cells at high cell density for infection and subsequent recombinant protein production. Experimental conditions High Five cells were cultivated in Ex-Cell 401 serum-free medium fortified with glucose, asparagine and glutamine. Suspension cultures were carried out in Techne spinner flasks as well as in membrane aerated bioreactors for studying the oxygen demand. For infection, a recombinant baculovirus was used expressing human protein. Synchronous infection of the cell population was achieved using a MOI of 5. Results and Discussion General Metabolic Pattern of High Five cells Fig. 1 shows the general metabolic behaviour of High Five cells during a batch culture which is characterized by following observations: The exponential growth phase ends with the almost simultaneous depletion of Gln and Asn. From all of the amino acids measured only the concentrations of Ala, Asn and Gln change substantially throughout the culture time. Alanine accumulates during the exponential phase of growth and its concentration remains constant after the depletion of asparagine and glutamine. Final values of 10 - 20 mM of can be found at the end of a batch cultivation of High Five cells. These values are extremely high in comparison with most insect as well as mammalian cell lines. Baculovirus infection does not affect the general metabolic behaviour of High Five cells (data not shown). 277
O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 277-279. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
278
Specific uptake rates of glutamine and asparagine (qGln and qAsn) during growth and infection are presented in Fig. 2. Whereas qGln shows a clear trend to reach a saturation in the experimental concentration range, qAsn still increases at concentrations higher than 10 mM of Asn. This fact is important for the design of feeding strategies for High Five cells. Although the general metabolic behaviour of
279 cells is not affected during baculovirus infection the cell specific consumption of Asn and Gln is significantly higher than during exponential growth.
Oxygen demand The specific oxygen uptake rates of High Five and IPLB Sf21 AE cells were measured
in membrane-aerated bioreactors. Results in Table I indicate that High Five cells have the highest cell specific oxygen consumption rate reported in the literature for insect as well as mammalian cell lines.
High Five cells showed a 270% higher cell specific oxygen consumption rate when compared to Sf21 cells. This difference is reduced to approximately 30% if the oxygen consumption rate is expressed per volume of the cell population due to the significantly bigger cell size of High Five cells (See Table I).
The overall oxygen uptake rate (OUR) of the bioreactor was measured online from the
DO controller response during growth and after infection (data not shwon). During exponential growth the OUR correlated well with the cell density. This correlation is only altered during the first 30 hours post infection (hpi), suggesting that there is a peak of the cell specific oxygen uptake rate which is associated to cellular events during the early phase of baculovirus infection. Conclusions High Five cells are characterized by a very active metabolism, by which Asn and Gln are consumed at very high rates. The use of feeding strategies, aimed to keep the concentrations of these amino acids in a region of lower qAsn and qGln, is strongly recommended to avoid nutrient limitations without extensive medium exchange. Due
to the high specific oxygen demand of High Five cells, the growth of this cell line up to high cell densities could be limited by the transfer capabilities of current animal cell bioreactor systems. An additional increase in the oxygen demand must be expected during the first 30 hours post infection. References 1. 2.
Eyer K, Oeggerli A, and Heinzle E (1995). Biotechnol. Bioeng. 45, 54-62. Taticek RA, Hammer DA, and Shuler ML (1995) in: Shuler ML, Wood HA, Granados RR, and Hammer DA (eds.), Baculovirus expression system and biopesticides, Wiley-Liss, New York, pp. 131-174
This page intentionally left blank.
EFFECTS OF AMMONIUM AND LACTATE DURING CONTINUOUS HYBRIDOMA FERMENTATIONS IN A FLUIDIZED-BED BIOREACTOR H.Heine, M. Spies, M. Biselli, C. Wandrey Institut für Biotechnologie 2, Forschungszentrum Jülich GmbH, 52425 Jülich, Germany
Introduction Cell immobilization in porous microcarriers in a fluidized-bed bioreactor is an efficient method to reach very high cell densities in continuous fermentations [1]. High medium fluxes have to be used to prevent cells from being limited by nutrient exhaustion. Accumulation of inhibitory compounds like ammonium or lactate [2] limits the degree of supplementation of the culture media. The aim of this work is to compare kinetic effects of ammonium and lactate in different fermentation systems. Hybridoma cells cultured in a fluidized-bed bioreactor using porous glass carriers have been compared with suspension batch culture in spinner vessels. It turned out that significant effects of three dimensional environment in porous carriers occur.
Material and Methods The cell line used is a mouse-mouse hybridoma secreting a monoclonal antibody of the subclass Suspension cultures were carried out in batch spinner flasks. The immobilized cultivations were performed in a fluidizedbed bioreactor (Fig. 1) with 60 ml carrier and 250 ml total volume. The carriers have a size of 400-710 µm and are coated with gelatine [3]. The perfusion rate was adjusted to after startup phase. Suspended cells were counted using a hemacytometer with Erythrosin B-staining, immobilized cells were lysed using a 100 mM citric acid buffer, with subsequently staining of nuclei with crystal voilet. The culture medium consists of a 3:1 mixture of DMEM and Ham´s F-12, supplemented with insulin, amino acids, transferrin, BSA, fatty acids, vitamins and trace elements (all Boehringer Ingelheim, Germany). For the ammonium experiments was added to final concentrations of 2, 4, 6, 8, 10, 12, 14 mmol/1. For the lactate experiments Na-lactate was added to a final concentration of 2, 4, 8, 12, 16, 20, 25 mmol/1. 281 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 281-283. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
282
Results and Discussion ADDITION OF AMMONIUM: In continuous immobilized culture addition of ammonium results in a reduction of immobilized cell density whereas suspended cell density and antibody titer remain constant (data not shown). This indicates an increasing growth rate due to more space on the carrier (Fig. 2a). Though the growth rate increases in immobilized culture the cell cycle distribution remains nearly constant at every ammonium concentration. But there is a significant difference between suspended cells and immobilized cells in the fluidized bed bioreactor. Indicating a faster proliferation, the greater part of the immobilized cells are in the S-phase compared to the suspended cells. The specific antibody production rate is coupled to growth (Fig. 2a). The metabolic rates increase by factor six (data not shown). Suspended cells in batch culture show a different
response to ammonium addition (Fig. 2b), their growth rate remains nearly constant whereas the specific productivity slightly decreases. Nevertheless the growth rate in immobilized culture is lower than in suspension culture and only at the highest ammonium concentrations growth rate is higher than in batch culture. The specific productivity of immobilized cells in continuous culture is much higher than in batch suspension culture. ADDITION OF LACTATE The addition of lactate has no influence on immobilized cell density, suspended cell density and antibody titer. The growth rate and specific productivity remain more or less constant (Fig. 3a). Due to the lower immobilized cell density in the continuous experiment compared to the ammonium experiment the initial rates are higher compared to Fig. 2a. In suspended spinner culture there is also no effect on the growth rate and the specific productivity (Fig. 3b).
283
Summary Our experiments show an influence of the three dimensional environment of the cells
during the addition of ammonium. Ammonium leads to decreasing immobilized cell densities and increasing metabolic rates in porous carriers. In suspended batch culture
growth rate remains constant whereas cell specific productivity decreases slightly. The addition of lactate shows no effect of the three dimensional environment. In both cases the cell cycle distribution shows differences between immobilized cells and suspended
cells in the fluidized bed bioreactor. References
[1] Thömmes, J. et al:The influence of dissolved oxygen tension on the metabolic activity of an immobilized hybridoma population, Cytotechnology 13 (1993), 29-39. [2] Miller, W.M., Wilke, C.R., Blanch, H.W.: Transient responses of hybridoma cells to lactate and ammonia pulse and step changes in continuous culture, Bioprocess Engeneering, 3 (1994), 113-122 [3] Lüllau, E. et al: Immobilization of animal cells on chemically modified carrier, in: Spier, Griffith (eds.): Animal cell technology, Butterworth-Heinemann,(1992), 469475 Acknowledgement
The authors thank the European Commission Directorat General XII for the sponsoring of this work.
This page intentionally left blank.
SERUM CONCENTRATION AND pH AFFECT THE CD13 RECEPTOR CONTENT OF HL60 CELLS CULTURED IN STIRRED BIOREACTORS C. L. MCDOWELL AND E. T. PAPOUTSAKIS Dept. of Chemical Engineering, Northwestern University 2145 Sheridan Road, Evanston, IL 60208-3120, USA
Keywords: antigen expression, agitation, pH, serum concentration
Abstract The effects of serum medium concentration and culture pH on CD 13 receptor content and mRNA levels of HL60 (human promyelocytic leukemia) cells were examined using flow cytometry and Northern blotting. Increasing the serum concentration from 5% to 10% increased the CD 13 receptor content and mRNA levels of HL60 cells cultured at 80 rpm in a 2 L bioreactor. When the agitation rate was increased to 300 rpm, 10% FBS increased the HL60 apparent growth rate, but decreased the CD 13 receptor content and
mRNA levels. Decreasing the culture pH from 7.4 to 7.2 (at 80 rpm) did not affect the
HL60 apparent growth rate, but increased the CD 13 receptor content. Unlike the results of the serum experiment, changes in CD 13 content in response to culture pH were not correlated with changes in CD13 mRNA levels. Introduction Large-scale culture of freely suspended cells is necessary for the production of whole cells for use in somatic therapies. Industry is now making use of agitated bioreactors, as they offer uniform culture conditions and the ability for growth to high cell densities. However, the high agitation rates and/or sparging often needed to satisfy the oxygen demand of high cell concentration cultures generate fluid-mechanical forces that affect cell physiology and/or injure cells. It is important to understand not only how hydrodynamic forces due to agitation affect cells, but also how other bioreactor parameters, such as serum medium concentration and pH, affect cell physiology. Of
particular interest is how bioreactor parameters affect receptor concentration on the cell surface, which has implications in the production of whole cells for somatic therapies. Somatic therapies involve interaction, through their surface receptors, of the transferred cells with other cells in the human body. Therefore, cells used in somatic therapies must be cultured in a manner that maintains the expression of key surface receptors. In addition to the requirement of intact and functional surface receptors, cells used in somatic therapies must be cultivated in numbers sufficient for treatment (7,9). Cultivation in agitated bioreactors could produce the cell numbers sufficient for treatment, but parameters such as agitation rate, serum medium concentration, and pH
could affect the expression of key surface receptors. Therefore, it is necessary to understand how agitation, serum medium concentration and pH affect cellular receptors. 285 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 285-291. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
286
This work examines the effects of serum medium concentration, agitation rate, and pH on the surface content of the CD 13 receptor (aminopeptidase N) of HL60 (human promyelocytic leukemia) cells. Materials and Methods CELLS AND CULTURE MEDIUM
HL60 cells (cell line ATCC CCL240) were cultured in IMDM supplemented with 5% or 10% fetal bovine serum (FBS), sodium bicarbonate, and sodium pyruvate. BIOREACTOR CULTURES Experiments were carried out in two Setric Genie 2 L bioreactors (Toulouse, France),
with an initial volume of 1.35 L. Temperature was maintained at 37°C. Dissolved oxygen concentration was maintained above 70% of air saturation. The pH was maintained at 7.4 or 7.2 by injection into the headspace. In the pH experiment, the cultures were grown at 80 rpm. In the FBS experiment, once the cultures reached midexponential growth, the agitation rate of both was increased to 300 rpm. Every 8-12
hours, samples were taken to determine cell concentrations, viability, CD13 receptor content, and CD 13 mRNA levels. FLOW CYTOMETRIC ANALYSIS OF SURFACE ANTIGENS
Samples from each experiment were analyzed in the same session using a Becton Dickinson FACSscan flow cytometer. Ten thousand cells were analyzed per sample. NORTHERN BLOT ANALYSIS Total RNA was purified using RNA STAT-60 (Tel-Test Inc., Friendswood, TX, USA). Northern blots and autoradiography were carried out as described previously (8). The amount of RNA was controlled by rehybridization of the blots with the glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) probe. Probes were labeled with using random hexamer primers. CD13 cDNA was provided by Dr. A. Thomas Look (St. Jude's Children's Research Hospital, Memphis, TN, USA). GAPDH cDNA was received from ATCC. Results EFFECT OF 5% VERSUS 10% FBS AT 80 AND 300 RPM
As shown in Figure 1a, the cell concentrations of the 5% and 10% FBS cultures were similar before the agitation rate increase to 300 rpm. After the agitation rate increase to 300 rpm, however, the 10% FBS culture had a cell concentration higher than the 5% FBS culture. The viability of both cultures remained above 90% for the duration of the experiment (data not shown). Prior to the agitation rate increase, the 10% FBS culture
had a higher CD 13 receptor content as compared to the 5% FBS culture (Figure 1b). After the agitation rate increase to 300 rpm, however, the CD 13 content of the 10% FBS culture continued to decline, while the decline in the 5% FBS culture was arrested. The
287
differences between the 5% and 10% FBS cultures in terms of CD 13 content correlated with differences in CD 13 mRNA levels (Figure 1c). EFFECT OF CULTURE pH 7.0 VERSUS 7.4 AT 80 RPM
Decreasing the culture pH from 7.4 to 7.2 had no affect on the HL60 apparent growth rate (Figure 2a). It also had no effect on cell viability, as the viability of both cultures remained at or above 90% (data not shown). However, decreasing the pH from 7.4 to
7.2 increased the CD13 receptor content, on average, by approximately 25% (Figure 2b). Unlike the FBS experiment, despite the differences in CD13 receptor surface content there were no differences in CD13 mRNA levels (Figure 2c). Discussion THE PROTECTIVE EFFECT OF FBS AT 300 RPM FBS protected HL60 cells from damage under conditions of agitation at 300 rpm. As
shown in Figure la, the 10% FBS culture had a higher cell concentration as compared to the 5% FBS culture. These results are consistent with experiments in the literature, which showed that serum protected cells cultured in agitated bioreactors (2, 3, 6). FBS DECREASES CD 13 RECEPTOR CONTENT AT 300 RPM
At 300 rpm, 10% FBS leads to a decrease in CD 13 receptor content. As shown in Figure 1b, the 10% FBS culture exhibited a continued decrease in CD 13 content at 300 rpm, while the 5% FBS culture exhibited an arrest in the decline of CD 13 content. The behavior of the 10% FBS culture is consistent with experiments that showed that HL60 cells cultured in 10% FBS exhibited a decrease in CD 13 content in response to agitation at 270 rpm, as compared to control cultures at 80 rpm (4). The behavior of the 5% FBS culture is consistent with previous experiments demonstrating that HL60 cells cultured in 5% FBS exhibited an arrest in the decline of CD13 content in response to agitation at 300 rpm, as compared to control cultures at 80 rpm (5). These results show that at 300 rpm, 10% FBS reduced the transduction of fluid-mechanical forces that affect CD 13 receptor content. In contrast, the 5% FBS culture sensed the fluid-mechanical forces due to agitation and responded by arresting the decline in CD 13 receptor content.
FBS INCREASES CD 13 RECEPTOR CONTENT AND mRNA LEVELS AT 80 RPM
As shown in Figure 1b, the 10% FBS culture had a higher CD13 receptor content at 80 rpm as compared to the 5% FBS culture. This observation is consistent with studies that showed that cytotoxic T lymphocytes cultured in serum had a higher CD38 and CD57 receptor content as compared to cells cultured in the absence of serum (10). As shown in Figure 1c, the higher level of CD 13 receptor content in the 10% FBS culture was correlated with higher levels of CD 13 mRNA. This higher level of CD 13 mRNA could be due to either an increase in the rate of CD 13 mRNA transcription, or a reduction in the rate of CD13 mRNA degradation. These results have implications for the culture of human hematopoietic cells with animal sera, or autologous serum or plasma in stirred tank reactors.
288
289
290
pH AFFECTS CD 13 RECEPTOR CONTENT BUT NOT CD 13 mRNA LEVELS
Decreasing the culture pH from 7.4 to 7.2 increased the CD13 receptor content by approximately 25% (Figure 2b). This behavior is consistent with experiments that showed that a decrease in pH from 7.4 to 7.0 increased the atrial natriuretic peptide receptor content on bovine aortic endothelial cells by approximately 100% (1). In contrast to the FBS experiment, higher CD13 mRNA levels in the pH 7.2 culture were not correlated with higher CD 13 mRNA levels (Figure 2c). Since culture pH affected the CD 13 receptor content, but not mRNA levels, another receptor processing step must be affected. Culture pH could affect CD 13 receptor protein synthesis, trafficking to the cell membrane, internalization, degradation, or recycling.
Acknowledgments This work was supported by a National Science Foundation Graduate Fellowship awarded to C.L.M. and a Predoctoral Biotechnology Training Grant (NIH GM08449). References
1. Katafuchi, T., Hagiwara, H., Ito, T. and Hirose, S. (1993) A Dramatic pH Dependent Alteration in ANP Receptor Density: a Note for Using Cultured Cells, American Journal of Physiology 264, C1345-C1349. 2. Kunas, K. T., and Papoutsakis, E. T. (1989) Increasing Serum Concentrations Decrease Cell Death and Allow Growth of Hybridoma Cells at Higher Agitation Rates, Biotechnology Letters 11,525-530. 3. Kunas, K. T., and Papoutsakis, E. T. (1990) The Protective Effect of Serum Against Hydrodynamic Damage of Hybridoma Cells in Agitated and Surface-Aerated Bioreactors, Journal of Biotechnology 15, 57-70. 4. Lakhotia, S., Bauer, K. D., and Papoutsakis, E. T. (1993) Fluid-Mechanical Forces in
Agitated Bioreactors Reduce the CD13 and CD33 Surface Protein Content of HL60 Cells, Biotechnology and Bioengineering 41, 868-877. 5. McDowell, C. L., and Papoutsakis, E. T. (1997) Increased Agitation Intensity Increases CD 13 Receptor Surface Content and mRNA Levels, and Alters the Metabolism of HL60 Cells Cultured in Stirred Tank Bioreactors (submitted 1997). 6. Michaels, J. D., Petersen, J. F., Mclntire, L. V., and Papoutsakis, E. T. (1991) Protection Mechanisms of Freely Suspended Animal Cells (CRL 8018) from FluidMechanical Injury. Viscometric and Bioreactor Studies Using Serum, Pluronic F68 and Polyethylene Glycol, Biotechnology and Bioengineering 38, 169-180. 7. Rosenberg, S. A., Anderson, W. F., Blaese, M., Hwu, P., Yanelli, J. R., Yang, J. C., Topalian, S. L., Schwartzentruber, D. J., Weber, J.S., Ettinghausen, S. E., Parkinson, D. N., and White, D. E. (1993) The Development of Gene Therapy for the Treatment of Cancer, Annals of Surgery 218, 455-464. 8. Sambrook, J., Fritsch, E. F. and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Plainview, NY. 9. Scheding, S., Franke, H., Brugger, W., Kanz, L. and Schmitz, S. (1995) How Many
Myeloid Post-Progenitor Cells Have to be Transplanted to Completely Abrogate Neutropenia After High-Dose Chemotherapy and Peripheral Blood Progenitor Cell Transplantation? Blood 86, 224a. 10.Trimble, L., Perales, M., Knazek, R., and Lieberman, J. (1996) Serum Enhances the Ex Vivo Generation of HIV-Specific Cytotoxic T Cells, Biotechnology and Bioengineering 50,521-528.
291
Discussion Wurm:
Have you looked at the protease activity in the supernatant under those various conditions?
Papoutsakis:
No.
Wurm:
It might give an explanation for your various levels. If you reduce serum, you might increase hydrodynamic damage and release more proteases, which would affect protein on the cell.
Papoutsakis:
We have not studied this but did show that increased damage increased the receptor level, which goes against the idea of
proteolytic attack. Barteling:
Could the serum effect be due to a reduction in shear which you could mimic by the addition of pluronic?
Papoutsakis:
The effect of serum is nothing to do with shear, but is complicated by the presence of fluid mechanical forces.
Bernard:
The signal which you receive is by facs, I presume. Did you calibrate this for actual C13 by another method?
Papoutsakis:
Yes, you can do an enzyme assay. There is a complication in that the culture environment might be changing in glycosylation and, therefore, the recognition of a particular receptor. We have been
looking for a suitable receptor to look at the effect of glycosylation in the culture medium but it is practically impossible. The only one which comes close is CD34, but this is very complicated. Al- Rubeai:
When you look at changes in cell size, do you think that there is a possibility that the concentration of CD 13 has not changed but the amount has?
Papoutsakis:
No, if you normalise it by cell size, you see the same thing.
This page intentionally left blank.
FOUR REGULATION-FRIENDLY SERUM-FREE MEDIA FOR MAMMALIAN
AND INSECT CELLS
Thomas W. Irish, Susan E. Lenk, Lisa A. Bugner, and Karen J. Etchberger JRH Biosciences, Inc., 13804 West 107th Street, Lenexa, KS 66215 USA
Abstract Mammalian and insect cell lines are used commercially to produce products for both the human and animal health markets. Due to regulatory issues surrounding the use of animal-derived raw materials in culture media, JRH Biosciences has developed four regulation-friendly media formulated using raw materials that are
recombinant, synthetic or non-animal-derived. Cells can be transferred directly from serum-containing cultures into these media without extensive adaptation or
extended lag phases. EX-CELL™Vero SF supports the growth of Vero cells in stationary flasks as well as on microcarriers. EX-CELL™293-S supports the growth of 293 cells as single cells in suspension cultures. EX-CELL™302 was designed for the culture of CHO cells in suspension systems. In each of these media, cells achieve doubling times and final cell densities comparable to 10% FBS controls. EX-CELL™420 was optimized for growth of Sf9 and Sf21 insect cell lines, supporting cell densities of cells/ml (viability >95%) for more than 10 days.
Materials and Methods EX-CELL™302: CHO-K1 cells (ATCC CCL 61) previously adapted to
EX-CELL™301 were transferred to 250 mL spinner flasks with a seeding density of cells/mL in 100 mL of EX-CELL™302 (~60 rpm). Daily cell counts and viabilities were determined by trypan blue exclusion. EX-CELL™420: Sf9 cells (ATCC CRL1711) were transferred directly into EX-CELL™420 as attachment cultures from an ampule of ATCC supplied cells.
Cells grown in the serum free control medium were adapted from attachment cultures grown in Hink's TNM-FH + 10% FBS. Cells in both serum-free media were
adapted to suspension culture in 125 mL shaker flasks at 130 rpm. For growth curves, cells were seeded at either cells/mL or cells/mL in 50 mL volume of media. Daily cell counts and viabilities were determined by trypan blue exclusion. Virus production and activity assays were performed 293
O.-W. Merten et at. (eds.). New Developments and New Applications in Animal Cell Technology, 293-302. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
294
by Invitrogen (Carlsbad, CA). Sf9 cells grown in EX-CELL™420 and Grace's + 10% FBS were infected with a pVL941 CAT clone HTS at an MOI of 5. Viral liters were determined by plaque assays were performed on the culture supernatants. production by Sf9 cells grown in EX-CELL™420 and Grace's + 10% FBS was determined by spectrophotometric activity assays. EX-CELL™293-S: 293 cells (ATCC 1573) were weaned to EX-CELL™293-S from cultures grown in MEM + 10% DBCS. For adaptation to serum-free medium, the cells were passaged as attachment cultures into EX-CELL™293-S + 1% FBS for one passage followed by two passages in EX-CELL™293-S. Cell dissociation was accomplished with trypsin followed by protease neutralization with ultrapure soybean trypsin inhibitor (0.1 %). Cells were transferred to roller bottles and spinner flasks at a density of Cell counts and viabilities were determined by trypan blue exclusion. EX-CELL™VERO-SF: Vero (ATCC CCL-81) and MDCK (CCL 34) cells were adapted directly to EX-CELL™VERO-SF from cells grown in MEM + 10% FBS.
Serum-free attachment cultures were seeded at Cell dissociation was accomplished with trypsin followed by protease neutralization with ultrapure soybean trypsin inhibitor (0.1%). For growth curves, cells were counted at culture days three though seven. Cell counts and viabilities were determined by trypan blue exclusion.
EX- CELL™ 302
Data presented here demonstrates extended cellular growth in JRH Biosciences EX-CELL™302 for nine (9) days in spinner batch cultures. Cultures of CHO-K1 cells achieved an approximate average maximum cell density of cells/mL with exponential doubling times in the range of 20 hrs., maintaining viabilities greater then 70%. EX-CELL™302 has been formulated without using animal derived proteins. EX-CELL™302 does contain very low levels (> 50 ug/L total) of recombinant proteins having a molecular weight less the 10 KD. CHO-K1 cells, cryopreserved and adapted to serum free growth in JRH Bioscience’s EXCELL™301, were transferred directly into EX-CELL™302 without an adaptation period. JRH Bioscience's "regulatory friendly" EX-CELL™302 can be safely used for production of human therapeutical products because it does not contain animal derived proteins, amino acids, or other components considered to be questionable.
295
296
Conclusions EX-CELL™302 can achieve cellular densities in suspension batch cultures greater then cell/mL. •
EX-CELL™302 can support batch cultures maintaining high viabilities for greater then 9 days without a refeed.
•
EX-CELL™302 does not contain any animal derived raw materials considered to be regulatory questionable.
•
Cells grown in serum free media can be directly transferred into EXCELL™302 without adaptation .
EX-CELL™420
Insect cells are commonly used for the expression of recombinant proteins and virus production in a variety of applications including vaccines, diagnostics, and biopesticides. Cells derived from the fall armyworm, Spodoptera frugiperda, have been the cells of choice for baculovirus infection and protein production. EXCELL™420 is a complete medium developed and optimized for the serum-free growth of Sf9 and Sf21 insect cell lines as either adherent or suspension cultures. This medium contains no proteins detectable by standard methods. Cells can be transferred directly from adherent cultures grown in serum-free or serum-containing media into EX-CELL™420 suspension culture without an adaptation period. Sf9 cells cultured in EX-CELL™420 routinely achieve cell densities of cells/mL with viabilities greater than 95% and can be maintained for more than 10 days at these densities with no loss of viability. Cultures seeded at low density cells/mL) over multiple passages do not exhibit the typical 24-48 hour lag phase seen with many serum-free media. Sf9 and Sf21 cultures have been carried in EXCELL™420 for more than 20 passages. Sf9 cells grown in EX-CELL™420 were infected with a pVL941 CAT clone HTS at an MOI of 5 and the resulting viral titer at 72 h was pfu/mL, approximately half a log less than the 1.3 x 10 pfu/mL titer obtained from cells grown in Grace's + 10% FBS. Expression of IL-6, CAT, and by Sf9 cells grown in EX-CELL™420 is comparable to that obtained from cells grown in Grace's + 10% FBS.
297
298
299
Conclusions •
Cells can be transferred directly to EX-CELL™420 from a serumcontaining medium without an adaptation period.
•
Cells grown in EX-CELL™420 routinely achieve cell densities of cells/mL with viabilities of >95%.
•
Cultures can be maintained for more than 10 days with no loss of viability.
•
Cultures seeded at low density do not exhibit the typical 24-48 hour lag phase seen with many serum-free media.
•
Virus production and protein expression in EX-CELL™420 is comparable to that obtained in serum-containing media.
EX-CELL™Vero-SF
JRH Bioscience's EX-CELL™Vero-SF media has been formulated to support the long term growth of the Vero cell line. This medium has demonstrated the ability to grow both Vero cells and MDCK cells both of which are commonly used by the human pharmaceutical industry to produce human and animal vaccines and protein produces. Because this media is free of animal derived raw materials it is considered to be regulatory friendly. Vero cells grown in EX-CELL™Vero-SF media achieve culture densities comparable to densities achieved in a serum containing media. MDCK cells grown in EX-CELL™Vero-SF media achieve densities and growth rates greater then those achieved when grown in a media containing serum. Both cells lines can be directly transferred into EX-CELL™VeroSF media from serum conditions without adaptation or lose of growth rates or densities.
300
301
Conclusions •
Vero and MDCK cells can be grown in EX-CELL™Vero to densities comparable to or higher then those achieved in a serum containing media.
•
EX-CELL™Vero media does not contain any animal derived raw materials making this media regulatory friendly.
•
Both Vero and MDCK can be directly transferred into EX-CELL™Vero media without adaptation.
•
Population doubling are sustained over extended periods of time.
EX-CELL™293-S
The 293 cell line used for production of proteins, and adeno virus can be grown in JRH Biosciences EX-CELL™293-S as a suspension culture. This media does contain BSA as a protectant for cellular growth in spinner cultures and very low levels of recombinant growth factors. Cells can be quickly adapted to serum free growth in stationary culture and then transferred into suspension culture conditions. Adaption of 293 cells acquired from ATCC requires three separate steps, adaptation to serum free growth in static cultures, adaptation to suspension in roller bottles and adaptation to spinner growth. 293 cells grown in JRH Biosciences EXCELL™293-S grow as single cells or small, loose, aggregates that can be easily broken up by gentle pipetting. Doubling times and cellular densities achieve in serum free growth are comparable to those achieved in a serum containing media.
302
Conclusions •
Cells can be transferred from serum containing media into low serum conditions within two subpassages.
•
293 cells in low serum conditions (1% DBCS) will form loose cell aggregates and grow as suspension cultures.
•
Adaptation to serum free conditions require an additional one to two subpassages for sustainable growth.
•
293 cells grown in EX-CELL™293-S will achieve culture densities of 1 x in roller bottles 5 -7 days from a seed of
PROTEOLYTIC ACTIVITIES IN THE BACULOVIRUS-INSECT CELL EXPRESSION SYSTEM Georg Schmid and Andrea Bischoff F. Hoffmann-La Roche Ltd., Pharmaceutical Research Building 66/112A, CH-4070 Basel, Switzerland Introduction Proteolytic degradation of recombinant proteins produced in the baculovirus-insect cell expression system is an often encountered phenomenon. The system encompasses proteases of viral and cellular origin At least one viral proteinase (v-cath), a cathepsin Llike cysteine proteinase, has been identified to date. The activities of cellular proteases are often regulated by the cells' metabolic state and oxidative stress, heat shock or amino acid (substrate) starvation induce formation of various stress proteins, including proteases, that may have a significant impact on product quality in any given bioprocess. We investigated the occurence of aspartic, metallo-, serine and cysteine proteinases in non-infected and infected Spodoptera frugiperda (Sf9) insect cells using chromogenic substrates, zymogram gels and SDS-PAGE analysis of degradation products of model proteins. The secreted and intracellular activities were evaluated for spinner flask, laband pilot-scale bioreactor cultures operated under different physiological conditions.
303
O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 303-306. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
304
305
306
MONITORING AND CONTROL
This page intentionally left blank.
DEVELOPMENT OF PROTEINASE ASSAYS FOR IMPROVED CHO CELL CULTURES C. TANS, C. VANDER MAELEN, S. WATTIAUX-DE CONINCK*, M.-M. GONZE AND L. FABRY SmithKline Beecham Biologicals S.A., Rixensart - *F.U.N.D.P., Namur, Belgium
1. Abstract Proteolytic activity in CHO cell culture supernatants is a key parameter to be considered towards an improved quality of secreted recombinant glycoproteins. In the present study, synthetic substrates have been used to evaluate the proteolytic activity in parental and recombinant CHO cell culture supernatants. Zymographic and isoelectric focusing analysis showed that modifications in the peptidic sequence of a model secreted glycoprotein are related to a protease activity detected in supernatants using the Z-GlyGly-Arg-AMC substrate. Protease measured by the substrate was suggested to be a form of plasminogen activator as its activity was inhibited by plasminogen activator inhibitor type 1 and its optimal pH was in the range of pH 8.5. Cell cultures performed at lower temperature, eg 29°C instead of 37°C resulted in a decrease of the protease activity in supernatants as assayed using the Z-Gly-Gly-ArgAMC substrate (3 fold decrease). Consequently, lower cell culture temperature is expected to be a key factor to improve the quality of recombinant secreted glycoproteins in CHO cell cultures. 2. Introduction The objective of the study was to evaluate the influence of CHO cell derived proteases on the integrity of secreted glycoproteins. The first step consisted of the characterization of proteases activity in CHO cell supernatants able to modify a model recombinant glycoprotein (rec. glycoprotein): potential synthetic substrate, inhibition profile, molecular weight. During the second step, changes in the culture conditions and their effects on the protease activity and rec. glycoprotein quality were evaluated. 309 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 309-316. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
310
3. Material and methods 3.1.
CHO CELL CULTURE
All cultures were carried out in serum-free medium. Parental (untransfected) CHO cellfree supernatants were obtained from suspension batch culture after 72 hours culture at 37°C. Suspension batch culture of rec. CHO cells were performed at different temperatures in spinner flask 1L. 3.2.
INCUBATION OF THE PURIFIED GLYCOPROTEIN IN PARENTAL CHO CELL CULTURE SUPERNATANTS
The purified rec. glycoprotein sample (4 % of N-terminal modifications) was incubated in the presence of parental CHO cell culture supernatants (5 fold concentrated by ultrafiltration with a cut-off limit of 10 kD) and 0.01 % merthiolate. Prior to incubation, pH was adjusted to pH 7.2 with 5N HC1 or 5N NaOH. Incubation time was 44 hours at 37°C. 3.3.
ISOELECTRIC FOCUSING/WESTERN BLOTTING (IEF/WB), IMMUNODETECTION TECHNIQUES
The glycoprotein samples were concentrated 15 fold by ultrafiltration (10kD cut off) prior to diafiltration and IEF/WB. Gel electrophoresis was performed under denaturing conditions as reported by O’Farrel (1975) and Lognonné (1994) in a vertical slab gel unit; a pH gradient between 3 and 6 was used; migration was stopped after 30 000 Vxhours. After several washes in a fixing solution, gels were blotted to PVDF membranes in the presence of SDS using a semidry transblot system. The blot was incubated with a polyclonal rabbit anti recombinant glycoprotein antibody and then with an anti-rabbit horseradish peroxidase conjugated antibody; the blot was developed with 3.3' diaminobenzamidine. The IEF/WB were analysed with a densitometer/image analyser (Bio-Rad). 3.4.
ZYMOGRAPHIC ANALYSIS OF PROTEOLYIC ACTIVITY IN CULTURE SUPERNATANT
Supernatants samples migration was realised in a 7.5 % acrylamid gel polymerized in presence of 0.2 % purified rec. glycoprotein at 4°C. After washes, gel was incubated at 37°C during 20 hours in 0.1 Tris-HCl buffer pH 8.5 and then stained with Coomassie blue (Heussen and Dowdle, 1980). 3.5.
ZYMOGRAPHIC DETECTION OF PROTEASE ACTIVITY AGAINST SUBSTRATE Z-GLY-GLY-ARG-AMC
Supernatants samples migration was realised in a 7.5 % acrylamid gel at 4°C. After gel washes, a membrane impregnated with Z-Gly-Gly-Arg-AMC was overlayed on the gel,
311
gel and membrane were incubated 3 hours at 37°C. Fluorescence picture was obtained using Bio-Rad Glyco Doc Analytical Software. 3.6.
PROTEASE ACTIVITY MEASUREMENTS
200 µl of CHO cell culture supernatants were incubated at 37°C in presence of 0.25 mM synthetic substrate, 0.1 M buffer (Glycine - Tris - Acetate); the reaction is stopped after 2 hours. 4. Results and discussion 4.1.
PROTEOLYTIC ACTIVITY IN PARENTAL CHO CELL CULTURE
SUPERNATANTS Four synthetic substrates containing a basic residue at the cleavage site have been used to detect the protease responsible for the N-terminal (N-term.) modifications of the model rec. glycoprotein. Maximal activity was detected at basic pH for all synthetic substrates. The results show that parental CHO cell culture supernatant contain proteolytic activity which can be easily measured using fluorescent synthetic substrates.
312 4.2.
DETERMINATION OF INHIBITION CHARACTERISTICS OF THE PROTEASE RESPONSIBLE FOR N-TERM. MODIFICATIONS OF THE REC. GLYCOPROTEIN
IEF/WB technique was used to analyse rec. glycoprotein isoforms and to evaluate the extent of rec. glycoprotein profile changes. Incubation of the rec. glycoprotein sample with CHO cell-free culture supernatant resulted in the appearance of five bands 1, 2, 2’, 3, 5 (figure 2 : positive control). When
incubation occured in fresh culture medium, the five bands 1, 2, 2’, 3, 5 did not appear (data not shown). N-terminal sequencing of bands 1, 2, 2’, 3, 5 in the IEF/WB profile revealed that they contained more than 70 % of N-modified forms of the rec. glycoprotein. The proposal was to use the relative amount of the bands 1, 2, 2’, 3, 5 in the IEF/WB profile as obtained from the densitometric analysis to assess the N-terminal integrity of the rec. glycoprotein. Incubation of parental CHO cell supernatant in presence of AEBSF,p-aminobenzamidine (data not shown) or human plasminogen activator inhibitor type 1 (hPAI-1) (figure 2) showed that the relative amount of the bands 1, 2, 2’, 3, 5 in the IEF/WB profile decreased significantly.
These data suggest that parental CHO cell culture supernatant contains protease(s) which can modify the glycoprotein of interest at the N-term. domain. The protease(s) responsible for the N-terminal modifications of the recombinant glycoprotein is a serine
protease inhibited by p-aminobenzamidme and could be a form of plasminogen activator.
313
4.3.
ZYMOGRAPHIC ANALYSIS OF PROTEOLYIC ACTIVITY IN PARENTAL CHO CELL CULTURE SUPERNATANT
Zymography was used to estimate the molecular weight of the protease(s) responsible of
rec. glycoprotein modifications in parental CHO cell culture supernatant (figure 3). Proteolytic activity against the rec. glycoprotein was observed mainly at 76 kD.
4.4.
ZYMOGRAPHIC DETECTION OF PROTEASE ACTIVITY AGAINST SUBSTRATE Z-GLY-GLY-ARG-AMC IN PARENTAL CHO CELL CULTURE SUPERNATANT
Z-Gly-Gly-Arg-AMC is described to be a good substrate to measure plasminogen
activator activity (Zimmerman & al, 1978). Z-Gly-Gly-Arg-AFC was used in zymography to determine if Z-Gly-Gly-Arg-AMC could be a good substrate to evaluate the activity of the protease responsible for the rec.
glycoprotein modifications (figure 4). Z-Gly-Gly-Arg-AMC is cleaved at the same molecular weight than the protease responsible for modifications of the rec. glycoprotein. Other experiments (data not shown) revealed that - Z-Gly-Gly-Arg-AMC cleavage in parental CHO cell supernatant is inhibited in the same way as the rec. glycoprotein modifications - rec. glycoprotein modifications are maximal at basic pH
- same zymographic results are obtained when analysing rec. CHO cell supernatants Z-Gly-Gly-Arg-AMC could be a good substrate to evaluate the activity of the protease responsible for rec. glycoprotein modifications.
314
4.5.
CHANGES IN CHO CELL CULTURE CONDITIONS TO REDUCE PROTEOLYTIC ACTIVITY
Culture temperature was modified in order to decrease proteolytic activity and increase rec. glycoprotein quality (figure 5-6).
Batch cultures conducted at different temperatures showed that culture temperature 29°C after 48 hours reduced significantly protease activity (about 3 times for 37-29°C
compared to 37°C). IEF profile confirmed the protease activity results : lower temperature could improve protein integrity, best conditions are a shift of temperature from 37°C to 33°C after 48 hours. Batch production at lower culture temperature could improve the glycoprotein quality in CHO cell culture supernatant.
315
316
5. Conclusions
The study demonstrates that N-term. heterogeneity of a rec. secreted glycoprotein can result from CHO cell derived proteases in the culture supernatant. The protease responsible for the N-term. modifications was identified as a serine protease of 76 kD with an optimal basic pH. Inhibition of the protease can be obtained by PAI-1 suggesting that the protease could be a form of plasminogen activator. Specific assay (Z-Gly-Gly-Arg-AMC substrate) can be used to detect the protease in CHO cell culture supernatant. Batch production at lower temperature could improve the glycoprotein quality in CHO cell culture supernatant. 6. Acknowledgements
This work was supported by a F.I.R.S.T grant nr 2369 from the Walloon Region of Belgium 7. References Heussen, C. and Dowdle, E. B. (1980), Anal. Biochem. 102, 196-202. Lognonné, J.-L. (1994) 2-D analysis : a practical guide to principle critical parameters, Cell. Mol. Biol. 40 (1), 41-55. O’Farrell, P.M. (1975) High resolution two-dimensional electrophoresis of proteins, J. Biol. Chem. 250 (10), 4007-4021. Zimmerman, M., Quigley, J. P., Ashe, B., Dorn, C., Goldfarb, R. and Troll, W. (1978) Direct fluorescent assay of urokinase and plasminogen activators of normal and malignant cells : kinetics and inhibitor profile, Proc. Natl. Acad. Sci. USA 75 (2), 750-753.
DIGITAL IMAGE ANALYSIS: QUANTITATIVE EVALUATION OF COLORED MICROSCOPIC IMAGES OF ANIMAL CELLS
K. Falkner and E.D. Gilles Institut für Systemdynamik und Regelungstechnik Universität Stuttgart, 70550 Stuttgart, FRG E-Mail:
[email protected]
Abstract
A fully automated PC-based image analysis system was developed to count and characterize animal cells in fermentation processes in a routine and reproducible way.
Chinese Hamster Ovary cells were used for the establishment of the system. Digital image analysis provided data for statistical evaluation and graphical representation of the cell population. This information improved the monitoring of the investigated processes and therefore facilitates the development of adequate process control
strategies. 1 . Introduction
Fast and accurate online determination of the number of viable cells plays an important role in fermentation processes with eucaryotic cells. Usually, the cells are stained, and then viable and dead cells are counted. There are different possibilities for counting
cells [1], e.g. Coulter Counter, flow cytometry and the conventional method by using the hemocytometer. In comparison to these methods, a digital image analysis (DIA) system has several advantages. It is easy to handle, the system is comparatively inexpensive and the results are operator independent. Fast characterization of the cells improves the monitoring of the investigated processes and therefore DIA is an important tool for the culture optimization. However, DIA can do much more than evaluation of staining methods: quantitative and reproducible determination of shape, size and morphology provides additional information about the state of the cells. DIA is therefor superior to the conventional manual method.
2. Material and Methods
CELL LINE, MEDIUM AND DYES. Chinese Hamster Ovary (CHO) cells were
cultivated in RPMI 1640 Medium (LIFE TECHNOLOGIES) supplemented with 5% fetal calf serum (LIFE TECHNOLOGIES) in culture flasks with 30 ml medium 317 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 317-319. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
318
at 37 °C in the presence of 5% The cell concentration was approximately cells/ml and after 3 days a cell passage was done. For the determination of the number of viable cells, the three different dyes Trypan Blue, Erythrosin B and Neutral Red were used. Before staining, 1 ml cell suspension was centrifugated for 5 min at 1500 rpm and subsequently resuspended in 0.5 ml PBS buffer (LIFE TECHNOLOGIES). Afterwards 0.4 % (w/v) dye solution prepared in 0.81 % NaCl and 0.6 % (w/v) was mixed with the cell suspension. Then, viable as well as non-viable cells were counted using a hemocytometer and a chamber (300µl) constructed for use with the DIA. IMAGE ANALYSIS. For image acquisition, a CCD color video camera (DXC-950P Power HAD, Sony) was coupled with an inverse microscope (Axiovert 10, Zeiss) and a PC equipped with an IMASCAN framegrabber. For image analysis the MS-Windows software package OPTIMAS (Stemmer) was used.
3. Results and Discussion For the fast determination of cell density and viability in fermentation processes, a fully automated DIA system was designed. The staining of dead CHO cells worked better with Erythrosin B than with Trypan Blue. Erythrosin B was taken up faster than Trypan Blue and the colouring was more intensive. Neutral Red was used to confirm the results from staining with Erythrosin B. Fig. 1 shows an original Erythrosin B stained image and the binary images resulting from image analysis. Table 1 shows the mean values of extracted data of a 3 days old culture of CHO cells.
For a comparison of the DIA system to the manual counting method, the data from all experiments were pooled for further statistical analysis. Table 2 shows that the DIA method provides better results, but still the confidence interval is only a little smaller than the confidence interval of the manual method. The variation of DIA data is mostly explained by the presence of cell heaps. If there are only single cells in the cell suspension, DIA is evidently superior to the manual counting method.
319 TABLE 2. A comparison of statistical results for the mean number of dead cells contained in 1 ml cell suspension
With the CHO cell line used in our experiments, it was not possible to omit the staining step and use only morphological characteristics of the cells for the determination of cell viability. In contrast to the results reported [2], we did not find any significant difference in size, shape or density of viable and non-viable cells. The results show that DIA is superior to the manual hemocytometer method, and an important additional advantage is the possibility of automation.
For automation of viability determination in fermentation processes, an online image processing system, developed for the characterization of morphology of mycelial microorganisms [3], can be used. Sampling, dilution, image acquisition and image analysis are done automatically under the control of a PC. Figure 2 shows the experimental set-up of the online DIA system.
4. Acknowledgements
The work was supported by the German Federal Ministry of Science and Technology (BMFT) and the Dr. Karl Thomae GmbH. The authors would like to thank Prof. Pfizenmaier for kindly providing the CHO cells and the possibility to perform the experiments at the Institut für Zellbiologie und Immunologie, Universität Stuttgart.
5. References [1] [2] [3]
Konstantinov, K. et al. (1994) Real-time biomass-concentration monitoring in animal-cell cultures, TIBTECH 12, 324-333 Frame, K. K. and Hu, W.-S. (1989) Cell Volume Measurement as an Estimation of Mammalian Cell Biomass, Biotechnol. Bioeng. 36, 191-197 Treskatis, S.-K. (1995) Wachstum, Morphologic und Antibiotikaproduktion von Streptomycten
in Submerskultur , PhD thesis, Universität Tübingen, Germany
This page intentionally left blank.
THE VIABLE CELL MONITOR: A DIELECTRIC SPECTROSCOPE FOR
GROWTH AND METABOLIC MACROPOROUS BEADS
STUDIES
OF ANIMAL
CELLS
ON
Y. GUAN and R.B. KEMP Institute of Biological Sciences University of Wales, Penglais, Aberyshvyth, SY23 3DA, UK
Abstract. One of the problems in using macroporous carriers to grow animal cells in culture has been to assess biomass on-line. The possibility that dielectric spectroscopy could be the solution was explored using a Viable Cell Monitor (VCM) optimised for animal cells. The instrument was validated using suspension-adapted CHO cells and was shown to measure the volume fraction of viable cells. It was then applied to
Cytopore 1 carrier cultures over 7-day periods, the results indicating that the technique was a reliable complement to metabolic studies. 1. Introduction
The biotechnological exploitation of animal cells to produce monoclonal antibodies
and recombinant proteins in culture has focused attention on the need to provide a precisely controlled environment for their growth. This was recognised more than a decade ago [1] but there is still a paucity of on-line biosensors to monitor culture variables [2], let alone use them to control the process. This is true even of the fundamental measurement of biomass where the only two methods available are optical density using laser light [3] and dielectric spectroscopy [4]. Whereas the former gives the total number (living and dead) of cells, the latter identifies only the living cells. Both sets of information are valuable in assessing percentage viability but viable cell number is of primary importance in metabolic studies and those relating to the efficiency of target protein production. Commercial dielectric spectroscopes designed to monitor the biomass of microorganisms have been available for several years [4, 5] and have been employed with limited success to measure the number of viable animal cells in culture [6]. It is only recently, however, that one optimised for that purpose has come on the market with the name of Viable Cell Monitor (VCM). The first aim of the present study was to evaluate the instrument using Chinese hamster ovary (CHO) cells growing in suspension. 321 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 321-328. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
322
The productivity per unit volume of animal cells in simple batch culture is poor because the cell number concentration is comparatively low at the end Various devices have been used to increase the numbers, including fed-batch and perfusion cultures, but one of the most promising ways is to allow the cells to stick to macroporous carriers [7]. A difficult problem with this method, however, is to ascertain the number and viability of the cells because many of them are buried deep within the bead. There was preliminary evidence that the dielectric spectroscopy could fulfil this role [8] and. thus, the second aim of the study was to see if the VCM was appropriate for this task. Earlier it had been shown that CHO cells could be grown in macroporous carriers for 3 weeks |9| and so these were used for this work.
2. Theoretical
A detailed theoretical treatment of the theory for measuring biomass by dielectric spectroscopy is available elsewhere [5] but. as a simplified account, the electric field set up by the 4 electrode pins of the VCM probe in the biorcactor creates a force field which pushes ions in opposite directions until stopped by intact cell plasma membranes [10]. Thus, a charge separation (polarisation) is set up at the poles which is measured as capacitance in Farads (F) by a phase shift between the outer electrodes (current) and the inner ones (voltage). The more the cells, the greater the amount of plasma membrane and the more the capacitance Dead cells and debris do not have intact and/or functioning plasma membranes and so do not contribute to capacitance. It is obviously necessary to reverse the field periodically and the rate of change in direction is measured by its frequency as Hertz (Hz). This has a profound effect on capacitance since the ions need a finite time to move up to and polarise the plasma membranes. The higher the frequency, the less time there is for polarisation and the smaller the value for capacitance. The curve of capacitance against frequency is called the The most appropriate frequency for animal cells has been found to be 0.5 Hz and the VCM is fixed at this point. The culture medium has a residual capacitance which must be deducted from the value for the cell suspension to give the capacitance increment of the As the biomass (cell number) concentration increases, so does the size of Capacitance of the cell suspension has a complex relationship to the conductivity of it. If the latter is constant during growth or only changes slightly, then no allowance for it needs to be made but there can be quite significant changes during long-term culture at high cell densities. For this reason, the VCM can be calibrated for a range of conductivity values simply by adding salt to a test sample of culture medium. Without this cross-talk calibration, an increase of from an initial value of can produce a shift in capacitance from 0 pF to 0.1 pF.
323
3. Experimental
The cells were CHO 320 which produce recombinant interferon when grown in a defined medium based on RPMI 1640 [11] with BSA free of fatty acids [12] For some experiments the cells were grown on Cytopore 1 macroporous carrier beads (Pharmacia) suspended at a mass concentration of The Applicon bioreator system (Applicon Ltd., Tewksbury. Glous.. UK) controlled the bicarbonatebuffered pH at temperature at and the dissolved oxygen concentration at 55% saturation [12]. It also received the analogue capacitance and conductivity signals from the VCM (Aber Instruments Ltd.. Aberystwyth. SY23 3AH, UK) operating at 0.5 MHz. All the digitised signals were logged by Applicon BioXpert and its moving average facility was used over 1 h to smooth the capacitance signal.
Off-line measurements [12] were made of cell density by Coulter counter Model D. (Coulter Ltd.. Luton, UK) and of cell size by Skatron Argus 100 flow cytometer (Skatron Ltd., POB 34, Newmarket, UK). The latter was calibrated with a range of highly monodisperse latex beads (Dyno Particles AS, POB 160, Lillestrom, Norway). Since these always underestimate cell size. 400 cells were photographed and measured for size distribution [12], The concentrations of glucose and lactate were measured, after deproteinisation, using respectively. Sigma kits 635 and 826. Protein was assayed by the BioRad DC protein assay kit. 4. Results and Discussion
When CHO 320 cells were cultured in suspension for 140 h. the capacitance curve gave the characteristic bell-shape (Figure 1A). depicting three phases; an increase for the first 80 h, followed by a plateau and then by a decline for the final 40 h. Statistical analysis gave a standard error for the curve of 0.085 pF. Calibrating capacitance in terms the viable cell number concentration gave the following semi-empirical correlation:
(1) where is the increment of viable cell number concentration and that of capacitance. There was considerable data scatter, but this was reduced by using the moving average smoothing technique over 1 h (see Figure 1A). As a result, the lowest measurable cell density was It was also calculated that 1 pF was equivalent to approximately It was necessary to establish what exactly capacitance measures in terms of biomass. Since animal cells take up a gross spherical shape in suspension, the dielectric principle of measurement is [15,12]. (2)
324
where K is a constant, N v is cell number concentration, V cell is the average individual cell volume and is volume fraction of the cell entity. Eq. (2) indicates that the capacitance measurements could relate to individual cell size and/or viable cell density and/or the volume fraction of viable cells. Estimates were made of all three variables and the results are shown in Figure 1B. In the first 100 h. the average cell volume varied by ca. 21%. In relation to Eq. (2). this finding implies that using the VCM signal to represent viable cell density would give a 20% relative error when compared to less than 10% for the volume fraction This difference is illustrated in Figure 1B which clearly shows that capacitance was better reflected in the volume fraction than in the viable cell density for the first 100 h. Cell counts were also unreliable at low number densities. This is common for Coulter counting and is due to sampling errors. After 100 h. there was a decline that correlated poorly with the viable cell volume fraction but may have been due to apoptotic cells, which are known to be smaller than living cells [13].
When the cells were grown on Cytopore 1 beads for long periods in batch culture, the medium had to be renewed by partial replacement after allowing the beads to settle for a short while by stopping the agitator. Thus, the growth as represented by the smoothed capacitance trace, was punctuated by sharp peaks (Figure 2A). Nevertheless, there was considerable growth over the 168-h period representing It is not possible to estimate the accuracy of this number because a direct measurement cannot be performed, but a similar increase with time was shown for the off-line protein measurement. Protein concentration in itself cannot be an accurate measurement of viable cells because (i) dead ones would accumulate in the carrier pores and (ii) BSA and other proteins can be trapped in the beads. However, the increase could be indicative of cell growth. The changing capacitance signal could not have been due to altered conductivity because there was very little change in it over the period (see Figure 2A).
325
Some indication of the metabolic rate of the cells could be gauged from the consumption of glucose (Figure 2A). With growth, the total glucose used by the cell population increased so that, with replacement taking place at regular intervals, the maximum amount of substrate available to the cells gradually decreased with time. One of the characteristics of cells in culture is that they produce considerable amounts of lactate. This can be seen in Figure 2B as a virtual mirror image of glucose consumption. Of course, some of it is removed as medium is replaced to give the sawtooth appearance. Lactate was excreted as a result of glycolysis and the oxidation of glutamine [11,12] but this was not due to anaerobic conditions, the oxygen saturation being maintained at 55%. Rather, it seems to be caused by the poorly designed medium which does not contain a sufficient amount of the required biosynthetic precursors [12,14], The cell has to resort to making some of the necessary components by oxidoreductive catabolic processes, leading to the formation of lactate as a by-product under fully aerobic conditions. Its excretion causes the pH of the culture medium to fall, necessitating the introduction of NaOH to neutralise it. The on-line record of this titration is probably a fairly accurate reflection of cell growth (Figure 2B), better than the protein estimation.
Although a great deal more needs to be done to authenticate the use of dielectric spectroscopy to measure biomass in beads, it is probable that it will become the standard method of assessment in due course. More confidence in its application could be derived from studies on whether it measures in proportion the number of cells in free-standing aggregates. Once validated for animal cell systems, the VCM will become a valued tool in metabolic studies because it makes these other measurements specific to size, in this case volume. This is already being done for the estimation of overall metabolic rate by combining the VCM with flow microcalorimetry to give heat flux [12]. a variable which can be used on-line to control the growth of animal cells in suspension culture.
326
5. Acknowledgements The authors are thankful to the Nuffield Foundation (NUF-URB97) and the Wellcome Trust (VS/3/97) for vacation scholarships to Dr R.B. Kemp which enabled Miss Rachel Ryan and Mr Stuart Martin, respectively, to
assist in part of these studies. He gratefully acknowledges that the research was supported by BBSRC grants, 2/3680 and 2/TO7389.
6. References 1. Cartwright, T. (1994) Animal Cells as Bioreactors. Cambridge University Press, Cambridge, UK. 2. Zhou, W. and Mulchandani. A. (1995) Recent advances in bioprocess monitoring and control. American Chemical Society Symposium Series 613, 88–98. 3. Zhou. W.C. and Hu. W.S. (1994) On-line characterisation of a hybridoma cell-culture process. Biotechnology and Bioengineering 44, 170–177. 4. Harris. C.M., Todd, R.W., Bungard. S.J., Lovitt. R.W., Morris, J.G. and Kell. D.B. (1987) The dielectric permittivity of microbial suspensions at radio-frequencies: a novel method for the real time estimation of microbial bilmass. Enzyme and Microbial Technology 9, 181–186. 5. Davey, C.L. and Kell. D.B. (1995) The low-frequency dielectric properties of biological cells, in D. Walz. H. Berg and G. Milazzo (eds.), Bioelectrochemistry of Cells and Tissues, Birkhauser Verlag, Basel, Swizerland, pp. 159–207. 6. Cerckel. I., Garcia. A.. Degouys. V., Dubois. D., Fabry. L. and Miller, A.O.A. (1993) Dielectric spectroscopy of mammalian cells 1. Evaluation of the biomass o f HeLa- and CHO cells in suspension by lowfrequency dielectric spectroscopy. Cytotechnology 13, 185–193. 7. Blüml, G.. Reiter. M., Gaida. T.. Schmatz. C., Assadian, A.. Strutzenberger, K. and Katinger, H. (1994) Development of a new type of macroporous carrier, in R.E. Spier, J.B. Griffiths and W. Berthold (eds.), Animal Cell Technology, Butterworth-Heinemann, Newton, MA, USA, pp.267–269. 8. Degouys, V., Cerckel. I., Garcia. A.. Harfield. J., Dubois, D., Fabry. L. and Miller, A.O.A. (1993) Dielectric spectroscopy of mammalian cells 2. Simultaneous in-situ evaluation by aperture impedance pulse spectroscopy and low-frequency dielectric spectroscopy of the biomass of HTC cells on Cytodex 3. Cytotechno/ogy 13, 195–202. 9. Reiter. M., Borth. N., Blüml. G., Wimmer. K., Harant. H., Zach. N., Gaida. T., Schmatz, C. and Katinger, N. (1992) Flow cytometry and two-dimensional eletrophoresis (2-DE) for system evaluation of long term continuous perfused animal cell cultures in macroporous beads. Cytotechnology 9, 247–253.
10. Davey, C.L., Guan. Y., Kemp. R.B. and Kell. D.B. (1997) Real-time monitoring of the biomass content of animal cell cultures using dielectric spectroscopy, in K. Funatsu, Y. Shirai and T. Matsushita (eds.). Animal Cell Technology. Vol. 8, Kluwer Academic Publishers. Dordrecht, The Netherlands, pp.61–65. 11. Hayter. P.M., Curling. E.M.A., Baines. A.J., Jenkins, N., Salmon. I., Strange, P.G. and Bull, A.T. (1991) Chinese hamster ovary cell growth and interferon production kinetics in stirred batch culture. Applied Microbiology and Biotechnology 34, 559–564. 12. Guan. Y . Evans. P.M. and Kemp. R.B. (1998) Specific heat flow rate: .An on-line monitor and potential control variable of specific metabolic rate in animal cell culture that combines microcalorimetry with dielectric spectroscopy. Biotechnology and Bioengineenng (in press). 13. Wyllie, A.H. and Durall, E. (1992) Cell death, in J.O’D. McGee. P.G.Isaacson and N.A. Wright Oxford Book of Pathology, Vol. 1. Oxford University Press. Oxford. UK. Pp. 141–157. 14. Kemp, R.B. and Y. Guan (1998) Probing the metabolism of genetically-engineered mammalian cells by heat flux. Thermochimica Acta (in press).
327
Discussion
Godia:
The capacitance measurement you make, is it not at a constant frequency? You also mention the importance of changes in conductivity in the medium and that you correct them by on-line conductivity measurements in parallel to your electrical measurements.
Kemp:
This is done at a set frequency of 0.5 MHz. This is not necessarily ideal for every mammalian cell, and the system can be changed to other frequencies. For conductivity measurements the instrument is calibrated with a range of conductivities by adding salt. The instrument will automatically adjust for changes in conductivity because conductivity will affect the capacitance measurement.
Konstantinov:
You stated that there are two basic methods for measuring cell density: the optical and the capacitance. I believe they are not conflicting, but complementary, because the optical method measures total cell density and the capacitance measures viable cell density, so you can combine both signals to measure viability. Can you comment on this possibility, and would you need 2 sensors to do this?
Kemp:
I think it is a good point. We have not tried it because we cannot afford to buy the additional sensors. I think that it is an excellent way of going forward.
Al-Rubeai:
Putting additional sensors into a culture gets complicated. Why is it necessary to have on-line measurement of cell number or viability? A one off sample gives you opportunities for flow cytometry, which measures viability very simply.
Kemp:
We want to measure the specific rate of heat production, and the combination of heat flow and biomass measurements will allow you to control the culture. The advantage of heat flow is that it is an instant rate, you do not have to measure concentrations of things. So when the cells start to decline you can immediately adjust the conditions.
328
Ozturk:
Wurm:
A comment on Al-Rubeai’s question: if you are doing a batch culture, you do not need to measure cell density because you have to live with what you have. However, perfusion of fed-batch systems, would benefit from this especially in high density culture where conditions change fast. Do the size and number of gas particles in your reactor affect the electronics?
Kemp:
No, it is a sparged system and there is no problem because bubbles do not charge up.
MEASUREMENTS OF CHANGES IN CELL SIZE DISTRIBUTION TO MONITOR BACULOVIRUS INFECTION OF INSECT CELLS. ERNESTO CHICO1,2 and VOLKER JÄGER1. 1 Gesellschaft für Biotechnologische Forschung mbH Mascheroder Weg 1, D-38124 Braunschweig, Germany. 2 Center of Molecular Immunology POBox 16040, Habana 11600, Cuba.
Abstract We have found that the cell size distributions measured by a CASYTM cell counter can be used to follow the infection process of various insect cell lines. After infection, cell size deviates from the typical distribution of exponentially growing cells, shifting to an increased amount of cells with bigger cell diameters. This deviation has proved to be dependent on the MOI as well as time post-infection. A method is proposed to estimate the degree of infection of a population of insect cells based on the cell size distribution (CSD). The potential of using this method for measuring the ratio of infected to non-infected cells is discussed.
Experimental conditions Cell size distributions were measured using a CasyTM cell counter with a measuring capillary of 150 µ m. No more than 5000 cells per single measurement were counted to avoid particle clumping inside the capillary. Most of the experiments were carried out with the BTI-Tn-5Bl-4 (High Five™) cell line grown in suspension using fortified ExCell 401 serum-free medium. A recombinant AcNPV was used for infection. Main experimental observations During some stages of the baculovirus infection, there is a mixed population of
infected and non-infected cells in the culture. However, there is a lack of a simple experimental method to distinguish between infected and non-infected cells, which can be reliably used for a numeric estimation of the degree of infection (DOI) of the culture, refered as the fraction of infected cells in the population. Cell size distribution (CSD) of insect cells, measured by a CASY™ cell counter, do not change significantly during the batch growth curve (data not shown). On the contrary, during the infection process the CSDs of insect cells deviate from the typical distribution of exponentially growing cells, shifting to an increased amount of cells with bigger cell diameters. This deviation has proved to be dependent on the
multiplicity of infection (MOI) as well as on time post-infection as shown in Figs. 1 and 2. Our experiments prove that cell size clearly increases with the time post infection and with increasing MOI, becoming a potential early qualitative indicator of a successful infection process. This qualitative indicator of infection could help in decisions 329
O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 329-331. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
330
concerning virus transfection and propagation as well as during recombinant protein production.
From qualitative monitoring to numeric estimation of the degree of infection
Based on our experimental data as well as on the statistical nature of the CSD measurements a calculation method is proposed for numeric estimating of the degree of infection in insect cell populations using its CSD.
331 Principles of the method: • A population of insect cells
after infection can be regarded as a mixture of infected and uninfected (growing) cells. • The fraction of cells in the population, which can not be statistically described as uninfected
cells,
will
be
considered as infected cells.
This method has been calibrated using samples of known degree of infection, resulting in good linearity and reproducibility. However, interference could be expected from other events affecting cell size (formation of cell aggregates, oxygen limitation,etc.) Conclusions From the changes in the cell size distribution of insect cells after baculovirus infection, it was possible to develop a method of monitoring the degree of infection of insect cell populations. Since the measurement of cell size distribution is a reproducible and rapid technique, the detection of changes in cell size after infection represents a more simple
approach to evaluate the success of baculovirus infection in comparison with other techniques such as PCR, plaque assay or detection of protein production. The approach for numeric estimation of the number of infected cells presented in this work
is simple, reliable, and has a lot of potential applications in process design and control, mathematical modelling and provides a tool for better understanding of the kinetics of baculovirus infection. Acknowledgement We want to thank Schärfe System GmbH for providing financial support allowing E. Chico to attend ihe 15th ESACT Meeting.
This page intentionally left blank.
DEAD CELL ESTIMATION - A COMPARISON OF DIFFERENT METHODS
A. FALKENHAIN , TH. LORENZ*,U. BEHRENDT*, J. LEHMANN Cell Culture Technology, P. O. Box 100131, University of Bielefeld, Germany *Boehringer Mannheim GmbH, Nonnenwald 2, 82377 Penzberg, Germany
1. Introduction
The success of a mammalian cell cultivation depends on the ratio of viable and dead cells - the viability. The viability is routinely measured by the trypan blue exclusion method [1]. In short cultivation processes the density of viable cells normally is high. Therefore, the trypan blue exclusion method gives an exact value for the viable as well as for the dead cells. For longer cultivation processes e.g. fed batch or dialysis
fermentations the trypan blue exclusion only shows a snapshot of the status of the culture: cells which died previously might have lysed and cannot be determined
microscopically. Therefore, further methods were evaluated to determine the total amount of cells which had been present during the cultivation process at a given time: conductive electronical cell count (CASY 1®; Schärfe System GmbH, Reutlingen, Germany) [2], biochemical determination of lactate dehydrogenase (LDH) [3] and biochemical determination of DNA [4]. 2. Material and methods
Murine hybridoma have been cultivated in RPMI based media in 1000 1-bioreactors [5, 6]. The cell densities were determined using the Trypan blue (Cat. No. 15250-061, Life
Technologies GmbH, Eggenstein, Germany) exclusion method and the CASY l ® - Cell Counter and Analyzer System (Schärfe System GmbH, Reutlingen, Germany).The principle of this method is the change of the conductivity along an aperture during the flow of a cell containing liquid. A pulse area analysis is performed. The result of a measurement is a size distribution curve. A 150 µm capillary was used to detect particles between 3.4 and 30 µm in diameter. The LDH activity was measured using a test combination (Cat. No. 139 084, Boehringer Mannheim GmbH, Germany) which has been adapted for the determination of LDH on a Hitachi 705 analyser. The DNA concentration was measured by staining with bisbenzimide (Cat. No. B 1782, SigmaAldrich Chemie GmbH, Germany). The DNA-bisbenzimide complex is detected with a fluorescence photometer. 333 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 333-336.
© 1998 Kluwer Academic Publishers. Printed in the Netherlands.
334
3. Results and discussion
For the quantification of dead cells by analysis of LDH activity and DNA concentration their intracellular content had to be determined. The intracellular LDH activity is instable during a cultivation and has to be determined for each sample of a fermentation process. The intracellular DNA concentration is regarded to be constant and has to be
measured only once for a specific cell line. The number of dead cells was calculated as follows: Number of dead cells = c (LDH in supernatant) / c (LDH per cell) Number of dead cells = c (DNA in supernatant) / c (DNA per cell) where c means concentration. The size distribution curve of the CASY® method was
classified for three types of particles: 3.4 to 5 µm cell debris 5 to 10 µm dead cells and 10 to 30 µm viable cells. Distribution curves for samples of a cultivation taken at different fermentation times are shown in Figure 1A and 1B. During a course of fermentation the amount of cell debris ( 3 . 4 - 5 µm) as well as the amount of dead cells (5 - 10 µ m) increases significantly. For both values a linear correlation versus the number of dead cells estimated by the LDH method was observed. Since dead cells disintegrate in an unknown number of particles it is difficult to assign the counts (3.4 - 10 µm) to a number of dead cells. Therefore the counts in the range of 5 - 10 µm were used during the following considerations.
335
Figure 2 shows the time course of dead cells during a fermentation process determined by the four different methods.
The dead cells measured by the trypan blue exclusion method show an inconsistent course. The number is very low due to the fast disintegration of dead cells and depends on the operator. The DNA concentration gives a higher number of dead cells during the fermentation. During the last third of the process the concentration is constant which
might be due to an equilibrium between the release of DNA from the cells and the degradation of DNA in the culture supernatant. The increase of the DNA concentration is observed later than the increase of the LDH activity. This can be explained by the higher stability of the cells' nucleus in comparison to the cells themselves. An increase of the LDH activity during fermentation can already be measured after about 40 hours. This shows the high sensitivity of this parameter. Since the enzyme is highly stable (about 10 days in RPMI based medium) [3] cells which just have lysed as well as cells which lysed previously are included. The density of the dead cells determined by CASY 1® shows a similar course in comparison to the LDH method. Slightly higher values were obtained.
336
4. Acknowledgement Many thanks to ESACT which offered a bursary.
5. References 1) 2)
3) 4)
5)
Cook, J.A., Mitchell, J . B . (1989) Viability measurements in mammalian systems, ANALYTICAL BIOCHEMISTRY, 179, 1-7 Winkelmeyer, P., Glauner, B., Lindl, T. (1993) Quantification of cytotoxicity by cell volume and cell proliferation, ATIA, 21, 269-280
Goergen, J.L., Marc, A., Engasser, J. M. (1993), Determination of cell lysis and death kinetics in continuous hybridoma cultures from measurement of lactate dehydrogenase release, CYTOTECHNOLOGY, 11, 189-195 Loontiens, F . G . , McLaughlin, L. W., Diekmann, S., Clegg, R. M. (1991) Binding of Hoechst 33528 and 4', 6-Diamidino-phenylindole to self-complementary decadeoxynucleotides with modified exocyclic base substituents, BIOCHEM1STRY, 30, 182-189 Comer, M. J., Kearns, M. J., Wahl, J., Munster, M., Lorenz, Th., Szperalski, B., Koch, S., Behrendt, U., Brunner, H. (1990) Industrial production of monoclonal antibodies and therapeutic proteins by dialysis fermentation, CYTOTECHNOLOGY , 3, 295-299
6)
Behrendt, U, Koch, S., Gooch, D. D., Steegmans; U., Comer, M. J. (1994) Mass spectrometry: A tool for on-line monitoring of animal cell cultures, CYTOTECHNOLOGY, 14, 157-165
FED-BATCH CULTURE DEVELOPMENT BASED ON BIOMASS MONITORING
Eric DE BUYL1, Alan M AXWELL 2 and Luc FABRY1 1. SmilhKline Beecham Biologicals s. a., 89 rue de l’Institut, B - 1330 Rixensart 2. University of Paisley, High Street, Paisley PA12BE, Scotland
INTRODUCTION It is known that glucose level in the culture medium is an important parameter influencing mammalian cells physiology (for inst., see ref.l); growth, lactate accumulation, recombinant protein production and glycosylation are among the parameters likely to be affected. The aim of this work was to investigate the effect of glucose level on the growth parameters of a recombinant CHO cell line expressing a viral glycoprotein (glucose consumption, recombinant protein production); the development of a feeding policy was also tested; the principle of this policy was based on the knowledge of the specific consumption rate in various growth conditions and on the on-line measurement of the biomass with an optical density sensor.
M ATERIAL AND METHODS Batch, fed-batch and continous culture were realised at the 1,5L scale (B.Braun Biostat B bioreactors); the growth conditions were: proprietary protein-free medium, temperature 33°C (see ref.3 for a discussion on growth at sub-physiological temperatures), initial pH of 7,4, maintained above 7,2 through head-space aeration, dissolved oxygen 35% of air saturation through O2 sparging. During fed-batches, glucose level was maintained by glucose addition through manual adjustment of a peristaltic pump setting, based on off-line glucose concentration measurement (YSI glucose/lactate analyser). Seed culture were produced in disposable shake flasks (500 ml total volume, 150 ml of culture, 100 RPM), the PDL at the seeding being identical for each bioreactor scale.
Fed-batches were also realised at the 10L scale, in a bioréactor (MBR) equipped with a Wedgewood optical density sensor. Glucose level was maintained in the same way, except during automated feeding trial, where the setting of the pump was based on the optical probe reading through a calibration curve of glucose consumption vs. OD 337 O.-W. Merlen et al. (eds.), New Developments and New Applications in Animal Cell Technology, 337-342. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
338
The evaluation of the glucose effect was based on the determination of kinetic parameters : qs, specific glucose consumption rate; qp, specific rec.protein production rate; qlac, specific lactate production rate (expressed in mM/106 cells.hour for qs and qlac and in µg/106cells.hour for qp) and of the release of protease in the growth medium; cathepsin L was chosen as a marker because it was demonstrated previously for other recCHO lines that its release in the growth medium was strongly affected by growth conditions, even for equally high viabilities during the culture (always higher than 90% during all the cultures). The specific growth rate was estimated by fitting of the equation dX/dt = µX (SigmaPlot software) to the data of cell count in function of time.
The recombinant protein was analysed by Elisa and Western Blotting (Pharmacia Phast system), with detection either with a Mab or with various lectins, to obtain a preliminary assessment of the quality of its glycosylation (kit Boehringer n° 1210 238). RESULTS AND DISCUSSION
1. Glucose level effect on cell metabolism The biomass, glucose, lactate and recombinant protein concentration profile of three relevant 10L bioreactor trials are given in fig. 1.
339
The specific glucose consumption rate is decreasing during fed-batches (fig.3 a to d); the mean value of is higher for higher glucose concentrations (fig. 2); however, the value of is not very reproducible (trial E16 vs. trial E17 for instance); the effect of glucose concentration is less clear on (contrary to what has been observed by others (ref. 1); these tendencies are also observed during chemostat trials (fig. 2): is reduced two fold and five fold during glucose-limited chemostat (residual glucose 0,19 mM), but is hardly affected by glucose limitation.
340
2. Development of an automated feeding policy The linearity of the link between cell count and the reading of the Wedgewood probe is well established (fig.4). The specific glucose consumption rate is steadily decreasing during the cultures (fig.3a to 3d). A calibration curve, with plotted vs. optical density, was established on the basis of the results obtained during trial E12/E13 (fig 5). However, it can be concluded that the evolution of is not reproducible enough to be used in a robust automated glucose feeding system: the glucose level during the automated feeding trial (trials El6 and El7) increases indeed very quickly above the set point of 1.1 mM. The arrows indicates the point where manual adjustment of glucose feed is resumed (fig. 1)
341
A slight tendency toward a decrease in protease release with decrease in glucose concentration could be concluded from fed-batches results; this tendency is not confirmed by chemostat results (fig. 6).
Although it gives only a limited insight into the glycosylation pattern of the protein,
the blots (fig.7) revealed with MAA (Maackia amurensis) lectin suggests that only in the conditions of severe glucose limitation is the glycosylation affected (main band detected being splitted in two sub-bands); the blots for all fed-batches are similar to the one for chemostat at 8.5 mM residual glucose (results not shown). Since the protein of interest here is heavily glycosylated, the determination of its heterogeneity as described in ref.2 (densitometry of WB) is probably not possible (detection with other lectins gives a smear, presumably because of an heterogeneous glycosylation).
342
CONCLUSION The glucose concentration in the growth medium influences specific glucose consumption rate; however, a glucose limitation well below 1.1 mM is needed to modify the specific growth rate or the lactate production rate; the limitation of lactate production could be interesting to facilitate scaling up of the production, as far as pH control is concerned.
The specific recombinant protein production rate is not affected by glucose limitation; however, a detailed analysis of the glycosylation should be carried out on sample produced under glucose limitation; a modification of the glycosylation in these
conditions is indeed detected by a simple lectin blot. The extracellular protease release is hardly affected by the glucose level for this cell line. The growth is adequately described by fitting the cell counts with the equation dX/dt = µX (exponential growth); again, between 1.1 mM and 16 mM, specific growth rate is not affected by glucose concentration. The cell count is well predicted by the reading of the Wedgewood probe; the specific glucose consumption rate, however, is not reproducible enough to be used as part of a glucose regulation loop; this lack of reproducibility is probably partly due to slight, unnoticed, modifications of seed culture generation; a clear tendency of diminution of with glucose concentration can be detected in the trials carried out at various glucose concentration from 1.1 to 16 mM; however, this variation is not very reproducible in our conditions, leading to the failure of the feeding policy tested. KEYWORDS
rec CHO cell line, fed-batch, chemostat on-line measurement, optical density, specific glucose consumption, specific recombinant protein production.
REFERENCES 1. Fieder, J., Schorn, P., Bux, R. and Noé, W., Cytotechnology 14 (suppl. l, 2.15), 1994 Increase of productivity in recombinant CHO-cells by enhanced glucose level 2. Hayter, P. et al., Biotech.Bioeng. 39, pp.327-335, 1992 Glucose-limited chemostat culture of CHO cells producing recombinant hu-INF 3. Kretzmer, G. et al., Proceedings of the 14th Esact meeting, p. 319, 1997 Temperature - A factor influencing cell behaviour
ON-LINE MONITORING OF PROTEIN AND SUBSTRATE/PRODUCT CONCENTRATION IN MAMMALIAN CELL CULTIVATION PROCESS
H.Lübben, J. Hagedorn and T. Scheper Institut für Technische Chemie, 30167 Hannover, Germany
Introduction
The characterisation and optimisation of mammalian cell culture process requires an on-line monitoring of product as well as low molecular weight concentration. For this purpose an automated analyzer based on the principle of flow injection analysis (FIA) was developed. It is an modular and flexible three channel set-up containing pumps, different valves, oxygen electrodes with amplifiers, a fluorescence detector and space for buffer reservoirs. The system can be used to monitor protein concentration via immunoassay as well as substrat and product concentration by enzymatic reaction. Heterogenous immunoassay
For the heterogenous immunoassay product depending antibodies or protein G are immobilized on a polymer loaded in a flow-through cartridge.
After sample injection all target proteins bind to the antibodies and will be eluted after a washing step. The protein fluorescence is monitored at 280 nm (exc.) and 340 nm (em.), so that labeling of the analyte is not necessary. The advantages of this set up are: short analysis time in the range of 6-8 minutes for each cycle, no sample dilution is necessary. Furthermore the immuno components can be used several times, which is very economically due to the high costs of specific antibodies. 343 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 343-346.
© 1998 Kluwer Academic Publishers. Printed in the Netherlands.
344
Enzymatic Analysis
For the analysis of low molecular weight metabolites, enzymes are immobilized on a epoxy activated support material. The detection is carried out by amperometric measurement of oxygen consumption. This method allows simultanous determination of different analytes such as glucose, maltose, L-amino acids, saccharose and L-glutamine.
345
Sampling
To obtain a representative, cell free sampling from the reactor for FIA analysis, a tubular in-situ filtration probe was applied during cultivation process (ESIP, EppendorfNetheler-Hinz, Germany). The sampling module is compatible with 19 mm or 25 mm standard port of a bioreactor. For the module a polypropylene micro filtration membrane with a pore size between 0,2 and 0,6 µm is used, providing a sterile barriere that cannot be penetrated by any microorganism. The module contains a small dead volume of less than 2 ml, a large filter surface of nearly 40 qcm and new membrane sealings made of PTFE ferrules well, known in HPLC technique. Continuous and discontinous performance with flow rates up to 2 ml/min are possible. The sampling device can be sterilised together with the culture medium inside the reactor. Experimental data
The major advantages of both techniques are their high selectivity, the short analysis time (6-8 or 3 minutes) and that the immobilized components can be used several times.
Product concentration:
The comparison of HIA showed a good correlation to ELISA data with a deviation below 5 %. A higher accuracy was achieved (CV < 5%) using a triplicate sample determination. The HIA detection in this case was performed off-line. A higher frequency seemed to be not appropriate regarding the low specific production rates of animal cells. Using the ESIP sampling module the detection frequency can be increased up to every 6 minutes. In order to preserve the activity of the immobilised antibodies a frequency every 30 minutes is recommended.
346
Substrate concentration: As a main substrate in all mammalian cell culture processes glucose was chosen as a target for on-line monitoring and as a modell system. The comparison of on-line and offline data (YSI 2700 analyser) showed sufficient correlation of the concentration values. See Figure 5.
The interruptions and interferences pointed out as (1) (2) and (3) were caused by air bubbles on the amperometric electrode or by blocking of the tubing after microbial contamination.
Aknowledgements The authors would like to thank the European Commission Directorat General XII for supporting the participation in this meeting and the presentation of our research. Reference Hilmer, J.-M., Scheper, Th.: A new Version of an In situ Sampling System for Bioprocess Analysis. Acta Biotechnol.16 (1996) 2-3
PROCESS CONTROL AND ON-LINE FEEDING STRATEGIES FOR FED-BATCH AND DIALYSIS CULTURES OF HYBRIDOMA CELLS J. O. SCHWABE, R. PÖRTNER Technische Universität Hamburg-Harburg, und Bioverfahrenstechnik, Denickestr. 15, D-21071 Hamburg, Germany
1. Abstract The concept of the fed-batch strategy was to minimise the formation of inhibiting metabolites and to increase the yield of monoclonal antibodies by carefully supplying substrates. A process control system based on fieldbus technology was used for monitoring and control. External program routines were implemented to control dissolved oxygen (DO) and to calculate the oxygen uptake rate (OUR) and cumulative
oxygen consumption (COC) simultaneously. Concentrated feed solution was supplied according to the off-line estimated stoichiometric relation between oxygen and glucose consumption (GC). The developed feeding strategy initiated feeding automatically when the OUR decreased because of substrate limitation. Hybridoma cells were cultivated in batch and fed-batch cultures in laboratory scale using media containing an iron-rich, protein-free supplement. The antibody concentration increased three- to four-fold compared to the conventional batch culture when applying this strategy. It was not possible to avoid inhibition by metabolic products such as lactate and ammonium during fed-batch phase. This was accomplished by using dialysis and ‘nutrient-split’ feeding in a membrane dialysis reactor [Pörtner et al., 1997] and resulted in a ten-fold increase of the antibody concentration compared to the batch.
2. Cell Line and Culture Conditions The hybridoma cell line IV Fl9.23 is producing monoclonal IgG1 antibodies (MAb) against penicillin-G-amidase for the application in an affinity chromatography. Cultivation was carried out in a 1:1 mixture of Iscove’s MDM and Ham’s F12. The media was completed with and 1 % (v/w) of a protein-free, iron-rich supplement and Dolníková, 1991]. During the fed-batch phase and for ‘nutrient-split’ feeding a 10fold concentrated, salt-free nutrient solution containing amino acids and vitamins with 50 mmol l-1 glucose and concentrated glutamine solution (200 mmol l-1, Life Technologies were supplied separately. Dialysis cultivation was carried out in a membrane dialysis reactor (Bioengineering AG, CH) described by Pörtner et al. (1994). 347 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 347-349. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
348
3. Process Control System The process control (Fig. 1) was based on a field bus technology under a Unixcompatible real-time environment. Control platform (X-Control, Direct Digital Control) and data management (X-Manager) were working independently for process safety reasons.
4. On-line Characterisation using OUR On-line characterisation is a basic approach to describe metabolism and physiological state of the cells on-line. A process control system stores and controls measurable data. An user-interface enables the operator to change process parameters and to provide data from off-line analysis. Non-measurable variables, e.g. the oxygen uptake rate OUR and cumulative oxygen consumption COC, were calculated to describe the current metabolism. Based on these variables the feed flow was calculated on-line. Metabolic rate ratios and stoichiometric coefficients were calculated from off-line analysis. The stoichiometric coefficient described the ratio of oxygen and glucose consumption. This parameter was not constant during cultivation and was therefore regularly updated from off-line glucose analysis.
349
5. Results 5.1. FED-BATCH STRATEGY The feeding strategy was based on the coupling of on-line and off-line measurements and enabled the fed-batch operation without expensive on-line substrate analysis. The cell growth was characterised on-line using the oxygen uptake rate OUR and the feed was supplied based on the stoichiometric relation of glucose and oxygen uptake. The viable cell concentration and oxygen uptake rate OUR of batch, fed-batch and dialysis fed-batch are shown in Figure 2. The cell concentration in fed-batch increased 1.5-fold and the antibody concentration about 3-fold compared to the conventional
batch. The fed-batch strategy was not able to avoid inhibition by accumulated metabolites after 80 h cultivation time. 5.2. DIALYSIS FED-BATCH
The removal of inhibiting metabolites such as ammonia and lactate from the cultivation chamber using a dialysis membrane resulted in a 10-fold increase in the viable cell and antibody concentration compared to batch cultivation. Substrate utilisation was very efficient due to nutrient split feeding strategy. The concentrated feed was supplied to the culture chamber and buffer solution was used as dialysate in the dialysis chamber.
6. References and Dolníková, J. 1991. Hybridoma growth and monoclonal antibody production in iron-rich
protein-free medium: Effect of nutrient concentration. Cytotechnology 7: 33-38 Lüdemann, I., Pötner, R. and Märkl, H. (1995) ‘Nutrient-Split’ feeding strategy for dialysis cultures of hybridoma cells. Proceedings 8th JAACT meeting, Iizuka, Japan Pörtner, R., Bohmann, A., Lüdemann, I. and Märkl, H. (1994) Estimation of specific glucose uptake rates in cultures of hybridoma cells. Journal of Biotchnology 34: 237-246
This page intentionally left blank.
METABOLIC NETWORK ANALYSIS OF A HYBRIDOMA CELL LINE USING MASS BALANCES AND C 14 -LABELLED GLUCOSE AND GLUTAMINE
P.-A. RUFFIEUX, I.W. MARISON, U. VON STOCKAR Swiss Federal Institut of Technology LGCB - 1015 Lausanne, Switzerland
1. Introduction Continuous cultures of a hybridoma cell line (Zac3) were performed with two C14 labelled substrates: glucose and glutamine. A simplified network was used to describe the metabolism of the cells [1], see figure 1. The measurement of the main species consumed or produced by the cells allows one to solve the network and determine the rate of the 20 reactions. The use of labelled glucose and glutamine allows determination of very small fluxes with high accuracy. Thus it was possible to determine the flux of carbon to biomass and also the ratio of substrate which is degraded into carbon dioxide from glucose and glutamine. These results could be confirmed from those obtained by the network, for example the CO2 production rate.
2. Materials and Methods A hybridoma cell line (ZacJ) was grown into a CSTR of 1.5 liter working volume. When the stationary phase is reached, the standard medium is changed to labelled medium, with exactly the same composition, the only difference is that a part of the glucose or glutamine is radioactive. The labelled atoms of carbon are followed in the different phases: the biomass is collected and the activity measured, the exiting the reactor is trapped into NaOH, and the activity of the medium is determined after liquid chromatography, which separate the different metabolites (glutamine, lactate, alanine.etc). This method is describe elsewhere[2]. The specific rate of consumption or production of all the major components is determined according to the following equations: (1) IN-OUT + PRODUCTION = ACCUMULATION; Where : F=Flow rate of species i X=biomass concentration consumption rate of Production rate of 351 O. - W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 351-353. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
352
The specific oxygen uptake rate is determined with a balance around the liquid phase. With a constant D.O. and a determined experimentally, it is possible to calculate the oxygen transfer rate from a knowledge of the molar fraction of oxygen in the gas phase[3].
3. Results
The concentration of the main metabolites was determined by off-line analysis and the specific rates of consumption/production are summarised in table 1:
353
The use of glucose and glutamine enables determination of the fate of the C labelled atoms [2]. This supplementary information allows confirmation of the model used for the network and to determine some fluxes which are difficult to measure : production rate, due to the use of buffer to control pH. • Carbon assimilation into biomass, not possible to determine without tracers.
With the stoichiometric coefficients of the reactions in the network, a matrix A is defined and Ar=q. With r being a vector of the flux through the biochemical reaction and q the measured rates of change of extracellular metabolites. By solving this system, the rates r1 to r20 are obtained measured = calculated = Thus 92% of the 14C in glucose goes to lactate. In the network, this value could be approximate by the calculation of r 5 / r 4 = 89%
4. Conclusions This simple metabolic network gives a good idea of the main fluxes into the cell, especially for the catabolic reactions. This calculation requires only 7 rates of consumption. The use of labelled glucose and glutamine enables the metabolic routes to be followed with great accuracy, especially production rate. Normally this rate is difficult to measure due to buffer system used to control pH. Therefore it was possible to validate the results of the network. To use completely the information provide by the C-labelled experiments, it is necessary to write equations, which take into account the position of each C-atom in all reactions (Mapping equations). However, such networks are very complicated and it is difficult to perform the required measurements, since this would involve the use of substrate with the C-labelled at different positions of the structure, together with analysis of the position of the label in the product. 5. Reference 1. 2.
Zupke C. et. al. Intracellular flux analysis in hybridomas using mass balances and in vitro 13C NMR Biotechnol. Bioeng.(1994) Vol. 45 Pp. 292-303 Ruffieux P-A. et. al. Development of carbon balances for continuous animal cell culture using 14-C labelled glucose, Animal cell technology, (1997), Pp. 725-729
3. Oeggerli. A. et al. Online Gas-Analysis in Animal-Cell Cultivation .1. Control of Dissolved-Oxygen and pH. Biotechnol. Bioeng., (1995) Vol 45. Pp. 42-53.
This page intentionally left blank.
DYNAMIC
MEDIUM
OPTIMIZATION
BY
ON-LINE
HEAT
FLUX
MEASUREMENT AND A STOICHIOMETRIC MODEL IN MAMMALIAN CELL CULTURE
Y. GUAN and R. B. KEMP Institute of Biological Sciences, The University of Wales
Aberystwyth, SY23 3DA, UK
Abstract. Metabolic flow rate was detected on-line and in real time by a Heat Flux Probe for animal cell culture. For a model system, CHO320 cells producing recombinant human Interferon-γ (IFN-γ ), this probe identified different metabolic states during cell growth. These were then related to dynamic changes in glucose and glutamine consumption, which would allow optimization of the feeding medium. Based on heat flux measurement and the collected data from a stoichiometric model, dynamic optimization of the two substrates in a feeding medium would then be possible by automatically triggering two peristaltic pumps.
1. Introduction
To increase the production duration and the culturing density of animal cells, an important factor is to feed the cells with the correctly formulated medium. Except for continuous culture, cellular metabolic activity varies during the culturing time and therefore the composition of the medium should be changed to meet the dynamically altered optimal medium requirement [ 1.2]. To achieve this aim. a direct measurement of cellular metabolic activity is
necessary. Cells produce heat as an integral part of their metabolism and its flow rate thus is a measure of total metabolic rate. Heat flow rate is measured on-line by calorimetry and its quantity per amount of cell mass is known as heat flux. Among other methods dielectric spectroscopy was chosen to measure cell mass in real time. 2. Experimental
CHO320 cells were grown in an Applikon 3-L bioreactor system with BioXpert
software for data acquisition and controlled medium feeding. Measurement of heat flow rate was realized by an ex situ flow microcalorimeter and that of viable cell biomass by an in situ dielectric Viable Cell Monitor [3,4]. 3. Results and Discussion
The data depicted in the figure are used to justify, by a thermochemical approach, the following growth equation: 355 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 355-357. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
356
The growth reaction is easily be characterized by its set of stoichiometric coefficients,
An important concept in the present work on the stoichiometric growth equation is that the set (matrix) of stoichiometric coefficients has a one-to-one corresponding
relationship to the metabolic status of the entire cell population [5]. If the metabolic status is expressed by the metabolic rate, this means that: (3)
where is advancement of eq. (1) and is the metabolic rate in terms of the growth equation. Eq. (3) clearly delivers the experimental strategy for optimizing cell growth and the production of target proteins, i.e. the on-line
diagnostics of cellular metabolic requirement can be achieved by on-line measurement of heat flux. For empirically divided time intervals in growth, the data are incorporated into the equation to obtain stoichiometric coefficients, see table 1 below.
The results show that the heat flux probe is an early and sensitive indicator of the changing metabolic state of cells. Since the production of the target protein deteriorates
with these changes, action must be taken to retard the metabolic decline. Analysis of stoichiometric coefficients at different time intervals showed the changing cellular requirement for the relative amounts of major catabolites.
357
For the present purpose, metabolic states are considered to be directly associated with the cellular metabolic rate whereas external physiological conditions are the extracellular environmental conditions in which the cells grow. Although different, they decrease in the same direction for a deleterious physiological condition, which thus will negatively affect the metabolic state, reducing the metabolic flux either for the cell growth or for the target protein production, or both. This implies it is possible to detect worsening physiological conditions using heat flux and then decide when to add fresh medium. The classical approach to this problem is fed-batch culture. The
difficulties here are to know when to add more nutrient and in what quantities. The use of on-line heat flux measurement can solve these by at least the following: (a) timing of feeding — as the heat flux curve decreases to a certain extent, medium is automatically fed by a control loop; (b) quantity of feeding — the basic approach would be to feed the cells with the correct relative amounts of the major substrates. For instance, to
maintain the maximal growth of CHO320 cells, glucose and glutamine should be fed by a molar ratio of 2.7 to 1 in the fast growing period (Table 1).
A more refined approach would be to feed the cells continuously at a rate determined by heat flux and dependent on the consumption rate of major substrates in their correct molar ratio. The same approach would be possible for the same cells grown on macroporous beads. Furthermore, since the increase in the proportion of unwanted heterogeneous proteins is also a reflection of worsening physiological conditions, it is likely that heat flux can also be used to monitor the quality of the products, typically glycoproteins
The heat probe in this work is a robust, reliable and novel biosensor for on-line use in cell culture. It detects total metabolic rate and changes in it. which are related to alterations in substrate consumption rates leading to their depletion. The stoichiometric approach has shown the actual substrate requirement of CHO320 cells for growth. In the fed-batch method advocated here, the cells are given substrates in the molar ratio determined by the stoichiometric coefficients. In recombinant cells, this would sustain production of foreign proteins and should lead to much needed improvements in quality. Acknowledgments: Y.G. was the recipient of a generous bursary from ESACT. The project is funded by the Biotechnology and Biological Sciences Research Committee (UK) under grants 2/3680 and 2/TO3789.
4. References 1.Kemp, R.B., Evans, P.M. and Guan, Y. (1997) An enthalpy balance approach to the study of metabolic activity in mammalian cells. .J. Thermal Anal., 49, 755-770. 2.Kemp. R.B. and Guan, Y., (1997) Heat flux and the calorimetric-respirometric ratio as measures of catabolic flux in mammalian cells, Thermochim. Acta 300, 199-211. 3.Guan, Y., Lloyd, P.C., Evans, P.M. and Kemp, R.B. (1997) A modified continuous flow microcalorimeter for
measuring heat dissipation by mammalian cells in batch culture, J. Thermal Anal., 49, 785-794. 4.Guan, Y., Evans, P.M., Kemp, R.B. (1998) Specific heat flow rate: An on-line monitor and potential control variable of specific metabolic rate in animal cell culture that combines microcalorimetry with dielectric
spectroscopy, Biotechnol. Bioeng. (in press). 5.Guan, Y., Kemp, R.B., (1996) Medium design with the aid of heat flux measurement in mammalian cell culture, in BioThermoKinetics of the living cell, eds. H.V. Westerhoff, J.L.Snoep, F.E.Sluse, J.E.Wijker and B.N. Knolodenko, pp. 387-397, BTK, Amsterdam.
This page intentionally left blank.
MODELING OF GLYCOPROTEIN PRODUCTION BY CHINESE HAMSTER OVARY CELLS FOR PROCESS MONITORING AND CONTROL J. STELLING*, R. K. BIENER*, J. HAAS†, G. OSWALD†, D. SCHULLER† W. NOE† and E. D. GILLES* * Institut für Systemdynamik und Regelungstechnik, 70550 Stuttgart, FRG †Dr. Karl Thomae GmbH, 88397 Biberach, FRG Abstract
Substantial improvements of animal cell culture process performance can be achieved by model-based methods of process optimization and control. Here, a structured mathematical model describing the dynamics of Chinese hamster ovary (CHO) cell growth and recombinant glycoprotein production has been developed. It covers the main aspects of cell metabolism as well as aspects linked to cell cycle regulation. Model predictions fit well to experimental data obtained from fed-batch cultures and allow for insight into the complex behaviour of CHO cells in culture. Model-based improvement of feeding trajectories is shown. Further applications for process monitoring and control are discussed.
1 Introduction In animal cell culture technology, substantial improvements of process performance can
be achieved by model-based methods of rational medium design, feeding strategy optimization and on-line monitoring and control. When applied to fed-batch processes, these methods can enhance growth and production efficiency by reducing growth limitations due to depletion of essential nutrients (e.g. glucose and amino acids) and / or accumulation of toxic by-products (e.g. ammonia and lactate). [1,2] Whereas most research in this area is focused on monoclonal antibody production by hybridoma cell lines [1,2], here a structured mathematical model describing the dynamics of CHO cell growth and recombinant glycoprotein production has been developed. As an exemplary application, the model-based improvement of feeding trajectories in laboratory scale fed-batch fermentations is shown.
2 Model structure
The CHO model is composed of two main modules: A cell cycle part including the subpopulations of phase cells (producers), phase cells (non-producers) and dead cells is used to describe population dynamics. Phase transitions are assumed to be 359 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 359-361. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
360
governed by the accumulation of cell-cycle phase specific cyclins and by cell size. The mathematical formulation results in the two-dimensional population balance
(1) with f: number density function, cell volume, intracellular cyclin concentration, velocities, source/sink, subpopulation index and time. The complementary metabolic part has been designed as a cybernetic model. For a close representation of cell physiology, the model includes the main metabolic pathways (glycolysis and PPW, citrate cycle, amino acid metabolism), metabolite production, formation of cellular components (proteins, lipids, nucleotides) and product, energy metabolism (ATP, NADH) and growth control by essential amino acids / toxic by-products [1].
3 Simulation results A series of CHO fed-batch fermentations has been used for parameter estimation. As shown in Fig. 1, simulation results agree well with experimentally observed time series.
Analysis of model simulations furthermore allows for the identification of growth-limiting steps, e.g. amino acid uptake rates and ATP generation as well as the plausible prediction of unmeasured variables, e.g. share of subpopulations and average cell size (Fig. 2).
361
4 Application: Feed design
The model-based optimization of the feed composition lead to a feed medium including lower glutamine concentration and higher levels of specific essential amino acids.
As a result - compared to a standard fed-batch fermentation - significantly higher cell yields and an increase in final product concentration have been achieved (Fig. 3).
5 Concluding remarks
The mathematical model presented is able to give a good description of CHO growth and production dynamics. Compared to purely metabolic models [1,2] or other combined cell-cycle / metabolic approaches [3], it provides a closer, modular representation of many aspects of cell biology. Model-based feed design serves only as one component of an integrated approach to process improvement. Further steps include complete off-line process optimization, on-line monitoring and (model-predictive) control [1].
6 Acknowledgements
This work was supported by the State Government of Baden-Württemberg (FRG) and Dr. Karl Thomae GmbH (Biberach, FRG).
7
References [1]
Biener, R.K. et al. (1996) Model-based control of animal cell cultures, in M.J.T. Carrondo, B. Griffiths and J.L.P . Moreira (eds.), Animal cell technology: from vaccines to genetic medicine, Kluwer Academic Publishers, pp. 639-645
[2]
Xie, L. and Wang, D.I.C. (1996) High cell density and high monoclonal antibody production
[3]
Martens, D.E. et al. (1995) A combined cell-cycle and metabolic model for the growth of hybridoma cells in steady-state continuous culture, Biotechnol. Bioeng. 48, 49-65
through medium design and rational control in a bioreactor,Biotechnol. Bioeng. 51, 725-729
This page intentionally left blank.
THE TEMPERATURE EFFECT IN MAMMALIAN CELL CULTURE AN ARRHENIUS INTERPRETTION
Gerlinde Kretzmer1, Torsten Buch1, Konstantin Konstantinov2, David Naveh2 1Institut für Technische Chemie, University Hannover, Germany 2Bayer Corporation, Pharmaceutical Division, Berkeley, USA
Introduction
Recently cultivation temperature has become of interest for process characterisation and optimisation for research and manufacturing. All chemical and biochemical reaction are known to be temperature dependent. Therefore, one expects reactions rates going down with reducing the cultivation temperature. Results show that the reduction in rates is different for different reactions. The primary metabolism is influenced by reducing the temperature, while the secondary metabolism especially the protein production is not effected or even improved. Cell growth rate as a bulk of reactions taking place is slowed down with temperature reduction in most cases. The extend to which the reduction will occur depends on the specific reaction studied. All reactions follow the thermodynamical rules and Arrhenius was the first to set up a mathematical equation to explain the relationship between chemical reaction rates and temperature. Material and Method
Data from Batch cultures of different cell lines were used for the calculations: adherent BHK 21, suspension rBHK, rCHO I, rCHO II, hybridoma. The cultivations of the adherent BHK were carried out in serum containing medium, the other in serum free medium. Data from continuous cultivation of rBHK (FVIII) were used.
For many reactions the rate expression can be written as a product of a temperaturedependent term and a composition term, or ri = f1 (temperature) * f2(composition) = k*f2(temperature) 363 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 363-366. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
364
For such reactions the temperature-dependent term, the reaction rate constant, has been found in practical all cases to be well represented by Arrhenius´law:
This was found true also for enzyme-activity-temperature relationship. For a small temperature range Arrhenius´law is also applicable for microbial cultivations.
For example the cell growth can be described as follows:
This can be plotted as an Arrhenius plot:
This equals Similar equations can be set up for metabolic reactions and for product formation. With quasi-linear regression of the following form
the activation energy and the frequency factor can be calculated. Results and discussion
Growth rate (Fig. 1) All cell lines show a decrease in growth rate with decreasing temperature. The non recombinant BHK and the hybridoma show a steady decrease whereas the recombinant cell lines show stable or better growth rate between 37 and 33°C.
365
Arrhenius plot growth rate (Fig. 2) All cell lines show two different slopes in their Arrhenius plots. The plot of the recombinant cell lines and the hybridoma have an area with a steep slope and one with
a flat slope. The non recombinant BHK cell line has two areas with nearly the same slope, separated by a plateau. Arrhenius plot growth rate and oxygen uptake rate of rBHK (Fig. 3) Again a two stage relationship occurs for the growth rate as seen with other
recombinant cell lines. The relationship between ln (OUR) and 1/T is linear.
366
Arrhenius plot glucose consumption rate and productivity of rBHK (Fig. 4) A linear relationship of ln (Glucose) and 1/T occurs. Specific glucose consumption rate is decreasing with decreasing temperature. The relationship between ln(Productivity) and 1/T is also linear but the slope is reverse. The specific productivity is increasing
with decreasing temperature Conclusions
The Arrhenius plot of the growth reaction is only in very small temperature range linear. For all the recombinant cell lines the activation energy at higher temperature differs from that a lower temperature. In between there is a temperature range where the activation energy does not change with temperature. There the activation energy.
is independent from
The kinetic reactions of glucose consumption, lactate production and oxygen uptake follow Arrhenius´ law linearly. The activation energy of those reaction lies in the range of 80 to 140 Ws/mol. The Arrhenius plot of the production reaction shows a negative slope at lower temperature. This would lead to a negative activation energy which is thermodynamical senseless.
The product formation is a very complex system build up of many single reaction steps. From the Arrhenius plot one can assume that at higher temperature one of the reactions must be inhibited . This occurs also by the cell growth: If the temperature is high enough the growth decreases because of the denaturation of proteins. Summary Cell growth and the primary metabolic reactions can be represented by Arrhenius´ law. That means Arrhenius´ law can be used for a process model in a small temperature range. For the product formation this simple approach is not sophisticated. The kinetic
approach for the production has to be studied furthermore.
INTEGRATED PROCESSES
AND SCALE-UP
This page intentionally left blank.
DIELECTROPHORETIC FORCES CAN BE EXPLOITED TO INCREASE THE EFFICIENCY OF ANIMAL CELL PERFUSION CULTURES N. KALOGERAKIS1, A. DOCOSLIS2 AND L. A. BEHIE3 1 Laboratory of Biochemical Engineering & Environmental Biotechnology
Technical University of Crete, Chania 73100, Greece Bioengineering Laboratory, Dept. of Chemical Engineering State University of New York, Buffalo, NY 14260 USA 3 Pharmaceutical Production Research Facility (PPRF), Faculty of 2
Engineering The University of Calgary, Calgary, Alberta, Canada T2N 1N4
1.
ABSTRACT
Dielectrophoresis is a well established and effective means for the manipulation of viable cells. Various applications have been found, ranging from electrofusion, to individual cell manipulation, and to differential separation from cell mixtures. Its effectiveness, however, greatly depends upon the utilization of very low electrical conductivity media. High conductivity media, as in the case with cell culture media result only in negative dielectrophoresis (i.e., induction of weaker repulsive forces) and excessive medium heating. Recently, a dielectrophoresis-based cell separation device (DEP-filter) has been developed for perfusion cultures that successfully overcomes these problems and provides a very high degree of viable cell separation while most of the nonviable cells are removed from the bioreactor by the effluent stream. The latter results in high viabilities throughout the culture period and minimization of lysed cell proteases in the bioreactor. However, an important question that remains to be answered is whether we have any adverse effects by exposing the cultured cells to high frequency dielectrophoretic fields for extended periods of time. A special chamber was constructed to quantitate the effect under several operational conditions. Cell growth, glucose, lactate and monoclonal antibody production data suggest that there is no appreciable effect and hence, operation over long periods of time of our DEP-filter should not have any adverse effect on the cultured cells. 2.
INTRODUCTION
Perfusion cultures represent the most cost effective mode of operation for the large scale production of therapeutic proteins, such as HBAg, tPA, erythropoietin, monoclonal antibodies, etc. The main characteristic of a perfusion culture is the retention of the cells in the bioreactor, i.e. no cells are removed by the effluent stream which results in high cell densities, increased volumetric productivity and reduced downstream purification requirements. A suitable cell retention device, located in the effluent stream of the bioreactor, is an important part of a cell perfusion bioreactor system. Existing cell retention systems are based on sedimentation, centrifugation or conventional filtration techniques and are subject to significant limitations. A recent device3, 17 that employs ultrasonic resonance fields to transiently aggregate animal cells and are intermittently
settled back in the bioreactor has also several limitations. The main disadvantage being its inability to selectively separate viable from nonviable cells and second the high power 369 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 369-375.
© 1998 Kluwer Academic Publishers. Printed in the Netherlands.
370
requirements that can cause excessive medium heating with possible detrimental effects to cellular viability. As an alternative to the existing devices, we have developed a cell retention device based on the exploitation of dielectrophoretic (DEP) forces4. Dielectrophoresis is the motion of neutral particles (e.g., spheres, bubbles, biopolymers, biological cells, etc.) under the influence of a divergent electric field. Numerous techniques have been developed using dielectrophoresis that include electroporation,37 electrofusion, 1,14,18 electroinjection, 13 measurements of the dielectric properties of the cell,6,7,10 as well as cell separation in low conductivity media.2,8,1112,15 We have recently shown that there is a frequency range where selective separation of the viable from non-viable cells is achievable in high conductivity media typically found in cell culture systems4. As Fuhr et al.5 has also shown using anchorage dependent mouse fibroblasts, cell separation in highly conductive culture media can only be achieved under negative DEP, using high frequency AC fields. Their results were also encouraging in that no adverse effects due to continuous exposure of the cells to high frequency electric fields were detected. They found that high field frequencies (above 10 MHz) had no significant effect on cell growth. In this present work, we examine whether there are any adverse effects by exposing the cultured cells to high frequency dielectrophoretic fields for extended periods of time. A special chamber was constructed to quantitate the effect under several operational conditions. Cell growth, glucose, lactate and monoclonal antibody production data are presented here that have been obtained from cultured cells exposed to high frequency dielectrophoretic fields over long periods of time. Finally, the inherent capability of the DEP-filter for preferential removal of apoptotic bodies is also discussed. 3.
MATERIALS AND METHODS
The murine lymphocyte hybridoma HFN 7.1 producing an IgG antibody reactive with human fibronectin (ATTC: CRL-1606) was used in these experiments. The cell culture medium was DMEM (Dulbecco's Modified Eagle's Medium, Sigma) supplemented with 10% Fetal Bovine Serum (Gibco/BRL). In addition CHO/dhfr- cells (ATCC: CRL-9096) were grown in EMDM (Iscove's modified Dulbecco's medium) supplemented with 4 mM L-glutamine, 0.1 mM hypoxanthine and 0.01 mM thymidine and adjusted to contain 1.5 g/L sodium bicarbonate and 10% FBS after adaptation to grow in suspension.. The cells were grown in suspension in a suitably modified (open bottom) polycarbonate vial at 37°C in a 5% and humidity controlled incubator. The bottomless vial was glued onto an oxidized silicon wafer where a grid of micro-electrodes were deposited. In this case the silicon was not etched through in the areas between adjacent electrodes as the case is for the construction of the DEP filter. We simply wanted to grow the cells in the vicinity of the electrodes and quantify any adverse effects from the exposure to the high frequency electrical fields. The analysis of glucose and lactate was done by an YSI-2700 analyzer, the aminoacids by HPLC (HP1090), the MAb by ELISA and cell viability by trypan blue. 4.
THEORY
The net time-averaged induced dielectrophoretic force for AC electric fields is directly proportional to the cell volume, the real part of the medium permittivity, and the gradient of the electric field intensity squared, E 2 (rms value), i.e.,
371
where r is the cell radius and is the intensity of the electric field. The frequency dependence of the induced DEP force is given by the dimensionless Clausius-Mossotti function,
where the underlined parameters denote complex quantities. The complex permittivity of the surrounding medium is given by where and is the angular frequency of the applied field. According to the single-shell model,9,10 the cell can be represented as an ohmic, spherical particle, enclosed by a thin insulating shell (cellular membrane). The transmembrane conductance and surface conductivity are assumed to be negligible since mammalian cells do not have a cell wall and their membrane thickness is at least three orders of magnitude smaller than their cell radius15,16. If, furthermore, the cell cytoplasm is modeled as a linear ohmic dielectric fluid (i.e., there are no dielectric losses) of permittivity and conductivity the resulting effective cell permittivity is given by 9
where is the area-specific membrane capacitance and constants. As shown in Equation (1), the real part of The sensitivity of
are time is directly related to
to cell size and various other electric parameters over a wide
frequency range have been discussed elsewhere4. Having estimated the unknown parameters in through a series of levitation experiments, one can plot versus and determine the frequency range where we can have preferential cell retention of viable cells in the bioreactor through the action of negative dielectrophoretic forces and withdrawl of nonviable cells by the effluent stream4. 5.
DESCRIPTION OF THE DEP-FILTRATION SYSTEM
The DEP-filter, shown in Figure la, can be briefly described as a grid of micro-electrodes deposited on a silicon substrate, with the silicon etched through in the areas between adjacent electrodes. The filter was made using photolithography and silicon microfabrication techniques. The electrodes are made of gold deposited on a chromium layer. Structural details can be found elsewhere4. The DEP-filter is mounted at the bottom of a housing device and the whole unit is submerged in the cell suspension. A schematic diagram with details of the whole system is given in Figure 1. A schematic of the forces acting on viable and nonviable cells as well as their expected trajectories in the vicinity of the DEP-filter is shown in Figure 2. Our first results have shown that, at low flow rates, the retention of the viable cells can be very high (up to 98%) whereas it is extremely low, often below 15%, for nonviable cells regardless of the operating conditions. The latter is an indication that cell debris does not experience any dielectrophoresis. It was also shown that the retention of viable cells is subject to many factors, such as frequency of the applied electric field, voltage across the filter electrodes and flow rate of the effluent stream4.
372
6.
EXPERIMENTAL RESULTS & DISCUSSION
A series of experiments were designed to examine whether cells staying in the vicinity of the DEP-filter electrodes suffer from adverse effects. In a typical perfusion culture due to bulk agitation, the cells are expected to arrive and stay near the DEP electrodes only for a short period of time. To emulate this, we applied a high frequency (10 MHz) electric field (25 V pk to pk) intermittently. However, we were unable to see any adverse effect. Hence, it was decided to expose the cells continuously and examine if any changes in their growth characteristics and metabolism can be observed. In figure 3, the results from three subcultures of HFN 7.1 cells are shown. Actually the last subculture was monitored throughout the stationary phase. Comparison of viable cell density, viability, glucose uptake, lactate production as well as monoclonal antibody production data between the DEP-culture and the control suggests that there are no adverse effects. Similar results were obtain for 15 aminoacids measured by HPLC analysis (data not shown). These experiments are quite conservative as in an actual perfusion culture, the cumulative exposure of the cells is expected to be much less. Similar results shown in Figure 4 are obtained from another series of experiments using CHO cells adapted to grow in suspension.
373
374
7.
REFERENCES
1. Abidor, I.G. and Sowers, A.E. 1992. J. 61: 1557-1569. 2. Archer, G.P., Render, M.C., Betts, W.B. and Sancho, M. 1993. Microbios 76: 237-244. 3. Doblhoff-Dier, O., Gaida, T., Katinger, H., Burger, W., Gröschl, M. and Benes, E. 1994.
Biotechnol. Prog. 10: 428-432. 4. Docoslis, A., Kalogerakis, N., Behie, L.A., Kaler, K.V.I.S. 1997. Biotechnol. Bioeng. 54: 239-250.
5. Fuhr, G. Glasser, H., Müller, T. and Schnelle, T. 1994. Biochim. Biophys. Acta 1201: 353-360. 6. Gascoyne, P.R.C., Becker, F.F. and Wang, X.-B. 1995. Bioelectrochem. Bioenerget. 36: 115-125. 7. Gimsa, J., Marszalek, P., Loewe, U. and Tsong, T.Y. 1991. Biophys. J. 60: 749-760. 8. Huang, Y., Wang, X.B., Tame, J.A. and Pethig, R. 1993. J. Phys. D: Appl. Phys. 26: 1528-1535. 9. Kaler, K.V.I.S. and Jones, T.B. 1990. Biophys. J. 57: 173-182.
10. Kaler, K.V.I.S., Xie, J.P., Jones, T.B. and Paul, R. 1992. Biophys. J. 63, 58-69. 11. Krishna, G.G., Anwar, A.K.W., Mohan, D.R. and Ahmad, A. 1989. J. Biomed. Eng. 11: 375-380.
12. Markx, G.H., Talary, M.S. and Pethig, R. 1994. J. Biotechnol. 32: 29-37. 13. Neil, G.A. and Zimmermann, U. 1993. Methods in Enzymology 221: 339-361. 14. Neumann, E., Sowers, A.E. and Jordan, C.A. 1989. Electroporation and Electrofusion in Cell Biology. Plenum Press, New York-London.
15. Pohl, H.A. 1977. In: Methods of cell separation (N. Catsimpoolas, ed.), Plenum Press, New York, vol.1, 67-169. 16. Sukhorukov, V.L., Arnold, W.M. and Zimmermann, U. 1993. J. Membrane Biol. 132: 27-40 17. Trampler, F., Sonderhoff, S.A., Pui, P.W.S., Kilburn, D.G. and Piret, J.M. 1994. Bio/Technol. 12: 281-284.
18. Zimmermann, U. 1986. Rev. Physiol. Biochem. Pharmacol. 105:176-256.
375
Discussion Al-Rubeai:
Have you done any work on the effect of cell density on cell retention?
Kalogerakis:
I only showed low cell densities (1 million cells/ml) as our prototype broke - it is very sensitive which is why we are moving away from it. There are problems, eg gas bubbles, so we incline the device by 40°, and pearl chains form, but we can overcome this problem with agitation. Your perfusion rate is going to be a constrained variable, so I was wondering if you have explored differences in field strength? Also, what are the practical limits for nano fabrication for the area?
Aunins:
Kalogerakis:
It is superficial velocity, and not perfusion rate, which limits the operation. The open area was 1.5 cm by 2 cm for a 1.5 1 fermenter working at 2 volumes per day. So it is not bulky and can be used in a modular battery.
Reuveny:
Do you look for the small ions in your medium?
Kalogerakis:
If you mean current going through the medium, yes, this is a serious problem. This is why we coat the electrodes with silicon dioxide, which is an insulator. An electrical field does exist and this poses problems in terms of manufacturing from the microfabrication point of view.
This page intentionally left blank.
USE OF A NEW MICROCARRIER WITH TWO-DIMENSIONAL GEOMETRY FOR THE CULTURE OF ANCHORAGE-DEPENDENT CELLS IN SONOPERFUSED, CONTINUOUSLY STIRRED TANK REACTORS
C. GATOT(1),
F. TRAMPLER(2), (3)
M.-P. WANDERPEPEN(1), (4)
J. HARFIELD , A. OUDSHOORN , A. JOHANSSON(5), (5) (6) V. NIELSEN , A.O.A. MILLER (1) Computer Cell Culture Center s.a. (Mons, Belgium) ; (2) Sonosep Biotech Inc (Vancouver, Canada) ; (3) Coulter Electronics Ltd (Luton, UK) ; (4) Applikon Dependable Instruments (Schiedam, Holland) ; (5) Nunc A/S (Roskilde, Denmark) ; (6) Biochimie/Technologie Cellulaire - Faculté de Médecine - Université de Mons-Hainaut (Mons, Belgique)
Dextran-based microbeads characterized by a 3-dimensional geometry (3D microsupport), on the surface of which anchorage-dependent cells (ADC's) attach and multiply, constitute a reference for the large scale cultivation of this type of cells. Using commercially available 3D microsupport at 5 g/L, allows one to reach cell concentrations around cells/ml, some 7 % of the culture volume being occupied by the microcarrier. Growing ADCs to higher cell densities can be obtained by increasing the concentration of the microsupport. However there rapidly conies a moment when the volume of the swollen microbeads becomes so high as to represent an important proportion of the culture volume, decreasing accordingly the volume of the growth medium available to the cells. Macroporous microbeads accomodate more cells per unit volume but their highly convoluted inner structure makes quantitative release of cells very difficult without extensive trypsinisation. Recently, a new generation of microcarriers with 2D geometry has been made available for evaluation. Photo 1 gives the rationale underlying their manufacture. It shows that the outside surface of the microbead available for cell growth equals the sum of the surfaces of two superimposed very thin discs situated at the equator. However the combined volumes of two such discs which becomes smaller the thinner the film used to manufacture them (Blodgett's monomolecular films would be ideal in this respect), represent only a very small fraction of the volume of the corresponding sphere (2D microhexagons cut from 25 microns thick polystyrene films have been preferred to discs since their manufacture generates less wastes (Photo 2). The characteristics of the 2D microhexagons used in this study are given in Table I. 377 O.-W. Merten et al. (eds.). New Developments and New Applications in Animal Cell Technology, 377-380. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
378
Photographs 3 and 4 give the growth kinetics of mouse L929- and Muntjac cells respectively.
379
Additional results also obtained from batch cultures conducted this time at at confluency) with 2D microhexagons suggest that still higher cell concentrating could be obtained provided the surface made available to cells is further increased and the growth medium renewed by perfusion. Acoustic perfusion is a re cently developed technology whereby isolated cells in suspension can be grown at concentrations of and higher. In this system, isolated cells in suspension accumulate at the nodes of a resonating acoustic wave. At regular intervals, in order to empty the resonating chamber, the accumulated cells are aspirated back into the culture by means of the suspension culture continuously recirculating at the apex of the resonating chamber at twice the perfusion rate. To adapt this technology to the cultivation of ADC's, recirculation is strictly prohibited since it would provoke extensive detachment of the cells from the microsupport. Sonoperfusion at 4L/day (4 culture volumes/day), of a 1L culture containing naked 2D microhexagons (8,75 g/L) shows few if any microsupport particles reaching the acoustic chamber. This effect is interpreted as being the result of the long (± 14 cm) large bore tube bringing the microcarrier suspension to the transducer playing the role of a settling tube. To compensate for the observed decreased density of cell-laden 2D microhexagons, a culture of 750 ml (inoculated with 7,5 g of microcarrier and
380
) is perfused at l,5L/day only (2 culture volumes/day). Three days after inoculation the cell concentration reaches allowing the collection of close to the maximum theoretical value of This 91,5 % recovery is obtained without recourse to trypsinisation by simply forcing several times the cell-laden 2D microhexagons suspension in 0,2 % EDTA-PBS through the orifice of a 25 ml capacity pipette. Provided means are found to prevent cell-laden 2D microhexagons from escaping through the resonating acoustic wave when very high perfusion rates are used, our results suggest that cell concentrations of can be routinely obtained with the microsupport occupying only some 30 % of the total culture volume, making it envisageable to reach even higher cell concentrations in the future. Discussion Anon:
Do you see aggregation of the carriers in the acoustic field or later in the reactor?
Miller:
The microcarriers-carriers align perfectly at the nodes of the wave and when they are returned back to the suspension they are totally isolated.
Ozturk:
What limits the cell density: just cell retention, particle number, oxygenation, or microcarrier concentration?
Miller:
We have enough microcarrier area to support 25 million cells/ml, theoretically.
Ozturk:
Do you sparge?
Miller:
No, we have tried horizontal semi-permeable tubing but the microcarriers sick horizontally. So now we are using a Braun device which is placed vertically.
Aunins;
Comparing the spherical and flat carriers, you need twice as many particles for the same surface area and they need inoculating on both sides. Do the inoculum requirements practically limit the multiplication ratios and scale-up?
Miller:
Our work is so preliminary that I cannot really answer your question. Starting in batch culture, we are reasonably confident that we can reach the theoretical results which we anticipate.
EVALUATION OF POROUS MICROCARRIERS IN FLUIDIZED BED REACTOR FOR PROTEIN PRODUCTION BY HEK 293 CELLS
M.A. VALLE1,2, J. KAUFMAN1, W.E. BENTLEY2, J. SHILOACH1 1. Biotechnology Unit, NIDDK, NIH Bethesda, MD 20892 USA 2. Center for Agricultural Biotechnology, University of Maryland Biotechnology Institute, University of Maryland College Park, MD 20742 USA
1. Purpose of Study In an effort to obtain large quantities of the human parathyroid binding domain, a recombinant protein secreted extracellularly in very low quantities from the anchorage dependent HEK 293 cells, polyethylenesilica (Cytoline ) macroporous microcarriers in a fluidized bed reactor (Cytopilot) were examined. 2. Introduction Microcarriers allow the cultivation of anchorage-dependent cell lines with efficient use of bioreactor volume. For sensitive cell lines, macroporous microcarriers are more advantageous. The pores protect the cells from shearing and because of the larger available surface area, the carriers can hold high cell densities (Nilsson et al., 1986)(Shiragami et al., 1993). Fluidized bed reactors (FBR) are a good complement to macroporous microcarriers (Kratje and Wagner, 1992). In addition to providing a homogeneous environment under gentle mixing, they offer good mass transfer characteristics, are easy to monitor allow for high cell densities and are readily scaled up. Of special interest is the modular FBR, which eliminates the necessity of a recirculating loop with its associated handling problems (Reiter et al., 1991). Human embryonic kidney cell line 293 (HEK 293) is a good candidate for culture with macroporous microcarriers in FBRs. As the name indicates, 381
O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 381-384. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
382
these cells are derived from secondary embryonic kidney cells transformed with sheared fragments of adenovirus (Graham et al., 1977). They are anchorage dependent and easily transformed to produce heterologous proteins (Berg et al., 1993)(Hamilton et al., 1993). Few attempts have been made to characterize this cell line and define the optimal conditions for its growth and protein production. This knowledge is essential if future scale-up is to be attempted. 3. Materials and Methods 3.1. CELL LINES AND MEDIA Human embryonic kidney cells (HEK 293) were obtained from ATCC (CRL 1573) (USA), and were routinely passaged in tissue culture flasks (Costar Corporation, USA) using DMEM (Biofluids Inc., USA) supplemented with 10% fetal bovine serum (Biofluids). HEK 293 transformed to produce the extracellular domain of the human parathyroid receptor (HEK 293add) were obtained from NPS Pharmaceuticals (USA) and passaged in T-flasks using DMEM containing 10% FBS and 200 u/mL Hygromicin B (Calbiochem Corporation, USA). Production medium for HEK 293add consisted of DMEM containing 293 Serum-Free Supplement (Shiloach et al., 1996), 2 mM glutamine (Gibco, USA), 200 U/mL Hyg B and 10,000 U/mL Penn-Strep (Gibco) . 3.2. REACTOR SYSTEM AND CULTIVATION CONDITIONS Stationary experiments were conducted in tissue culture flasks (Costar). Cells in mid-exponential to late exponential growth phase were inoculated at a density of and incubated at 37°C in 5% atmosphere. Bioreactor experiments were conducted in a 2L modular fluidized bed reactor (Cytopilot) (Pharmacia, Sweden) containing 300-400 mL (15-20% v/v) macroporous microcarriers (Cytoline , Pharmacia). pH and dissolved oxygen concentration were kept at values of 7.00 and 30% saturated air respectively sparging with and . 3.3. ANALYSIS OF SAMPLES Cell density was determined using a Coulter Counter ZM (Coulter Electronics, FRG).Glucose, lactate and glutamine concentrations were determined using a YSI analyzer (Yellow Spring Instruments, USA). Ammonia concentration was determined using a Biolyzer (Eastman Kodak Corporation,
USA).
383
4. Results and Discussion For evaluating the system, fermentations using HEK 293 and HEK 293add were conducted in the Cytopilotand T-flasks. Results from these fermentations are shown in Table 1. In the first 100 hours after attachment, HEK 293 cells in the Cytopilotshowed exponentially increasing consumption of glucose and production of lactate. After 100 hours, the rates of glucose and glutamine consumption and lactate and ammonia production became constant indicating that stationary or maintenance phase was reached.
The fermentation of HEK 293add in the Cytopilotdid not perform as smoothly as the HEK 293 fermentation due to interruptions caused by temperature and dissolved oxygen control problems. Nevertheless, during the first 70 hours after attachment, the cells exhibited exponential consumption of glucose and lactate production, with faster rates than the ones observed with the HEK 293 cells and a smaller yield of lactate on glucose. Rates of consumption of glutamine and production of ammonia during this phase were faster with the HEK 293add than with the HEK 293 and yield of ammonia on glutamine was also larger. After 330 hours of operation, the growth medium was replaced with production medium. Constant rates
384 of glucose consumption and lactate production indicated a maintenance phase. These rates were slower than the ones observed in the HEK 293 fermentation during maintenance phase even though yield of lactate on glucose was similar. The yield constants in the T-flasks were similar to the yield constants observed in the fermentor. However, the culture was not allowed to reach stationary phase. The fermentations in the Cytopilotwere conducted in repeated batch mode as opposed to perfused mode as suggested by the manufacturer. Some problems resulted from this decision. The small head space in the reactor did not allow efficient gas exchange and the filters often became clogged. Sampling was made difficult because the volume of medium that can be removed without affecting recirculation is small. Also, the process of medium replacement puts the beads under violent bubbling and mixing which might have a detrimental effect on the cells. References Berg, D.T., Mcclure, D.B. and Grinnel, B.W. (1993) High-level expression of secreted proteins from cells adapted to serum-free suspension culture, Biotechniques 14, 972978. Graham, F.L., Smiley, J., Russel, W.C. and Nairn, R. (1977) Characteristics of a human cell line transformed by DNA from human adenovirus type 5, J. gen. Virol. 36, 59-72. Hamilton, B.J., Lennon, D.J., Im, H.K., Seeburg, P.H. and Carter, D.B. (1993) Stable expression of cloned rat GABA-A receptor subunits in a human kidney cell line, Neuroscience Lett. 153, 206-209. Kratje, R.B. and Wagner, R. (1992) Evaluation of production of recombinant human interleukin-2 in fluidized bed bioreactor, Biotechnol. Bioeng. 39, 233-242. Nilsson, K., Buzsaky, F. and Mosbach, K. (1986) Growth of anchorage-dependent cells on macroporous microcarriers, Bio/Technology 4, 989-990. Reiter, M., Blml, G., Gaida, T., Zach, N., Unterluggauer, F., Doblhoff-Dier, O., Noe, M., Plail, R., Huss, S., and Katinger, H. (1991) Modular integrated fluidized bed bioreactor technology, Bio/Technology 9, 1100-1102. Shiloach, J., Kaufman, J., Trinh, L. and Kemp, K. (1996) Continuous production of the extracellular domain of recombinant receptor from HEK 293 cells using novel serum free medium, in Carrondo, J.T., Griffiths, B. and Moreira, J.L.P. (eds.), Animal Cell Technology, Kluwer Academic Publishers, Dordrecht, pp. 535-540. Shiragami, N., Honda, H. and Unno, H. (1993) Anchorage-dependent animal cell culture using a porous microcarrier, Bioproc. Engin. 8, 295-299.
FLUIDIZED BED TECHNOLOGY: INFLUENCE OF FLUIDIZATION VELOCITY ON NUTRIENT CONSUMPTION AND PRODUCT EXPRESSION
G. BLÜML 1 , M. REITER 2 , TH.GAIDA2, N. ZACH2, A. ASSADIAN 2 , C. SCHMATZ2 and HERMANN KATINGER 2 1 )Pharmacia Biotech Europe, Vienna, Austria 2 )Institute for Applied Microbiology, Vienna, Austria
Introduction
Fluidized beds in combination with macroporous microcarriers are based on the perfusion technology. Perfusion technology was developed as it was recognised that cells in vivo are continuously supplied with blood, lymph, or other body fluids to keep
them in a constant physiological environment. To exploit the high productivity potential per reactor volume of a fluidized bed system optimisation of fluidization
velocities for anchorage dependent as well suspension cells immobilized in
macroporous matrices are needed to guarantee a sufficient nutrient supply similar to in vivo conditions.
Fluidized bed with internal circulation Fig 1 shows the principle of the internal circulation with microsparging for oxygenation. In the Cytopilot (Vogelbusch / Pharmacia Biotech) oxygen microbubbles are sparged homogeneously into the downcomer flow of the draft tube and uniformly
distributed by the impeller (Fig. 1). This minimizes on one hand pO2 gradients of the system and on the other hand increases theoretical height of the fluidized bed enormously. 385 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 385-387. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
386
Culture Run Comparison During the Fermentation run with Cytoline 2 a bed expansion of 120 % (fluidization velocity 12 cm/min) lead to a concentration gradient of nutrients throughout the carrier bed. The Volume stream was 2.1 L/min that equals one medium exchange in 8.3 min, which is insufficient for high density cultures. Fig 2a shows Mol produced lactate per Mol consumed Glucose. The Quotient was 50% higher than the CSTR and FBCytolinel which were well supported with Oxygen. After increasing the fluidization velocity to 25 cm/ min the culture of FBCytoline2 came nearly to the same level of lactate production per Glucose consumption. Fig 2 b (showing the relation between secreted product per consumed Glucose) demonstrates the same effect of circulation rate on sufficient nutrient supply. After increasing the circulation rate to 25 cm/min (day 57) the culture behaved similar to CSTR and fluidized bed culture with heavier beads. 2 Amino acids (Arginin and Serin) were analysed at different Glucose levels on all 3 culture runs. The CSTR and FBCytolinel (45 cm/min) are much more similar in spite of the different fermentation system than the slow circulating culture FBCytoline2 (Fig 2c,d)
Summary These fermentation runs showed that the minimum bed expansion for light beads like
Cytoline 2 is 200% at 25cm/min to give a reasonable nutrient supply to the cells in the pores. For Heavier beads like Cytoline 1 a bed expansion of 150% at 45 cm/min is enough. That implements a higher carrier load in the fermenter than with lighter
387
beads. The disadvantage of the higher speed is the higher shear stress especially for
sensitive cells like hu hybridoma cells in the attachment phase of the culture. The relation between volume specific productivity of hu-hybridoma and fluidization velocity shows an optimum of about 25 cm/min using Cytoline2 (sufficient medium supply and low shear stress). Using Cytolinel, CHO cells (expressing the same monoclonal antibody) and a fluidization rate of 45 cm/min (necessary for oxygen supply) the productivity could be increased by a factor of 3 compared to the fluidized bed with hu-hybridoma and by a factor of 30 compared to the CSTR (Tab 2).
The required fluidization velocity in Tab 3 are 3-4 times lower than the sedimentation
velocities of Cytoline 1 or 2. There is a small risk of flushing out the carriers from the upper chamber of the fluidized bed.
Product formation could be growth dependent for some cell lines. In that case a higher fluidization velocity could be useful to create cell bleeding out of the pores to keep the
growth rate as high as possible. The fluidization velocity could be reduced about 15 20 % by using macromolecules such as Dextran, Pluronic, Xanthan etc., maintaining
the same bed expansion.
This page intentionally left blank.
HIGH DENSITY AND SCALE-UP CULTIVATION OF RECOMBINANT CHO CELL LINE AND HYBRIDOMAS WITH POROUS MICROCARRIER CYTOPORE CHENGZU XIAO, ZICAI HUANG, WENGQING LI, XIANWEN HU, WENLU QU, LIHUA GAO AND GAOYAN LIU. Department of Cell Engineering, Institute of Biotechnology, 20 Dongdajie, Fengtai, Beijing 10007l, P.R. China Abstract Using porous microcarrier Cytopore and a low-serum medium supplement BIGBEF-3, we have successfully cultivated recombinant CHO cell line CL-11G producing prourokinase and hybridomas producing prourokinase monoclonal antibody in Celligen 1.5L or 5L bioreactor. The cell density could reached the yields of prourokinase and monoclonal antibody increased with increasing cell density. As all of these cells could release spotaneously and reattach to porous microcarriers, it was very easy to scale-up the cultivation. Thus the bead to bead cells transfer method has been used to scale up the culture of CL-11G cells in 20L bioreactor in the pilot production of prourokinase, and to scale-up the culture of hybridomas in the production of McAB for purification of prourokinase. Key Words antibody
Porous microcarrier;
recombinant CHO cells;
prourokinase;
monoclonal
1. Introduction The development of microcarrier culture by van Wezel in 1967 (1) made the large- scale industrial culture of anchorage dependent cells for the production of vaccine and interferon possible. In 1980s, a great advance of this procedure was achieved by the development of a series of porous microcarriers (2-4). In previous paper we reported that using porous microcarrier Cytopore, we had successfully cultivated a genetically-engineered CHO cell line and some hybridomas to produce pro-UK and McAB (5). This paper reports our successful results in using the bead to bead cells transfer method to sule up the cultivation of both the CHO cells and hybridomas in the pilot production of pro-UK and McAB. 2. Materials and Methods 2.1 .CELL LINES AND MEDIA The cell lines used were genetically-engineered CHO cell line CL-11G producing prourokinase ( 6 ) and hybridomas X15 and 38-1-7 cell lines producing prourokinase monoclonal antibody (McAB) ( 7 ). The medium for CL-1G cells was DMEM:F12 (1:1), with the addition of some amino acids and low-serum medium supplement BIGBEF-3 ( 5 ), and supplemented with 1% NCS, aprotinin and kanamycin. The medium for hybridomas was RPMI 1640, supplemented with 1% NCS and 0.1% pepton. 389
O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 389-393. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
390 2.2. POROUS MICROCARRIER The dry Cytopore microcarriers ( Pharmacia Co. Sweden ) were hydrated and swelled in PBS before cultivation. After autoclaving at for 20 min, removed the supernatant and washed the microcarriers with culture medium once or twice. 2.3. CULTURE VESSELS Firstly spinner flask (Wheaton Co., USA) was used. The stirring rate was 30-40rpm. Then 1.5L or 5L Celligen bioreactor (NBS Co., USA) supplemented with a modified perfusion controller (8) and Biostat UC 20L bioreactor with spin filter was used. 2.4. CELLS COUNTING The citric acid-crystal violet method was used to count cells in porous microcarriers. In order to avoid a part of cells remaining in pores, the carriers were incubated for 4-5 hours and shaked several times during incubation. At the same time, the MTT ( 9 ) method was also used to confirm the satisfactory growth of cells inside the microcarriers. 2.5. GLUCOSE, PRO-UK AND McAB ASSAY The methods used in measuring glucose and pro-UK were the same as that mentioned in reference ( 10 ). The method for measuring McAB was ELISA assay ( 7 ).
3. Results 3.1. THE CULTURE OF CL-11G CELLS AND HYBRIDOMAS IN WHEATON SPINNER FLASK When the concentration of Cytopore was
, and the medium was exchanged once or
391 twice each day, the cell density of both the CL-11G and hybridomas could reach over ( Fig. 1 ). The pro-UK and McAB yields increased with increasing cell density .
3.2. CELLS TRANSFER FROM BEADS TO BEADS
Just like the culture with Biosilon (10) and MC-1 (11) microcarriers, CL-11G cells could detach from Cytopore porous microcarriers spotaneously and reattach on fresh ones. So it was also very easy to scale up the cultivation as reported by Kamiya ( 12 ). When the scale up ratio was 3, as shown in Fig 2,we withdrew 2/3 of culture from a spinner flask (200ml) and added the same volume of fresh midium and microcarriers at 18th day, and then transfered the whole 200ml culture into a larger flask with 500ml of fresh midium and microcarriers at 28th day, the final cell density could still reach over each time (Fig.2, 3).
392 3.3. SCALE-UP CULTIVATION OF CL-11G CELLS FROM 5L BIOREACTOR TO 20L BIOREACTOR When we used the bead to bead cells transfer method to scale up the cultivation of CL-11G cells from Wheaton spinner flask (700 ml ) to Celligen bioreactor ( 5L ), then to Biostat UC 20L bioreactor, the cell density could also reach , and the highest yield of proUK was ( Fig. 4 ).
3.4. SCALE-UP CULTIVATION OF HYBRIDOMAS FROM WHEATON TO 1.5L BIOREACTOR Using the same method we also successfully scaled up the cultivation of hybridomas from Wheaton spinner flask ( 700 ml ) to Celligen 1.5L bioreactor. The cell density reached , and the titer of McAB could reach ( Fig. 5 ). Using this McAB affinity chromatograph, we purified the prourokinase to a purity of over 95% by HPLC assay with the specified activity of (reported elsewhere).
4. Discussion In a privious paper (5) we demonstrated that porous microcarriers had a lot of advantages compared to solid microcarriers, such as : l.The concentration of carriers in the culture was much less than that of solid microcarrier.2. Cells grown inside pores were protected for damage by shearing stress, so that higher stirring speed could be used. 3. Cytopore porous microcarrier was not only suitable to culture anchorage-dependent cells such as CHO cells, but also suitable to culture anchorage-independent cells such as hybridomas. 4. As most of cells were neted inside pores, cells suspended in the supernatant were much less. In addition, the cells cultured inside the porous microcarriers were less depandent on attachment factor, so the serum used in the culture might be furtherly reduced. This time we find an another advantage,
393
that is it can also be used to scale up the cultivation with bead to bead cells transfer method. So we definitely consider that using porous microcarriers to large-scale culture geneticallyengineered cells for the production of recombinant products including prourokinase is a very prospective approach. 5.References
1. 2. 3. 4. 5.
van Wezel AL. Growth of cell-strains and primary cells on microcarriers in homogeneous culture. Nature, 1967; 216:64 Looby D, et al. Immobilization of animal cells in porous carrier culture. TIBTECH, 1990; 8:204 Gotoh T, et al. A new type porous carrier and its application to culture of suspension cells. Cytotechnology, 1993; 11:35 Shirokaze J, et al. High density culture using macroporous microcarrier. in: Spier RE. Griffith B eds. Products for today, prospects for tomorrow. Oxford: ButterwerthHeinemann, 1994; 261 Xiao CZ, et al. High density cultivation of recombinant CHO cell line and two strains of hybridomas with porous microcarrier Cytopore. Bull Acad Mil Med Sci, 1996; 20:191
6.
Li FZ, et al. High-level expression of pro-urokinase cDNA in Chinese hamster overy cell
7.
line (1). Bull Acad Mil Med Sci, 1993; 17:89 Ai X, et al. Preparation and characterization of monoclonal antibodies against uPA and their application for purification of uPA. Bull Acad Mil Med Sci, 1995; 19:248
8.
Xiao CZ, et al. An autocontroller system for cell perfusion cultivation on microcarrier.
Chinese Patent, ZL 91208893.1, 1994-09-14 9.
Jia XH, Xiao CZ. MTT method for the esstimation of the number of cells cultivated in microcapsules. Bull Acad Mil Med Sci, 1993; 17:207
10.
Xiao CZ, et al. High density cultivation of a recombinant CD-1 cell line producing prourokinase using a Biosilon microcarrier culture system. Chin Med Sci J,1994;9:203
11.
Xiao CZ, et al. High density cultivation of genetically-engineered CHO cell lines with microcarrier culture systems. Chin Med Sci J, 1994; 9:71
12.
Kamiya K, et al. Subculture for large scale cell culture using macroporoous microcarrier. in: Beuvery EC. et al. eds. Animal Cell Technology: Development towards the 21st Century. Kluwer Acad Publ, The Netherlands, 1995;759
This page intentionally left blank.
CELL-SETTLER PERFUSION SYSTEM FOR THE PRODUCTION AND GLYCOSYLATION OF HUMAN INTERFERON- BY CLUMPED CELLS D. LAMOTTE1, J. STRACZEK2 & A. MARC1 1 LSGC-CNRS, BP 451, 54001 Nancy Cedex - France 2 Lab. de Chimie - CHU, 54035 Nancy Cedex - France 1. Introduction The production of recombinant proteins by mammalian cells is commonly performed in batch or fed-batch cultures. Nevertheless, productivity in such a culture can be low. In cell lines where protein synthesis is proportional to the cell division, a variety of means have been designed to increase the maximum cell density. Amongst them are perfusion systems, in which cells are retained whilst spent medium is replaced continuously with fresh medium1,2. Natural aggregation of animal cells has also been widely studied and proven to be an efficient means of culture3 and sedimentation of aggregates in a column allows the efficient retention of cells4. However, we report here the first animal cell perfusion
culture based upon cell aggregate sedimentation. This shape is very convenient for cells sensitive to shear stress that can not be cultivated in classic perfusion systems. Culture conditions may dramatically affect glycosylation and therefore the efficacy of glycoproteins. Because the cell environment could change in perfusion cultures, the glycosylation pattern of the protein of interest may be altered in a long-term culture, and hence the product quality could be compromised. Few studies have reported the protein glycosylation changes in perfusion cultures 5 despite the emergence of cell perfusion systems for industrial purposes6. In this study, we have cultivated the CHO 320 cell line for the production of human interferon- (IFN) in an 'in-house' perfusion system based on cell retention by gravitational sedimentation. The IFN glycosylation was monitored by capillary electrophoresis throughout the culture. 2. Materials & Methods The producing IFN CHO cell line (CHO 320) was supplied by the Wellcome Foundation Laboratories. Cultures were performed with a serum-free medium. We have modified a 2L-stirred-tank bioreactor to allow the perfusion, and it was fitted with an internal glassware tube (diameter: 1 cm, length: 12.5 cm) to provide a cell settling zone. The bottom of the tube was lower than the agitation blades. The supernatant was removed continuously from the vessel through the top of the glassware tube using a peristaltic pump. The working volume in the reactor was 1.1L during the perfusion phase. Prior to perfusion, cells were grown in batch culture for 80 hours. Separations and detections of the IFN glycoforms were performed with a Beckman P/ACE 2100 capillary electrophoresis according to the protocol of James et al.7 395
O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 395-397. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
396
3. Results 3.1. KINETICS OF THE CHO 320 PERFUSION CULTURE
Cells were seeded in the reactor with an initial density of After being propagated in batch culture for 80 hours to reach , the perfusion was initiated in standard medium and the dilution rate increased daily from 0.022 to 0.055 until 350 hours of culture. During this phase, the IFN level increased rapidly to reach the mean value of In parallel, initial clumps (100 m diameter) enlarged with cell growth to reach a maximum diameter of 800 m after 550 hours of culture (phase I). Thereafter, the perfusion rate was kept constant leading to the stabilisation of the cell density at . The addition of amino-acids (excepted glutamine) in the standard feeding medium (phase II) gave a transient decrease of the IFN level. Conversely, the addition of vitamins in medium did not have significant effect on the kinetic parameters (phase III). Figure 1 shows that perfusion culture generated a twofold higher IFN accumulation than batch culture. Consequently, the volumetric IFN production (in IU/1/hr) is significantly higher in perfusion culture (x8). These results confirm that perfusion systems are powerful tools to increase productivity of recombinant proteins.
397
3.2. IFN GLYCOSYLATION MACRO-HETEROGENEITY
The IFN glycosylation macro-heterogeneity was monitored during the perfusion culture by use of capillary electrophoresis. The three classes of IFN glycoforms (doubly (2N), singly (IN) and non glycosylated (ON)) were observed and their proportions reported in figure 2. The proportion of fully glycosylated IFN decreased throughout the initial batch phase of culture. Conversely, the glycoform proportions were constant during the four phases of the perfusion culture and similar to those found at the end of the batch culture. The cell-settler system described here allows the good product consistency for more than 1000 hours despite changes in the culture environment and the kinetic parameters. 4. References 1. Goergen J.L., Lourenso da Silva A., Marc A. and Engasser, J.M. (1995) Fast propagation of hybndoma cells in a forced-flow membrane perfusion reactor, in E.G. Beuvery, R.E. Spier and W.P. Zeistemaker (eds.). Animal Cell Technology: Developments towards the 21st century, Kluwer Academic Press. Dordrecht, pp.
705-710. 2. Pinion H., Rabaud J-N., Engasser J.M. and Marc A. (1991) Cytoflow: a new perfusion bioreactor for research and production, BFE 8, 344-347. 3 Chevalot I., Visvikis A., Nabet P., Engasser J.-M. and Marc A (1994) Production of a membrane-bound
protein, the human gamma-glutamyl transferase, by CHO cells cultivated on miccrocarriers, in aggregates and in suspension, Cytotechnology 16 121-129. 4. Moreira J.L., Alves P.M., Rodrigues J.M., Cruz P.E., Aunins J.G. and Carrondo M.J.T. (1995) Growth of BHK aggregates in a 2 liter bioreactor, in E.C. Beuvery, R.E. Spier and W.P. Zeistemaker (eds.). Animal Cell Technology: Developments towards the 21st century, Kluwer academic press, Dordrecht, pp. 805-809 5. Gawlitzek M., Valley U., Nimtz M., Wagner R. and Conradt H.S. (1995) Characterization of changes in the glycosylation pattern of recombinant proteins from BHK-21 cells due to different culture conditions, J. Biotechnol. 42 117-131.
6. Bödecker B.G.D. (1994) Production of recombinant factor VIII from perfusion cultures: 1. large-scale fermentation, in R.E. Spier, J.B. Griffiths and W. Benhold (eds.). Animal Cell Technology: Products of today, prospects for tomorrow, Butterworths, London, pp. 580-583. 7 James D.C., Freedman R.B., Hoare M. and Jenkins N. (1994) High-resolution separation human interferongamma glycoforms by micellar electrokinetic capillary chromatography, Anal. Biochem. 222 315-322.
This page intentionally left blank.
DISPOSABLE BIOREACTOR FOR CELL CULTURE USING WAVE-INDUCED AGITATION
Vijay Singh Schering-Plough Research Institute 1011 Morris Avenue Union, NJ 07016 US A email:
[email protected]
Abstract This work describes a novel bioreaclor system for the cultivation of animal, insect, or plant cells using
wave agitation induced by a rocking motion. This agitation system provides good nutrient distribution, off-bottom suspension, and excellent oxygen transfer without damaging fluid shear or gas bubbles. Unlike other cell culture systems, such as spinners, hollow-fiber, roller bottles, scale-up is simple, and systems
with up to 10 liter liquid volume have been operated successfully. The device is disposable and therefore requires no cleaning or sterilization. Additions and sampling can be done without the need for a laminar flow cabinet. The unit can be placed in an incubator requiring
minimal controls. All these features dramatically lower the purchase and operating cost of a lab scale cell cultivation system. Results are presented for various model systems: 1) recombinant NS0 cells in suspension; 2) human 293 cells in suspension/adenovirus production; 3) sf9 insect cell/baculovirus system; and 4) human 293 cells
on microcarrier. These examples show the general suitability of the system for suspension cells, anchorage-dependent culture, and virus production. The system is especially well suited to virus and
vaccine production because of the high degree of containment.
Background Technology for the cultivation of animal, plant and insect cells depends on the batch volume required. In the laboratory, devices such as spinner flasks, roller bottles, T-flasks and similar systems are typically used However, these devices can only produce 1 to 2 liters or culture per batch due to inherent oxygen transfer limitations. In particular, spinner flasks are very popular for suspension culture as well for anchorage-dependent systems on microcarriers, but they can only be used for a maximum liquid volume of 1 liter. There is no simple system to make 1 to 10 liters of cell culture which is the volume often needed for protein characterization, inoculum production and pilot production. It is usually necessary to use bioreactors which are typically stirred-tank bacterial fermentors modified to reduce shear forces. These bioreactors are complex, expensive, and do not really provide an optimum environment for cell growth due to high local shear and bubble aeration. Adapting stirred tank technology to cell culture is a futile exercise because this design has intrinsically high local shear rates. Instead it is critical to recognize the special demands of cell culture and design directly to satisfy these needs. It is also essential to make the cultivation system as simple as possible to operate. There have been many designs in the past, for example fluidized bed bioreactors and hollow-fiber systems which have worked well, but were too complex to displace the spinner flask as the workhorse of cell cultivation. The objectives of this work was to develop a new cell culture bioreactor that: 1. Can be used to cultivate 100 ml to 10 liters of cells A high turndown ratio (maximum volume : m i n i m u m volume) is also required to reduce the number of transfers. The poor 2:1 turndown 399 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 399-407. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
400 ratio of a conventional spinner flask makes inoculum scale-up very labor intensive, because the culture
must be transferred from one size spinner to the next larger size many times under sterile conditions. 2. Eliminates sparging of gas. It is clear that hubbies cause damage, so any good cell culture device should
not generate bubbles. Gas diffusion membranes are not satisfactory because of cost, complexity and poor reliability. Also scale-up is limited by the membrane surface available for diffusion. 3. Eliminates mechanical agitation. Mixers generate high local shear. Seals around the mixer shaft are costly and have poor reliability. 4. Guarantees sterility. The bioreactor should be available presterilized and disposable after use. This eliminates the need for heat sterilization and cleaning. A large portion of the cost of a bioreactor is the sterilization system. Cleaning of a bioreactor can take 8-10 hours per run making this a major operating expense. 5. Containment. The unit should operate as a closed system so that it can be operated in the laboratory or plant without the need for a laminar flow cabinet. 6. Simple controls. Like a spinner, the unit should not require complex controls. In cell culture, media can be buffered to control pH and if the aeration system is capable of delivering the maximal oxygen demand
there is no need for DO control. 7. Low cost. A stainless steel bioreactor (10 liters) costs about $ 80,000. It should be possible to develop a cell cultivator for 1/10 of this cost. The lack of moving parts, seals and instrumentation should also significantly reduce operating expenses. 8. Easy to operate. Conventional bioreactors and pump-around systems require extensive training to operate. Even small mistakes can lead to contamination. Just mastering the sterilization and calibration
procedures requires 1 -2 weeks of training. Many scientists just want to grow cells to study the protein being expressed rather than become bioreactor experts. The cell cultivation system should therefore be
simple to learn. The goal was to develop a bioreactor which could be operated by an undergraduate student with 1 hour of instruction.
A bioreactor system was developed that meets all these objectives. It is low cost, simple to operate, and provides an optimal environment for cell and virus culture. This paper summarizes the oxygen transfer capabilities, mixing time and cell cultivation potential of this technology based on wave-induced agitation.
Materials and Methods Bioreactor System and Operation
The bioreactor consists of a presterilized plastic bag that is partially filled with media and inoculated with cells. The remainder of the bag is inflated with air which is also continuously passaged during the cultivation. Mixing and mass transfer are achieved by rocking the bag back and forth. This rocking motion generates waves at the liquid-air interface, greatly enhancing oxygen transfer. The wave motion also promotes bulk m i x i n g and off-bottom suspension of cells and particles such as microcarriers. The bag is discarded after harvest, eliminating any need for cleaning or sterilization since this is the only component in contact with the cells. New bags are delivered guaranteed sterile by gamma radiation. Bags are made of FDA approved biocompatible polyethylene. These bag materials are commonly used for blood collection and biological fluid handling. Special ports have been developed to allow sterile additions to the
bag and to withdraw samples, without the need to place the bag inside a biosafety cabinet.
401
The rocking mechanism was developed by the author. The device as shown in Figure 1 consists of a platform that rotates or rocks in one axis through an angle of 5 to 10°. Pneumatic bellows are used to rock the platform at an adjustable rocking rate between 5 to 40 rocks/minute (rpm). A pre-sterilized bag is
placed on the platform; partially filled with media and then inflated using the sterile inlet gas filter integral to the bag. Air is continuously passaged through the headspace of the bag by a pneumatically driven pump. This provides oxygenation and gas exchange for pH control and CO2 removal. Exhaust air passes through an exit sterilizing filter and a backpressure control valve. The unit requires only compressed air (2 - 3 bar) to operate. No electrical connection is necessary. Temperature and pH control is
achieved by placing the entire unit inside a conventional cell culture CO2 incubator. The rocking platform systems: CellbagTM, including specially designed cultivation bags (2 liter and 20 liter), are available from BioPro
International, Farmingdale, New York, USA (
[email protected]).
Oxygen Transfer Measurement
The oxygen transfer capabilities of the system were assessed by measuring the volumetric oxygen transfer coefficient kLa at various rocking rates, liquid volumes and aeration rates. The dynamic method was used for kLa measurement. Here, the liquid in the bag is deoxygenated by passing nitrogen through the
headspace. Once the dissolved oxygen (DO) concentration was near zero, air was introduced in to the headspace and the rise in DO recorded. kLa was calculated from the slope of the following mass balance equation:
For the oxygen transfer studies an oxygen sensitive dye was added to enable non-invasive dissolved oxygen measurement. Selected runs were confirmed using conventional DO probes inserted into the bag. Mixing Time Measurement
Mixing time in the bag at various rocking rates were determined by injecting a fluorescent tracer dye into the bag and videotaping the dispersion of the dye in the bag. UV light was used to enhance the contrast.
402 Time-tagged images were captured from the videotape and the mixing time was determined visually from photographs. Mixing time was defined as the time required after injection to achieve complete homogeneity.
Dissolved Oxygen and Carbon Dioxide Off-line measurement of dissolved oxygen and dissolved were done by sampling the bag using a syringe and analyzing it with a blood gas analyzer (Radiometer ABL5). Cell counts were done by
hemocytometer, and product assays were done by appropriate methods such as ELISA. Results - Oxygen Transfer and Mixing
I. Oxygen Transfer Studies:
The rocking motion of liquid in the bags generates a larger mass transfer surface that static culture which leads to much greater volumetric transfer coefficient Figures 2 and 3 show the rocking and aeration rates in 2 liter bags and 20 liter bags.
The oxygen transfer studies show that a
achieved at various
of 3 hr -1 is possible in a 1000 ml liquid volume (2Lbag).
This is almost three-fold higher than the for 1000ml in a comparable 2L spinner (Table 1). This should result in potentially 3X higher maximal cell densities in the bag compared to a spinner.
The data for spinner flasks in good agreement with published values. Aunins, et al (1989) report a around 1 hr-1 for 500ml liquid in a 500ml spinner. Dorresteijn et al (1994) report a value around 2 hr -1 for 300ml liquid in a 600ml spinner system. For the l0liter scale (in 20L bag) the maximum is around There is no comparable spinner system since the surface to volume ratio decreases substantially as the spinner volume is increased. For example, a 5 liter spinner would have a less than making it essentially useless for cell cultivation. With
of 3 to
possible to grow up to
and assuming a typical oxygen demand of
(Singh, 1996), it is
while maintaining dissolved oxygen concentrations above 10%
saturation.
With this knowledge of oxygen transfer it is possible to guarantee against oxygen depletion at any given
cell density by selecting the appropriate rocking/aeration rate. Unlike stirred tank bioreactors, there is no bubble damage or danger of “overaeration”. stripping can be controlled by adjusting the concentration of the inlet air. This effectively eliminates the need for a dissolved oxygen probe/ control
403 system. Samples may be taken and assayed periodically on a blood gas analyzer, off-line, to verify the DO and levels. II. Mixing Studies: Estimates of mixing time were made by injecting a fluorescent dye and videotaping the dispersion of the dye under various conditions. These experiments showed that the wave-induced motion was very effective in mixing the liquid in the bag. Mixing time (defined as time for complete homogeneity) was typically 5 to 10 seconds. Subsequent studies with microcarrier cultivation showed good off-bottom suspension with some particle gradients in the liquid. However, no significant settling of microcarriers or cells was
observed. The wave-agitation phenomena is the subject of a pending patent application. Results - Biological Systems 1. Monoclonal Antibody Production - 1 liter and 10 liter scale
An important application for cell culture is the production of monoclonal antibodies in vitro. Spinner or shake flasks can be used for 1 to 3 liters or culture, however oxygen transfer limitations in these system preclude further scale-up. For larger volume it is necessary to use complex bioreactors based on stirred
tanks, hollow fiber, or immobilized technology.
The applicability of the Wave Bioreactor system for lab-scale (10 liter) culture was evaluated. The cells used were a NS0 cell line expressing a humanized monoclonal antibody. Culture was performed in serumfree media commonly used for this cell line. Cultivation was started in a 1 liter culture volume with 250ml
of inoculum generated in a 500ml spinner flask. After 96 hours the cell density was cells/ml.
Two liters of fresh media was added to the bag and the cultivation continued. After an additional 96 hours the cell density again reached and 7 liters of fresh media was added to the bag to bring to the final culture volume of 10 liters, and cultivation was continued until zero viability (300 hours). Figure 4 shows the cell counts and monoclonal antibody production. The stepwise dilution technique used demonstrates how the large turndown ratio (maximal volume/minimum volume) of the bag enables large culture volumes without the need for transfers as would be the case using spinner flasks. Culture profile was very consistent with smaller scale spinners. Cell densities exceeded Dissolved oxygen levels remained above 50% saturation. Antibody expression was normal at over 600
mg/l. The system is clearly well suited for suspension cell cultivation and monoclonal production. Inoculum scale-up can be done within the system without the need for splits.
404 2. 293 cells/Adenovirus Production
The potential of the Wave Bioreactor for virus production was tested using a recombinant adenovirus system. A human embryonic kidney cell line (293) grown in suspension was used as the host. Initial seeding density in a 2L bag containing 1000ml of serum-free media was The
unit was placed in a 37°C incubator with a 5% CO2 atmosphere. The culture was grown for 5 days at a rocking rate of 10 rpm and 0.1 vvm aeration. At this stage, the viable cell count was 500 ml of the culture was removed and replaced with 500 ml of fresh media. After an additional 24 hours the culture was infected with an MOI of 30 virus particles/cell. The culture was harvested three days postinfection at which point the viable count was essentially zero (Figure 5). The final virus titer was 10,000 particles/cell. From Figure 5, it is apparent that the system is quite capable of maintaining adequate dissolved oxygen
levels at these cell densities. The pH remains very constant due to the excellent gas exchange as evidenced by the constant until late in the infection when the pH drops rapidly beyond the capability of the buffer system. The system is very easy to use. All additions and sampling were done in the incubator itself. No biosafety hood was required. The standard 0.1 micron exhaust filter was supplemented by a Pall DFA cartridge filter. The integrity of the exhaust filter system was tested by passing the exhaust gases to an uninfected
293 culture. Absence of any infection in the second culture confirmed the effectiveness of the exhaust filtration in containing adenovirus.
3. Baculovirus Production - 10 liter scale
The sF9/Baculovirus system is an excellent method for the rapid expression of large amounts of recombinant proteins. However, the oxygen requirements of sF9 cells are higher than mammalian cells
and this restricts the volume of spinner or flask culture to around 1 liter. Typically, larger volumes than are possible in flasks are required to produce sufficient protein for isolation and complex bioreactors are usually necessary. It was desired to determined if the simple Wave Bioreactor system could be used to scale-up inoculum and produce virus in 10 liter liquid volume. The gene sequence for a recombinant protein was cloned into the pAcHLT-B baculovirus expression
vector, transfected into sf9 cells and a high titer virus slock was generated. For cultivation in the bag, 1 liter of Bio-Whittaker X-Press Insect Cell Media was added to a 20 liter (total volume) bag. This was inoculated with Rocking rate was 20 rpm in a humidified
405 incubator at 25 °C. After 6 days of cultivation the cell count reached At this point 4 liters of fresh media was added to the bag. Within an additional 4 days the cell count reached
in this increased volume. At this point another 4 liters of fresh media was added along with the virus at a MOI of 0.5 bringing the system to a total volume of close to 10 liters. Harvest was done 2 days post infection.
This system produced a titer comparable to 100 ml shake flasks. It demonstrated the ability to increase cell mass by simply added fresh media to the system. No conventional series of flasks or splits were required, reducing labor and potential for contamination. All additions and transfers into the bag were done in the incubator. Figure 6 shows that oxygen transfer and CO2 desorption was not limiting. 4. Microcarrier Culture Human 293 cells were cultivated on Cytodex 3 microcarriers. Growth media was DMEM with 10%
bovine calf serum. Inoculum was collected by trypsinizing microcarrier cultures grown in spinner flasks. 60ml of inoculum was added to 3g Cytodex 3 in 900 ml of media and then transferred to a 2 liter bag. 10 ml of the inoculum was added to a spinner flask with 0.45g Cytodex 3 and 140ml media (250ml Bellco) that was run in parallel at 40rpm. Growth in the bag culture was very similar to the spinner. Cell counts, glucose consumption and lactate formation were equivalent with the exception of slightly higher cell counts in the supernatant from the bag. Cells grew to confluency ( >50 cells/bead) in the bag . Applications 1. Substitute for Spinner Flasks and Roller Bottles
Spinner flasks cannot be used for liquid volumes greater than 1 liter because of insufficient oxygen transfer. The Wave Bioreactor generates much more mass transfer surface because of the unique wave action. Operation to 10 liters is routine with cell densities over
406
The Wave Bioreactor has a greater range of operating volumes. This reduces the number of transfers that
need to be made minimizing handling and potential for contamination.
The Wave Bioreactor is an ideal way to make a few liters of cell culture for lab purification, inoculum propagation and cell bank generation. 2. Ultra Low cost Bioreactor: Traditionally the only way to produce 5 to 20 liters of cell or virus culture was to use expensive and complex bioreactors. The Wave Bioreactor is 1/10 the price of a comparable bioreactor and does not require substantial training. No utilities such as steam, cooling water and process gasses are required. No complex instrumentation is necessary. The unit can be set up in a conventional cell culture incubator. A CO2 controlled incubator can be used if pH control is desired. This makes lab scale cell and virus cultivation possible even in small labs, hospitals and universities.
3. High Containment / GMP Systems: The u n i t is completely closed. Additions and samples can be taken using a hospital-type needleless syringe connector or tube-fuser. These operations do not require a laminar flow cabinet but can be done with the unit inside the incubator. The bag is certified to be sterile by gamma radiation. Air into and out of the bag is sterilized by filters appropriate to the containment level necessary. At the end of cultivation the bag can be removed to another area for processing. The disposable nature of the system makes is very suitable for virus production and BL2/BL3 operations.
407
4. Cell Therapy and Gene Screening: The Wave Bioreactor allows even the smallest lab or clinic to perform cell culture. The simplicity of the
systems enables the scientist to concentrate of the use of the cells rather than learning how to operate complex bioreactor systems. The large cultivation volumes and the ability to grow attachment-dependent lines make it useful for primary cell cultivation for cell therapy applications and the simplicity of the system allows the rapid expression and screening of hundreds of genes needed for gene therapy and human genome elucidation. Conclusions
A novel bioreactor (patent pending) for cell culture has been developed. The system utilizes an inflated disposable plastic bag as the cell cultivation chamber. These specially designed bags are made of biocompatible materials and are delivered sterile, eliminating the need for cleaning and sterilization.
Oxygen transfer and mixing are accomplished by wave-induced agitation caused by rocking the bag back and forth. The rocking mechanism has been optimized in terms of rocking angle, rocking rate, aeration, and mechanical design to provide a kLa for oxygen transfer of 2 to
Based on typical cell respiration
rates, this transfer rate is sufficient to grow up to The bioreactor system, unlike spinner flasks, is not limited by gas-liquid transfer surface and scale-up to 10 liters operating volume has been demonstrated using several typical cell and virus production systems. This simple, low cost wave bioreactor system can be used for animal, insect and plant cell culture. The closed design is very suitable for virus production or other applications requiring high containment. The system requires minimal instrumentation and can be operated inside a laboratory incubator. All handling can be done in the open, eliminating the need for a laminar flow hood. References Aunins. J.G., Woodson, B.A.. Hale, T.K. and Wang, D.I.C.. 1989. Effects of Paddle Impeller Geometry on power Input and Mass Transfer
in Small-Scale Animal Cell Culture Vessels. Biotechnol. Bioeng. 34: 1127-1132. Dorresteijn, R.C., de Gooijer, C.D., Tramper, J. and Beuvery, E.C., 1994. A Simple Dynamic Method for On-line Determination of k L a During Cultivation of Animal Cells. Biotechnol. Techniques. 8, 9 675-680. Singh.V., 1996. On-Line Measurement of Oxygen Uptake in Cell Culture Using the Dynamic Method. Biotechnol. Bioeng. 52: 443-448.
Acknowledgments: *US and European patents are pending for portions of this work. I would like thank my many collaborators especially Nancy Connelly, John McDowall, Edward Glowacki, Raphael Nir, Colleen Brolly, Peter Pappas and Jeffery Mutter.
This page intentionally left blank.
USE OF miniPERM SYSTEM FOR AN EFFICIENT PRODUCTION OF MOUSE MONOCLONAL ANTIBODIES
M.L.NOLLI*, R.ROSSI°, A.SOFFIENTINI°, D.ZANETTE°, C.QUARTA° °Biosearch Italia, Via R Lepetit 34, 21040 Gerenzano (VA) Italy *Consultant Biotechnology, Biosearch Italia
ABSTRACT
A rapid and efficient method for the production of monoclonal antibodies has been set up using the miniPERM system. The miniPERM represents a new generation of compact and disposable laboratory bioreactors for the growth of suspension cells. The combination of some important requirements as 1) high surface volume ratio; 2) sterility; 3) small space occupied; 4) monouse; 5) easy to use; 6) possibility to use four modules at the same time makes the system very useful for an efficient production of hundreds of milligram quantities
of MAbs. A mouse hybridoma cell line, from NSO Ag 14 non secreting cells, has been cultivated in miniPERM modules and the corresponding IgG1 MAb was collected after 1 week run. 70-100 mg of MAb/module/week have been produced either in conventional medium (with serum) or in serum free medium. This module productivity permits a production of more than 300 mg of MAb/week using at the same time the four modules. The SDS-PAGE and IEF analysis of the purified IgG1 MAb is presented. 1. INTRODUCTION
At early phases of a biotechnology project, aimed to produce either monoclonal antibodies (MAbs) or recombinant proteins, it is crucial to have available several mg quantities of the protein, possibly in one batch, to set up purification and analytical methods and to carry out preformulation studies. Small disposable bioreactors, specifically designed for high density cell cultures, offer the possibility to easily cultivate either hybridomas or recombinant cells using a high-surface volume ratio concept and produce the needed secreted product. Furthermore, the combination of the use of these flexible bioreactors with appropriate serum free media permits reliable cell cultivation and product generation (1). We describe here the production of a mouse monoclonal antibody from NSO myeloma parent cells in miniPerm bioreactor (2). The production was shown to be very efficient. 70100 mg/module/week of MAb were produced in serum free medium. It was also demonstrated that, when using simultaneously four modules, there is a consistency in the MAb production in terms of number and composition of isoforms and quantity of MAb produced. 409
O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 409-415. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
410
2. METHODS 2.1 CELLS The mouse hybridoma, deriving from NSO parent myeloma cells, was adapted to grow in serum free medium
(SFM,Gibco cat. N: 12045-084) using the following protocol: 2.1.1. Cells were plated at in RPMI + 10% FCS + 5% Origen (Igen). 2.1.2. Then they were progressively diluted with SFM, 1:2, 1:4, 1:16, 1:32 and then in SFM alone. Every dilution with SFM, cells were left to grow for several generations, monitoring the cell viability and MAb production. 2.2 BIOREACTOR miniPERM bioreactor (Heraeus Instruments GmbH) is a small size bioreactor made up of two connected modules:
2.2.1. a production module (disposable culture chamber) 2.2.2. a nutrient module (reusable culture chamber) The bioreactor is rolled on a special turning device, specifically designed for a 37 °C
incubator. This roller apparatus permits the simultaneous use of four modules. 2.3 MODE OF CULTURE (FED-BATCH) 2.3.1 .The two miniPERM modules (nutrient and production module) were assembled in sterility following the operating instructions. 2.3.2. , at the end of the log phase, in 35 ml of SFM were then inoculated into the production module. 2.3.3. 350-400 ml of SFM were used to fill the nutrient module. 2.3.4. The apparatus was put onto the roller apparatus and then rolled. 2.3.5. 7-8 days runs were carried out, changing medium twice and taking samples every day. 2.4 .MAb TITRATION
The MAb produced was tested by an antibody capture ELISA set up in house. The antibody quantitation was done by using a standard curve of the purified MAb. The results were calculated with the use of logit-log regression. 2.5. MAb PURIFICATION AND ANALYSIS 2.5.1. The MAbs in the ascitic fluids and miniPERM supematants were purified using
Protein G Sepharose 4 FF (Pharmacia cat N° 17-0618-02). The samples were loaded onto the column with the conductivity and pH of the equilibration buffer (0.02M Na-phosphate pH=7.0). The column was washed with the same buffer. The MAbs were eluted with 0.1M
411
Gly-HCl pH=2.7 and immediately neutralized with 1 .0M Tris-HCl pH=9.0. 2.5.2. SDS PAGE (reduced): The reduced SDS-PAGE was done with a precast NOVEX™ Tris-Glycine gel with a 4-20 % gradient (Cat. N° EC6025). -mercaptoethanol was used as reducing agent. The running time was about 90 min. at a constant voltage of 120 V. At the end of the run the gel was fixed and then stained with Coomassie blue. 2.5.3. Isoelectric Focusing (IEF)(3): The IEF analysis was done using precast NOVEX™ IEF pH 3-7 gels (Cat. N° EC6655B). After running, the gels were fixed and then stained with Coomassie blue. 2.5.4.Densitometric measurements: The densitometric measurements were done with the SHIMADZU CS-9301PC dual wavelength flying spot scanning densitometer.
3. RESULTS AND DISCUSSION The miniPERM is a small modular bioreactor for the production of MAbs for analytical use. The results of the MAb production using this system are reported in Table 1. Four modules were simoultaneously used on the same roller apparatus to carry out one-week runs. The fed-batch mode of culture was used, changing medium twice/week. As shown, the quantity of MAb produced and its concentration in the medium, is comparable in the four modules. In fact the total quantity of MAb is in a range of 80-100 mg/module, while the concentration of the MAb is in the range of 2.5-3 mg/ml in 32 ml volume /module. The MAb production is very efficient. The recovery of MAb in the medium is at a high concentration (2.5-3 mg/ml) and in a limited volume (32 ml). The quantity of MAb, 80-100 mg /module /week, is an important amount for analytical use. In addition, the simultaneous use of the 4 modules makes possible a production of more than 350 mg of MAb in one week. An additional advantage is the production in serum free medium that allows either the use of MAb as it is or for an easier purification. Once purified, the MAb produced in the four modules (A,B, C, D) was analysed by SDSPAGE and by isoelectric focusing along with the densitometric distribution of the glycoforms. The results of these analyses demonstrate: 1) in reduced SDS-PAGE this MAb contains the typical IgGl heavy and light chain bands as those produced by the MAb from the ascitic fluid (fig. 1) and 2) both the IEF and densitometric analyses show the consistency of the glycoform distribution of the MAb produced in the four modules (fig 2 and fig. 3). Isoelectric focusing was also used to compare the respective glycoform distribution of the MAb produced by miniPERM and ascitic fluid(fig.4). The densitometric analysis (fig. 5) of the IEF gels show that the MAbs have the same number of glycoforms and similar percentage distribution for every glycoform.
412
413
414
415 4. CONCLUSION The consistency of the glycoform distribution and the amount of the MAb produced in the miniPERM modules prove the reliability ofthe system for production of hundred mg quantities of Mab in a single batch.
REFERENCES 1) Merck & CO., INC. Large scale production of mammalian cell infective viruses e.g. hepatitis A- in order to produce a commercial vaccine. Pubblication: WO95/04812. 16 February 1995. 2) Falkenberg, F.W., Hengelage, T., Krane, M., Bartels, I., Albrecht, A., Holtmeier, N., and Wuthrich, M.: A simple and inexpensive high density dialysis tubing cell culture system for the in vitro production of monoclonal antibodies in high concentration., J. Immunol. Methods 165 (1993), 193-206. 3) Williamson, A.R.: Isoelectric focusing of immunoglobulins. In " Handbook of Experimental Immunology 1, Blackwell scientific Publication Oxford, 1978.
This page intentionally left blank.
PRODUCTION OF ANTI-EGF RECEPTOR hMAB IN HOLLOW FIBER BIOREACTORS FOR IN VIVO DIAGNOSIS.
Arias, M.A., Valdés A., Curbelo D., Morejón O.M., Caballero I., Villán J., Gómez J.A., Fernandéz A., Rodríguez J., Morales A., Boggiano T., Castillo A., Bouzó L., Hermida C., García G., Vitón P., Pérez N., Rodríguez T. Center of Molecular Immunology, P.O.Box 16040, Havana 11600,Cuba. 1. ABSTRACT NSO transfected myeloma producing an anti-EGF receptor humanized MAb was cultivated in hollow fiber bioreactors up to production scale (Acusyst-P3/X). Its production rate and metabolic uptakes were compared with a hybridoma, that secreted the murine variant of this product also produced in hollow fiber. The control strategy of the fermentation is discussed. The purification scheme, mainly based on affinity and ion exchange, was established to obtain a product with a purity higher than 96 %. The freeze dring process was studied to obtain a final reduced product for labeling with for “in vivo” diagnosis. 2. INTRODUCTION The production of an anti-EGF receptor humanized MAb was carried out in the GMP facilities of the Center of Molecular Immunology, which is a Cuban Biotechnology institution devoted to production of proteins from animal cell culture(1). NSO myeloma was transfected to secrete a “reshaped” monoclonal antibody, which recognizes the EGF-receptor (2). It has been demonstrated that this MAb is a very efficient as marker of tumors with high level of anti-EGF receptor (lung, breast, brain, head and neck) (3). 3. RESULTS AND DISCUSSION
417 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 417-419. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
418 3.1 Upstream process
The production process is summarized in Figure. 1. Hollow fiber bioreactors were used to cultivate NSO transfected myeloma up to production scale. The inoculum preparation was done in T flasks and spinners (feed-batch mode) to obtain with viability higher than 90 %, using DMEM/F12 medium plus 5% of FBS. During stationary culture it was demonstrated that the protein production rate increases when the growth rate decreases due to nutrient limitation (4). The protein production rate (PPR) at large scale was stabilize around 280 mg/d (Figure 2). The metabolic profiles don't suggest any limitation in perfusion (Figure 3) and the dissolved oxygen
was kept high enough (data not showed). The PPR could be increased by manipulation of the cell line.
The control strategy for nutrients was designed from kinetic studies in stationary culture (5). It was shown that during the growth phase the glucose concentration had a minimum range between 6 - 7 mM and the lactate concentration has a maximum of 12 mM. Considering the difference between stationary culture and hollow fiber systems, the
main parameters to be controlled during the run were defined as follows. During the growth phase, pH should be 7.2 ; minimum glucose concentration, 8.3 mM and maximum lactate concentration, 11.1 mM. During production phase, pH should be 7.0, minimum glucose concentration, 5.5 mM and maximum lactate concentration, 16.6 mM. The minimum partial pressure of oxygen should be 100 mm Hg during both phases. 3.2 hMAb Purification Process
As it is shown in Figure 4, during anion exchange there are losses of about 20 % of the initial mass, probably due to pH (7,3), which should be 1 unit lower than the isoelectric point of the protein. According to DNA contents of the product, the relation A280/A260
was kept above 1,5 in the different streams after Protein A, implying a low level.
419
3.3 Formulation of freeze-dried product
To enhance the performance and quality during in vivo diagnosis a freeze-dried
formulation is used, which contains the reduced MAb ready for labeling with The reduction process is done by the Schwartz method, Mather modified (3). Then the
product is desalted to nitrogen purged PBS. After that, a reducer agent
is added.
The filled vials are lyophilized to with a first freezing to -45°C, a primary drying to -20°C and a secondary drying to 25°C. The final product is submitted to Quality Control criteria, which is summarized in Table 1. 4. CONCLUSIONS
The process showed produces a freeze-dried formulation of anti-EGF receptor hMAb
with the required quality to be used as an “in vivo” diagnosis drug, in the programmed phase I clinical trial. The production process of this hMAb can be enhanced, mainly during the upstream and purification steps. 5. REFERENCES 1. 2.
3.
Villán J. Et. Al., Strategy for Scale Up of Mammalian Cell Culture in the New GMP Manufacturing Facility of the Cuban Biotechnology Industry. In : Animal Cell Technology. From Vaccines to Genetic Medicine. Proceedings 14th ESACT Meeting. Mateo C., Moreno E., Amour K., Lombardero J., Harris W., Pérez R., (1997). Reshaped of humanized monoclonal antibody to EGF-R with retention of full binding activity. Immunotechnology 3: 71-81
Iznaga N., Morales A., Ducongé J., Caballero I., Fernández E., Gómez J.A., (1998) Pharmacokinetics, biodistribution and dosimetry of anti-human epidermal growth factor receptor humanized monoclonal antibody R3 in rats. Nuclear Medicine & Biology, Vol. 25. (in press).
4. 5.
Boggiano T. (oral communication) Castillo A. J., Fernández A., Boggiano T., (1997), Study of different cell culture conditions for the production of “reshaped” Mab in NSO cells, ESACT Meeting poster.
This page intentionally left blank.
OPTIMISATION OF THE PRODUCTION OF VLP'S IN 2 LT STIRRED BIOREACTORS
P. E. Cruz 1 , A. Cunha 1 , C. C. Peixoto1, J. Clemente 1 , J. L. Moreira1, M.J.T. Carrondo 1,2 1 - IBET/ITQB, Apartado 12, P-2780 Oeiras, Portugal 2 - Laboratório de Engenharia Bioquímica, F. C. T./ U. N. L, P-2825 Monte da Caparica, Portugal
1. Abstract In this work the production of virus like particles (VLP’s) in insect cells was optimised for 2 Lt bioreactors. For this purpose the effects of and hydrodynamic conditions on product quality were evaluated. Although the did not show a significant effect upon cell growth in the range from 10 to 50%, cell infection and specific productivity were dramatically affected. The production was optimal at a of 25% and decreased up to two fold when the decreases to 10 or increases to 50%. The highest VLP titre was obtained at 96 hours post infection (hpi) and at of 25%. The effect of overcritical conditions upon productivity was also studied: cell infection is affected by agitation rates above 270 rpm or by aeration rates higher than 0.04 vvm, with a three fold decrease in VLP titre. 2. Introduction Several strategies have been used to design a safe and efficient vaccine for AIDS including whole inactivated virus (Murphey-Corb et al., 1989), recombinant HIV subunits like gp120 (el-Amad et al., 1995) and genetically engineered virus like particles (Rovinsky et al., 1992). In this work, the insect cell (Spodopter a frugiperda, Sf-9) / baculovirus (AcNPV) system expressing Pr55gag particles was used. The Pr55gag is targeted to the plasma membrane and assembles in 100-120nm particles and therefore this product is extracellular. In order to gel high quality product it is essential to ensure that particle formation is performed correctly, since it has been shown that the titre of antibodies after immunisation with virus like particles is significantly higher than after immunisation with cell lysate or recombinant proteins (Vzorov et al., 1991). The cells were infected at several values and product titre and quality were determined for the hydrodynamic conditions previously optimised for this system (270 rpm and 0.04 vvm). 421
O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 421-427. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
422
Finally, to confirm that these hydrodynamic conditions cannot be overcome, two experiments were performed: one at higher agitation rate and the other at higher aeration rate; the Pr55gag titre obtained was compared with the ones obtained in the optimal conditions. 3. Materials and Methods 3.1 CELL GROWTH AND INFECTION EXPERIMENTS Spodoptera frugiperda Sf-9 insect cells (ECACC no. 89070101), previously adapted to SF900II (Gibco, Glasgow, UK) (Cruz et al, 1997) were maintained in Wheaton stirred vessels (Wheaton, Millville, USA). Cell growth and infection experiments were performed in a fully controlled stirred bioreactor (B. Braun, Melsungen, Germany) inoculated at Cell concentration was determined as previously described (Cruz et al, 1997). Cells were infected with baculovirus that generate Pr55gag particles, provided by Prof. Polly Roy (IVEM, Oxford, UK), in the mid exponential phase of cell growth with a multiplicity of infection (MOI) of 2 pfu/cell. Samples were taken at several times post infection and the supernatant was collected for VLP quality analysis. The effect of upon cell growth and infection was studied at 10, 25 and 50% controlled by the aeration rate up to a maximum of 0.04 vvm. The agitation rate in these experiments was maintained at 270 rpm. To test the effect of overcritical conditions in VLP titre two experiments were conducted: one to test the effect of an overcritical aeration rale (0.06 vvm) and another to test the effect of an overcritical agitation rate (300 rpm); the was maintained at 25% in both cases. 3.2 PR55GAG CONCENTRATION MEASUREMENTS AND QUALITY ANALYSIS Pr55gag was quantified by using the Innotest HIV Antigen Mab (Innogenetics N.V., Zwijndrecht, Belgium), kindly provided by Innogenetics N.V. (Ghent, Belgium). Since this test uses monoclonal antibodies against p24, related polypeptides containing the recognised p24 epitopes will also be detected (e.g. breakdown products of Pr55gag). In order to determine the fraction of Pr55gag in the form of high molecular weight particles the culture supernatant was injected into a gel filtration column (Pharmacia Biotech, Uppsala, Sweden) connected to a FPLC system (Pharmacia Biotech). Phosphate buffer (10 mM pH7.2) was used as running buffer at a flow rate of 0.4 ml/min. The column was calibrated with high and low molecular weight standards (Bio-Rad, Hercules, USA) and the void volume was determined by using blue dextran 2000 (Bio-Rad). Fractions of 1 ml were collected for 1.5 column volumes and the activity was measured using the ELISA test described above. The fraction of product in the form of particles was determined by calculating the ratio between the activity in the high molecular weight fractions (0.9 to 2.4 MD) and the tolal measured activity.
423 4. Results and Discussion 4.1 INFLUENCE OF
IN CELL GROWTH AND INFECTION
Figure 1 shows the results of three cell growth and infection experiments performed at different values: 10, 25 and 50%. In all cases the agitation rate was maintained at 270 rpm and the was controlled by the sparged air flow up to a maximum of 0.04 vvm (the critical values obtained in previous experiments)(data not shown).
As can be observed in Figure 1A, maximum sustainable cell concentration (obtained at 270 rpm, 0.04 vvm sparged air) increased from to as the was lowered from 50 to 10% resulting from an increase in the oxygen supply. As can also be observed, the specific growth rate was the same in all the experiments (0.031 ) which indicates that cell growth is not significantly affected by in this range. In fact, the optimal values reported for cell growth range from 5 to 100, depending on bioreactor size and configuration, culture medium and inlet gas (Schmid, 1996). The optimal dissolved oxygen tension is known to be different for different proteins (Agathos, 1996); to study the influence of upon cell infection, the variation of normalised cell concentration, (the ratio between the cell concentration at a given time and the cell concentration at infection), with time was obtained for 10, 25 and 50% (Figure IB). As can be observed, cell death caused by virus infection is slightly faster for 25% dissolved oxygen than at 10 or 50%. Since the decrease in viability is related with virus infection, higher titres can be expected for the experiment with 25% From these results it can also be concluded that a MOI of 2 is sufficient for synchronous infection, since the cell concentration did not increase after infection. In addition, since the infection is performed in the mid exponential growth phase, higher MOIs would not give significant enhancement of the final product titre (Neutra et al., 1992).
424 4.2 INFLUENCE OF
IN PRODUCT TITRE AND QUALITY
In order to determine if these differences in infection profiles affect the product and particle titre, ELISA and gel filtration chromatography tests were performed with the samples obtained from each experiment (Figure 2).
In terms of total product (Figure 2A) a much higher titre was obtained when
was
maintained at 25%; higher or lower values decreased the maximum titre to half of the one obtained at the optimal Moreover, the specific productivity at 25% was similar to the one found in small
spinner flasks under no oxygen limitation,
indicating that the cells are not affected by the increase in scale (data not shown). The product quality determined by gel filtration chromatography is defined as the percentage of product in the form of high molecular weight particles; this analysis is depicted in
figure 2B for 10, 25 and 50% By applying these percentages to the total titre (Figure 2A) the particle titre could be obtained (Figure 2C). As can be observed from Figure 2C, also the particle titre was larger at 25% than at 10 or 50%. By comparing the results obtained for 10% and 50% it can be observed that, although the total titre
425
was similar in both cases (Figure 2A), the particle titre at 10% was almost twice the one obtained at 50% due to the higher quality achieved at 10% From Figure 2B, it is possible to conclude that the maximum particle titre is not coincident with the maximum quality, i.e. with the maximum particle percentage. While the maximum particle titre was obtained at 96 hpi (Figure 2C) the best quality was obtained at 48 hpi, independently of the value (Figure 2B). In fact, it is at 48 hpi that the cell lysis caused by baculovirus begins (King and Possee, 1992), indicating that there may be some proteolythic degradation starting at that time, resulting in a decrease in the relative amount of particulate material. From these results it is possible to conclude that the harvest time has to be carefully optimised for each product and for each bioreactor size.
In order to study the extent of the influence of conditions slightly more harsh than the ones at which cells are affected, but less stringent than the ones at which cells are killed two experiments were conducted. In the first experiment the agitation rale was
increased to 300 rpm and in the second case the aeration rate was increased to 0.06 vvm. In order to maintain the a the aeration rate had to be decreased to 0.03 vvm in the first experiment and the agitation rate had to be decreased to 200 rpm in the second experiment. Figure 3 represents the particle titre obtained in these two experiments, compared with the results obtained in the optimal conditions.
As can be observed, the small increase in the shear stress caused a dramatic decrease in the case of higher agitation rate (74%) and a similar decrease in the case of higher aeration rate (77%), when compared with the titre obtained in the previously determined optimal conditions. Since in both cases of overcritical conditions neither a change in morphology due to stress nor an abnormal decrease in cell viability were observed it can be concluded that although the stress is below the cell killing threshold it is already
affecting productivity.
426
5. Conclusions
From this work the following conclusions can be drawn: A) The did not show a significant effect upon cell growth in the range from 10% to 50%. Conversely, cell infection and specific productivity were dramatically affected up to a two fold decrease when the decreases to 10 or increase to 50%, the optimal value being 25%. B) The maximum product quality is not coincident with maximum product titre. Although the best quality product was obtained at 48 hpi, independently on the , the highest particle titre was obtained at 96 hpi and at of 25% (according to the gel filtration chromatography and Western immunoblot results).
C) It was demonstrated that cell infection is affected by agitation rates above 270 rpm and by aeration rates higher than 0.04 vvm, even when the overcritical values are still far from the limit at which cell death starts to occur. These results emphasise the importance of working within the limits where the cells are not affected by the environmental conditions, not only in terms of but also in terms of agitation and aeration rate. ACKNOWLEDGMENTS
The authors acknowledge and appreciate the technical support of Ms. Maria do Rosário Clemente, the financial support received from the European Commission (VALUE CE-CTT-535) and Fundação para a Ciência e Tecnologia - Portugal (EUREKA PUEM/C/EU and BD/4545/94) and the partnership with Innogenetics S.A.. REFERENCES
Agathos, S N. (1996) Insect cell bioreactors. Cytotechnol., 20, 173-189. Cruz, P. E., Moreira, J. L., Carrondo, M. J. T. (1997). Insect cell growth evaluation during serum-free adaptation in stirred suspension cultures. Biotechnol. Techniques 11, 117-120. el-Amad, Z., Murthy, K. K., Higgins, K., Cobb, E. K., Haigwood, N. L., Levy, J. A., Steimer, K. S. (1995)
Resistance of chimpanzees immunized with recombinant gp120SF2 to challenge by H1V-ISF2. AIDS 9, 1313-1322. Murphey-Corb, M., Martin, L. N., Davison-Fairburn, B., Monelaro, R. C., Miller, M., West, M., Ohkawa, S., Baskin, G. B., Zhang, J. Y., Putney, S. D., Allison, A. C., Eppstein, D. A. (1989) A formalin-inactivated whole SIV vaccine confers protection in macaques. Science 246, 1293-1297. Neutra, R., Levi, B.-Z., Shoam, Y. (1992) Optimisation of protein production by the baculovirus expression vector system in shake flasks Appl. Microbiol. Biotechnol. 37, 74-78.
Rovinsky, B., Haynes, J. R., Cao, S. X., James, O., Sia, C., Zolla-Pazner, S., Matthews, T. J., Klein, M H.
(1992) Expression and characterization of genetically engineered human immunodeficiency virus-like particles containing modified envelope glycoproteins: implications for development of a cross-protective AIDS vaccine. J. Virol 66, 4003-4012. Schmid, G. (1996) Insect cell cultivation: growth and kinetics. Cytotechnol. 22, 43-56. Vzorov, A. N., Bukrinsky, M. I., Grigoriev, V. B., Tentsov, Y., Bukrinskaya, A. G. (1991) Highly
immunogenic human immunodeficiency virus-like particles are produced by recombinant vaccinia virusinfected cells. AIDS Res. Hum. Retroviruses 7, 29-36.
427
Discussion
Anon:
What evidence do you have for having capsid particles, other than size occlusion? We have had trouble finding capsid particles that are stable when they are non-enveloped from Maloney Leukaemia virus. You could just have a conglomeration of gag proteins. Do you have EM confirmation?
Cruz:
Yes, we have confirmed the presence of particles. However, the particles are not that stable as after 1 month at 4° C there is a considerable reduction.
Bernard:
I am unsure of your strategy for process control after you had set maximal operating parameters - do you have constant agitation and air gassing and on top oxygen supply, or do you vary to these points?
Cruz:
These are limiting points. So we have done experiments both maintaining agitation and aeration rates, whilst the other variables went to the limit, and the results were similar. If you increase the scale to 10 1 the air is not enough, so we use oxygen-enriched gas and in that case we are already working at the limiting conditions.
This page intentionally left blank.
DIRECT CAPTURE OF MONOCLONAL ANTIBODIES WITH A NEW HIGH CAPACITY STREAMLINE SP XL ION EXCHANGER
C. PRIESNER, N. AMESKAMP, D. LÜTKEMEYER, J. LEHMANN Cell Culture Technology, P. O. Box 100131, University of Bielefeld Germany
1. Abstract A new sulphopropyl-based strong cation exchange matrix STREAMLINE®SP XL (Pharmacia Biotech) designed for fluidized bed adsorption was tested in both bench and pilot scale for direct capture of mouse from undiluted and unclarified feedstock containing 500 mg/L human serum albumin (HSA) and 30-50 mg/L MAb. In scouting
experiments in packed bed mode with clarified feedstock the optimal pH for binding of the target protein (pI = 6.3) was found to be 4.6 where co-chromatography of HSA (pI = 4.8) predictably occurred. Frontal adsorption analysis under the same conditions gave enhanced dynamic capacities of more than 6 mg IgG/ml STREAMLINE®SP XL matrix compared to those attainable with conventional STREAMLINE®SP matrix (1.5 mg IgG/ml). These results could not be reproduced in expanded bed mode with unclarified feedstock (0.5 mg IgG/ml matrix) where massive biomass adsorption to the matrix could be observed. By adding glucose in different concentrations to the feedstock and buffers the dynamic capacity increased to 2 mg IgG/mL matrix (200 mM glucose) and 4.5 mg IgG/ml matrix (400 mM glucose), respectively (Table 1). The cochromatography of HSA varied according to the glucose content. In pilot scale no break-through of the antibody could be achieved due to the limiting dynamic capacity.
2. Materials and Methods
2.1. Cultivation Murine hybridoma cells were cultivated in 5-, 20-, and 100-L-bioreactors in split batch
mode using a culture media with 500 mg/L HSA, 10 mg/L bovine insulin and 8 mg/L human transferrin. Except those used in the scouting experiments all feedstocks contained 0.002 % Pluronic F-68® and 0.003 % Antifoam C®. Until the end of each batch the number of viable cells reached up to with a viability higher than 90%. 429 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 429-431. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
430
2.2. Chromatography STREAMLINE®SP and SP XL are strong cation exchangers based on highly crosslinked 6% agarose including an inert quartz core (density 1.2 g/ml, particle size 100 300 m). The sulphonate groups of SP XL are coupled to polydextran spacers to obtain a higher ligand density. Experiments were carried out in packed bed mode with CIO/10 columns / 4 ml adsorbent / FPLC® system, expanded bed mode with a SL®25 column / 75 ml adsorbent / GradiFrac® system (bench scale), and a SL®200 column / 5000 ml adsorbent / pilot system (pilot scale). All chromatographic equipment: Pharmacia Biotech. Buffer A: 20 mM Acetate, 150 mM NaCl, pH 4.6, 0/200/400 mM Glucose; Buffer B: 20 mM Acetate, 1 M NaCl, pH 4.6, 0/200/400 mM Glucose. Equilibration, loading and washing: 300 cm/h, upward flow direction; Elution: 100 cm/h, upward flow direction.
2.3 Analytics Total antibody concentration was measured by ELISA. Particle number and distribution were measured with a Casyl-system (Schärfe) and interpreted according to the definition of Glauner [1].
3. Results
431
4. Summary and conclusion
The new high capacity cation exchange matrix STREAMLINE SP XL has proved its
enhanced capacity compared to STREAMLINE SP. The values for dynamic capacities
for pure substances could not be reached due to the co-chromatography of HSA, other media components, high salt concentration in the feedstock and the biomass adsorption to the matrix. A scale up was successfully performed: 100 L of unclarified hybridoma broth were concentrated with a binding rate of 96 % in less than three hours. Future investigations have to focus on the observed effects of additives as Glucose and surfactants as well as on the cell binding which seems to be the major problem of the expanded bed ion exchange chromatography under the chosen conditions.
5. Acknowledgement
We would like to thank Pharmacia Biotech - especially Dr. P. Girard and Dr. L. Larsson - for kindly supplying the pilot equipment and 5 L of SP XL matrix.
6. References Glauner, B. (1991) Vitalitätskontrolle in der Zellkulturtechnik; BioTec 3(5)
This page intentionally left blank.
THE EFFECT OF DIFFERENT PURIFICATION SCHEMES ON THE ACTIVITY OF A MONOCLONAL ANTIBODY D.J. BLACK 1 , J.P. BARFORD 1 , C. HARBOUR 2 , and A. FLETCHER3
Departments of Chemical Engineering1 and Infectious Diseases1, University of Sydney, NSW 2006 and NSW Blood Transfusion Service3, Sydney, NSW 2000, Australia
Abstract Five different chromatographic purification schemes, encompassing affinity, hydrophobic interaction, cation exchange and gel filtration techniques, were developed and used to purify monoclonal antibody from a common supernatant pool produced by human
lymphoblastoid cells grown in batch culture. Comparison of purified samples revealed that the purification scheme could affect both the antigen binding and functional activities of the purified product. Introduction
Advances in genetic engineering and cell culture technology have made it possible to generate an increasing number of biopharmaceuticals in non-traditional ways. Factor VIII for example, a coagulation factor, can now be derived from mammalian cell cultures rather than the traditional source of pooled human plasma. Many of these biopharmaceuticals are glycoproteins and it is recognised that the post-translational modifications involved in the production of complex biological molecules can differ from species to species and thus result in different product profiles when produced in vitro compared to in vivo. Thus the product is often a complex mixture of different glycoforms which may have different activities. It is possible that the use of different purification systems could preferentially select certain glycoforms resulting in final products with different glycoform compositions and hence activities. In order to address this issue a human monoclonal antibody with both antigen binding (Fab-dependent) and functional (Fc-dependent) activities was selected as the model protein for study. The effects of five different purification schemes on both
these activities have been studied and a preliminary report is presented here. Materials and methods Human monoclonals (IgG) with therapeutic potential (anti-D) were produced from
lymphoblastoid cells (generated by Dr A. Fletcher at the NSW BTS) grown in IMDM medium supplemented with 10% fetal calf serum and 2 mM glutamine. A pooled, single batch which was then aliquoted and stored at -20°C until purified using one of five different
purification schemes shown in the tables, i.e., protein G; protein A; anti-human IgGagarose; two stage hydrophobic interaction chromatography (HiC) and combined HiC, ion exchange (Ion-X) and gel filtration (GF) chromatography. Antigen (Fab-dependent) 433 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 433-435.
© 1998 Kluwer Academic Publishers. Printed in the Netherlands.
434
435
binding activity is presented as the anti-D titre determined by haemagglutination performed according to Whitson (1985). The percentage of active antibody was calculated by subtracting the mean antibody content of supernatant contacted with from the mean content of supernatant contacted with and dividing this figure by the latter and multiplying by 100. The antibody content was determined by IgG ELISA after purified anti-D was mixed with either washed cells and incubated at 37°C for 3 hr. The
suspension was centrifuged at 2000 g for 10 min to pellet red cells. Functional (Fcdependent) binding activity was determined by measuring monocyte-mediated antibody dependent cellular cytotoxicity (ADCC) performed according to Kirkwood et al., (1993). In addition resetting with U937 monocyte-like cells was determined as described by Krumpel and Hadley (1990). The analysis of monosaccharide and sialic acid content was performed as described by Cant et al., (1994). Results and discussion The effects of the different purification schemes on antibody yield and purity are shown in Table 1. The antibody yield was clearly highest using the protein G purification scheme but highest purity was achieved using protein A. The Fab and Fc activities of antibodies generated by different purification schemes are shown in Table 2. It was noted that the
purification scheme did affect the amount of antibody in the final purified product which was bound to antigen. The HiC (2 stage) and combined methods produced the highest Fabdependent activity and the anti-human IgG-agarose the lowest activity. In terms of Fcdependent activity rosetting activity was highest in the anti-human IgG-agarose preparation. The increase in functional activity compared to the raw superantant pool implies that a preferential separation was occurring and this most likely reduced the proportion of aglycosyl (and hence functionally inactive) molecules in the purified product. The effect may have been more subtle however, with more active species being preferentially separated from less active ones. The monosaccharide composition of the purified products was then analysed to determine which of these mechanisms was the most likely. It was concluded that the amount of aglycosyl anti-D present was the main determinant of the overall sugar content and was the most likely explanation for the increase sugar content of the combined HiC/lon X/GF-purified anti-D. This scheme also separated certain sugar species over others generating a product with a lower sialic acid content and appeared the most applicable for production scale applications although its cost would be a disadvantage compared to either protein A or G. In conclusion the purification system did affect the Fab and Fc activities and is clearly an issue which must be addressed in designing a manufacturing process. References Cant, D., et al. (1994) Cytotechnology, 14, 223-228.
Kirkwood, J., et al. (1993) Trans. Med. 3, 269-273. Krumpel, B.M. and Hadley, A.G. (1990) Mol. Immunol. 27 (3) 247-256. Whitson, K.J. (1985) Aust. J. Med. Lab. Sci., 6, 106-109.
This page intentionally left blank.
INTERFACING OF PROTEIN PRODUCT RECOVERY WITH AN INSECT CELL BACULOVIRUS PRODUCTION SYSTEM
I.A. CARMICHAEL, M. AL-RUBEAI AND A. LYDDIATT Biorecovery Group, Centre for Bioprocess Engineering, School of Chemical Engineering, University of Birmingham, Edgbaston, Birmingham B15 2TT, U.K. 1. Abstract Conventional protein recovery requires several unit operations to clarify, concentrate and isolate the product, resulting in high processing costs, extended separation times and reduction in molecular yield. Any foreshortening in this purification process will therefore be beneficial. Interfacing of fluidised bed adsorption with production systems achieves this goal, negating the need for problematic centrifugation and filtration steps. Direct processing of an unclarified insect cell-Baculovirus -galactosidase feedstock with a custom made, fluidisable adsorbent has facilitated successful clarification, 10-fold concentration and purification, and greater than 30% improvement in capture efficiency over conventional purification operations. Keywords: Fluidised Bed, Product Recovery, -galactosidase. 2. Introduction Animal cell culture is commonly used for the production of complex, high-value protein therapeutics, often characterised by extensive post-translational modification. Regulatory approval requires stringent levels of reproducible purity and defined molecular integrity. To achieve such demands, product purification conventionally uses many unit operations to clarify, concentrate and isolate the product. However, this is disadvantaged by high capital, space and time investments1, reduction in yield (due to multistep operations) and concomitant product degradation. Rapid purification would therefore confer benefits of reduced costs and increased product quality. Realisation of this goal has been achieved by replacing centrifugation and microfiltration steps in the purification process with fluidised bed adsorption2. The fluidisable adsorbent employed herein facilitates capture, concentration and purification of product, without the need for centrifugation or filtration of feedstock, which is mandatory for conventional chromatography and contribute to product losses (see Figure 1). 437
O.-W. Merten et al. (eds.). New Developments and New Applications in Animal Cell Technology, 437-439. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
438
3. Materials and Methods SF9 cells were grown in suspension at using TC-100 + 5% FCS. Infection was achieved by resuspension of cells, at late log phase, in fresh media and addition of recombinant Baculovirus lacZ-ACMPV at a multiplicity of infection (m.o.i.) of 10. Protein concentrations were determined by the method of Bradford3, -galactosidase assays were performed using a modification of the method of Miller4. The fluidisable affinity matrix was constructed by CDI activation of Macrosorb-K4AX (Phase Separations Ltd) and sequential derivatisation with 3,3’-iminobis-propylamine (DADPA), glycidol and the affinity ligand p-aminobenzyl-1-thio -Dgalactopyranoside (ABTG)5. The matrix was designated Macrosorb-ABTG. Fixed bed operation involved loading and elution at a linear flow rate of 0.22cm/hr. Desorption was achieved by a step of 0.1 M borate buffer, pH 10, followed by immediate desalting in Sephadex G50. Fluidised bed operation was achieved by recirculation of unclarified feed upwards through a custom-built fluidised contactor (dimensions 20x2.2cm), containing 7mls of Macrosorb K4AX-ABTG, at 600cm/hr. This yielded a bed expansion of 100%. Bound protein was desorbed as in conventional fixed bed mode. 4. Results Macrosorb-ABTG was constructed with the final chemistries of 10 mole/ml DADPA, 13 mole/ml glycidol modified DADPA and 1 mole/ml ligand. As can be seen in Figure 1, lab scale purification involved losses of 27% in steps which serve only to clarify the feedstock for further processing. Fixed bed affinity chromatography achieved a final concentration factor of 20-fold and purification factor of 10-fold. The final specific activity of the product was ~400units/mg protein (data not shown).
Figures 2 and 3 show the loading and elution data for interfaced recovery of product from unclarified culture. 180mls of unclarified insect cell culture was contacted with Macrosorb-ABTG in a fluidised bed. The matrix removed 85% of enzyme activity, conferring a capacity of 2.5 mg enzyme/ml matrix. Figure 3 shows fixed bed desorption of the saturated matrix, yielding a recovery of >90% of total protein, with an overall concentration of 4.5-fold, of which 30% was in a 0.1 M borate pool (pH10) that retained activity upon desalting (specific activity ~700units/mg protein). Elution of Macrosorb-ABTG, in 3M potassium thiocyanate, recovered the remaining protein.
439
5. Conclusions The opportunity for enhancement of the conventional purification process by circumvention of clarification steps is clearly shown in Figure 1. Judicious sizing of the matrix volume allows removal of at least 85% of enzyme activity from unclarified culture. Greater than 90% of total protein can then be recovered in a two stage desorption strategy. The first stage recovers -galactosidase with a purity 40% higher than conventional recovery, achieving an overall purification factor and volume reduction both of ~10 fold, together with clarification of the product stream.
The
remaining bound protein can then be desorbed with 3M KSCN. Although overall recovery of enzyme activity from this system is only ~30%, this is clearly a system specific problem (compare with previous work with yeast and bacteria2,6) concerned with heterogeneous interaction of -galactosidase with the surface chemistries of the Macrosorb-ABTG. In order to increase recovery of activity, (i) manipulation of contact time, (ii) matrix construction and (iii) ligand chemistries are currently under investigation. A logical extension of this work is the use of direct product sequestration (DPS) during fermentation. This will offer the advantages outlined above, coupled with potential to decrease negative feedback of protein synthesis, stabilise product structure and steepen secretion gradients2. 6. References 1) Datar, R., (1986) Process Biochemistry 21 19-26. 2) Morton, P.M. and Lyddiatt, A., (1994) In: Separations for Biotechnology 3. Ed; Pyle, D.L., Elsevier Applied Science pp. 329-325. 3) Bradford, M., (1972) Analytical Biochemistry 72 248-254. 4) Miller, I.M., (1972) In: Experiments in Molecular Genetics, Ed; L. Cold Spring New York, Cold Spring Laboratories pp. 352-355. 5) Hermanson, G.T., Krishna Mallia, A. and Smith, P., (1992) Immobilised Affinity Ligand Techniques. Academic Press Inc, New York. 6) Burns, M.T. and Lyddiatt, A., (1996), Proceedings of the 5th World Congress Of Chemical Engineering 2 633-639. Acknowledgements : IC was funded by a BBSRC quota studentship.
This page intentionally left blank.
PREPARATION OF PLASMID DNA USING DISPLACEMENT CHROMATOGRAPHY
R. FREITAG and S. VOGT Laboratoire de biotechnologie cellulaire Institut de Génie Chimique IV ETH Lausanne Switzerland
1. Introduction Large amounts of pure plasmid DNA are increasingly in demand. Possible areas of application include, of course, gene therapy but also the transient transfection of mammalian cells. The plasmids are routinely produced in E. coli and their recovery from the cell lysates may involve precipitation and extraction operations, -density gradient centrifugation or various adsorption techniques. By these operations numerous E coli proteins, other polynucleotides, the toxic lipopolysaccharides (LPS) stemming from the cell membrane, etc. are removed. While extraction and precipitation are easily scaled, the resulting product is often of insufficient quality. The -density gradient centrifugation yields a highly purified product, but is difficult to use at large scale. Adsorption and especially chromatographic techniques combine scalability with high resolution and thus present a possibility for large scale applications. Concentrated DNA-solutions are viscous, however, thus only diluted fractions may be collected from ordinary gradient elution chromatography, Figure 1. Displacement chromatography (DC) is a littleknown alternative to preparative elution chromatography [1]. In DC the substances are focused into consecutive zones of constant concentration by an advancing displacer front. The displacer may be any substance which shows a superior binding to the stationary phase under operating conditions. The concentration in the zones can be controlled via the displacer concentration and thus be kept in its entirety just below the critical value, Figure 2. The overall concentration in the pooled product fractions 441
O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 441-443. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
442 may thus be considerably higher than in the elution mode, while smaller columns can be used to give the same amount of product due to a more effective use of the column’s capacity [2]. The results are higher throughputs and easier scale up [3]. 2.
Experimental
Plasmid preparation:: Double-stranded plasmid DNA (DH5 , C2007-1, Lot 56682, Clontech Laboratories Palo Alto, USA) was produced in E. coli. Qiagen kits were used for isolation according to the manufacturer’s instructions. The final preparations were free of protein and non-plasmid DNA, but some of the large scale preparations contained residual LPS [4]. Sample preparation for DC: Samples were prepared by spiking pure plasmid DNA preparations with equal amounts of protein (holo-transferrin, Sigma) and/or E. coli LPS (scrotype 026:B6, Lot 46H4024, Sigma). Displacement chromatography: Investigated were a 2 ml Bio-Scale Q2 strong anion exchanger column (7 x 52 mm, porous 10 m beads, Bio-Rad), a 1.3 ml UNO™ Ql continuous bed strong anion exchanger column (7 x 35 mm, Bio-Rad), and two columns (250 x 4 mm) filled with porous, ceramic hydroxyapatit beads (10 m, type I and type II, Bio-Rad). The carrier was a 0.02 M TRIS/HC1 buffer, pH 8.0. A flow rate of 0.1 ml/min was used throughout. Column regeneration was by a high salt step (2 M NaCl). Fractions were collected twice per minute. Analytical methods: Protein concentrations in solution were measured either by the BCA assay (Pierce) according to the manufacturers instruction or by reversed phase chromatography (RPC) as described previously [2]. Plasmid DNA in the DC fractions was quantified as described by Sten et al. [5]. LPS concentrations were measured either by a kinetic LAL assay or by capillary electrophoresis as described previously [4]. 3.
Results
The purification of plasmid DNA from cell lysates involves the removal of proteins, polynucleotides, and lipopolysaccharides. Residual LPS does present a major problem to both gene therapy and transient transfection. Its maximum residual dosis in parenteralia is 0.5 ng/kg of body mass and LPS has also been known to influence the transfection efficiency in eukaryotic cells [6]. The possibility of separating all three substance classes by displacement chromatography was investigated by us. Mass transfer tends to present a problem in plasmid preparation with columns packed from conventional i.e. porous stationary phase particles. The major part of the adsorptive surface in the pores can only be reached by diffusion, a time consuming task for large biopolymers. Evidence has been presented that within the normal time frame of a chromatographic separation the inner pore surface is not at all accessible to the plasmid molecules and adsorption is restricted to the - small - outer surface of the particles [7]. 3.1
CONVENTIONAL STATIONARY PHASES (POROUS PARTICLES)
Displacement chromatography is based on the displacer enforced competition of the feed components for the stationary phase binding sites. If this is not possible, e.g. because the inner article surface is accessible to the proteins but not to the larger DNA molecules or the equally large LPS aggregates, no separation takes place. This was indeed observed by us in the case of the BioScale Q 2 column. Plasmid DNA and LPS aggregates are of equal size
443 and do compete for binding. Their separation is possible, but the zone overlap (shock layer) between the zones is broad, presumably also due to pronounced mass transfer limitations. 3.2
HYDROXYAPATIT
Hydroxyapatit (HA) is a crystalline calciumphosphate modification with known affinity to molecules containing phosphate groups. For HPLC application two types of ceramic porous particles are available. The type II material is advertised for its DNA binding ability. While the DNA binding capacity of the type I material was indeed unsatisfactory, and the corresponding column had to be abandoned, columns packed with the type II HA showed similar problems as the particulate anion exchanger as far as the DNA / protein separation were concerned. A separation of LPS and DNA was not possible at all with the type II material, both substances were found in all fractions at roughly the same concentration ratio. 3.3
CONTINUOUS BED COLUMNS (UNO™ Q COLUMN)
The mass transfer poses a problem to all types of biopolymer chromatography, not only to displacement. Recently, special stationary phases have been introduced that hope to circumvent the problem. The continuous bed UNO™ column by Bio-Rad is investigated here. The UNO column is a polymer rod prepared in situ by radical polymerisation. It consists of a continuous network of polymer nodules with interconnecting channels. Thus the surface is high, while there is no « intraparticle » surface. Band broadening is small even at high flow rates. In the displacement mode the UNO™ Q column behaves as the comparable BioScale Q anion exchanger from the same manufacturer. Displacers designed for the BioScale Q column [8,9] could also be used with the UNO™ Q. The separation between plasmid DNA and LPS aggregates became sharper, although it was still not possible to collect the pure substances. 4.
Conclusions
The isolation of plasmid DNA at larger scale continuous to present a problem to preparative biotechnologists. Given both its scalabilty and its high resolution, chromatographic operations and especially displacement chromatography may well contribute to the final answer to this problem. 5. References [1] [2] [3] [4] [5] [6] [7] [8] [9]
Freitag R.: In: Analytical and Preparative Separation Methods for Biomolecules. H.Y. Aboul-Enein (Ed.) Marcel Dekker, 1998 Kasper C., Vogt S., Breier J., Freitag R. Bioseparation 6 (1996) 247-262 Gerstner J.A. BioPharm 9 (1) (1996), 30-35 Freitag R., Fix M., Brüggemann O.: Analysis of Endotoxins by Capillary Electrophoresis. Electrophoresis (1997), in press Sten R.G., MacDonald C.G., Weaver A.L., Pitt A.M. Bio Techniques 15(5) (1993) 932-933 Weber M., Möller K., Welzeck M., Schorr J. BioTechniques 19(6) (1995) 930940 Schwarz A., Data presented at the PREP´97, Washington DC, June 1 to 4, 1997 Vogt S., Freitag R. J. Chromatogr., 760 (1996) 125-137 Freitag R., Vogt S., Mödler M.: Customised in affinity and solubility - new protein displacers for ion exchange protein displacement chromatography. (submitted)
This page intentionally left blank.
NOVEL METHODS FOR LARGE-SCALE PREPARATION OF NUTRIENT MEDIA AND BUFFERED SALT SOLUTIONS.
David W. Jayme Life Technologies, Inc. 3175 Staley Road, Grand Island, NY 14072 USA
1.
ABSTRACT
Large-scale manufacture of solutions used to feed bioreactors and purify biologicals creates logistical challenges which impact facility footprint, personnel utilization and overall manufacturing cost. In collaboration with large volume users, we have identified novel formulation configurations and reconstitution options for preparation of nutrient media and buffered salt solutions. Some options exploit continuous reconstitution from concentrated intermediates using an automated mixing device. Other options enhance traditional batch reconstitution processes by automatically adjusting pH and osmolality (conductivity) to target ranges in a closed formulation tank or bioreactor. We have also identified hybrid options for campaigned manufacture of similar formulations from common intermediates. These alternatives produce solutions of comparable quality, reduce capital investment in facility and equipment, improve space/time utilization within kitchens, optimize personnel utilization, focus on user core competencies, and reduce the overall cost of biological fluid production.
2.
INTRODUCTION
Traditional approaches to formulate nutrient medium and buffered salt solutions from biochemical constituents or homogeneous powders have been adequate for production requirements of a few thousand liters. Biotechnology industry maturation has escalated required volumes substantially and justified exploration of alternative approaches [1]. 2.1.
The Challenge
Beyond the daunting volumes of batch-scale mammalian cell fermenters ( 10,000 liters) perfusion bioreactor feeding during an extended production campaigns (30-200 days), requiring 1-2 volume exchanges per day, can consume vast quantities of nutrient fluids. A pilot-scale bioreactors (100L) operating over a 30 day campaign will consume 30006000 liters of nutrient medium. By comparison, a production scale bioreactor (1000L) 445 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 445-448. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
446
operating over a 200 day campaign may consume over 400,000 liters. Protein-free supplemental nutrient concentrates, designed to replenish exhausted nutrients in fedbatch mode, have been implemented to reduce medium cost and harvest volume [1-2]. Beyond logistical concerns relating to nutrient medium quantities, downstream product purification typically requires 1-3 times that volume in buffered salt solutions for column equilibration, elution, and regeneration and final product formulation [3]. 2.2.
The Issues
Escalating volumetric demands for nutrient medium or buffer to meet production projections stresses the kitchen facility, equipment and personnel. Balancing capital investment for facility space, formulation and holding tanks, and water systems against risks for a biological undergoing clinical investigation is a challenging task. Various additional factors contribute to the complexity of determining the “preferred” method for preparing large-scale biological fluids: • Technical factors: solubilization time, constituent degradation, endotoxin generation, number and diversity of formulations; • Quality assurance factors: batch-to-batch precision, status of existing facility and equipment, batch-driven testing requirements, project regulatory status; • Human resource factors: recruitment and training, utilization efficiency; • Business factors: storage space, geographic location, distribution logistics, current and projected volumetric scale, accuracy of planning and market projections
3.
THE OPTIONS
Alternatives used or under evaluation by global biotechnology and biopharmaceutical manufacturers for large-scale production of nutrient media and buffers include: 3.1.
Continuous preparation from intermediate concentrates using a mixing device.
Liquid medium or buffer concentrates are purchased in bulk packaging compatible with mixing device connections. A mixing device [4], custom-engineered to user specifications, is resident at the user facility. High precision I X fluid is reconstituted at the user site either in large batches or as a continuous feedstream. Advantages include increased batch size or potential for continuous bioreactor feeding, and reduction in facility footprint, technical labor and overall manufacturing and qualification cost. Considerations include the design and capital cost of the mixing device, requirement for supplemental validation, and maximal benefit derived by commitment to mixing device and concentrate utilization at the design phase. 3.2.
Campaigned production of similar formulations
Campaigning [1] permits manufacture of multiple, similar formulations from a minimal number of common concentrated intermediates, with reconstitution performed either in
447
batch or continuous mode. Examples include growth and perfusion media or column
equilibration, elution and regeneration buffer combinations. Advantages include increased manufacturing flexibility, facilitated inventory management, and more efficient use of kitchen space and formulation/holding tanks. Considerations include the initial design complexity of concentrate sub-groups and formulation-specific limitations. 3.3.
Hybrid of powdered base and liquid concentrated additive
A common example is a complete medium which combines a powdered component with a concentrated liquid supplement of “difficult to solubilize” components. Another option is a “salt-free” concentrated supplement designed to replenish key nutrients which have been metabolically consumed or degraded [1-2]. Advantages include the ability to produce a complex nutrient formulation which may be challenging to solubilize with full potency and biological performance from a single component powder. Bulk powders may be solubilized in a pre-existing kitchen facility. Nutrient replenishment improves bioreactor productivity in terms of space/time utilization and specific product yield. Nutrient supplement composition may vary with bioreactor type and feeding regimen.
3.4.
Batch formulation using either single concentrated component or multiple concentrated sub-groups
The multiple component option formulates IX fluid from 2-5 concentrated sub-groups
[1]. Single component concentrates may be provided in bulk containers with integral filter and recirculation tubing for user dilution [3]. Concentrate formulation accelerates mixing time, personnel utilization, and batch consistency, particularly as reconstitution may be performed in closed vessels without manual adjustment of pH or osmolality (conductivity). Diluting a single component concentrate within a disposable container with an integral filter reduces capital investment in facility and equipment and may be a useful transition strategy pending regulatory agency approval and volumetric scale-up. 3.5.
Internal production vs. out-sourcing
Ready-to-use IX fluids are manufactured per user specification in large batches (1050,000 liters), aseptically dispensed into bulk containers, and released for manufacturing
based on vendor certification. Advantages include forestalling of capital investment in facility, equipment and utilities. Considerations include the aseptic connections to the bioreactor and inventory management based upon consumption rate, batch size and stability and refrigerated storage space. Cost effectiveness will depend upon volumetric requirement and regulatory status and capacity of existing kitchen facility [4]. 4.
SUMMARY
Escalating volume requirements for nutrient media and buffered salt solutions demand novel formulation options to improve quality and consistency, increase batch size,
448 decrease fully-burdened cost and retain manufacturing flexibility. Stable concentrated intermediates have been successfully implemented at pilot and production scales to accelerate media and buffer production time, increase batch size and decrease batchdriven costs, combine with powdered components to improve solubility and performance of complex formulations, replenish consumed nutrients in fed-batch and perfusion bioreactor feeding modes, and facilitate inventory management flexibility. Coupling bulk concentrates with an automated, high precision mixing device provides additional options. Large-volume batches (10-50,000 liters) of liquid medium have been commercially produced from concentrated intermediates using this validated process. Customized mixing devices for continuous reconstitution of concentrated fluids are under active design and qualification for various biotechnology applications.
5.
REFERENCES
1.
Jayme DW, Fike RM, Kubiak JM, Nash CR and Price PJ (1993), "Use of Liquid Medium Concentrates to Enhance Biological Productivity", In Animal Cell Technology: Basic & Applied Aspects. Volume 5, eds. S. Kaminogawa, A. Ametani and S. Hachimura (Kluwer) pp. 215-222.
2.
Jayme D, Kubiak J, Fike R, Rashbaum S, and Smith S (in press), “Costsaving Design and Operational Options for Large-Scale Production of Nutrient Medium and Buffers” (JAACT ‘96 meeting in Yokohama, Japan, September 1996)
3.
Fike R, Kubiak J, Price P and Jayme D, BioPharm (1993) 6(8): 49-54, "Feeding Strategies for Enhanced Hybridoma Productivity: Automated Concentrate Supplementation".
4.
Jayme DW, Kubiak JM, Battistoni, and Cady DJ Cytotechnology (1996) 22: 255-261, “Continuous, High Capacity Reconstitution of Nutrient Media from Concentrated Intermediates.”
LARGE SCALE APPLICATION OF THE SEMLIKI FOREST VIRUS SYSTEM: 5-HT3 RECEPTOR PRODUCTION
H.D. BLASEY, B. BRETHON , R. HOVIUS , K. LUNDSTRÖM , L. REY, H. VOGEL , A.-P. TAIR1 AND A.R. BERNARD Geneva Biomedical Research Institute, 14 Chemin des Aulx, CH 1228 Plan les Ouates, Switzerland EPFL, Lausanne, Switzerland, Institut National des Sciences Appliquées, Toulouse, France, Hoffmann-La Roche, Basel, Switzerland
Abstract After we had applied the Semliki Forest Virus (SFV) expression system to produce large amounts of hCOX-2 in spinners, we succeeded in the first reactor runs with the SFV used and produced the serotonin receptor 5-HT3 in large quantities. We successfully scaled up the SFV technology allowing rapid gene expression at 11.5 litre scale. BHK cells were chosen as host cells for expression. They were grown in a bioreactor, equipped with a Vibromix agitation system providing for mixing and preventing cell aggregation. Medium exchange and subsequent viral infection was followed by a one day expression phase yielding 3 million of serotonin receptors per cell. After the harvest the, receptor protein could be purified in a single step at high yield (50%).
Introduction The Semliki Forest Virus expression system (Liljeström and Garoff, 199la) is a recent system for the expression of heterologous genes in mammalian cells cultures offering distinct advantages over other mammalian systems with respect to expression levels and speed. Co-transfection of in vitro transcribed recombinant and helper RNA into BHK cells leads to the in vivo packaging of only recombinant RNA and the production of infectious, but non replicative, recombinant virus particles at high titer (approximately This virus can infect most mammalian, insect and amphibian cells.. On the other hand, the ability of the virus to infect almost any eukaryotic cell raises a biological safety issue. These concerns however have been met by the production of recombinant virus particles which are only conditionally infectious due to three mutations in the pSFV-Helper2 plasmid (Berglund et al, 1993). Various recombinant proteins (enzymes, receptors, viral proteins and others) have been expressed with the SFV system (reviewed by Bernard and Blasey, in press). Table 1 449 O.-W. Merten et al. (eds.), New Developments and New Applications in Animal Cell Technology, 449-455. © 1998 Kluwer Academic Publishers. Printed in the Netherlands.
450 summarises one specific class of proteins, the receptors, which in addition to the 5-HT3
receptor were expressed with SFV.
Recently we have applied the SFV technology to the expression of human cyclooxygenase-2 in spinners and produced this enzyme at the one litre scale (Blasey et
al., 1997). Already at this scale we could satisfy the demand for large amounts of active cytosolic recombinant protein preparations to run high-throughput compound screens. The 5-HT3 receptor has become of great interest as an object for functional and structural studies due to its important role as a drug target. The serotonin receptor is a ligand-gated cation channel and belongs to the group of nicotinic acetylcholine receptors
which are involved in several CNS disorders and for which drugs are on the market (e.g. against emesis induced by chemotherapy). In order to enable structural studies of the 5HT3 receptor we scaled up receptor expression. To achieve the goal of producing between 10-20mg receptor protein, we had to demonstrate satisfactory protein production at the scale of 11.5 litres using a mechanically mixed bioreactor, and thus showing for the first time the feasibility of using the SFV expression system at large scale.
Materials and methods
Medium, cell maintenance and glucose/ lactate analysis were reported earlier (Blasey et al., 1997). The plasmids pSFV3-LacZ, pSFVHelper-2 have been described elsewhere (Liljestrom and Garoff, 1991; Berglund et al., 1993). The pSFVl-5HT3 plasmid has been described earlier by Werner et al. (1994). However, to facilitate purification, an inframe hexa-histidine tag was introduced at the C-terminus of the 5-HT3 receptor by PCR technique. The amplified 5-HT3 receptor gene was then subcloned into the BAM HI site of the pSFVl vector. Generation of recombinant 5-HT3 SFV. In-vitro RNA transcripts were made from pSFVl-5-HT3 and pSFV Helper plasmids (Lundström et al., 1994) and the RNA products were co-electroporated into BHK cells according to Liljeström and Garoff (1991b). The in-vivo packaging of virus particles was completed 24 hours after
451 clectroporation, virus stocks collected and stored at -80° C after eliminating cell debris by centrifugation (5 min at 200g). Activation of virus stocks generated with pSFV-Helper2 was done with Chymotrypsin
followed by enzyme inactivation with Aprotinin. The virus titre estimation was described earlier (Lundström et al., 1994). 5-HT3 receptor characterisation: The and total binding were determined by binding of [3H]-GR65630 in absence or presence of the 5-HT3 antagonist quipazine. Assays were done in duplicates.
Results and Discussion
After we had found that 5-HT3 receptor expression was highest in BHK (amongst a variety of 10 cell lines, Fig. 1) we had selected BHK cells as host for the production of
5-HT3 receptors. Also, BHK cells are widely used to express a large variety of different recombinant proteins.
Large scale production was carried out in a mechanical mi